About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Tacrolimus
- Company
- University of Alberta
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 254 recruiting
Efficacy results: Not yet reported
254 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 16, 2026
Find a Clinical Trial Near Me
See recruiting studies for Tacrolimus and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT00920972
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
Not yet reported, Not yet reported Washington University School of Medicine 220 participants Est. completion 2031-12 28 sites Stand-aloneOther conditions: Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies, Non-malignant DisordersView official trial listing → -
Recruiting NCT NCT01241864
Islet Transplantation in Type 1 Diabetic Kidney Allograft
Not yet reported University of Chicago 10 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Recruiting NCT NCT01459107
Human Upper Extremity Allotransplantation
Not yet reported Johns Hopkins University 30 participants Est. completion 2036-06-30 1 site Stand-aloneOther conditions: Amputation, Traumatic, Wounds and Injuries, Hand InjuriesView official trial listing → -
Recruiting NCT NCT01630850
Islet Transplantation in Patients With "Brittle" Type I Diabetes
Not yet reported University of Chicago 20 participants Est. completion 2030-06 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Recruiting NCT NCT01706692
Swiss Dermatology Network of Targeted Therapies (SDNTT)
Swiss Dermatology Network for Targeted Therapies 1121 participants Est. completion 2032-03-15 6 sitesOther conditions: PsoriasisView official trial listing → -
Recruiting NCT NCT01804634
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60 participants Est. completion 2030-01 3 sites Stand-aloneOther conditions: Refractory and/or Relapsed Metastatic Solid TumorsView official trial listing → -
Recruiting NCT NCT01848028
PsoBest - The German Psoriasis Registry
Universitätsklinikum Hamburg-Eppendorf 3500 participants Est. completion 2032-12 1 siteOther conditions: Psoriasis, Psoriatic-arthritisView official trial listing → -
Recruiting NCT NCT01861106
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
Not yet reported National Cancer Institute (NCI) 144 participants Est. completion 2028-12-31 1 siteOther conditions: GATA2, Immunodeficiency, MDSView official trial listing → -
Recruiting NCT NCT01889381
Human Craniomaxillofacial Allotransplantation
Not yet reported Johns Hopkins University 15 participants Est. completion 2041-08 1 site Stand-aloneOther conditions: Facial Injuries, Traumatic Wounds and Injuries, Craniofacial Injuries, Craniofacial Defects, Facial Transplantation, Facial DeformityView official trial listing → -
Recruiting NCT NCT02029001
Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment
Not yet reported Centre Leon Berard 900 participants Est. completion 2028-10 7 sitesOther conditions: Malignant Solid NeoplasmsView official trial listing → -
Recruiting NCT NCT02042326
Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
Not yet reported Centre Hospitalier Universitaire, Amiens 50 participants Est. completion 2027-09 13 sites Stand-aloneOther conditions: Arteriovenous MalformationsView official trial listing → -
Recruiting NCT NCT02395497
Human Penile Allotransplantation
Not yet reported, Not yet reported Johns Hopkins University 60 participants Est. completion 2039-06 1 site Stand-aloneOther conditions: Amputation, Wounds and Injuries, Amputation, Traumatic, Urologic Surgical Procedures, Male, Amputation, Traumatic/Surgery, Penis/Transplantation, Penis/Surgery, Penis/Injuries, Congenital Anomaly, Male GenitaliaView official trial listing → -
Recruiting NCT NCT02432560
Safety and Durability of Sirolimus for Treatment of LAM
University of Cincinnati 600 participants Est. completion 2025-07-31 20 sitesOther conditions: LymphangioleiomyomatosisView official trial listing → -
Recruiting NCT NCT02446431
Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence
Not yet reported Miller Children's & Women's Hospital Long Beach 20 participants Est. completion 2029-07 2 sites Stand-aloneOther conditions: Solid TumorView official trial listing → -
Recruiting NCT NCT02846571
Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye
Not yet reported, Not yet reported Midhat H. Abdulreda 2 participants Est. completion 2027-12-31 2 sitesOther conditions: DiabetesView official trial listing → -
Recruiting NCT NCT03097185
Analysis of Graft Function Following Autologous Islet Transplantation
Baylor Research Institute 100 participants Est. completion 2026-12 1 siteOther conditions: Chronic PancreatitisView official trial listing → -
Recruiting NCT NCT03128996
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Not yet reported, Not yet reported Washington University School of Medicine 29 participants Est. completion 2033-04 4 sites Stand-aloneOther conditions: Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders, Immunologic Disorders, Hemoglobinopathies, Non-malignant DisordersView official trial listing → -
Recruiting NCT NCT03178149
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
Not yet reported Astellas Institute for Regenerative Medicine 42 participants Est. completion 2027-12-31 20 sites Stand-aloneOther conditions: Age-Related Macular DegenerationView official trial listing → -
Recruiting NCT NCT03214354
Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor
Not yet reported University of Calgary 12 participants Est. completion 2028-07 1 site Stand-aloneOther conditions: Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder, Pure Red Cell AplasiaView official trial listing → -
Recruiting NCT NCT03243019
Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations
Not yet reported University Hospital, Lille 28 participants Est. completion 2027-02 2 sites Stand-aloneOther conditions: Lymphatic Malformation, PediatricView official trial listing → -
Recruiting NCT NCT03297606
Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)
Not yet reported Canadian Cancer Trials Group 720 participants Est. completion 2027-01-31 10 sitesOther conditions: Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid TumorsView official trial listing → -
Recruiting NCT NCT03314974
Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders
Not yet reported Masonic Cancer Center, University of Minnesota 300 participants Est. completion 2028-06-10 1 site Stand-aloneOther conditions: Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Lymphoma, Chronic Myelogenous Leukemia, Plasma Cell Leukemia, Myeloproliferative Neoplasms, Myelofibrosis, Myelodysplasia, Refractory Anemia, High Risk Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Marginal Zone B-Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Leukemia, Diffuse Large Cell Non Hodgkins Lymphoma, Lymphoblastic Lymphoma, Burkitt Lymphoma, High Grade Non-Hodgkin's Lymphoma, Adult, Multiple Myeloma, Juvenile Myelomonocytic Leukemia, Biphenotypic/Undifferentiated/Prolymphocytic Leukemias, MRD Positive Leukemia, Natural Killer Cell Malignancies, Acquired Bone Marrow Failure SyndromesView official trial listing → -
Recruiting NCT NCT03321656
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
Not yet reported, Not yet reported Roberto Gedaly 78 participants Est. completion 2027-03-31 1 siteOther conditions: End Stage Renal DiseaseView official trial listing → -
Recruiting NCT NCT03414502
Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response
Not yet reported University of Nebraska 400 participants Est. completion 2029-03 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Recruiting NCT NCT03443999
S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System
Sahajanand Medical Technologies Limited 10000 participants Est. completion 2027-12 7 sitesCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT03481881
Pharmacokinetics of Drugs Administered to Children
Duke University 200 participants Est. completion 2033-08-14 1 siteOther conditions: Pediatric ALLView official trial listing → -
Recruiting NCT NCT03500731
Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure
Not yet reported, Not yet reported Paul Szabolcs 8 participants Est. completion 2028-12 2 sites Stand-aloneOther conditions: Idiopathic Pulmonary Fibrosis, Emphysema or COPDView official trial listing → -
Recruiting NCT NCT03587272
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
Not yet reported Robert Nickel 100 participants Est. completion 2030-11 7 sites Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Recruiting NCT NCT03670966
211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
Not yet reported, Not yet reported Fred Hutchinson Cancer Center 30 participants Est. completion 2029-10-20 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome With Excess Blasts, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Refractory Mixed Phenotype Acute Leukemia, Hematopoietic and Lymphoid Cell NeoplasmView official trial listing → -
Recruiting NCT NCT03746769
Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes
Not yet reported, Not yet reported City of Hope Medical Center 20 participants Est. completion 2028-08-01 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Recruiting NCT NCT03769298
CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients
Not yet reported, Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2027-12 1 site Stand-aloneOther conditions: Kidney Pancreas TransplantationView official trial listing → -
Recruiting NCT NCT03827876
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
Not yet reported Psoriasis Treatment Center of Central New Jersey 30 participants Est. completion 2019-12-15 1 siteOther conditions: PsoriasisView official trial listing → -
Recruiting NCT NCT03839862
Faecal Analyses in Spondyloarthritis Therapy
Region Skane 50 participants Est. completion 2026-12-31 1 siteOther conditions: Spondyloarthropathies, Ankylosing SpondylitisView official trial listing → -
Recruiting NCT NCT03952637
A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis
Not yet reported, Not yet reported National Human Genome Research Institute (NHGRI) 54 participants Est. completion 2030-01-01 1 site Stand-aloneOther conditions: Lysosomal Diseases, Gangliosidosis, GM1View official trial listing → -
Recruiting NCT NCT03955172
Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection
Not yet reported Hospices Civils de Lyon 20 participants Est. completion 2027-12-03 1 site Stand-aloneOther conditions: Kidney Transplant Failure and RejectionView official trial listing → -
Recruiting NCT NCT03970096
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Not yet reported Fred Hutchinson Cancer Center 120 participants Est. completion 2030-12-31 3 sites Stand-aloneOther conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative NeoplasmView official trial listing → -
Recruiting NCT NCT03976245
Advanced Therapeutics in Rheumatoid Arthritis (RA)
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 144 participants Est. completion 2025-03 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Recruiting NCT NCT04022239
Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
Not yet reported, Not yet reported M.D. Anderson Cancer Center 25 participants Est. completion 2027-07-31 1 site Stand-aloneOther conditions: Hematopoietic and Lymphoid System NeoplasmView official trial listing → -
Recruiting NCT NCT04022616
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
Ohio State University Comprehensive Cancer Center 99 participants Est. completion 2027-12-31 1 siteOther conditions: Breast CancerView official trial listing → -
Recruiting NCT NCT04083183
Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases
Not yet reported, Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2028-01-09 1 site Stand-aloneOther conditions: Non-Malignant NeoplasmView official trial listing → -
Recruiting NCT NCT04182984
TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study
Tang-Du Hospital 200 participants Est. completion 2026-06-30 1 siteOther conditions: Ocular Myasthenia GravisView official trial listing → -
Recruiting NCT NCT04187105
BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)
Not yet reported University of Illinois Chicago 27 participants Est. completion 2026-12 1 siteOther conditions: Acute Leukemia, MDSView official trial listing → -
Recruiting NCT NCT04199026
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
Not yet reported M.D. Anderson Cancer Center 20 participants Est. completion 2028-12-31 1 siteOther conditions: Metastatic Sarcoma, Recurrent Sarcoma, Resectable SarcomaView official trial listing → -
Recruiting NCT NCT04232085
Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure, Short Telomere Length, Fanconi Anemia, Non Fanconi DNA-DSB Repair Disorder, Hoyeraal-Hreidarsson Syndrome, Dyskeratosis Congenita, Telomere Biology Disorder, Short Telomere SyndromeView official trial listing → -
Recruiting NCT NCT04302870
Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial
Not yet reported, Not yet reported University of Edinburgh 1150 participants Est. completion 2030-12 22 sites Stand-aloneOther conditions: Motor Neuron Disease, Amyotrophic Lateral SclerosisView official trial listing → -
Recruiting NCT NCT04314219
Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients
Not yet reported King Faisal Specialist Hospital & Research Center 264 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid Leukemia (AML) in RemissionView official trial listing → -
Recruiting NCT NCT04339777
Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity
Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2032-11-30 1 siteOther conditions: Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases, Common Variable Immunodeficiency, Primary T-cell Immunodeficiency DisordersView official trial listing → -
Recruiting NCT NCT04370301
Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis
Not yet reported Fred Hutchinson Cancer Center 20 participants Est. completion 2029-08-31 1 site Stand-aloneOther conditions: Primary Myelofibrosis, Secondary MyelofibrosisView official trial listing → -
Recruiting NCT NCT04380740
Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis
Not yet reported Boston Children's Hospital 160 participants Est. completion 2028-06 15 sites Stand-aloneOther conditions: Graft Vs Host DiseaseView official trial listing → -
Recruiting NCT NCT04469842
Early Use of Long-acting Tacrolimus in Lung Transplant Recipients
Not yet reported Vanderbilt University Medical Center 48 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Lung Transplant; ComplicationsView official trial listing → -
Recruiting NCT NCT04477629
Belatacept in De Novo Heart Transplantation
Not yet reported NYU Langone Health 12 participants Est. completion 2026-09 2 sites Stand-aloneOther conditions: Heart TransplantationView official trial listing → -
Recruiting NCT NCT04496479
Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes
Not yet reported LyGenesis, Inc. 12 participants Est. completion 2027-12-30 2 sites Stand-aloneOther conditions: End Stage Liver DiseaseView official trial listing → -
Recruiting NCT NCT04526431
Tacrolimus Pharmacokinetic Subpopulations
University Hospital, Grenoble 180 participants Est. completion 2027-08-01 2 sitesOther conditions: Kidney Transplant Failure and Rejection, Immunosuppression-related Infectious DiseaseView official trial listing → -
Recruiting NCT NCT04629586
The T1D Exchange Registry
T1D Exchange, United States 50000 participants Est. completion 2030-12-31 1 siteOther conditions: Diabetes Mellitus, Type 1, Diabetes, Type 1 Diabetes, Diabetes MellitusView official trial listing → -
Recruiting NCT NCT04644016
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
Not yet reported Memorial Sloan Kettering Cancer Center 31 participants Est. completion 2026-12-20 1 site Stand-aloneOther conditions: AML, ALL, MDS, MPD Withou Myelofibrosis, NHL or HL, Inherited Metabolic Disorders, Hemoglobinopathies, Bone Marrow Failure, HLHView official trial listing → -
Recruiting NCT NCT04665739
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
Not yet reported National Cancer Institute (NCI) 70 participants Est. completion 2032-09-01 29 sitesOther conditions: Advanced Lung Neuroendocrine Tumor, Functioning Lung Neuroendocrine Tumor, Locally Advanced Lung Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm, Lung Neuroendocrine Tumor G1, Lung Neuroendocrine Tumor G2, Metastatic Lung Neuroendocrine Neoplasm, Metastatic Lung Neuroendocrine Tumor, Non-Functioning Lung Neuroendocrine Tumor, Recurrent Lung Neuroendocrine Neoplasm, Unresectable Lung Neuroendocrine Neoplasm, Unresectable Lung Neuroendocrine TumorView official trial listing → -
Recruiting NCT NCT04679740
Resorbable Magnesium Scaffolds Registry
Biotronik AG 1106 participants Est. completion 2030-05 13 sitesCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT04802759
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
Not yet reported, Not yet reported Hoffmann-La Roche 316 participants Est. completion 2029-05-30 32 sitesOther conditions: Inoperable, Locally Advanced or Metastatic, ER-positive Breast CancerView official trial listing → -
Recruiting NCT NCT04871607
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
Not yet reported City of Hope Medical Center 33 participants Est. completion 2029-10-02 1 site Stand-aloneOther conditions: Recurrent Hodgkin Lymphoma, Refractory Hodgkin LymphomaView official trial listing → -
Recruiting NCT NCT04877288
A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
Not yet reported Bristol-Myers Squibb 102 participants Est. completion 2034-06-30 38 sites Stand-aloneOther conditions: Renal Allograft RecipientsView official trial listing → -
Recruiting NCT NCT04888741
Methods of T Cell Depletion Trial (MoTD)
Not yet reported University of Birmingham 400 participants Est. completion 2027-08-23 17 sites Stand-aloneOther conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Chronic Myelogenous Leukemia, MyelofibrosisView official trial listing → -
Recruiting NCT NCT04923191
The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent
Not yet reported National University of Ireland, Galway, Ireland 2540 participants Est. completion 2029-01 19 sitesCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT04936854
Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease
Not yet reported Haukeland University Hospital 60 participants Est. completion 2028-12 1 siteOther conditions: Thyroid-Associated OphthalmopathyView official trial listing → -
Recruiting NCT NCT04948749
Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial
Not yet reported Beijing Tiantan Hospital 358 participants Est. completion 2027-12 18 sites Stand-aloneCardiovascular disease Other conditions: ICAD - Intracranial Atherosclerotic Disease, ICAS - Intracranial Atherosclerosis, Drug-eluting Stent, Drug Eluting Stents (DES), Medical TreatmentView official trial listing → -
Recruiting NCT NCT04959175
Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies
Not yet reported, Not yet reported National Cancer Institute (NCI) 320 participants Est. completion 2027-04-30 2 sites Stand-aloneOther conditions: Hematologic NeoplasmsView official trial listing → -
Recruiting NCT NCT04988685
SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters
Luzerner Kantonsspital 2000 participants Est. completion 2031-12-31 1 siteCardiovascular disease Other conditions: Coronary Disease, Coronary Restenosis, Coronary Arteriosclerosis, Coronary Artery Calcification, Stable Chronic Angina, Angina Pectoris, Angina, Stable, Angina, Unstable, Stent ThrombosisView official trial listing → -
Recruiting NCT NCT04989491
Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft
Not yet reported University Hospital, Strasbourg, France 120 participants Est. completion 2029-12-01 1 siteOther conditions: Epstein-Barr Virus InfectionsView official trial listing → -
Recruiting NCT NCT05009992
Combination Therapy for the Treatment of Diffuse Midline Gliomas
Not yet reported University of California, San Francisco 360 participants Est. completion 2029-06-30 32 sitesOther conditions: Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent Diffuse Intrinsic Pontine Glioma, Recurrent Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent WHO Grade III Glioma, WHO Grade III GliomaView official trial listing → -
Recruiting NCT NCT05027945
A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome
Not yet reported National Cancer Institute (NCI) 54 participants Est. completion 2031-07-01 1 site Stand-aloneOther conditions: Immunodeficiency, Hematopoietic Stem Cell TransplantationView official trial listing → -
Recruiting NCT NCT05031897
Two Step Haplo With Radiation Conditioning
Not yet reported Thomas Jefferson University 63 participants Est. completion 2032-04 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult T-Cell Leukemia/Lymphoma, Aplastic Anemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Essential Thrombocythemia, Hematopoietic and Lymphatic System Neoplasm, Hodgkin Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Myelofibrosis, Myeloid Neoplasm, Non-Hodgkin Lymphoma, Polycythemia Vera, Small Lymphocytic LymphomaView official trial listing → -
Recruiting NCT NCT05089604
Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations
Not yet reported University of British Columbia 124 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Liver Transplantation, Immunosuppression, Neurotoxicity, Tremor, TacrolimusView official trial listing → -
Recruiting NCT NCT05105152
PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML
Not yet reported Seattle Children's Hospital 18 participants Est. completion 2041-01-31 1 siteOther conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in RelapseView official trial listing → -
Recruiting NCT NCT05116072
Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula
Not yet reported, Not yet reported University Hospital, Lille 36 participants Est. completion 2030-02-20 1 siteOther conditions: Adenocarcinoma of the Pancreas, Adenocarcinoma of the Duodenum, Ampullary AdenocarcinomaView official trial listing → -
Recruiting NCT NCT05126849
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression
Not yet reported Assistance Publique - Hôpitaux de Paris 31 participants Est. completion 2027-01-06 35 sites Stand-aloneOther conditions: Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell TransplantationView official trial listing → -
Recruiting NCT NCT05144698
RAPA-201 Therapy of Solid Tumors
Not yet reported, Not yet reported Rapa Therapeutics LLC 37 participants Est. completion 2026-12-31 1 siteOther conditions: Solid Tumor, Small Cell and Non-small Cell Lung Cancer, Head and Neck Cancer, Squamous Cell Carcinoma of Oral Cavity, Squamous Cell Carcinoma of Larynx, Squamous Cell Carcinoma of Nasopharynx, Squamous Cell Carcinoma of Other Specified Sites of Skin, Malignant Melanoma, Esophageal Squamous Cell CarcinomaView official trial listing → -
Recruiting NCT NCT05242315
Extended-Release Tacrolimus Following Liver Transplantation
Not yet reported University of Alberta 94 participants Est. completion 2034-02-15 1 siteMetabolic syndromeCardiovascular disease Other conditions: Liver Transplant; Complications, Renal Insufficiency, Immunosuppressant Adverse ReactionView official trial listing → -
Recruiting NCT NCT05252754
Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis
Not yet reported Johns Hopkins University 4874 participants Est. completion 2026-12 5 sites Stand-aloneOther conditions: Post-ERCP Acute PancreatitisView official trial listing → -
Recruiting NCT NCT05305066
Stand UP to Rheumatoid Arthritis (SUPRA)
Not yet reported Marie Hudson, MD 75 participants Est. completion 2030-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Recruiting NCT NCT05327023
Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies
Not yet reported, Not yet reported National Cancer Institute (NCI) 430 participants Est. completion 2029-07-02 1 site Stand-aloneOther conditions: Hematologic NeoplasmsView official trial listing → -
Recruiting NCT NCT05356104
GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)
Not yet reported Chinese University of Hong Kong 110 participants Est. completion 2027-12 2 sitesOther conditions: Cerebral Small Vessel DiseaseView official trial listing → -
Recruiting NCT NCT05365672
Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation
Not yet reported TolerogenixX GmbH 126 participants Est. completion 2028-12 8 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Recruiting NCT NCT05385432
Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies
Not yet reported University Hospital, Tours 244 participants Est. completion 2030-12-30 1 site Stand-aloneOther conditions: Renal Transplant Rejection, Induction TherapyView official trial listing → -
Recruiting NCT NCT05426252
Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia
Not yet reported, Not yet reported The Hospital for Sick Children 20 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Thalassemia in ChildrenView official trial listing → -
Recruiting NCT NCT05476939
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 433 participants Est. completion 2031-09 56 sitesOther conditions: Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Midline Glioma, H3K27-alteredView official trial listing → -
Recruiting NCT NCT05482789
Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
Not yet reported Maisa N. Feghali, MD 13 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Gestational DiabetesView official trial listing → -
Recruiting NCT NCT05525507
Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants
Not yet reported University of California, Los Angeles 10 participants Est. completion 2026-12 1 site Stand-aloneChronic kidney disease Other conditions: End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and RejectionView official trial listing → -
Recruiting NCT NCT05549167
Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA)
Not yet reported Federal Research Institute of Pediatric Hematology, Oncology and Immunology 117 participants Est. completion 2029-12-30 1 site Stand-aloneOther conditions: Juvenile Nasopharyngeal AngiofibromaView official trial listing → -
Recruiting NCT NCT05562869
Belatacept as a Replacement for CNIs 3 to 12 Months Post-transplantation in Patients With Early Graft Dysfunction
Not yet reported Nantes University Hospital 30 participants Est. completion 2027-05-03 1 site Stand-aloneOther conditions: Chronic Kidney FailureView official trial listing → -
Recruiting NCT NCT05627960
First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies
Not yet reported A&G Pharmaceutical Inc. 77 participants Est. completion 2026-11 1 siteOther conditions: Triple Negative Breast Cancer, Hormone-Resistant Breast Cancer, Non Small Cell Lung Cancer, MesotheliomaView official trial listing → -
Recruiting NCT NCT05646992
Uterus Transplantation to Treat Infertility
Not yet reported, Not yet reported Johns Hopkins University 40 participants Est. completion 2043-02-28 1 site Stand-aloneOther conditions: Uterine Factor InfertilityView official trial listing → -
Recruiting NCT NCT05650411
Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)
Not yet reported IGLESIAS Juan Fernando 828 participants Est. completion 2032-05-01 1 site Stand-aloneOther conditions: Left Main Coronary Artery StenosisView official trial listing → -
Recruiting NCT NCT05662189
Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus
Not yet reported Azienda Ospedaliero-Universitaria di Parma 70 participants Est. completion 2025-12 1 siteOther conditions: Type1diabetes, Type2diabetes, Pre Diabetes, HyperinsulinismView official trial listing → -
Recruiting NCT NCT05663515
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
AstraZeneca 24000 participants Est. completion 2026-10-01 8 sitesOther conditions: Pancreatic CancerView official trial listing → -
Recruiting NCT NCT05692882
A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China
Not yet reported Sino Medical Sciences Technology Inc. 1000 participants Est. completion 2029-12-30 5 sites Stand-aloneOther conditions: Intracranial Arteriosclerosis, Stenosis Artery, Drug-Eluting Stents, Intracranial Artery StenosisView official trial listing → -
Recruiting NCT NCT05726305
Transplantation of Uterus for Uterine infertiLIty From Living Donor or Deceased Donor
Not yet reported Rennes University Hospital 16 participants Est. completion 2037-12 1 site Stand-aloneOther conditions: Uterine Factor InfertilityView official trial listing → -
Recruiting NCT NCT05736419
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Not yet reported Memorial Sloan Kettering Cancer Center 24 participants Est. completion 2027-02-09 6 sites Stand-aloneOther conditions: Sickle Cell Disease, Thalassemia, Beta, ThalassemiaView official trial listing → -
Recruiting NCT NCT05773274
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
Not yet reported National Cancer Institute (NCI) 100 participants Est. completion 2029-04-30 43 sitesOther conditions: Metastatic Digestive System Neuroendocrine Tumor G1, Metastatic Digestive System Neuroendocrine Tumor G2, Unresectable Digestive System Neuroendocrine Tumor G1, Unresectable Digestive System Neuroendocrine Tumor G2View official trial listing → -
Recruiting NCT NCT05807932
Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML
Not yet reported, Not yet reported Heinrich-Heine University, Duesseldorf 38 participants Est. completion 2029-04-30 6 sites Stand-aloneOther conditions: Myelodysplastic Syndromes, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic LeukemiaView official trial listing → -
Recruiting NCT NCT05908331
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
Not yet reported Concept Medical Inc. 492 participants Est. completion 2028-07 28 sites Stand-aloneCardiovascular disease Other conditions: In-Stent RestenosisView official trial listing → -
Recruiting NCT NCT05917522
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 800 participants Est. completion 2029-07 15 sites Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Recruiting NCT NCT05918302
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
Not yet reported Grupo Espanol de Tumores Neuroendocrinos 170 participants Est. completion 2029-10 27 sitesOther conditions: Neuroendocrine Tumors, Lung Neuroendocrine Neoplasm, Thymus NeoplasmsView official trial listing → -
Recruiting NCT NCT05925023
Sirolimus in the Treatment of Refractory/Relapsed wAIHA
Not yet reported Peking Union Medical College Hospital 22 participants Est. completion 2025-12 1 site Stand-aloneOther conditions: Warm Autoimmune Hemolytic AnemiaView official trial listing → -
Recruiting NCT NCT05933395
Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
Not yet reported Dartmouth-Hitchcock Medical Center 135 participants Est. completion 2031-10 1 siteOther conditions: Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT05949541
Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer
Not yet reported Fudan University 265 participants Est. completion 2028-01 1 siteOther conditions: Breast Cancer, Advanced Breast CancerView official trial listing → -
Recruiting NCT NCT05983107
Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer
Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102 participants Est. completion 2027-07-15 1 siteOther conditions: HR+/HER2- Advanced Breast Cancer, Targeted TherapyView official trial listing → -
Recruiting NCT NCT05998759
Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia
Not yet reported Beijing Hospital 296 participants Est. completion 2025-12 23 sites Stand-aloneOther conditions: Connective Tissue Diseases, ThrombocytopeniaView official trial listing → -
Recruiting NCT NCT06011889
Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome
Not yet reported, Not yet reported National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland 60 participants Est. completion 2028-10-18 1 site Stand-aloneOther conditions: SAPHO SyndromeView official trial listing → -
Recruiting NCT NCT06018766
LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.
Not yet reported Steven Hays, MD 30 participants Est. completion 2026-12 1 siteOther conditions: Bronchiolitis Obliterans Syndrome, Chronic Lung Allograft Dysfunction, Lung TransplantationView official trial listing → -
Recruiting NCT NCT06033196
Tocilizumab in Lung Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 100 participants Est. completion 2029-01-08 21 sites Stand-aloneOther conditions: Lung TransplantView official trial listing → -
Recruiting NCT NCT06055608
Advancing Transplantation Outcomes in Children
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 200 participants Est. completion 2028-06-30 21 sites Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Recruiting NCT NCT06066450
Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis
Genoss Co., Ltd. 1000 participants Est. completion 2026-12-31 1 siteCardiovascular disease Other conditions: Drug-eluting StentView official trial listing → -
Recruiting NCT NCT06075433
Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure
Genoss Co., Ltd. 1000 participants Est. completion 2027-12-31 1 siteCardiovascular disease Other conditions: Percutaneous Coronary Intervention, Dual Antiplatelet TherapyView official trial listing → -
Recruiting NCT NCT06092034
A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
Not yet reported Rocket Pharmaceuticals Inc. 18 participants Est. completion 2032-06 6 sites Stand-aloneOther conditions: Danon DiseaseView official trial listing → -
Recruiting NCT NCT06126588
Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial
Not yet reported Central Hospital, Nancy, France 28 participants Est. completion 2028-05-01 2 sitesOther conditions: MeningiomaView official trial listing → -
Recruiting NCT NCT06128070
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Not yet reported City of Hope Medical Center 40 participants Est. completion 2030-11-22 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic SyndromeView official trial listing → -
Recruiting NCT NCT06182397
Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease
Not yet reported Concept Medical Inc. 368 participants Est. completion 2031-02-01 29 sitesOther conditions: Arterial Disease of Legs, Below-the-knee Obstruction, PAD - Peripheral Arterial DiseaseView official trial listing → -
Recruiting NCT NCT06183892
Prospective, Multicenter Clinical Study of Prolonged-release Tacrolimus in Stable Pediatric Liver Transplant Recipients
Not yet reported RenJi Hospital 80 participants Est. completion 2026-07-01 1 site Stand-aloneOther conditions: Liver TransplantView official trial listing → -
Recruiting NCT NCT06211790
Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma
Not yet reported Fudan University 66 participants Est. completion 2026-12-30 1 siteOther conditions: Kidney Cancer, Renal Cell Carcinoma, Renal Clear Cell CarcinomaView official trial listing → -
Recruiting NCT NCT06235892
Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure
Not yet reported Nantes University Hospital 300 participants Est. completion 2028-12-10 3 sites Stand-aloneOther conditions: Organ GraftsView official trial listing → -
Recruiting NCT NCT06254248
Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma
Not yet reported Assistance Publique - Hôpitaux de Paris 50 participants Est. completion 2030-01-01 10 sites Stand-aloneOther conditions: Liver Transplant, Hepatocellular Carcinoma Recurrent, Systemic TreatmentView official trial listing → -
Recruiting NCT NCT06261060
Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder
Not yet reported M.D. Anderson Cancer Center 10 participants Est. completion 2028-06-11 1 site Stand-aloneOther conditions: Familial Platelet Disorder, HematopoieticView official trial listing → -
Recruiting NCT NCT06265584
Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant
Not yet reported University of Alabama at Birmingham 56 participants Est. completion 2028-11 1 site Stand-aloneOther conditions: Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative DisordersView official trial listing → -
Recruiting NCT NCT06280950
Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 340 participants Est. completion 2030-06-30 12 sites Stand-aloneOther conditions: Liver TransplantView official trial listing → -
Recruiting NCT NCT06287944
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
Not yet reported City of Hope Medical Center 15 participants Est. completion 2029-05-19 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic SyndromeView official trial listing → -
Recruiting NCT NCT06315309
Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant
Not yet reported University of Alabama at Birmingham 29 participants Est. completion 2027-05 1 site Stand-aloneOther conditions: GVHD,Acute, Acute Leukemia, Myelodysplastic Syndromes, Myeloproliferative DisordersView official trial listing → -
Recruiting NCT NCT06325709
Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 15 participants Est. completion 2032-12-31 1 site Stand-aloneOther conditions: Chronic Granulomatous Disease (CGD), X-Linked Chronic Granulomatous DiseaseView official trial listing → -
Recruiting NCT NCT06326190
177Lu-DOTATATE for Recurrent Meningioma
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 136 participants Est. completion 2028-12-22 19 sitesOther conditions: Recurrent MeningiomaView official trial listing → -
Recruiting NCT NCT06345495
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
Not yet reported M.D. Anderson Cancer Center 30 participants Est. completion 2029-01-01 1 site Stand-aloneOther conditions: Splenomegaly, MyelofibrosisView official trial listing → -
Recruiting NCT NCT06354179
Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)
Not yet reported University Hospital, Limoges 162 participants Est. completion 2028-04-15 18 sites Stand-aloneOther conditions: Liver Transplantation, ImmunosuppressionView official trial listing → -
Recruiting NCT NCT06358638
Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody
Not yet reported Children's National Research Institute 12 participants Est. completion 2054-09 1 site Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Recruiting NCT NCT06394232
Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.
Not yet reported, Not yet reported Eyestem Research Pvt. Ltd. 54 participants Est. completion 2030-12 3 sitesOther conditions: Retinal Disease, Macular Degeneration, Age-Related Macular Degeneration, Geographic Atrophy, Eye DiseasesView official trial listing → -
Recruiting NCT NCT06412250
A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)
Translumina Therapeutics Pvt Ltd. 2000 participants Est. completion 2027-11 32 sitesCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT06412497
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
Not yet reported Masonic Cancer Center, University of Minnesota 60 participants Est. completion 2036-05-01 1 site Stand-aloneOther conditions: Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia, Paroxysmal Nocturnal HemoglobinuriaView official trial listing → -
Recruiting NCT NCT06420505
Evaluation of the Vivo Isar Stent System in Routine Clinical Practice
Translumina GmbH 3000 participants Est. completion 2027-01-01 19 sitesOther conditions: Artery Coronary StenosisView official trial listing → -
Recruiting NCT NCT06437574
Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer
Not yet reported Cedars-Sinai Medical Center 140 participants Est. completion 2028-05-31 1 siteOther conditions: Prostate CancerView official trial listing → -
Recruiting NCT NCT06472388
Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors
Not yet reported AC Camargo Cancer Center 100 participants Est. completion 2026-12-31 2 sitesOther conditions: Neuroendocrine Tumors, Progression, Neuroendocrine Tumor Grade 1, Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor of Pancreas, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor CarcinoidView official trial listing → -
Recruiting NCT NCT06478017
Belatacept in Heart Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 66 participants Est. completion 2028-01-31 8 sites Stand-aloneOther conditions: Heart TransplantView official trial listing → -
Recruiting NCT NCT06482086
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
Not yet reported West China Hospital 75 participants Est. completion 2025-12-01 1 siteOther conditions: Locally Advanced Thyroid Gland CarcinomaView official trial listing → -
Recruiting NCT NCT06517641
Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia
Not yet reported Medical College of Wisconsin 60 participants Est. completion 2029-02-01 25 sitesOther conditions: Severe Aplastic AnemiaView official trial listing → -
Recruiting NCT NCT06529536
Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.
Not yet reported Murdoch Childrens Research Institute 45 participants Est. completion 2027-08-02 1 site Stand-aloneOther conditions: Solid Organ TransplantView official trial listing → -
Recruiting NCT NCT06551584
Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT
Not yet reported Stanford University 24 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic SyndromesView official trial listing → -
Recruiting NCT NCT06551662
DCB vs. DES in Bifurcation Coronary Lesions
Not yet reported Fondazione Ricerca e Innovazione Cardiovascolare ETS 321 participants Est. completion 2028-02-01 17 sites Stand-aloneCardiovascular disease Other conditions: DCBView official trial listing → -
Recruiting NCT NCT06552169
REgulatory T Cell Therapy to Achieve Immunosuppression REduction
Not yet reported Singulera Therapeutics Inc. 34 participants Est. completion 2031-12 7 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Recruiting NCT NCT06575426
A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus
Not yet reported, Not yet reported Otsuka Pharmaceutical Factory, Inc. 13 participants Est. completion 2027-06-30 1 siteOther conditions: Diabetes Mellitus, Type 1, Hypoglycemia, Islet Cell Transplantation, Type 1 Diabetes, Type 1 Diabetes Mellitus, T1D, T1DM, T1DM - Type 1 Diabetes Mellitus, Type 1 Diabetes (T1D), Severe Hypoglycemia, Xenotransplantation, Hypoglycemic Episode, Islet Transplantation in Diabetes Mellitus Type 1, Glucose Metabolism Disorders (Including Diabetes Mellitus), Immune System Diseases, Autoimmune Diseases, Metabolic DiseaseView official trial listing → -
Recruiting NCT NCT06585384
Safety of a Strategy Combining Etanercept Administration With Repeated Contrast Ultrasound in Patients With Alzheimer's Disease
Not yet reported Fondation Ophtalmologique Adolphe de Rothschild 5 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: Alzheimer DiseaseView official trial listing → -
Recruiting NCT NCT06591884
Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus
Not yet reported, Not yet reported Hospital de Clinicas de Porto Alegre 46 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: Oral Erosive Lichen PlanusView official trial listing → -
Recruiting NCT NCT06615050
A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)
Not yet reported Incyte Corporation 572 participants Est. completion 2031-01-17 30 sites Stand-aloneOther conditions: Graft-versus-host Disease (GVHD)View official trial listing → -
Recruiting NCT NCT06618248
Efficacy and Safety of Sirolimus-Coated Spiral Balloon for Coronary Bifurcation Lesions
Not yet reported Dongguan TT Medical 280 participants Est. completion 2027-03 1 site Stand-aloneOther conditions: Coronary Bifurcation LesionView official trial listing → -
Recruiting NCT NCT06646497
Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years
Not yet reported Assistance Publique - Hôpitaux de Paris 52 participants Est. completion 2030-01-24 26 sites Stand-aloneOther conditions: Aplastic AnemiaView official trial listing → -
Recruiting NCT NCT06654882
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis
Not yet reported Duke University 400 participants Est. completion 2029-11 7 sitesOther conditions: Polyarticular Course Juvenile Idiopathic Arthritis (JIA)View official trial listing → -
Recruiting NCT NCT06663696
CRUZ Tunisia-Multivessel Registry
Sahajanand Medical Technologies Limited 1000 participants Est. completion 2028-05 2 sitesOther conditions: Patient Population With Multivessel DiseaseView official trial listing → -
Recruiting NCT NCT06676696
Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure
Not yet reported Hospital Universitari Vall d'Hebron Research Institute 202 participants Est. completion 2028-01-31 1 siteOther conditions: Renal Failure , Chronic, Graft Failure, Graft Rejection, Allograft, Renal Failure Chronic Requiring DialysisView official trial listing → -
Recruiting NCT NCT06692426
Trial of Cell Based Therapy for DMD
Not yet reported Masonic Cancer Center, University of Minnesota 8 participants Est. completion 2027-03-03 1 site Stand-aloneOther conditions: Duchenne Muscular DystrophyView official trial listing → -
Recruiting NCT NCT06701825
Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
Not yet reported Instituto de Investigación Hospital Universitario La Paz 114 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Kidney Disease, Chronic, Transplant Recipient (Kidney), ImmunosuppressionView official trial listing → -
Recruiting NCT NCT06705062
Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation
Not yet reported Shanghai Jiao Tong University School of Medicine 316 participants Est. completion 2028-07-01 1 site Stand-aloneOther conditions: Allogeneic Hematopoietic Cell Transplant, Graft Versus Host DiseaseView official trial listing → -
Recruiting NCT NCT06707194
Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis
Not yet reported Nanfang Hospital, Southern Medical University 340 participants Est. completion 2027-07-31 6 sites Stand-aloneOther conditions: Spondyloarthritis (SpA), Ankylosing Spondylitis (AS)View official trial listing → -
Recruiting NCT NCT06710210
Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease
Not yet reported University Hospital, Geneva 150 participants Est. completion 2028-04-01 4 sites Stand-aloneCardiovascular disease Other conditions: Percutaneous Coronary Intervention (PCI)View official trial listing → -
Recruiting NCT NCT06719024
Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus
Not yet reported, Not yet reported Hospital Authority, Hong Kong 20 participants Est. completion 2026-01-30 1 siteOther conditions: VitiligoView official trial listing → -
Recruiting NCT NCT06719791
Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)
Not yet reported Xuanwu Hospital, Beijing 15 participants Est. completion 2028-12-01 1 site Stand-aloneOther conditions: Epilepsy, Drug ResistantView official trial listing → -
Recruiting NCT NCT06722586
Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia
Not yet reported Peking University First Hospital 84 participants Est. completion 2027-12 10 sites Stand-aloneOther conditions: Antiphospholipid (aPL)-Positive, ThrombocytopaeniaView official trial listing → -
Recruiting NCT NCT06731504
HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT
Not yet reported Duke University 10 participants Est. completion 2028-07 1 site Stand-aloneOther conditions: Hematologic MalignancyView official trial listing → -
Recruiting NCT NCT06751199
UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of Diabetes
Not yet reported Shanghai Changzheng Hospital 16 participants Est. completion 2026-12-01 1 siteOther conditions: DiabetesView official trial listing → -
Recruiting NCT NCT06751992
Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients
Not yet reported Massachusetts General Hospital 92 participants Est. completion 2027-10-01 1 site Stand-aloneOther conditions: Kidney Transplant Recipients, Old AgeView official trial listing → -
Recruiting NCT NCT06777719
Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients
Not yet reported Nantes University Hospital 9 participants Est. completion 2027-05-18 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Recruiting NCT NCT06779630
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Not yet reported Teleflex 150 participants Est. completion 2031-09 23 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT06799195
Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation
Not yet reported University of Nebraska 126 participants Est. completion 2031-11 1 site Stand-aloneOther conditions: Hematological Malignancies, Graft-versus-Host Disease (GVHD)View official trial listing → -
Recruiting NCT NCT06802315
Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)
Not yet reported University of Illinois Chicago 38 participants Est. completion 2032-03 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Relapsed, Adult, Acute Myeloid Leukemia Refractory, Chronic Myeloid Leukemia - Accelerated Phase, Myelodysplastic SyndromesView official trial listing → -
Recruiting NCT NCT06807606
Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
Not yet reported M.D. Anderson Cancer Center 35 participants Est. completion 2029-11-30 1 site Stand-aloneOther conditions: Hematologic MalignanciesView official trial listing → -
Recruiting NCT NCT06815003
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
Not yet reported City of Hope Medical Center 35 participants Est. completion 2028-10-15 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Graft Versus Host Disease, Myelodysplastic Syndrome, Myeloproliferative NeoplasmView official trial listing → -
Recruiting NCT NCT06822712
Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions
Not yet reported BrosMed Medical Co., Ltd 250 participants Est. completion 2026-06 1 site Stand-aloneOther conditions: Coronary Arterial Disease (CAD)View official trial listing → -
Recruiting NCT NCT06828796
Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
Not yet reported Northside Hospital, Inc. 20 participants Est. completion 2028-06-30 1 site Stand-aloneOther conditions: Hematologic Disease and Disorders, Hematopoietic Cell TransplantView official trial listing → -
Recruiting NCT NCT06829719
TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation
Not yet reported Hospices Civils de Lyon 600 participants Est. completion 2031-02-02 4 sites Stand-aloneOther conditions: Infection, Cancer, Rejection, Kidney TransplantationView official trial listing → -
Recruiting NCT NCT06832189
EVR and EPO for Liver Transplant Tolerance
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 20 participants Est. completion 2030-06-01 3 sites Stand-aloneOther conditions: Liver TransplantView official trial listing → -
Recruiting NCT NCT06833463
Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients
Chiesi Poland Sp. z o.o. 120 participants Est. completion 2028-01-30 6 sitesOther conditions: Kidney TransplantView official trial listing → -
Recruiting NCT NCT06857058
Standardized Procedure for Intracranial Drug-Eluting Stenting in the Treatment of Intracranial Atherosclerotic Stenosis
Not yet reported Sino Medical Sciences Technology Inc. 300 participants Est. completion 2026-06-08 1 site Stand-aloneOther conditions: Intracranial Atherosclerotic StenosisView official trial listing → -
Recruiting NCT NCT06859424
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Not yet reported Center for International Blood and Marrow Transplant Research 358 participants Est. completion 2028-06 13 sites Stand-aloneOther conditions: AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category), MDS (Myelodysplastic Syndrome), CML (Chronic Myelogenous Leukemia), CLL (Chronic Lymphocytic Leukemia), Prolymphocyctic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasm (MPN), Lymphoma, MyelofibrosisView official trial listing → -
Recruiting NCT NCT06872333
Allo HSCT for High Risk Hemoglobinopathies
Not yet reported Masonic Cancer Center, University of Minnesota 62 participants Est. completion 2032-06-01 1 site Stand-aloneOther conditions: Graft Failure, Sickle Cell Disease, HemoglobinopathiesView official trial listing → -
Recruiting NCT NCT06900777
Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT
Not yet reported Xijing Hospital 90 participants Est. completion 2026-04-01 1 site Stand-aloneOther conditions: Vitiligo, Child, Progressive DiseaseView official trial listing → -
Recruiting NCT NCT06918990
Treatment of Antibody-Mediated Rejection (ABMR) With CarBel
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 25 participants Est. completion 2027-06-30 11 sites Stand-aloneOther conditions: Kidney Transplant RejectionView official trial listing → -
Recruiting NCT NCT06926595
Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention
Not yet reported Milton S. Hershey Medical Center 41 participants Est. completion 2031-11-01 1 site Stand-aloneOther conditions: Graft-versus-Host Disease (GVHD), Hematologic Malignancies, Allogeneic Stem Cell TransplantationView official trial listing → -
Recruiting NCT NCT06943755
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Not yet reported, Not yet reported Exelixis 440 participants Est. completion 2029-06-30 135 sitesOther conditions: Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)View official trial listing → -
Recruiting NCT NCT06950385
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Not yet reported Rapamycin Holdings Inc. 168 participants Est. completion 2031-01 29 sitesOther conditions: Familial Adenomatous Polyposis (FAP)View official trial listing → -
Recruiting NCT NCT06962800
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)
Not yet reported Biogen 180 participants Est. completion 2031-01-17 117 sites Stand-aloneOther conditions: Primary Membranous NephropathyView official trial listing → -
Recruiting NCT NCT06973668
A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease
Not yet reported M.D. Anderson Cancer Center 80 participants Est. completion 2030-01-31 1 site Stand-aloneOther conditions: AMLView official trial listing → -
Recruiting NCT NCT06996119
Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant
Not yet reported City of Hope Medical Center 15 participants Est. completion 2028-11-05 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Graft Versus Host Disease, Myelodysplastic SyndromeView official trial listing → -
Recruiting NCT NCT07015684
131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)
Not yet reported Columbia University 24 participants Est. completion 2032-03-12 1 site Stand-aloneOther conditions: Sickling Disorder Due to Hemoglobin SView official trial listing → -
Recruiting NCT NCT07033858
Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney Transplantation
Not yet reported Shahid Beheshti University of Medical Sciences 50 participants Est. completion 2026-07-01 1 siteOther conditions: Kidney Transplant; ComplicationsView official trial listing → -
Recruiting NCT NCT07042035
Study of Tacrolimus Melt-Dose® for Lung Transplant Patients
Chiesi España, S.A.U. 240 participants Est. completion 2026-12-31 2 sitesOther conditions: Lung Trasplant, Lung TransplantationView official trial listing → -
Recruiting NCT NCT07052929
Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators
Not yet reported, Not yet reported Astellas Gene Therapies 9 participants Est. completion 2027-10-31 5 sites Stand-aloneOther conditions: X-Linked Myotubular MyopathyView official trial listing → -
Recruiting NCT NCT07053462
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Not yet reported, Not yet reported AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90 participants Est. completion 2028-12-28 1 site Stand-aloneOther conditions: End-Stage Renal Disease, End Stage Renal Disease on Dialysis, End Stage Renal Disease With Renal Transplant, Kidney Transplant Rejection, Kidney Tumor, Kidney Failure, Kidney IschemiaView official trial listing → -
Recruiting NCT NCT07077486
Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
Not yet reported Tongji Hospital 100 participants Est. completion 2027-03-25 1 site Stand-aloneOther conditions: Lupus or SLE, Interstitial Lung Disease, Systemic Lupus ErythematosusView official trial listing → -
Recruiting NCT NCT07092618
Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation
Not yet reported, Not yet reported AgelessRx 150 participants Est. completion 2025-08 1 siteOther conditions: Longevity, GLP-1, Geroscience, AgingView official trial listing → -
Recruiting NCT NCT07104799
Momelotinib During and After HCT in Myelofibrosis
Not yet reported Massachusetts General Hospital 28 participants Est. completion 2030-01 1 site Stand-aloneOther conditions: Myelofibrosis, Hematopoietic Cell Transplantation (HCT)View official trial listing → -
Recruiting NCT NCT07122167
Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions
Not yet reported MDCECRO LLC 153 participants Est. completion 2027-02-01 1 siteOther conditions: Peripheral Arterial DiseaseView official trial listing → -
Recruiting NCT NCT07124078
A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)
Not yet reported Incyte Corporation 60 participants Est. completion 2029-07-31 41 sitesOther conditions: Chronic Graft-versus-host-diseaseView official trial listing → -
Recruiting NCT NCT07131644
Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma
Not yet reported West China Hospital 120 participants Est. completion 2028-02-01 1 site Stand-aloneOther conditions: Kaposiform HemangioendotheliomaView official trial listing → -
Recruiting NCT NCT07138898
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
Not yet reported NYU Langone Health 80 participants Est. completion 2028-01 1 site Stand-aloneOther conditions: Rheumatic DiseaseView official trial listing → -
Recruiting NCT NCT07144150
EVERO Drug-coated Balloon (DCB) Randomized Trial
Not yet reported Cook Research Incorporated 410 participants Est. completion 2032-10 15 sitesOther conditions: Peripheral Vascular Disease, Peripheral Arterial DiseaseView official trial listing → -
Recruiting NCT NCT07162038
Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation
Not yet reported National Cancer Institute (NCI) 155 participants Est. completion 2034-10-01 1 site Stand-aloneOther conditions: Hematologic Malignancies, Hematologic NeoplasmsView official trial listing → -
Recruiting NCT NCT07173114
New Approaches for Evaluating the Interchangeability of Reference Materials and Quality Controls (COMET-MPL)
University Hospital, Montpellier 300 participants Est. completion 2026-09-22 2 sitesOther conditions: Hospitalization, All ConditionsView official trial listing → -
Recruiting NCT NCT07191353
Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women
Not yet reported Odense University Hospital 148 participants Est. completion 2027-03-01 2 sitesOther conditions: Healthy, Osteopenia, Osteoporosis RiskView official trial listing → -
Recruiting NCT NCT07204275
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Not yet reported, Not yet reported Vertex Pharmaceuticals Incorporated 176 participants Est. completion 2028-12-29 117 sitesOther conditions: Primary Membranous NephropathyView official trial listing → -
Recruiting NCT NCT07206277
Fibroscan to Guide Post Transplant Immunosuppression Minimization
Not yet reported University of Alberta 50 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: ImmunosuppressionView official trial listing → -
Recruiting NCT NCT07214688
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
Not yet reported Hackensack Meridian Health 209 participants Est. completion 2032-01 3 sites Stand-aloneOther conditions: Allogeneic Stem Cell Transplant RecipientView official trial listing → -
Recruiting NCT NCT07216443
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Not yet reported Orca Biosystems, Inc. 80 participants Est. completion 2028-12 6 sites Stand-aloneOther conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Mixed Phenotype Acute LeukemiaView official trial listing → -
Recruiting NCT NCT07228195
SGLT2i Therapy in Islet Transplantation (SIT)
Not yet reported University of Minnesota 40 participants Est. completion 2028-12-01 1 siteOther conditions: Partial Islet Function, TPIAT, DiabetesView official trial listing → -
Recruiting NCT NCT07228624
Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes
Not yet reported Fred Hutchinson Cancer Center 50 participants Est. completion 2030-09-01 1 site Stand-aloneOther conditions: Myelodysplastic/Myeloproliferative Neoplasm, Primary Myelofibrosis, Secondary MyelofibrosisView official trial listing → -
Recruiting NCT NCT07238712
Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor
Not yet reported St. Petersburg State Pavlov Medical University 60 participants Est. completion 2026-12-10 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia, Myelodysplastic Syndromes (MDS), Myeloprolipherative Neoplsm, Atypical Chronic Myeloid LeukemiaView official trial listing → -
Recruiting NCT NCT07241936
A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors
Not yet reported, Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 444 participants Est. completion 2028-10-30 1 site Stand-aloneOther conditions: Advanced Solid TumorsView official trial listing → -
Recruiting NCT NCT07249346
Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation
Not yet reported Hannah Choe, MD 124 participants Est. completion 2027-06-01 3 sites Stand-aloneOther conditions: Leukemia, Myelodysplasia, Chronic Myelomonocytic LeukemiaView official trial listing → -
Recruiting NCT NCT07252050
Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease
Not yet reported, Not yet reported Arkansas Children's Hospital Research Institute 24 participants Est. completion 2029-11-19 4 sites Stand-aloneOther conditions: Sickle Cell Disease, Hematopoetic Stem Cell Transplant, Haploidentical Hematopoietic Stem Cell Transplant, Haploidentical Stem Cell Transplantation, Graft FailureView official trial listing → -
Recruiting NCT NCT07258290
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
Not yet reported Teleflex 1859 participants Est. completion 2033-06 3 sites Stand-aloneCardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Vascular Diseases, Chest Pain, Pain, Neurologic Manifestations, Signs and Symptoms, Pathological Conditions, Signs and Symptoms, Myocardial Ischemia, Acute Coronary Syndrome, Angina PectorisView official trial listing → -
Recruiting NCT NCT07285070
Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis
Not yet reported Novaliq GmbH 20 participants Est. completion 2026-10 6 sitesOther conditions: Non-infectious Anterior UveitisView official trial listing → -
Recruiting NCT NCT07290777
VEL-101 to Prevent Rejection After Kidney Transplantation
Not yet reported Veloxis Pharmaceuticals 120 participants Est. completion 2028-10 1 siteOther conditions: Transplantation, KidneyView official trial listing → -
Recruiting NCT NCT07291258
Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation
University Medical Center Groningen 200 participants Est. completion 2028-06 1 siteOther conditions: Solid Organ Transplantation, Pregnancy, Long-term Follow-up, Kidney Transplant, Liver Transplant, Pancreas Transplant, Heart Transplantation, Lung Transplantation, Offspring, Adult, Children, Cardiovascular Abnormalities, Kidney Disease, Quality of LifeView official trial listing → -
Recruiting NCT NCT07297173
Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia
Not yet reported Beijing 302 Hospital 5 participants Est. completion 2030-12-01 1 site Stand-aloneOther conditions: Relapsed Leukemia, Refractory LeukemiaView official trial listing → -
Recruiting NCT NCT07302776
TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT
Not yet reported Stanford University 50 participants Est. completion 2028-02 1 site Stand-aloneOther conditions: GVHD, Hematopoietic Cell Transplantation (HCT), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes, Myelofibrosis (MF), Chronic Myeloid Leukemia (CML), Chronic Myelomonocytic Leukemia (CMML)View official trial listing → -
Recruiting NCT NCT07309094
Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD
Cardenal Herrera University 250 participants Est. completion 2028-12-31 1 siteChronic kidney diseaseType 2 diabetes Other conditions: ObesityView official trial listing → -
Recruiting NCT NCT07318324
Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer
Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2030-08-01 1 siteOther conditions: Phase IB, Avutometinib, RAS Pathway, EndometrialView official trial listing → -
Recruiting NCT NCT07340541
Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies
Not yet reported UNC Lineberger Comprehensive Cancer Center 700 participants Est. completion 2031-06-02 6 sitesOther conditions: Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-positive Breast Cancer, Hormone Receptor Negative Breast CarcinomaView official trial listing → -
Recruiting NCT NCT07359859
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant
Not yet reported Memorial Sloan Kettering Cancer Center 40 participants Est. completion 2029-01 7 sites Stand-aloneOther conditions: Hematologic MalignanciesView official trial listing → -
Recruiting NCT NCT07363161
BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)
Not yet reported B. Braun Melsungen AG 2184 participants Est. completion 2031-03 3 sitesCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT07366801
Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies
Not yet reported, Not yet reported Federal Research Institute of Pediatric Hematology, Oncology and Immunology 64 participants Est. completion 2028-02-03 1 siteOther conditions: Acute Myeloid Leukemia, Relapsed, Acute Lymphoblastic Leukemia, High Risk, Acute Myeloid Leukemia, High Risk, Acute Lymphoblastic Leukemia, RelapseView official trial listing → -
Recruiting NCT NCT07377058
RCT of Tocilizumab for Anti-MDA5+DM
Not yet reported Peking Union Medical College Hospital 110 participants Est. completion 2026-10 1 siteOther conditions: DermatomyositisView official trial listing → -
Recruiting NCT NCT07378657
Systematic Approach for Children With Orbital Malformation With Sirolimus Use
Not yet reported Ain Shams University 30 participants Est. completion 2027-11-01 1 siteOther conditions: Orbital Lymphatic MalformationView official trial listing → -
Recruiting NCT NCT07406932
A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome
Not yet reported China-Japan Friendship Hospital 80 participants Est. completion 2027-07-01 1 site Stand-aloneOther conditions: Antisynthetase Syndrome, Interstitial Lung Disease (ILD)View official trial listing → -
Recruiting NCT NCT07412470
A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation
Not yet reported, Not yet reported Sanofi 526 participants Est. completion 2033-08-15 73 sitesOther conditions: Kidney Transplant RejectionView official trial listing → -
Recruiting NCT NCT07444957
Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease
Fundación Interhospitalaria para la Investigación Cardiovascular FIC 1118 participants Est. completion 2030-07-06 1 siteCardiovascular disease Other conditions: Coronary Arterial Disease (CAD), Stable Angina, Unstable Angina, NSTEMI, Drug Coated Balloon, Silent IschemiaView official trial listing → -
Recruiting NCT NCT07493538
MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
Not yet reported Masonic Cancer Center, University of Minnesota 132 participants Est. completion 2035-03 1 site Stand-aloneOther conditions: AML, MDS, Acute Leukemia, Acute Myeloid Leukemia, Myelodysplastic SyndromesView official trial listing → -
Recruiting NCT NCT07497399
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Not yet reported Johns Hopkins University 120 participants Est. completion 2030-01 3 sitesOther conditions: Multiple SclerosisView official trial listing → -
Recruiting NCT NCT07508787
A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant
Not yet reported ITB-Med LLC 120 participants Est. completion 2028-03-28 27 sitesOther conditions: Renal Transplant Failure and RejectionView official trial listing → -
Recruiting NCT NCT07542938
Medeliver Intracranial Drug Coated Balloon Catheter for Symptomatic Intracranial Atherosclerotic Stenosis
Not yet reported Xuanwu Hospital, Beijing 264 participants Est. completion 2027-11-30 15 sites Stand-aloneOther conditions: Symptomatic Intracranial Atherosclerotic StenosisView official trial listing → -
Recruiting NCT NCT07548983
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
Not yet reported OHSU Knight Cancer Institute 40 participants Est. completion 2028-12-29 1 site Stand-aloneOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Recruiting NCT NCT07549503
Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 100 participants Est. completion 2031-10-01 11 sites Stand-aloneOther conditions: Liver TransplantView official trial listing → -
Recruiting NCT NCT07566091
Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers
Not yet reported Jung-min Ahn 2034 participants Est. completion 2028-06-15 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Recruiting NCT NCT07566377
Cord Blood Transplantation in Children and Young Adults With Blood Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 71 participants Est. completion 2030-04-28 1 site Stand-aloneOther conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Leukemia, Lymphoma, Graft-versus-host DiseaseView official trial listing → -
Recruiting NCT NCT07572071
Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease
Not yet reported Royan Institute 6 participants Est. completion 2030-08-01 3 sites Stand-aloneOther conditions: Parkinson Disease (PD)View official trial listing → -
Recruiting NCT NCT07581704
Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma
Not yet reported Christopher Strouse 10 participants Est. completion 2029-10-01 1 site Stand-aloneOther conditions: Multiple MyelomaView official trial listing → -
Recruiting NCT NCT07582172
Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome
Not yet reported City of Hope Medical Center 35 participants Est. completion 2031-11-05 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia With Complex Karyotype, Myelodysplastic Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome, Recurrent Secondary Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Refractory Myelodysplastic Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome, Refractory Secondary Acute Myeloid LeukemiaView official trial listing → -
Recruiting NCT NCT07592000
Breakthrough - T1DM and Chronic Kidney Disease
Not yet reported, Not yet reported University of Chicago 10 participants Est. completion 2030-01-31 2 sitesChronic kidney disease Other conditions: Diabete Type 1View official trial listing → -
Recruiting NCT NCT07616154
Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease
Not yet reported St. Jude Children's Research Hospital 45 participants Est. completion 2035-09 1 site Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Recruiting NCT NCT07656909
Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP
Not yet reported, Not yet reported Yi Ji 76 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: Kaposiform Hemangioendothelioma (KHE), Kasabach Merritt PhenomenonView official trial listing → -
Recruiting NCT NCT07702461
Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists
Ohio State University 300 participants Est. completion 2027-01 1 siteOther conditions: Obesity & Overweight, Diabetes (DM)View official trial listing → -
Recruiting NCT NCT07725380
Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma
Not yet reported, Not yet reported H. Lee Moffitt Cancer Center and Research Institute 74 participants Est. completion 2031-08 4 sites Stand-aloneObstructive sleep apnea Other conditions: SarcomaView official trial listing → -
Recruiting NCT NCT07735533
A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies
Not yet reported, Not yet reported Umoja Biopharma 274 participants Est. completion 2031-08 2 sites Stand-aloneOther conditions: Lymphoma, B Cell, Lymphoma Non-Hodgkin, High Grade B Cell Lymphoma, Richter Transformation Lymphoma, Grade 3b Follicular Lymphoma, Primary Mediastinal B Cell Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL)View official trial listing → -
Recruiting NCT NCT07735546
A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple Myeloma
Not yet reported Umoja Biopharma 100 participants Est. completion 2029-12-31 1 site Stand-aloneOther conditions: Multiple Myeloma in Relapse, Multiple Myeloma (MM)View official trial listing → -
Recruiting NCT NCT07739914
Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIver transplantatiON (ALTERNATION)
Not yet reported Hannover Medical School 150 participants Est. completion 2031-06-30 16 sitesOther conditions: Liver Allograft, Liver Diseases, Liver TransplantationView official trial listing → -
Recruiting NCT NCT07775235
Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease
Singapore General Hospital 80 participants Est. completion 2029-07-01 1 siteOther conditions: Interstitial Lung Disease, MyositisView official trial listing → -
Recruiting NCT NCT07781722
Tacrolimus as Prophylaxis of Post-ERCP Pancreatitis
Not yet reported Amsterdam UMC, location VUmc 520 participants Est. completion 2028-12-07 1 site Stand-aloneOther conditions: Post-ERCP PancreatitisView official trial listing → -
Recruiting NCT NCT07811024
First-in-Human Study Using the SiroMax™ Sirolimus-Coated Balloon Catheter as a Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter to Treat Subjects Who Have Coronary Artery Disease (CAD) Involving In-Stent Restenosis (ISR) or an Unstented Lesion in a Small Coronary Vessel (DNSV).
Not yet reported Tonic Medical, Inc. 60 participants Est. completion 2032-05 2 sites Stand-aloneCardiovascular disease Other conditions: In-Stent Restenosis or De Novo Coronary Artery Lesions, In-Stent Stenosis (Restenosis) of Coronary Artery Stent, Small Vessel Disease, CAD, CAD Patients, PTCA, PCI, Stenosis Coronary, Stenosis Artery, Stenotic Coronary LesionView official trial listing → -
Recruiting NCT NCT07843381
Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease
Peking University People's Hospital 60 participants Est. completion 2027-11-20 1 siteOther conditions: Sjögren's Disease, Interstitial Lung DiseaseView official trial listing → -
Recruiting NCT NCT07844694
Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder
Not yet reported OHSU Knight Cancer Institute 6 participants Est. completion 2030-12-31 1 site Stand-aloneOther conditions: Familial Platelet Disorder With Associated Myeloid MalignancyView official trial listing → -
Recruiting NCT NCT07851220
A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy
Not yet reported Amgen 159 participants Est. completion 2033-09-26 4 sitesOther conditions: Glomerulonephritis, MembranousView official trial listing → -
Recruiting NCT NCT07904910
Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer Light in the Treatment of Stable Non-segmental Facial Vitiligo: a Prospective Randomized Controlled Study.
Not yet reported Cairo University 35 participants Est. completion 2026-11-30 1 siteOther conditions: Vitiligo, Non-Segmental Vitiligo (NSV), Stable VitiligoView official trial listing → -
Completed NCT NCT00000433
Blocking Tumor Necrosis Factor in Ankylosing Spondylitis
Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 42 participants Est. completion 2002-03 1 siteOther conditions: Spondylitis, AnkylosingView official trial listing → -
Completed NCT NCT00001859
Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 621 participants Est. completion 2014-05-30 1 siteOther conditions: Diabetes Mellitus, Kidney FailureView official trial listing → -
Completed NCT NCT00001901
Etanercept to Treat Wegener's Granulomatosis
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 60 participants Est. completion 2005-03 1 siteOther conditions: Vasculitis, Wegener's GranulomatosisView official trial listing → -
Completed NCT NCT00001955
Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)
Not yet reported National Institute of Dental and Craniofacial Research (NIDCR) 150 participants Est. completion 2004-02 1 siteOther conditions: Temporomandibular Joint DisorderView official trial listing → -
Completed NCT NCT00002657
SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
Not yet reported SWOG Cancer Research Network 20 participants Est. completion 2011-07 86 sitesOther conditions: Lymphoma, Multiple Myeloma and Plasma Cell NeoplasmView official trial listing → -
Withdrawn NCT NCT00002790
Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant
Not yet reported, Not yet reported Fred Hutchinson Cancer CenterOther conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00002792
Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders
Not yet reported Fred Hutchinson Cancer Center 20 participants Est. completion 2003-04 1 siteOther conditions: Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative DiseasesView official trial listing → -
Completed NCT NCT00002809
Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
Not yet reported Temple University 10 participants Est. completion 2003-12 1 siteOther conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative DiseasesView official trial listing → -
Completed NCT NCT00002831
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia
Not yet reported, Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2002-12-31 1 site Stand-aloneOther conditions: LeukemiaView official trial listing → -
Completed NCT NCT00003572
Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20 participants Est. completion 2002-04 1 siteOther conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00003712
CCI-779 in Treating Patients With Advanced Solid Tumors
Not yet reported The University of Texas Health Science Center at San Antonio 15 participants Est. completion 2002-06 2 sitesOther conditions: Brain and Central Nervous System Tumors, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00004145
Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Not yet reported University of Chicago 16 participants Est. completion 2011-08 1 site Stand-aloneOther conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00004255
Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation
Not yet reported, Not yet reported Chimeric Therapies Est. completion 2003-05 15 sitesOther conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic SyndromesView official trial listing → -
Withdrawn NCT NCT00004878
Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
Not yet reported Jonsson Comprehensive Cancer CenterOther conditions: Graft Versus Host Disease, LeukemiaView official trial listing → -
Completed NCT NCT00004904
Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Not yet reported Northwestern University Est. completion 2000-07 1 siteOther conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous/Nonmalignant Condition, Small Intestine CancerView official trial listing → -
Terminated NCT NCT00005113
A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant
Not yet reported Boston Children's Hospital 102 participants Est. completion 2006-03 1 site Stand-aloneOther conditions: End-Stage Renal Disease, Kidney TransplantationView official trial listing → -
Completed NCT NCT00005853
Biological Therapy in Treating Patients With Myelodysplastic Syndrome
Not yet reported Fred Hutchinson Cancer Center Est. completion 2005-08 1 siteOther conditions: Leukemia, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00006042
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 siteOther conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative DiseasesView official trial listing → -
Completed NCT NCT00006070
Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction
Not yet reported National Institute of Dental and Craniofacial Research (NIDCR) 86 participants Est. completion 2004-05 1 siteOther conditions: Healthy, InflammationView official trial listing → -
Completed NCT NCT00006350
Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Not yet reported University of Maryland, Baltimore Est. completion 2001-11 1 siteOther conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00006747
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
Not yet reported Alliance for Clinical Trials in Oncology 4 participants Est. completion 2003-02 48 sites Stand-aloneOther conditions: Graft Versus Host Disease, LymphomaView official trial listing → -
Completed NCT NCT00007787
Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 350 participants Est. completion 2004-03 1 site Stand-aloneOther conditions: Kidney Transplantation, Chronic Allograft NephropathyView official trial listing → -
Completed NCT NCT00014469
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer
Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2007-05 1 siteOther conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative NeoplasmsView official trial listing → -
Completed NCT NCT00014911
Islet Transplantation for Type 1 Diabetes
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 36 participants Est. completion 2010-08 9 sites Stand-aloneOther conditions: Diabetes Mellitus, Insulin-DependentView official trial listing → -
Status unknown NCT NCT00018122
Patterns and Natural History of Insulin Secretion in Islet Cell Transplant Recipients and Controls
National Center for Research Resources (NCRR) 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00021801
Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Est. completion 2000-09 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00022464
CCI-779 in Treating Patients With Metastatic Melanoma
Not yet reported City of Hope Medical Center Est. completion 2005-09 21 sitesOther conditions: Melanoma (Skin)View official trial listing → -
Completed NCT NCT00022724
CCI-779 in Treating Patients With Malignant Glioma
Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 49 participants Est. completion 2007-12-15 10 sitesOther conditions: Brain and Central Nervous System TumorsView official trial listing → -
Terminated NCT NCT00023244
Steroid Withdrawal in Pediatric Kidney Transplant Recipients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 274 participants Est. completion 2005-06 19 sites Stand-aloneOther conditions: End-Stage Renal DiseaseView official trial listing → -
Withdrawn NCT NCT00025519
Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer
Not yet reported Fox Chase Cancer Center Est. completion 2006-10Other conditions: Kidney CancerView official trial listing → -
Completed NCT NCT00027573
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer
Not yet reported Alliance for Clinical Trials in Oncology 36 participants Est. completion 2006-06 6 sites Stand-aloneOther conditions: Kidney CancerView official trial listing → -
Completed NCT NCT00028028
CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Not yet reported National Cancer Institute (NCI) 80 participants 1 siteOther conditions: Extensive Stage Small Cell Lung CancerView official trial listing → -
Completed NCT NCT00028171
Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily Dosing
Not yet reported National Center for Research Resources (NCRR) 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00028600
Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma
Not yet reported Alliance for Clinical Trials in Oncology 60 participants Est. completion 2010-02 15 sites Stand-aloneOther conditions: Multiple Myeloma, Plasma Cell NeoplasmView official trial listing → -
Terminated NCT NCT00031551
Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury
Not yet reported National Institute of Nursing Research (NINR) 27 participants Est. completion 2010-08 2 sites Stand-aloneOther conditions: StomatitisView official trial listing → -
Completed NCT NCT00031824
Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
Not yet reported Children's Oncology Group 82 participants Est. completion 2011-01 104 sitesOther conditions: Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT00033267
CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma
Not yet reported National Cancer Institute (NCI) 27 participants Est. completion 2008-02 1 siteOther conditions: Recurrent Mantle Cell LymphomaView official trial listing → -
Terminated NCT NCT00034528
Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 2 participants Est. completion 2003-11 1 siteOther conditions: Hemoglobinopathies, Anemia, Sickle Cell, Hemoglobin SC Disease, Thalassemia, Thalassemia MajorView official trial listing → -
Terminated NCT NCT00035958
Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis
Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 75 participants Est. completion 2002-08 1 siteOther conditions: DermatomyositisView official trial listing → -
Completed NCT NCT00036153
Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis
Not yet reported Astellas Pharma Inc 210 participants Est. completion 2004-01 45 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00037531
Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 769 participants Est. completion 2004-08 20 sitesOther conditions: Graft vs Host Disease, Kidney TransplantationView official trial listing → -
Completed NCT NCT00038948
Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 830 participants Est. completion 2008-05Other conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00039013
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
Not yet reported AstraZeneca 336 participants Est. completion 2003-06 129 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00039377
Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Not yet reported National Cancer Institute (NCI) 58 participants Est. completion 2014-02 97 sites Stand-aloneOther conditions: Adult Acute Lymphoblastic Leukemia in RemissionView official trial listing → -
Terminated NCT NCT00040417
Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies
Not yet reported Baylor College of Medicine 15 participants Est. completion 2003-11-21 2 sitesOther conditions: Sickle Cell Anemia, Hemoglobinopathy, ThalassemiaView official trial listing → -
Terminated NCT NCT00041288
Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL
Not yet reported University of Texas Southwestern Medical Center 10 participants Est. completion 2003-01 23 sitesOther conditions: Leukemia, LymphomaView official trial listing → -
Completed NCT NCT00043979
Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas
Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2011-12-14 1 site Stand-aloneOther conditions: SarcomaView official trial listing → -
Completed NCT NCT00044694
Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
Not yet reported AstraZeneca 156 participants Est. completion 2003-05 33 sitesOther conditions: Diabetes Mellitus, Non-Insulin-DependentView official trial listing → -
Completed NCT NCT00044720
Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 484 participants Est. completion 2005-07Other conditions: Chronic Kidney Failure, Graft vs Host Disease, Kidney TransplantationView official trial listing → -
Completed NCT NCT00045305
Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes
Not yet reported Eastern Cooperative Oncology Group 17 participants Est. completion 2014-09 6 sites Stand-aloneOther conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative NeoplasmsView official trial listing → -
Completed NCT NCT00045370
Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2003-11 1 siteOther conditions: Kidney CancerView official trial listing → -
Terminated NCT NCT00048399
Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H
Not yet reported, Not yet reported Baylor College of Medicine 40 participants Est. completion 2003-10-31 2 sitesOther conditions: Graft FailureView official trial listing → -
Completed NCT NCT00049504
Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer
Not yet reported Fred Hutchinson Cancer Center 53 participants Est. completion 2014-02 1 site Stand-aloneObstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Hematopoietic/Lymphoid Cancer, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage II Multiple Myeloma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Testicular Lymphoma, Waldenström MacroglobulinemiaView official trial listing → -
Completed NCT NCT00050713
Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12 participants Est. completion 2007-08-27 1 siteOther conditions: Membranous Glomerulonephritis, Lupus Membranous NepropathyView official trial listing → -
Completed NCT NCT00053196
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
Not yet reported Alliance for Clinical Trials in Oncology 82 participants Est. completion 2010-08 12 sites Stand-aloneOther conditions: Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myeloproliferative NeoplasmsView official trial listing → -
Completed NCT NCT00053989
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders
Not yet reported Roswell Park Cancer Institute 41 participants Est. completion 2018-07-19 1 site Stand-aloneOther conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Fanconi Anemia, Aplastic AnemiaView official trial listing → -
Completed NCT NCT00056966
Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases
Not yet reported, Not yet reported Baylor College of Medicine 24 participants Est. completion 2006-12 2 sitesOther conditions: Hematologic MalignancyView official trial listing → -
Terminated NCT NCT00056979
Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases
Not yet reported, Not yet reported Baylor College of Medicine 2 participants Est. completion 2003-06 2 sitesOther conditions: Inherited Metabolic Storage DiseasesView official trial listing → -
Terminated NCT NCT00057954
Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma
Not yet reported Eastern Cooperative Oncology Group 6 participants Est. completion 2011-05 19 sites Stand-aloneOther conditions: LymphomaView official trial listing → -
Terminated NCT NCT00058825
Stem Cell Transplant for Hematologic Diseases
Not yet reported, Not yet reported Baylor College of Medicine 27 participants Est. completion 2014-09 2 sites Stand-aloneOther conditions: Hematologic MalignanciesView official trial listing → -
Completed NCT NCT00060632
Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 46 participants Est. completion 2005-10Other conditions: Tumors, Lymphoma, Multiple MyelomaView official trial listing → -
Completed NCT NCT00060645
Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 33 participants Est. completion 2009-02 1 siteOther conditions: Tumors, Lymphoma, Multiple MyelomaView official trial listing → -
Active, not recruiting NCT NCT00061568
Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 130 participants Est. completion 2028-01-20 1 site Stand-aloneOther conditions: Congenital Hemolytic Anemia, Sickle Cell DiseaseView official trial listing → -
Completed NCT NCT00062751
Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 108 participants Est. completion 2009-10Other conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT00064701
Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients
Not yet reported Astellas Pharma Inc 668 participants Est. completion 2009-03 57 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00065468
Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma
Not yet reported Pfizer 626 participants Est. completion 2011-03 153 sitesOther conditions: Carcinoma, Renal Cell, Kidney NeoplasmsView official trial listing → -
Terminated NCT NCT00068302
Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma
Not yet reported Children's Hospital of Philadelphia 10 participants Est. completion 2013-07 1 site Stand-aloneOther conditions: Leukemia, LymphomaView official trial listing → -
Completed NCT NCT00070135
Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
Not yet reported Alliance for Clinical Trials in Oncology 121 participants Est. completion 2016-06-15 21 sites Stand-aloneOther conditions: Adult Acute Myeloid Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT00071968
Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse
Not yet reported Jonsson Comprehensive Cancer Center 15 participants 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00072176
Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer
Not yet reported National Cancer Institute (NCI) 62 participants Est. completion 2009-08 1 siteOther conditions: Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma, Stage IIIA Endometrial Carcinoma, Stage IIIB Endometrial Carcinoma, Stage IIIC Endometrial Carcinoma, Stage IVA Endometrial Carcinoma, Stage IVB Endometrial CarcinomaView official trial listing → -
Completed NCT NCT00073281
Islet Transplantation for Patients With Type 1 Diabetes
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 10 participants Est. completion 2004-12 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT00074490
Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers
Not yet reported National Cancer Institute (NCI) 442 participants Est. completion 2017-08-16 2 sites Stand-aloneOther conditions: Lymphoma, Leukemia, Myeloproliferative Disorders, Multiple Myleoma, Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT00076570
Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 31 participants Est. completion 2012-08 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00078559
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
Not yet reported, Not yet reported University of Wisconsin, Madison 10 participants Est. completion 2010-02 1 site Stand-aloneOther conditions: Kidney Transplantation, Kidney DiseaseView official trial listing → -
Completed NCT NCT00078689
Daclizumab and Sirolimus to Treat Uveitis
Not yet reported National Eye Institute (NEI) 6 participants Est. completion 2008-07-18 1 siteOther conditions: UveitisView official trial listing → -
Terminated NCT NCT00078806
Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis
Not yet reported Amgen 19 participants Est. completion 2004-05-06 Stand-aloneOther conditions: Juvenile Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00079183
Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment
Not yet reported Fred Hutchinson Cancer Center 44 participants Est. completion 2010-06-10 1 site Stand-aloneOther conditions: Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT00079235
CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer
Not yet reported National Cancer Institute (NCI) 50 participants 1 siteOther conditions: Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung CancerView official trial listing → -
Completed NCT NCT00081874
RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma
Not yet reported, Not yet reported M.D. Anderson Cancer Center 29 participants Est. completion 2006-09 1 siteOther conditions: Leukemia, Mantle Cell Lymphoma, MyelofibrosisView official trial listing → -
Completed NCT NCT00082381
Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin
Not yet reported AstraZeneca 551 participants Est. completion 2008-07 91 sites Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT00083993
Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 1236 participants Est. completion 2006-10 129 sitesOther conditions: Breast Neoplasms, Neoplasm MetastasisView official trial listing → -
Completed NCT NCT00084916
CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
Not yet reported National Cancer Institute (NCI) 74 participants 1 siteOther conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Blastic Phase Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00085566
Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 61 participants Est. completion 2008-02 2 sitesOther conditions: Brain and Central Nervous System Tumors, Prostate CancerView official trial listing → -
Terminated NCT NCT00086346
Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 607 participants Est. completion 2008-07 42 sitesOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00087581
Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation
Not yet reported Hoffmann-La Roche 720 participants Est. completion 2007-09 57 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00089011
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
Not yet reported Fred Hutchinson Cancer Center 150 participants Est. completion 2018-07 5 sites Stand-aloneObstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Prolymphocytic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Small Lymphocytic Lymphoma, Stage IA Mycosis Fungoides/Sezary Syndrome, Stage IB Mycosis Fungoides/Sezary Syndrome, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage IIA Mycosis Fungoides/Sezary Syndrome, Stage IIB Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Small Lymphocytic Lymphoma, Stage IIIA Mycosis Fungoides/Sezary Syndrome, Stage IIIB Mycosis Fungoides/Sezary Syndrome, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Stage IVA Mycosis Fungoides/Sezary Syndrome, Stage IVB Mycosis Fungoides/Sezary Syndrome, Testicular Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Waldenström MacroglobulinemiaView official trial listing → -
Completed NCT NCT00089037
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
Not yet reported, Not yet reported Fred Hutchinson Cancer Center Est. completion 2005-04 1 siteOther conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative DiseasesView official trial listing → -
Completed NCT NCT00089947
A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection
Not yet reported Genzyme, a Sanofi Company 150 participants Est. completion 2005-12 19 sitesOther conditions: Renal Transplantation, Graft RejectionView official trial listing → -
Completed NCT NCT00093080
Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 216 participants Est. completion 2008-11Obstructive sleep apnea Other conditions: Sarcoma, Soft Tissue, MetastasesView official trial listing → -
Completed NCT NCT00093366
Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Not yet reported, Not yet reported Fred Hutchinson Cancer Center 32 participants Est. completion 2006-07 1 siteOther conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative DiseasesView official trial listing → -
Completed NCT NCT00093782
Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma
Not yet reported National Cancer Institute (NCI) 36 participants Est. completion 2011-04 1 siteOther conditions: Metastatic Gastrointestinal Carcinoid Tumor, Pulmonary Carcinoid Tumor, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Islet Cell CarcinomaView official trial listing → -
Completed NCT NCT00094341
Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes
Not yet reported Amgen 215 participantsOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00096096
Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
Not yet reported Fred Hutchinson Cancer Center 1 siteOther conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative DiseasesView official trial listing → -
Terminated NCT NCT00096460
Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)
Not yet reported, Not yet reported Medical College of Wisconsin 30 participants Est. completion 2009-03 30 sitesOther conditions: Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Follicular LymphomaView official trial listing → -
Completed NCT NCT00096486
Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 74 participants Est. completion 2010-07 1 siteOther conditions: Lung CancerView official trial listing → -
Completed NCT NCT00098007
A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients
Not yet reported Novartis Pharmaceuticals 199 participants Est. completion 2007-01-08 28 sitesOther conditions: Heart TransplantationView official trial listing → -
Withdrawn NCT NCT00098462
Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Not yet reported, Not yet reported Jonsson Comprehensive Cancer CenterOther conditions: Lung CancerView official trial listing → -
Completed NCT NCT00098501
CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors
Not yet reported National Cancer Institute (NCI) 42 participants 1 siteOther conditions: Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00098553
Everolimus in Treating Patients With Stage IV Melanoma
Not yet reported Alliance for Clinical Trials in Oncology 53 participants Est. completion 2010-02 94 sitesOther conditions: Melanoma (Skin)View official trial listing → -
Completed NCT NCT00099320
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
Not yet reported AstraZeneca 182 participants Est. completion 2005-08 51 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00099333
Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents
Not yet reported AstraZeneca 49 participants Est. completion 2005-08 5 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00101738
Freedom Study: Myfortic in Kidney Transplant Patients
Not yet reported Novartis Pharmaceuticals 342 participants Est. completion 2005-05 44 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00103935
Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes
Not yet reported AstraZeneca 45 participants Est. completion 2005-10 7 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00104975
Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Not yet reported Yale University 20 participants Est. completion 2008-05 1 siteOther conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative NeoplasmsView official trial listing → -
Completed NCT NCT00105001
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
Not yet reported Fred Hutchinson Cancer Center 210 participants Est. completion 2015-05-08 11 sites Stand-aloneOther conditions: Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic Lymphocytic Leukemia, Refractory Plasma Cell Myeloma, Waldenstrom Macroglobulinemia, Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA, Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Lymphoma, Childhood Myelodysplastic Syndrome, Stage II Contiguous Adult Burkitt Lymphoma, Stage II Contiguous Adult Diffuse Large Cell Lymphoma, Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma, Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma, Stage II Adult Contiguous Immunoblastic Lymphoma, Stage II Contiguous Adult Lymphoblastic Lymphoma, Stage II Grade 1 Contiguous Follicular Lymphoma, Stage II Grade 2 Contiguous Follicular Lymphoma, Stage II Grade 3 Contiguous Follicular Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Adult Burkitt Lymphoma, Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma, Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma, Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma, Stage II Adult Non-Contiguous Immunoblastic Lymphoma, Stage II Non-Contiguous Adult Lymphoblastic Lymphoma, Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Stage II Grade 2 Non-Contiguous Follicular Lymphoma, Stage II Grade 3 Non-Contiguous Follicular Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma, Stage II Small Lymphocytic Lymphoma, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Burkitt Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Recurrent Childhood Hodgkin Lymphoma, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Secondary Myelodysplastic Syndrome, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Immunoblastic Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Burkitt Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Small Lymphocytic Lymphoma, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Burkitt Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Burkitt Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Burkitt Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic LymphomaView official trial listing → -
Completed NCT NCT00105235
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 27 participants Est. completion 2011-03 9 sites Stand-aloneOther conditions: Liver Disease, Liver TransplantationView official trial listing → -
Completed NCT NCT00106392
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
Not yet reported Astellas Pharma Inc 131 participants Est. completion 2008-11 6 sites Stand-aloneOther conditions: Erectile Dysfunction, Prostate CancerView official trial listing → -
Completed NCT NCT00106496
A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis
Not yet reported Astellas Pharma Inc 410 participants Est. completion 2006-07 24 sitesOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00106639
A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients
Not yet reported Pfizer 61 participants Est. completion 2006-07 20 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00107016
Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women
Not yet reported Novartis Pharmaceuticals 267 participants Est. completion 2007-04 46 sitesOther conditions: Breast NeoplasmView official trial listing → -
Completed NCT NCT00107237
AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme
Not yet reported, Not yet reported Novartis Pharmaceuticals 16 participants Est. completion 2006-06 3 sitesOther conditions: Brain and Central Nervous System TumorsView official trial listing → -
Completed NCT NCT00107991
Etanercept for Treatment of Hidradenitis
Not yet reported University of Pennsylvania 15 participants Est. completion 2008-11 Stand-aloneOther conditions: Hidradenitis SuppurativaView official trial listing → -
Completed NCT NCT00109967
CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Not yet reported National Cancer Institute (NCI) 71 participants Est. completion 2012-03 195 sitesOther conditions: Recurrent Mantle Cell LymphomaView official trial listing → -
Completed NCT NCT00109993
Campath-1H + FK506 and Methylprednisolone for GVHD
Not yet reported Case Comprehensive Cancer Center 34 participants Est. completion 2007-05 6 sitesOther conditions: Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell TumorView official trial listing → -
Completed NCT NCT00110903
Treatment for Subjects With Active Rheumatoid Arthritis (RA)
Not yet reported AmgenOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00110981
Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis
Not yet reported Amgen 86 participants Est. completion 2006-03 Stand-aloneOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00111111
An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis
Not yet reported AmgenOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00111124
Enbrel® in Psoriatic Arthritis
Not yet reported AmgenOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00111540
Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes
Not yet reported AstraZeneca 456 participants Est. completion 2006-09 60 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00112736
Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
Not yet reported, Not yet reported National Cancer Institute (NCI) 69 participants Est. completion 2014-04 8 sitesObstructive sleep apnea Other conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Mixed Glioma, Adult Pilocytic Astrocytoma, Adult Pineal Gland Astrocytoma, Adult Subependymal Giant Cell Astrocytoma, Recurrent Adult Brain TumorView official trial listing → -
Completed NCT NCT00112840
CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer
Not yet reported, Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2015-09-10 2 sitesOther conditions: Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell CancerView official trial listing → -
Completed NCT NCT00113269
Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
Not yet reported Astellas Pharma Inc 501 participants Est. completion 2009-03 29 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00116103
A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma
Not yet reported Astellas Pharma Inc Est. completion 2006-04 21 sitesOther conditions: AsthmaView official trial listing → -
Completed NCT NCT00116727
Rheumatoid Arthritis DMARD Intervention and UtilizationStudy
Amgen 5103 participants Est. completion 2008-10Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00117689
Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection
Not yet reported Genzyme, a Sanofi Company 75 participants Est. completion 2007-12 16 sites Stand-aloneOther conditions: Liver Dysfunction, Rejection, Transplant, Transplantation, LiverView official trial listing → -
Terminated NCT NCT00117702
Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus
Not yet reported, Not yet reported Technische Universität Dresden 24 participants Est. completion 2008-05 1 siteOther conditions: Graft vs Host DiseaseView official trial listing → -
Completed NCT NCT00118742
Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant
Not yet reported Hoffmann-La Roche 293 participants Est. completion 2008-12 46 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00121056
REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations
AmgenOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT00121186
S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma
Not yet reported SWOG Cancer Research Network 1 participants Est. completion 2011-12 33 sites Stand-aloneOther conditions: LymphomaView official trial listing → -
Terminated NCT NCT00121784
Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients
Not yet reported Hoffmann-La Roche 12 participants Est. completion 2006-08 29 sitesOther conditions: Heart TransplantationView official trial listing → -
Completed NCT NCT00121810
Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients
Not yet reported Hoffmann-La Roche 305 participants Est. completion 2009-11 36 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00124280
Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Not yet reported Novartis Pharmaceuticals 85 participants 2 sitesOther conditions: Non-small-cell Lung CarcinomaView official trial listing → -
Completed NCT NCT00124982
Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy
Not yet reported Bristol-Myers Squibb 1286 participants Est. completion 2009-08 148 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00125307
Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
Not yet reported Chinese University of Hong Kong 20 participants Est. completion 2008-02 1 siteOther conditions: Lupus Nephritis, Lupus Erythematosus, SystemicView official trial listing → -
Completed NCT NCT00126672
RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS
Not yet reported Dana-Farber Cancer Institute 36 participants Est. completion 2010-04 7 sitesOther conditions: Nonmalignant Neoplasm, Tuberous Sclerosis, Lymphangioleimyomatosis, Kidney AngiomyolipomaView official trial listing → -
Terminated NCT NCT00127387
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
Not yet reported, Not yet reported The University of Texas Health Science Center at San Antonio 54 participants Est. completion 2005-11 1 siteOther conditions: Lung Cancer, Prostate Cancer, Neoplasm Metastasis, Bone CancerView official trial listing → -
Completed NCT NCT00127842
REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)
Not yet reported Amgen 110 participants Est. completion 2009-09Other conditions: Psoriatic ArthritisView official trial listing → -
Completed NCT NCT00129961
Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 86 participants Est. completion 2009-01 23 sitesOther conditions: Skin Neoplasms, Kidney TransplantationView official trial listing → -
Completed NCT NCT00130546
Intra-Individual Comparison of Sirolimus and Paclitaxel Coated Stent (FRE-RACE Study)
Not yet reported University Hospital Freiburg 112 participants Est. completion 2008-07 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00132418
Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders
Not yet reported Amgen 564 participants Est. completion 2004-02Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00132691
Multicenter Uveitis Steroid Treatment (MUST) Trial
Not yet reported JHSPH Center for Clinical Trials 255 participants Est. completion 2010-12 23 sitesOther conditions: UveitisView official trial listing → -
Terminated NCT NCT00133172
Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection
Not yet reported Astellas Pharma Inc 85 participants Est. completion 2007-03 14 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00133315
TNFalfa Blocking Treatment of Spondylarthropathies
Not yet reported Hvidovre University Hospital 50 participants Est. completion 2007-04 9 sitesOther conditions: Spondylarthropathies, Ankylosing Spondylitis, Psoriatic ArthritisView official trial listing → -
Completed NCT NCT00133367
Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus
Not yet reported Massachusetts General Hospital 32 participants Est. completion 2011-11 2 sitesOther conditions: Multiple Myeloma, Non-Hodgkin's Lymphoma, Hodgkin's Disease, Myelogenous Leukemia, Lymphoblastic LeukemiaView official trial listing → -
Completed NCT NCT00133809
Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression
Not yet reported Emory University 8 participants Est. completion 2014-12 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00133887
TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients
Not yet reported Hospices Civils de Lyon 77 participants Est. completion 2014-05 1 siteOther conditions: Skin Cancer, Kidney TransplantationView official trial listing → -
Completed NCT NCT00134004
Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 210 participants Est. completion 2015-01 3 sites Stand-aloneOther conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00134394
Etanercept With Tacrolimus for Psoriasis
Not yet reported University of Medicine and Dentistry of New Jersey 20 participants Est. completion 2007-12 1 siteOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00135330
An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus
Not yet reported AstraZeneca 137 participants Est. completion 2008-07 19 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00135694
Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 275 participants Est. completion 2015-09 8 sites Stand-aloneOther conditions: Hepatitis C, Hepatitis C, Chronic, Nonimmune Nonviral Causes of Liver FailureView official trial listing → -
Completed NCT NCT00135720
Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
Not yet reported Massachusetts General Hospital 12 participants Est. completion 2007-11 1 siteOther conditions: Pemphigus VulgarisView official trial listing → -
Completed NCT NCT00136903
Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)
Not yet reported Mesoblast, Inc. 32 participants Est. completion 2008-07-14 9 sitesOther conditions: Graft Vs Host DiseaseView official trial listing → -
Completed NCT NCT00139386
Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial
Not yet reported Kumamoto University 1119 participants Est. completion 2012-04 1 siteCardiovascular disease Other conditions: HypertensionView official trial listing → -
Completed NCT NCT00140530
Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)
Not yet reported Deutsches Herzzentrum Muenchen 450 participants Est. completion 2005-06 2 sitesOther conditions: Coronary DiseaseView official trial listing → -
Completed NCT NCT00140543
European Trial of Immunosuppression in SPK Tx
Not yet reported EUROSPK Study Group 228 participants Est. completion 2005-09-30 14 sitesChronic kidney disease Other conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00141037
Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 130 participants Est. completion 2010-11 12 sites Stand-aloneOther conditions: Kidney Diseases, Kidney Transplantation, Kidney Transplant, Renal Transplantation, Renal TransplantView official trial listing → -
Completed NCT NCT00141726
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
Not yet reported University of Michigan Rogel Cancer Center 34 participants Est. completion 2009-02 1 site Stand-aloneOther conditions: Lung Injury, Acute, Respiratory Distress Syndrome, Adult, Bronchiolitis ObliteransView official trial listing → -
Completed NCT NCT00141739
Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)
Not yet reported University of Michigan Rogel Cancer Center 100 participants Est. completion 2012-09 2 sites Stand-aloneOther conditions: Graft-Versus-Host DiseaseView official trial listing → -
Completed NCT NCT00141791
Study Evaluating Etanercept in Moderate to Severe Asthma
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 120 participants Est. completion 2006-07 13 sitesOther conditions: AsthmaView official trial listing → -
Status unknown NCT NCT00141804
Efficacy and Safety of Sirolimus in Combination With Tacrolimus
Not yet reported University Hospital Muenster 190 participants Est. completion 2005-06 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00141921
Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis
Not yet reported Amgen 182 participants Est. completion 2017-08-16 Stand-aloneOther conditions: Pediatric Plaque PsoriasisView official trial listing → -
Completed NCT NCT00143845
Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant
Not yet reported University of Michigan Rogel Cancer Center 54 participants Est. completion 2013-02 1 site Stand-aloneOther conditions: Multiple Myeloma, Lymphocytic Leukemia, Chronic, Lymphoma, Low-GradeView official trial listing → -
Completed NCT NCT00144677
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation
Not yet reported Dana-Farber Cancer Institute 30 participants Est. completion 2006-06 1 siteOther conditions: Acute Myelogenous Leukemia, Graft Versus Host Disease, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndromes, Non-Hodgkin's Lymphoma, Hodgkin's DiseaseView official trial listing → -
Completed NCT NCT00144703
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation
Not yet reported Dana-Farber Cancer Institute 55 participants Est. completion 2006-11 1 siteOther conditions: Hematologic Malignancies, Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma, Hodgkin's DiseaseView official trial listing → -
Completed NCT NCT00146575
Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)
Not yet reported Deutsches Herzzentrum Muenchen 360 participants Est. completion 2005-02 2 sites Stand-aloneOther conditions: Coronary DiseaseView official trial listing → -
Completed NCT NCT00146614
Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation
Not yet reported Dana-Farber Cancer Institute 105 participants Est. completion 2003-04 3 sitesOther conditions: Graft Versus Host Disease, Hematologic MalignanciesView official trial listing → -
Completed NCT NCT00147381
Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection
Not yet reported Dr. Claudia Bösmüller 197 participants Est. completion 2011-07 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00148746
Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis
Not yet reported Technische Universität Dresden Est. completion 2008-03 1 siteOther conditions: Moderate to Severe Atopic DermatitisView official trial listing → -
No Longer Available NCT NCT00149981
A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation
Novartis Pharmaceuticals 153 sitesOther conditions: Organ TransplantationView official trial listing → -
Completed NCT NCT00149994
Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients
Not yet reported Novartis Pharmaceuticals 171 participants Est. completion 2007-12 1 siteOther conditions: Liver TransplantView official trial listing → -
Terminated NCT NCT00150085
Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion
Not yet reported Novartis 50 participants Est. completion 2005-10Other conditions: Tacrolimus-associated Abnormal Glucose Metabolism in Kidney and Liver Transplant RecipientsView official trial listing → -
Completed NCT NCT00150891
Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection
University of Giessen 84 participants Est. completion 2006-01 1 siteOther conditions: Renal Failure, ChronicView official trial listing → -
Terminated NCT NCT00151632
Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation
Not yet reported Rennes University Hospital 195 participants Est. completion 2009-05 8 sites Stand-aloneOther conditions: Evidence of Liver TransplantationView official trial listing → -
Completed NCT NCT00151658
Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)
Not yet reported Copenhagen University Hospital, Rigshospitalet 322 participants Est. completion 2006-06 1 siteOther conditions: Ischaemic Heart DiseaseView official trial listing → -
Completed NCT NCT00154297
Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients
Not yet reported Novartis Pharmaceuticals 139 participants 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00156364
Studies of Organ Transplantation in Animals and Man
Michael Mauer, MD 655 participants Est. completion 2014-08 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00157014
Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens
Not yet reported Astellas Pharma Inc 111 participants Est. completion 2008-07-18 13 sites Stand-aloneOther conditions: Heart Diseases, Heart TransplantationView official trial listing → -
Active, not recruiting NCT NCT00160732
Allogenic Islet Cell Transplantation
Not yet reported, Not yet reported University of Chicago 50 participants Est. completion 2030-10 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00160966
Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy
Not yet reported University of Giessen 108 participants Est. completion 2010-03 1 siteOther conditions: Polyomavirus InfectionsView official trial listing → -
Completed NCT NCT00161655
Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 60 participants Est. completion 2006-12 8 sitesOther conditions: Psoriasis, Arthritis, PsoriaticView official trial listing → -
Completed NCT NCT00163657
Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection
Not yet reported Baylor Research Institute 312 participants Est. completion 2007-01 1 siteOther conditions: End Stage Liver Disease, Hepatitis CView official trial listing → -
Completed NCT NCT00166244
Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation
Not yet reported Erasmus Medical Center 901 participants Est. completion 2006-04 67 sitesOther conditions: De Novo Renal Transplant Recipient.View official trial listing → -
Completed NCT NCT00166556
A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation
Not yet reported Mayo Clinic 10 participants Est. completion 2006-12 1 siteOther conditions: Transplantation, LiverView official trial listing → -
Terminated NCT NCT00166712
A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression
Not yet reported Northwestern University 40 participants Est. completion 2010-04 1 siteOther conditions: Kidney Transplant Failure and RejectionView official trial listing → -
Status unknown NCT NCT00166816
The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients
Not yet reported National Taiwan University Hospital 40 participants Est. completion 2003-06 1 siteOther conditions: Transplantation, Kidney Transplantation, ImmunosuppressionView official trial listing → -
Status unknown NCT NCT00166829
The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus
Not yet reported National Taiwan University Hospital 40 participants 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT00166842
Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
Not yet reported National Taiwan University Hospital 40 participants 1 siteOther conditions: Transplantation, Kidney Transplantation, ImmunosuppressionView official trial listing → -
Withdrawn NCT NCT00167557
Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment
Not yet reported The University of Texas Health Science Center, Houston Est. completion 2008-03 1 siteOther conditions: Hepatitis CView official trial listing → -
Completed NCT NCT00170053
Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids
Not yet reported Mayo Clinic 177 participants Est. completion 2008-09 1 siteOther conditions: Kidney DiseasesView official trial listing → -
Completed NCT NCT00170820
Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen
Not yet reported Novartis Pharmaceuticals 20 participants 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00170833
Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients
Not yet reported Novartis Pharmaceuticals 80 participantsOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00170859
Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients
Not yet reported Novartis Pharmaceuticals Est. completion 2006-12 1 siteOther conditions: Heart TransplantationView official trial listing → -
Completed NCT NCT00171392
Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus
Not yet reported Novartis 132 participants Est. completion 2005-06Other conditions: Prevention of Acute Rejection After Kidney TransplantationView official trial listing → -
Completed NCT NCT00171496
Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients
Not yet reported Novartis 693 participants Est. completion 2006-03Other conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT00171717
Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant
Not yet reported Novartis 39 participants Est. completion 2005-12Other conditions: Maintenance Liver Transplant Patients With New Onset DiabetesView official trial listing → -
Completed NCT NCT00171743
Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients
Not yet reported Novartis 47 participants Est. completion 2006-01Other conditions: Liver TransplantView official trial listing → -
Completed NCT NCT00175253
Alemtuzumab Induction in Islet Transplantation
Not yet reported University of Alberta 12 participants Est. completion 2012-04 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00175266
Islet Transplantation Using Campath-1H and Infliximab Induction
Not yet reported University of Alberta 12 participants 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00176059
Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients
Not yet reported University of Giessen 50 participants Est. completion 2006-05 1 siteOther conditions: Renal Failure, Chronic, Renal TransplantationView official trial listing → -
Completed NCT NCT00177099
Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice
Not yet reported Hordinsky, Maria K., MD 35 participants Est. completion 2004-09 1 siteOther conditions: AlopeciaView official trial listing → -
Terminated NCT NCT00177138
Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation
Not yet reported University of Minnesota 9 participants Est. completion 2006-11 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00178425
PK of MMF in Cadaveric vs Living Donor Liver Transplant Recipients
Not yet reported University of Rochester 24 participants Est. completion 2006-06 1 siteOther conditions: Transplantation, LiverView official trial listing → -
Completed NCT NCT00182559
The Vienna Prograf and Endothelial Progenitor Cell Study
Not yet reported Medical University of Vienna 148 participants Est. completion 2009-05 1 siteOther conditions: End Stage Renal DiseaseView official trial listing → -
Completed NCT NCT00183248
Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients
Not yet reported, Not yet reported University of Miami 9 participants Est. completion 2009-11 1 site Stand-aloneOther conditions: Kidney Transplantation, Kidney Disease, Kidney FailureView official trial listing → -
Completed NCT NCT00186667
Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease
Not yet reported Stanford University 30 participants Est. completion 2005-09 1 siteOther conditions: Graft vs Host Disease, Blood and Marrow Transplant (BMT)View official trial listing → -
Completed NCT NCT00187174
Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors
Not yet reported St. Jude Children's Research Hospital 41 participants Est. completion 2008-10 1 siteObstructive sleep apnea Other conditions: Tumors, Brain Tumors, Sarcoma, Soft TissueView official trial listing → -
Completed NCT NCT00187915
Pilot Trial for Implementation of a MPA PK Monitoring Strategy
Not yet reported University of Florida 24 participants Est. completion 2004-12 1 siteOther conditions: Transplant, KidneyView official trial listing → -
Completed NCT NCT00187941
MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression
Not yet reported University of Florida 22 participants Est. completion 2006-11 1 siteOther conditions: Transplantation, Renal, ImmunosuppressionView official trial listing → -
Completed NCT NCT00188825
Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant
Not yet reported University Health Network, Toronto 22 participants Est. completion 2007-10 1 site Stand-aloneOther conditions: COPD, Emphysema, Alpha-1 Antitrypsan DeficiencyView official trial listing → -
Completed NCT NCT00189202
Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans
Not yet reported, Not yet reported University of Michigan 49 participants Est. completion 2008-07-01 1 site Stand-aloneOther conditions: End Stage Renal Disease, Kidney TransplantationView official trial listing → -
Completed NCT NCT00189722
Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma
Not yet reported Astellas Pharma Inc 160 participants Est. completion 2005-07 28 sitesOther conditions: Asthma, Bronchial, Bronchial AsthmaView official trial listing → -
Completed NCT NCT00189735
A Study to Evaluate FK778 in Kidney Transplant Patients
Not yet reported Astellas Pharma Inc 364 participants Est. completion 2005-10 37 sitesOther conditions: Kidney Transplantation, Renal Transplantation, Transplantation, Renal, Transplantation, Kidney, Grafting, KidneyView official trial listing → -
Completed NCT NCT00189748
A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-
Not yet reported Astellas Pharma Inc 4 sitesOther conditions: Bone Marrow Transplantation, Graft Versus Host Disease, Graft-Versus-Host Disease, Graft-Vs-Host DiseaseView official trial listing → -
Completed NCT NCT00189761
A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients
Not yet reported Astellas Pharma Inc 4 sitesOther conditions: Bone Marrow Transplantation, Graft Versus Host Disease, Graft-Vs-Host Disease, Graft-Versus-Host DiseaseView official trial listing → -
Completed NCT NCT00189787
Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma
Not yet reported Astellas Pharma Inc 370 participants Est. completion 2005-08 49 sitesOther conditions: Asthma, Bronchial, Bronchial AsthmaView official trial listing → -
Completed NCT NCT00189826
A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.
Not yet reported Astellas Pharma Inc 475 participants Est. completion 2006-12 51 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00189839
A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation
Not yet reported Astellas Pharma Inc 699 participants Est. completion 2006-12 80 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00195273
Study Evaluating Sirolimus in Kidney Transplant Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 61 participants Est. completion 2008-07 3 sites Stand-aloneOther conditions: Graft vs Host Disease, Kidney TransplantationView official trial listing → -
Completed NCT NCT00195338
Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg
Pfizer 25 participants Est. completion 2010-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00195364
Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain
Wyeth is now a wholly owned subsidiary of Pfizer 93 participants Est. completion 2008-10 1 siteOther conditions: Rheumatoid Arthritis, InflammationView official trial listing → -
Completed NCT NCT00195377
Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain
Wyeth is now a wholly owned subsidiary of Pfizer 1000 participants Est. completion 2006-04 1 siteOther conditions: Arthritis, Psoriatic, Arthritis, RheumatoidView official trial listing → -
Completed NCT NCT00195403
A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA
Pfizer 1014 participants Est. completion 2008-02 4 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00195429
A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 47 participants Est. completion 2007-10 1 site Stand-aloneOther conditions: Kidney Failure, Graft vs Host DiseaseView official trial listing → -
Completed NCT NCT00195494
Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 542 participants Est. completion 2008-03 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00195507
Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 720 participants Est. completion 2007-02 127 sitesOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00195988
Comparison of Immunosuppression Protocols After LTx in Children
Not yet reported Children's Memorial Health Institute, Poland 40 participants Est. completion 2006-07 1 siteOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00201682
Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Not yet reported, Not yet reported John Byrd 36 participants Est. completion 2009-08 1 site Stand-aloneOther conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic LymphomaView official trial listing → -
Completed NCT NCT00201838
Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma
Not yet reported, Not yet reported Ohio State University Comprehensive Cancer Center 38 participants Est. completion 2007-05 1 site Stand-aloneOther conditions: Pancreatic Neoplasms, AdenocarcinomaView official trial listing → -
Withdrawn NCT NCT00203281
Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Est. completion 2009-09 2 sitesOther conditions: Kidney Transplantation, PlasmapheresisView official trial listing → -
Status unknown NCT NCT00204191
Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation
Not yet reported Uniwersytet Mikolaja Kopernika w Toruniu 300 participants Est. completion 2007-12 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00204321
Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients
Not yet reported University Hospital Muenster 80 participants Est. completion 2010-01 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00205231
A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease
Not yet reported University of Wisconsin, Madison 25 participants Est. completion 2004-05-01 1 siteOther conditions: HIV InfectionsView official trial listing → -
Completed NCT NCT00214201
Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation
Not yet reported University of Wisconsin, Madison 40 participants Est. completion 2009-05 1 site Stand-aloneOther conditions: Primary Renal TransplantView official trial listing → -
Completed NCT NCT00214253
Islet Transplantation in Type 1 Diabetic Patients
Not yet reported University of Wisconsin, Madison 14 participants Est. completion 2011-10 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00214279
MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal
Not yet reported University of Wisconsin, Madison 32 participants Est. completion 2007-11 1 site Stand-aloneOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00214786
Pancreatic Islet Cell Transplantation
Not yet reported Baylor Research Institute 4 participants Est. completion 2007-07 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00217256
The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial
Not yet reported Medtronic Vascular 436 participants Est. completion 2010-12Cardiovascular diseaseView official trial listing → -
Status unknown NCT NCT00220558
GISSOC II: Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions
Not yet reported Società Italiana di Cardiologia Invasiva 150 participants Est. completion 2010-02 14 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT00223015
Investigation of the Steady State Pharmacokinetics of Tacrolimus, Mycophenolate Mofetil and Fluvastatin After Renal Transplantation
Not yet reported University Hospital Schleswig-Holstein 15 participants Est. completion 2005-04Other conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00223028
Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation
Not yet reported University Hospital Schleswig-Holstein 15 participants Est. completion 2005-07Other conditions: Renal TransplantationView official trial listing → -
Terminated NCT NCT00223041
Cranoc Lipid Study in Renal Transplantation
Not yet reported, Not yet reported University Hospital Schleswig-Holstein 200 participants Est. completion 2010-12 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00223054
Polymorphism of the Cytochrome P450-system in Renal Transplants
University Hospital Schleswig-Holstein 200 participants Est. completion 2006-10 1 siteOther conditions: Function of Renal TransplantView official trial listing → -
Completed NCT NCT00223678
Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure
Not yet reported Vanderbilt University Medical Center 20 participants Est. completion 2009-10 1 siteOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT00224393
Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis
Not yet reported The Cleveland Clinic 60 participants Est. completion 2005-08-31Other conditions: Primary Systemic AmyloidosisView official trial listing → -
Completed NCT NCT00227240
Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis
Pfizer 753 participants Est. completion 2009-06 2 sitesOther conditions: Plaque PsoriasisView official trial listing → -
Completed NCT NCT00229138
Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients
Not yet reported Novartis Pharmaceuticals 291 participants Est. completion 2007-03 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT00229515
Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI
Not yet reported Marco Valgimigli 744 participants Est. completion 2012-03 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00231283
NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions
Not yet reported Cordis US Corp. 100 participants Est. completion 2005-07 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00232791
The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.
Not yet reported, Not yet reported Cordis US Corp. 102 participants Est. completion 2005-03 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00232856
A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.
Not yet reported Cordis US Corp. 162 participants Est. completion 2006-08 2 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT00234455
A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.
Not yet reported Cordis US Corp. 86 participants Est. completion 2007-04 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00234728
Study of a New Dressing for Use With Topical Medications
Not yet reported Teikoku Pharma USA, Inc. 120 participants Est. completion 2007-06 1 siteOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00235092
The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus
Not yet reported Cordis US Corp. 1335 participants Est. completion 2006-03 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00235144
The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.
Not yet reported Cordis US Corp. 353 participants Est. completion 2008-09 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00235157
A Comparison of Coated and Uncoated Stents in Renal Artery Treatment.
Not yet reported Cordis US Corp. 105 participants Est. completion 2005-07 3 sites Stand-aloneOther conditions: Renal Artery StenosisView official trial listing → -
Completed NCT NCT00235170
The Arterial Revascularization Therapies Study Part II.
Not yet reported Cordis US Corp. 607 participants Est. completion 2009-04 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00235300
An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.
Not yet reported Genzyme, a Sanofi Company 240 participants Est. completion 2005-06 28 sitesOther conditions: Cadaveric Donor Renal Transplantation, Acute Renal Allograft Rejection, Induction TherapyView official trial listing → -
Completed NCT NCT00235560
Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients
Not yet reported University Hospital, Toulouse 50 participants Est. completion 2008-06 3 sites Stand-aloneOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT00236106
Short Term Growth in Children With Atopic Dermatitis
Not yet reported Children´s Clinic, Randers 20 participants Est. completion 2005-06Other conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT00236171
Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test
Not yet reported Technische Universität Dresden 14 participants Est. completion 2010-06 1 siteOther conditions: Psoriasis VulgarisView official trial listing → -
Completed NCT NCT00238979
A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)
Not yet reported Novartis Pharmaceuticals 50 participantsOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00239031
Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids
Not yet reported Novartis 117 participants Est. completion 2005-07Other conditions: Denovo Renal TransplantationView official trial listing → -
Completed NCT NCT00239876
Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients
Not yet reported Novartis Pharmaceuticals 140 participantsOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00240994
Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 35 participants Est. completion 2009-11 4 sites Stand-aloneOther conditions: Kidney Failure, Chronic, Kidney Transplantation, ImmunosuppressionView official trial listing → -
Completed NCT NCT00241189
Rapamycin vs Methotrexate in Diffuse SSc
Not yet reported, Not yet reported University of California, Los Angeles 17 participants Est. completion 2006-06 1 siteOther conditions: Systemic SclerosisView official trial listing → -
Completed NCT NCT00244556
Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 300 participants Est. completion 2004-05Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00245401
CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)
Not yet reported Cordis US Corp. 2070 participants Est. completion 2004-12Cardiovascular diseaseView official trial listing → -
Completed NCT NCT00245934
Study Evaluating Enbrel in Patients With Rheumatoid Arthritis
Wyeth is now a wholly owned subsidiary of Pfizer 1500 participants Est. completion 2005-07Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00245960
Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 752 participants Est. completion 2008-03-29 120 sitesOther conditions: Psoriatic ArthritisView official trial listing → -
Completed NCT NCT00246129
CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation
Not yet reported EMagnusson 123 participants Est. completion 2011-06 1 site Stand-aloneOther conditions: Kidney Transplantation, Kidney Diseases, Kidney FailureView official trial listing → -
Completed NCT NCT00251004
Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients
Not yet reported Novartis 833 participants Est. completion 2009-10 1 site Stand-aloneOther conditions: Kidney Transplantation, Graft RejectionView official trial listing → -
Status unknown NCT NCT00252655
Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients
Not yet reported Wayne State University 40 participants Est. completion 2009-06 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT00253318
RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer
Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2012-04 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00255593
Safety and Efficacy Study of Rituximab in Renal Transplantation
Not yet reported Karolinska University Hospital 140 participants Est. completion 2007-10 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00255710
Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60 participants 1 siteOther conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative DiseasesView official trial listing → -
Completed NCT NCT00257387
Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants
Not yet reported, Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 120 participants Est. completion 2006-08Other conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT00259610
Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)
Not yet reported University of Alabama at Birmingham 755 participants Est. completion 2009-06 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00259896
In-patient Study in Patients With Type 2 Diabetes Mellitus
Not yet reported GlaxoSmithKline 30 participantsType 2 diabetesView official trial listing → -
Terminated NCT NCT00260208
Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus
Not yet reported Novartis Pharmaceuticals 361 participants 2 sitesOther conditions: Liver Transplant, Hepatitis CView official trial listing → -
Completed NCT NCT00261820
Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 160 participants Est. completion 2005-01Other conditions: Graft Rejection, Kidney Failure, Kidney TransplantationView official trial listing → -
Completed NCT NCT00262886
Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer
Not yet reported University of Rochester 35 participants 1 siteOther conditions: Kidney CancerView official trial listing → -
Completed NCT NCT00263328
Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient
Not yet reported Pfizer 46 participants Est. completion 2014-06 27 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00265473
MGA031, Sirolimus and Tacrolimus in Islet Transplantation
Not yet reported, Not yet reported University of Minnesota 5 participants Est. completion 2010-06 1 siteOther conditions: Type 1 Diabetes Mellitus, HypoglycemiaView official trial listing → -
Completed NCT NCT00266123
Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 420 participants Est. completion 2007-07Other conditions: Graft Rejection, Kidney Failure, Kidney TransplantView official trial listing → -
Completed NCT NCT00267189
RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency
Not yet reported Novartis Pharmaceuticals 145 participants Est. completion 2007-11 2 sitesOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00268515
Aerosol Cyclosporine for Prevention of Lung Rejection
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2003-03Other conditions: Lung DiseasesView official trial listing → -
Completed NCT NCT00270634
Study of ISA247 (Voclosporin) in De Novo Renal Transplantation
Not yet reported Aurinia Pharmaceuticals Inc. 334 participants Est. completion 2009-07 45 sitesOther conditions: Kidney DiseasesView official trial listing → -
Completed NCT NCT00273871
Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 190 participants Est. completion 2006-09Other conditions: Graft Rejection, Kidney Failure, Kidney TransplantationView official trial listing → -
Completed NCT NCT00275509
Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch
Not yet reported Johns Hopkins University 56 participants Est. completion 2010-06 1 site Stand-aloneOther conditions: Kidney Failure, ChronicView official trial listing → -
Completed NCT NCT00275522
The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.
Not yet reported Mayo Clinic 16 participants Est. completion 2007-12 1 siteOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT00275535
The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
Not yet reported Mayo Clinic 165 participants Est. completion 2008-12 1 siteOther conditions: Kidney DiseasesView official trial listing → -
Completed NCT NCT00276250
Islet Transplantation Using Abatacept
Not yet reported Emory University 5 participants Est. completion 2014-12 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00276575
Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors
Not yet reported Herbert Hurwitz, MD 65 participants Est. completion 2014-09 1 siteOther conditions: Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Terminated NCT NCT00276744
Individualized Drug Treatment for Treating Patients With Pancreatic Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 249 participants Est. completion 2010-04 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Terminated NCT NCT00278512
Hematopoietic Stem Cell Support in Vasculitis
Not yet reported Northwestern University 7 participants Est. completion 2016-06 1 site Stand-aloneOther conditions: VasculitisView official trial listing → -
Terminated NCT NCT00281879
Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer
Not yet reported OHSU Knight Cancer Institute 200 participants Est. completion 2008-03 1 siteOther conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unusual Cancers of ChildhoodView official trial listing → -
Completed NCT NCT00281957
Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery
Not yet reported National Cancer Institute (NCI) 109 participants Est. completion 2011-01 173 sitesOther conditions: Recurrent Melanoma, Stage IV MelanomaView official trial listing → -
Completed NCT NCT00282217
Study Evaluating Sirolimus in the Treatment of Kidney Transplant
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 100 participants 13 sitesOther conditions: Kidney Failure, Kidney DiseasesView official trial listing → -
Terminated NCT NCT00282230
A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients
Not yet reported Astellas Pharma Inc 150 participants Est. completion 2005-10 23 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00282243
A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients
Not yet reported Astellas Pharma Inc 70 participants Est. completion 2008-10 10 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00282256
A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients
Not yet reported Astellas Pharma Inc 19 participants Est. completion 2008-10 5 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00282282
Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation
Not yet reported Dana-Farber Cancer Institute 31 participants Est. completion 2009-07 1 siteOther conditions: Graft Versus Host Disease, GVHDView official trial listing → -
Completed NCT NCT00282568
A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients
Not yet reported Astellas Pharma Inc 70 participants Est. completion 2008-10 9 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00284934
Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients
Not yet reported Novartis 94 participants Est. completion 2008-06 1 site Stand-aloneOther conditions: Kidney DiseasesView official trial listing → -
Completed NCT NCT00284947
Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids
Not yet reported Novartis 7 participants Est. completion 2008-12 1 site Stand-aloneOther conditions: Kidney Transplantation, Adverse EffectsView official trial listing → -
Completed NCT NCT00285194
hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients
Not yet reported, Not yet reported University of Minnesota 6 participants Est. completion 2004-01 1 siteOther conditions: Type 1 Diabetes, HypoglycemiaView official trial listing → -
Completed NCT NCT00285233
Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes
Not yet reported, Not yet reported University of Minnesota 8 participants Est. completion 2005-03 1 siteOther conditions: Type 1 Diabetes, HypoglycemiaView official trial listing → -
Terminated NCT NCT00285779
Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus
Not yet reported Stanford University 27 participants Est. completion 2009-11 12 sites Stand-aloneOther conditions: Lichen PlanusView official trial listing → -
Completed NCT NCT00286156
Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Not yet reported, Not yet reported The Cleveland Clinic 30 participants Est. completion 2014-12 1 siteOther conditions: Polycystic Kidney DiseasesView official trial listing → -
Completed NCT NCT00286871
Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen
Not yet reported Duke University 40 participants Est. completion 2009-02 1 siteOther conditions: Chronic Hepatitis C, Organ Transplantation, ImmunosuppressionView official trial listing → -
Status unknown NCT NCT00288210
Sirolimus Eluting Stenting in Acute Myocardial Infarction
Not yet reported San Camillo Hospital, Rome Est. completion 2006-03 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00288977
Islet Transplantation in Type 1 Diabetic Recipients of Kidney Transplants
Not yet reported Beth Israel Deaconess Medical Center 8 participants Est. completion 2008-06Other conditions: Diabetes, Kidney TransplantationView official trial listing → -
Status unknown NCT NCT00290069
Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA)
Not yet reported Sociedad Andaluza de Trasplantes de Organos y Tejidos 94 participants 7 sitesOther conditions: Kidney Diseases, Graft RejectionView official trial listing → -
Completed NCT NCT00290472
CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
Not yet reported National Cancer Institute (NCI) 89 participants Est. completion 2010-04 13 sitesObstructive sleep apnea Other conditions: B-cell Chronic Lymphocytic Leukemia, Malignant Neoplasm, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Splenic Marginal Zone Lymphoma, Waldenström MacroglobulinemiaView official trial listing → -
Terminated NCT NCT00293202
Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients
Not yet reported Kaysen, George A., M.D., Ph.D. 10 participants Est. completion 2010-06 1 siteOther conditions: End Stage Renal DiseaseView official trial listing → -
Completed NCT NCT00293709
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists
Pfizer 129 participants Est. completion 2013-02 1 siteOther conditions: Arthritis, Psoriatic, Psoriasis, Skin Diseases, PapulosquamousView official trial listing → -
Completed NCT NCT00293722
Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
Pfizer 1308 participants Est. completion 2013-02 1 siteOther conditions: Arthritis, Psoriatic, Psoriasis, Skin Diseases, PapulosquamousView official trial listing → -
Completed NCT NCT00293891
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
Not yet reported Astellas Pharma Inc 658 participants Est. completion 2007-01 33 sitesOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00293917
A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis
Not yet reported Astellas Pharma Inc 658 participants Est. completion 2007-08 37 sitesOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00293930
A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis
Not yet reported Astellas Pharma Inc 645 participants Est. completion 2006-11 32 sitesOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00295594
Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.
Not yet reported Astellas Pharma Inc 627 participants Est. completion 2007-06 41 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00295607
Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients
Not yet reported Astellas Pharma Inc 138 participants Est. completion 2008-06 17 sites Stand-aloneOther conditions: Hepatitis C, Liver TransplantationView official trial listing → -
Status unknown NCT NCT00295997
Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia
Not yet reported University of California, San Francisco 35 participants 2 sitesOther conditions: Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative NeoplasmsView official trial listing → -
Completed NCT NCT00296023
Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer
Not yet reported University of California, San Francisco 25 participants Est. completion 2008-06 2 sites Stand-aloneOther conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00296244
Steroid Free Immunosuppression in Liver Transplantation
Not yet reported Thomas Jefferson University 40 participants Est. completion 2008-06 1 siteOther conditions: Liver Cirrhosis, Liver Transplant DisorderView official trial listing → -
Completed NCT NCT00296296
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
Not yet reported Stanford University 29 participants Est. completion 2014-10 1 siteType 2 diabetesChronic kidney disease Other conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT00296309
Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.
Not yet reported Astellas Pharma Inc 267 participants Est. completion 2006-08 33 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00296348
Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation
Not yet reported Astellas Pharma Inc 198 participants Est. completion 2008-02 35 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00296361
To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.
Not yet reported Astellas Pharma Inc 634 participants Est. completion 2006-07 59 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00297310
Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation
Not yet reported Janssen-Cilag Pty Ltd 89 participants Est. completion 2007-04Other conditions: Kidney Transplantation, TransplantationView official trial listing → -
Completed NCT NCT00297661
Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization
Not yet reported University of Bern 1012 participants 1 siteOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00297765
Optimizing Prograf® Therapy in Renal Transplant Patients
Not yet reported Astellas Pharma Inc 323 participants Est. completion 2006-03 42 sitesOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00298506
Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)
Not yet reported Nanjing University School of Medicine 120 participants Est. completion 2009-06 2 sitesOther conditions: Lupus NephritisView official trial listing → -
Status unknown NCT NCT00298662
Combination Therapy of Betaseron-Prograf in Multiple Sclerosis
Not yet reported Clinique de sclérose en plaques et neuromusculaire de l'Outaouais 30 participants Est. completion 2006-09 1 siteOther conditions: Multiple SclerosisView official trial listing → -
Completed NCT NCT00299221
Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients
Not yet reported Newark Beth Israel Medical Center 150 participants Est. completion 2009-12 2 sitesOther conditions: ImmunosuppressionView official trial listing → -
Withdrawn NCT NCT00301912
Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Not yet reported University of California, San Francisco 1 siteOther conditions: Anemia, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative DiseasesView official trial listing → -
Completed NCT NCT00301951
Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Not yet reported University of California, San Francisco 7 participants Est. completion 2009-07 1 site Stand-aloneOther conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00302523
Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy
Not yet reported Nanjing University School of Medicine 16 participants Est. completion 2009-12 2 sitesOther conditions: Idiopathic Membranous NephropathyView official trial listing → -
Withdrawn NCT NCT00302536
Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis
Not yet reported Nanjing University School of Medicine Est. completion 2010-09 1 site Stand-aloneOther conditions: Focal GlomerulosclerosisView official trial listing → -
Completed NCT NCT00302549
To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN
Not yet reported Nanjing University School of Medicine 61 participants Est. completion 2006-02 1 siteOther conditions: Lupus NephritisView official trial listing → -
Terminated NCT NCT00303134
Islet Cell Transplants for Diabetes
Not yet reported Weill Medical College of Cornell University 3 participants Est. completion 2010-06-24 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00304018
Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer
Not yet reported University of California, San Francisco 5 participants Est. completion 2009-03 1 site Stand-aloneOther conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Status unknown NCT NCT00304720
Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor
Not yet reported Colorado Blood Cancer Institute 40 participants 1 siteOther conditions: Multiple Myeloma, Lymphoma, Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT00306397
Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients
Not yet reported University Hospital, Basel, Switzerland 100 participants Est. completion 2008-12 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00308425
Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS
Not yet reported Novartis 119 participants Est. completion 2005-06Other conditions: De Novo Renal TransplantationView official trial listing → -
Completed NCT NCT00309088
FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients
Not yet reported Astellas Pharma Inc 80 participants Est. completion 2008-06 9 sites Stand-aloneOther conditions: Myasthenia GravisView official trial listing → -
Completed NCT NCT00309101
An Open Study for Steroid Resistant, Non-Thymectomized MG Patients
Not yet reported Astellas Pharma Inc 11 participants Est. completion 2009-02 9 sites Stand-aloneOther conditions: Myasthenia GravisView official trial listing → -
Withdrawn NCT NCT00309231
Clinical Islet Transplantation Using the Edmonton Protocol
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Est. completion 2008-01 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00309907
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant
Not yet reported Children's Oncology Group 39 participants Est. completion 2011-09 26 sites Stand-aloneObstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Disseminated Neuroblastoma, Juvenile Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndromes, Pulmonary Complications, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Neuroblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Recurrent/Refractory Childhood Hodgkin Lymphoma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic SyndromesView official trial listing → -
Terminated NCT NCT00311311
Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients
Not yet reported Pfizer 72 participants Est. completion 2012-01 8 sites Stand-aloneOther conditions: Atherosclerosis, Kidney FailureView official trial listing → -
Completed NCT NCT00311623
Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer
Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32 participants Est. completion 2010-06 3 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00313001
Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.
Not yet reported Novo Nordisk A/S 373 participants Est. completion 2007-07 1 siteType 2 diabetes Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00313625
Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma
Not yet reported Fred Hutchinson Cancer Center 20 participants 1 siteOther conditions: Multiple Myeloma and Plasma Cell NeoplasmView official trial listing → -
Completed NCT NCT00315588
Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation
Not yet reported Rodolfo Alejandro 7 participants Est. completion 2014-05 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT00315614
Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus
Not yet reported University of Miami 3 participants Est. completion 2010-12 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00315627
Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation
Not yet reported Rodolfo Alejandro 3 participants Est. completion 2014-01 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00316810
Simultaneous Pancreas-kidney Transplantation With Campath Protocol
Not yet reported Dr. Claudia Bösmüller 30 participants Est. completion 2011-06 1 site Stand-aloneOther conditions: Pancreas-Kidney TransplantationView official trial listing → -
Completed NCT NCT00317499
Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis
Not yet reported Amgen 205 participants Est. completion 2002-07 Stand-aloneOther conditions: Psoriatic Arthritis, PsoriasisView official trial listing → -
Completed NCT NCT00317538
Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept
Not yet reported Centocor Ortho Biotech Services, L.L.C. 28 participants Est. completion 2004-11Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00317681
Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)
Not yet reported Heinrich-Heine University, Duesseldorf 30 participants Est. completion 2007-02 1 siteOther conditions: Cutaneous Lupus ErythematosusView official trial listing → -
Completed NCT NCT00317785
Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases
Not yet reported Fred Hutchinson Cancer Center 50 participants 2 sitesOther conditions: Leukemia, Lymphoma, Myelodysplastic SyndromesView official trial listing → -
Terminated NCT NCT00318110
Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma
Not yet reported Center for International Blood and Marrow Transplant Research 4 participants Est. completion 2009-03 5 sites Stand-aloneOther conditions: Metastatic Renal Cell CarcinomaView official trial listing → -
Status unknown NCT NCT00319878
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
Not yet reported, Not yet reported Office of Rare Diseases (ORD) 52 participants Est. completion 2009-12 4 sites Stand-aloneOther conditions: Anemia, AplasticView official trial listing → -
Completed NCT NCT00319917
A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients
Not yet reported Astellas Pharma Inc 123 participants Est. completion 2008-10 8 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00321074
Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts
Not yet reported Astellas Pharma Inc 101 participants Est. completion 2007-10 9 sites Stand-aloneOther conditions: LIVER TRANSPLANTATIONView official trial listing → -
Completed NCT NCT00321113
Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys
Not yet reported Astellas Pharma Inc 142 participants Est. completion 2008-03 14 sites Stand-aloneOther conditions: KIDNEY TRANSPLANTATIONView official trial listing → -
Completed NCT NCT00321256
Human Islet Transplantation in Brittle Type 1 Diabetes Mellitus. The GRAGIL 2 Study.
Not yet reported, Not yet reported University Hospital, Grenoble 22 participants Est. completion 2007-07 6 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00321906
Comparison of Sirolimus and Azathioprine in Lung Transplantation
Not yet reported University of Chicago 181 participants Est. completion 2011-08 1 siteOther conditions: Delayed Graft Function, Acute Graft RejectionView official trial listing → -
Completed NCT NCT00322101
Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia
Not yet reported Fred Hutchinson Cancer Center 25 participants Est. completion 2014-10 8 sites Stand-aloneOther conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00323895
The Intra-Drug Eluting Stent (DES) Restenosis Study
Not yet reported Cordis US Corp. 320 participants Est. completion 2010-01 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT00325325
Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus
Not yet reported Hospital Universitario Ramon y Cajal 40 participants Est. completion 2007-06 1 siteOther conditions: Kidney DiseasesView official trial listing → -
Completed NCT NCT00328770
De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma
Not yet reported, Not yet reported University of Alberta 70 participants Est. completion 2006-03 1 site Stand-aloneOther conditions: Liver CarcinomaView official trial listing → -
Completed NCT NCT00329719
Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma
Not yet reported, Not yet reported National Cancer Institute (NCI) 115 participants Est. completion 2013-02-02 190 sitesObstructive sleep apnea Other conditions: Adult Glioblastoma, Recurrent Adult Brain NeoplasmView official trial listing → -
Completed NCT NCT00329823
Etanercept in Hidradenitis Suppurativa
Not yet reported University of Athens 10 participants Est. completion 2006-05 1 siteOther conditions: Hidradenitis SuppurativaView official trial listing → -
Completed NCT NCT00331162
Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation
Not yet reported Wake Forest University Health Sciences 222 participants Est. completion 2011-11-28 1 siteOther conditions: Graft RejectionView official trial listing → -
Completed NCT NCT00332332
Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis
Not yet reported Amgen 246 participants Est. completion 2010-02 Stand-aloneOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00332397
The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis
Not yet reported Deutsches Herzzentrum Muenchen 1007 participants Est. completion 2007-07 2 sitesOther conditions: Coronary DiseaseView official trial listing → -
Terminated NCT NCT00332839
Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.
Not yet reported Novartis Pharmaceuticals 93 participants Est. completion 2013-03 11 sites Stand-aloneOther conditions: Renal TransplantationView official trial listing → -
Terminated NCT NCT00337376
A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers
Not yet reported Yale University 23 participants Est. completion 2010-07 1 siteOther conditions: Advanced Solid CancersView official trial listing → -
Completed NCT NCT00337493
Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.
Not yet reported Hoffmann-La Roche 155 participants Est. completion 2008-01 20 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00337545
Phase II Trial of RAD001 in Refractory Colorectal Cancer
Not yet reported Swedish Medical Center 22 participants Est. completion 2007-04 1 siteOther conditions: Colorectal CancerView official trial listing → -
Completed NCT NCT00343226
An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.
Not yet reported Novartis 48 participantsOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00344851
Exenatide and Metformin Therapy in Overweight Women With PCOS
Not yet reported Metabolic Center of Louisiana Research Foundation 60 participants Est. completion 2007-06 1 siteOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Terminated NCT NCT00346151
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2010-02 2 sites Stand-aloneOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT00346359
Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2007-11 1 siteOther conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative DiseasesView official trial listing → -
Completed NCT NCT00347048
Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients
Not yet reported Astellas Pharma Inc 62 participants Est. completion 2008-04 6 sites Stand-aloneOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT00350181
Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT
Not yet reported Stanford University 11 participants Est. completion 2010-04 1 site Stand-aloneOther conditions: Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases, Acute GVHDView official trial listing → -
Completed NCT NCT00350454
Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)
Not yet reported Deutsches Herzzentrum Muenchen 605 participants Est. completion 2007-10 2 sitesOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00350545
A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease
Not yet reported Stanford University 37 participants Est. completion 2014-10 1 site Stand-aloneOther conditions: Graft vs Host DiseaseView official trial listing → -
Withdrawn NCT NCT00352950
Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer
Not yet reported Amgen Est. completion 2008-02Other conditions: Oncology, Non-Small Cell Lung CancerView official trial listing → -
Completed NCT NCT00352976
TBI Dose De-escalation for Fanconi Anemia
Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 83 participants Est. completion 2020-10-09 1 site Stand-aloneOther conditions: Fanconi AnemiaView official trial listing → -
Completed NCT NCT00353119
A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis
Not yet reported Innovaderm Research Inc. 15 participants Est. completion 2007-03 3 sitesOther conditions: Palmoplantaris PustulosisView official trial listing → -
Completed NCT NCT00353301
Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma
Not yet reported University of Colorado, Denver 25 participants Est. completion 2012-03 1 site Stand-aloneOther conditions: Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT00355862
Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
Not yet reported University of Regensburg 525 participants Est. completion 2014-05 1 site Stand-aloneOther conditions: Hepatocellular CarcinomaView official trial listing → -
Completed NCT NCT00356356
16.0040 Ankylosing Spondylitis Study
Not yet reported Amgen 257 participants Est. completion 2006-09 Stand-aloneOther conditions: Ankylosing SpondylitisView official trial listing → -
Completed NCT NCT00356590
Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012
Not yet reported Amgen 468 participants Est. completion 2009-04Other conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT00358657
Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders
Not yet reported Fred Hutchinson Cancer Center 14 participants Est. completion 2019-05-25 3 sites Stand-aloneOther conditions: Immunodeficiency Syndrome, Severe Aplastic Anemia, Genetic DisorderView official trial listing → -
Completed NCT NCT00359879
Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes
Not yet reported AstraZeneca 377 participants Est. completion 2007-07 15 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00360334
A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients
Not yet reported AstraZeneca 235 participants Est. completion 2008-04 31 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00360685
Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 89 participants Est. completion 2011-01 1 siteOther conditions: Mucositis, Graft-versus-host DiseaseView official trial listing → -
Completed NCT NCT00361634
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis
Not yet reported Amgen 14 participants Est. completion 2010-03 3 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00362531
Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome
Not yet reported, Not yet reported Peking University Est. completion 2007-01Other conditions: Idiopathic Membranous Nephropathy, Nephrotic SyndromeView official trial listing → -
Completed NCT NCT00363116
A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients
Not yet reported University of Cincinnati 298 participants Est. completion 2004-12 24 sitesOther conditions: Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant RecipientsView official trial listing → -
Completed NCT NCT00364572
Efficacy of Epidural Etanercept in the Treatment of Sciatica
Not yet reported, Not yet reported Johns Hopkins University 24 participants Est. completion 2007-12 1 site Stand-aloneOther conditions: SciaticaView official trial listing → -
Completed NCT NCT00365846
"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"
Not yet reported University of Wisconsin, Madison 29 participants Est. completion 2006-07 1 site Stand-aloneOther conditions: Renal TransplantView official trial listing → -
Withdrawn NCT NCT00368719
Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis
Not yet reported University of California, Davis Est. completion 2016-07Other conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT00368914
Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30 participants Est. completion 2009-06 1 siteOther conditions: Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00369161
A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients
Not yet reported Novartis 228 participants Est. completion 2008-12 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00369226
Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
Not yet reported, Not yet reported Dana-Farber Cancer Institute 45 participants Est. completion 2011-09 2 sites Stand-aloneOther conditions: Hematologic MalignanciesView official trial listing → -
Completed NCT NCT00369382
Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 121 participants Est. completion 2010-05 23 sites Stand-aloneOther conditions: Graft Rejection, Kidney FailureView official trial listing → -
Completed NCT NCT00371319
Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis
Not yet reported Tuen Mun Hospital 150 participants Est. completion 2014-06 1 siteOther conditions: Lupus NephritisView official trial listing → -
Terminated NCT NCT00373815
Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease
Not yet reported University Hospital Tuebingen 10 participants Est. completion 2009-10 1 siteOther conditions: Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT00374140
Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer
Not yet reported Ahmad Tarhini 40 participants Est. completion 2012-06 19 sitesOther conditions: Small Cell Lung CancerView official trial listing → -
Completed NCT NCT00374231
Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients
Not yet reported University of Cincinnati 40 participants Est. completion 2008-01 1 site Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00374803
Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal
Not yet reported University of Cincinnati 45 participants Est. completion 2008-01 2 sitesOther conditions: End Stage Renal Disease (ESRD)View official trial listing → -
Terminated NCT NCT00375895
Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation
Not yet reported Rennes University Hospital 11 participants Est. completion 2009-12 13 sitesOther conditions: Chronic Hepatitis C, Evidence of Liver TransplantationView official trial listing → -
Completed NCT NCT00376688
Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Not yet reported National Cancer Institute (NCI) 31 participants Est. completion 2019-12-16 2 sitesOther conditions: Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT00377962
Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation
Not yet reported Novartis Pharmaceuticals 282 participants Est. completion 2010-02 6 sites Stand-aloneOther conditions: Disorder Related to Cardiac TransplantationView official trial listing → -
Completed NCT NCT00378326
Immunotherapy of the Paraneoplastic Syndromes
Not yet reported Rockefeller University 26 participants Est. completion 2014-05 1 site Stand-aloneOther conditions: Paraneoplastic SyndromesView official trial listing → -
Completed NCT NCT00378703
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
Not yet reported National Cancer Institute (NCI) 361 participants Est. completion 2017-03-21 559 sitesOther conditions: Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7View official trial listing → -
Completed NCT NCT00381342
Safety and Efficacy of Exenatide as Monotherapy
Not yet reported AstraZeneca 233 participants Est. completion 2007-09 19 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00382109
Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
Not yet reported Children's Oncology Group 146 participants Est. completion 2017-06-30 50 sites Stand-aloneOther conditions: B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic LeukemiaView official trial listing → -
Completed NCT NCT00384137
A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients
Not yet reported Astellas Pharma Inc 128 participants Est. completion 2007-07 13 sites Stand-aloneOther conditions: TransplantationView official trial listing → -
Completed NCT NCT00384202
A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients
Not yet reported Astellas Pharma Inc 112 participants Est. completion 2007-11 13 sites Stand-aloneOther conditions: TransplantationView official trial listing → -
Completed NCT NCT00384969
Sorafenib and RAD001 Renal Cell Carcinoma
Not yet reported University of California, San Francisco 21 participants Est. completion 2014-03 1 siteOther conditions: Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT00385788
Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease
Not yet reported M.D. Anderson Cancer Center 52 participants Est. completion 2016-08 1 site Stand-aloneOther conditions: Hodgkin's DiseaseView official trial listing → -
Completed NCT NCT00387400
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Not yet reported NCIC Clinical Trials Group 32 participants Est. completion 2012-01-06 9 sitesOther conditions: Brain and Central Nervous System TumorsView official trial listing → -
Status unknown NCT NCT00390195
Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)
Not yet reported, Not yet reported National Health Research Institutes, Taiwan 134 participants Est. completion 2011-06 2 sitesOther conditions: Hepatocellular CarcinomaView official trial listing → -
Terminated NCT NCT00390364
Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 participants Est. completion 2007-10 1 siteOther conditions: Colorectal CancerView official trial listing → -
Completed NCT NCT00392821
Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer
Not yet reported, Not yet reported SCRI Development Innovations, LLC 78 participants Est. completion 2013-10 11 sitesOther conditions: Kidney CancerView official trial listing → -
Completed NCT NCT00392951
Sirolimus for Autoimmune Disease of Blood Cells
Not yet reported, Not yet reported Children's Hospital of Philadelphia 30 participants Est. completion 2016-02 1 site Stand-aloneOther conditions: Autoimmune Pancytopenia, Autoimmune Lymphoproliferative Syndrome (ALPS), Evans Syndrome, Idiopathic Thrombocytopenic Purpura, Anemia, Hemolytic, Autoimmune, Autoimmune Neutropenia, Lupus Erythematosus, Systemic, Inflammatory Bowel Disease, Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00397982
Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma
Not yet reported National Cancer Institute (NCI) 17 participants Est. completion 2013-07 2 sitesOther conditions: Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma, Stage IV Skin MelanomaView official trial listing → -
Completed NCT NCT00400400
Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance
Not yet reported Novartis Pharmaceuticals 400 participants 53 sites Stand-aloneOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00401115
Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
Not yet reported Santen Inc. 50 participants Est. completion 2008-06 2 sitesOther conditions: Diabetic Macular Edema, Diabetic RetinopathyView official trial listing → -
Completed NCT NCT00401778
Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Not yet reported Emory University 33 participants Est. completion 2013-12 1 siteOther conditions: Lung CancerView official trial listing → -
Completed NCT NCT00402168
A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids
Not yet reported Bristol-Myers Squibb 173 participants Est. completion 2013-06 44 sitesOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT00402532
Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation
Not yet reported Hannover Medical School 190 participants Est. completion 2011-12 1 siteOther conditions: Lung TransplantationView official trial listing → -
Completed NCT NCT00402558
Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2014-04 1 site Stand-aloneOther conditions: Myelodysplastic Syndrome, LeukemiaView official trial listing → -
Terminated NCT NCT00402662
A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma
Not yet reported Yale University 3 participants Est. completion 2006-06 1 siteOther conditions: Metastatic MelanomaView official trial listing → -
Completed NCT NCT00403338
The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)
Cordis US Corp. 1500 participants Est. completion 2006-04Other conditions: Coronary StenosisView official trial listing → -
Completed NCT NCT00403416
Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients
Not yet reported, Not yet reported Novartis Pharmaceuticals 215 participants Est. completion 2008-05 28 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00404794
A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis
Not yet reported Hospital Authority, Hong Kong 20 participants Est. completion 2009-10 1 siteOther conditions: Lupus Nephritis, Glomerulonephritis, MembranousView official trial listing → -
Terminated NCT NCT00406276
Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer
Not yet reported, Not yet reported Emory University 28 participants Est. completion 2013-02 1 siteOther conditions: Lung CancerView official trial listing → -
Completed NCT NCT00406393
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)
Not yet reported Medical College of Wisconsin 304 participants Est. completion 2015-10 24 sites Stand-aloneOther conditions: Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00407160
A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients
The University of Texas Medical Branch, Galveston 21 participants Est. completion 2011-01 1 siteOther conditions: Kidney DiseasesView official trial listing → -
Terminated NCT NCT00409461
Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts
Not yet reported Universitair Ziekenhuis Brussel 2 sitesOther conditions: Islet Transplantation, Type 1 DiabetesView official trial listing → -
Completed NCT NCT00410124
RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib
Not yet reported Novartis Pharmaceuticals 416 participants Est. completion 2011-10 93 sitesOther conditions: Metastatic Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT00411619
Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex
Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 28 participants Est. completion 2014-01 1 siteOther conditions: Tuberous Sclerosis, Subependymal Giant Cell AstrocytomaView official trial listing → -
Completed NCT NCT00411944
Long-Term Pharmacokinetics of Tacrolimus in Renal Recipients
KU Leuven 100 participants Est. completion 2005-09 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00413400
Study of TNF-Antagonism in the Metabolic Syndrome (II)
Not yet reported Massachusetts General Hospital 40 participants Est. completion 2009-09 1 siteMetabolic syndromeView official trial listing → -
Completed NCT NCT00413452
Etanercept SFP in RA Patients
Not yet reported Amgen 224 participants Est. completion 2007-10 Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00414440
Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease
Not yet reported Novartis Pharmaceuticals 431 participants Est. completion 2013-10 24 sitesOther conditions: Autosomal Dominant Polycystic Kidney DiseaseView official trial listing → -
Terminated NCT NCT00417677
A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma
Not yet reported, Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 124 participants Est. completion 2007-05 4 sitesOther conditions: Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT00418067
Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions
Not yet reported Seung-Jung Park 2645 participants Est. completion 2009-01 20 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT00418548
Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 350 participants Est. completion 2005-02Other conditions: Ankylosing SpondylitisView official trial listing → -
Completed NCT NCT00420238
Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 82 participants Est. completion 2009-05 21 sites Stand-aloneOther conditions: Ankylosing SpondylitisView official trial listing → -
Completed NCT NCT00420303
Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 24 participants Est. completion 2008-09 15 sites Stand-aloneOther conditions: Spondylarthropathies, EnthesitisView official trial listing → -
Completed NCT NCT00421174
Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 37 participants Est. completion 2013-07 12 sites Stand-aloneOther conditions: Pneumonia, Idiopathic Pneumonia SyndromeView official trial listing → -
Completed NCT NCT00421980
An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 84 participants Est. completion 2004-07 1 siteOther conditions: Ankylosing SpondylitisView official trial listing → -
Completed NCT NCT00422344
A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma
Not yet reported Memorial Sloan Kettering Cancer Center 20 participants Est. completion 2010-02 1 siteOther conditions: Renal Cell Carcinoma, Kidney CancerView official trial listing → -
Completed NCT NCT00423514
Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease
Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 38 participants Est. completion 2021-06-18 1 site Stand-aloneOther conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic SyndromesView official trial listing → -
No Longer Available NCT NCT00423826
Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Barbara Ann Karmanos Cancer Institute Est. completion 2015-01 1 siteOther conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary MyelofibrosisView official trial listing → -
Completed NCT NCT00423865
Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors
Not yet reported Memorial Sloan Kettering Cancer Center 30 participants Est. completion 2011-09 1 siteOther conditions: Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00425308
Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance.
Not yet reported Novartis Pharmaceuticals 30 participants 1 siteOther conditions: Renal TransplantationView official trial listing → -
Status unknown NCT NCT00426049
Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation
Not yet reported German Heart Institute 484 participants 1 siteCardiovascular disease Other conditions: Coronary RestenosisView official trial listing → -
Completed NCT NCT00426517
Donor Stem Cell Transplantation for Congenital Immunodeficiencies
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2019-11-01 1 site Stand-aloneOther conditions: Inherited Immune DeficienciesView official trial listing → -
Completed NCT NCT00426530
Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer
Not yet reported Novartis Pharmaceuticals 50 participants Est. completion 2010-06 6 sitesOther conditions: Breast Neoplasms, Neoplasm MetastasisView official trial listing → -
Completed NCT NCT00428454
Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions
Not yet reported R&D Cardiologie 301 participants Est. completion 2015-06 5 sites Stand-aloneCardiovascular disease Other conditions: Coronary Disease, Coronary StenosisView official trial listing → -
Terminated NCT NCT00429052
Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease
University of Florida 24 participants Est. completion 2008-09 1 siteOther conditions: Coronary DiseaseView official trial listing → -
Completed NCT NCT00429143
A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative
Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 27 participants Est. completion 2010-06 1 site Stand-aloneOther conditions: Hematologic MalignanciesView official trial listing → -
Completed NCT NCT00429377
Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study
Not yet reported Astellas Pharma Inc 64 participants 7 sitesOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT00429416
Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation
Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14 participants Est. completion 2009-05 1 site Stand-aloneOther conditions: Hematologic MalignanciesView official trial listing → -
Completed NCT NCT00429793
Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2012-01 1 siteOther conditions: Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial CancerView official trial listing → -
Completed NCT NCT00430898
Basiliximab in Moderate to Severe Ulcerative Colitis
Not yet reported Cerimon Pharmaceuticals 181 participants Est. completion 2008-09 68 sites Stand-aloneOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT00432406
Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
Not yet reported Chinese University of Hong Kong 40 participants Est. completion 2009-03 1 siteOther conditions: Psoriatic ArthritisView official trial listing → -
Completed NCT NCT00433485
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
Not yet reported Yale University 16 participants Est. completion 2008-03Other conditions: Neoplastic Syndrome, Non-melanomatous Skin CancerView official trial listing → -
Completed NCT NCT00434174
Safety of Everolimus and Pemetrexed in Lung Cancer Patients
Not yet reported Novartis Pharmaceuticals 48 participants Est. completion 2010-12 5 sitesOther conditions: Non Small Cell Lung CancerView official trial listing → -
Completed NCT NCT00434811
Islet Transplantation in Type 1 Diabetes
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2014-05 8 sites Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00434850
Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 14 participants Est. completion 2013-11 3 sites Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00434954
Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
Not yet reported AstraZeneca 494 participants Est. completion 2009-06 39 sites Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT00436722
Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial
Not yet reported Hospital Clinic of Barcelona 72 participants 1 siteOther conditions: Liver DiseasesView official trial listing → -
Terminated NCT NCT00437398
Islet Transplantation for Type 1 Diabetes Mellitus
Not yet reported, Not yet reported Mayo Clinic 2 participants Est. completion 2012-01 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00439556
Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant
Not yet reported M.D. Anderson Cancer Center 40 participants Est. completion 2018-06-07 1 site Stand-aloneOther conditions: CD20 Positive, Hematopoietic and Lymphoid Cell Neoplasm, Lymphocytic Neoplasm, LymphomaView official trial listing → -
Status unknown NCT NCT00443105
Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study
Not yet reported Assaf-Harofeh Medical Center 1 siteOther conditions: Allergic ConjunctivitisView official trial listing → -
Status unknown NCT NCT00443508
Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based Immunosuppresion
Not yet reported Rabin Medical Center 60 participants Est. completion 2010-02 1 siteOther conditions: Kidney DiseasesView official trial listing → -
Completed NCT NCT00443950
Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 150 participants Est. completion 2007-07 6 sitesOther conditions: Arthritis, RheumatoidView official trial listing → -
Completed NCT NCT00444340
An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 70 participants Est. completion 2007-07Other conditions: Ankylosing SpondylitisView official trial listing → -
Completed NCT NCT00445744
Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
Not yet reported Fred Hutchinson Cancer Center 52 participants Est. completion 2013-06 1 site Stand-aloneOther conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Myelodysplastic Syndrome With Isolated Del(5q), Polycythemia Vera, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Secondary Myelofibrosis, Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid MalignanciesView official trial listing → -
Completed NCT NCT00446264
Islet Allotransplantation With Steroid Free Immunosuppression
Not yet reported University Hospital, Lille 14 participants Est. completion 2009-02 1 site Stand-aloneOther conditions: Type 1 Diabetes, Hypoglycemia, Metabolic DiseasesView official trial listing → -
Completed NCT NCT00446368
Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer
Not yet reported The Methodist Hospital Research Institute 66 participants Est. completion 2008-10 1 siteOther conditions: Carcinoma, Renal CellView official trial listing → -
Terminated NCT NCT00447265
Etanercept for the Treatment of Lupus Nephritis
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 1 participants Est. completion 2009-03 6 sites Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT00448149
Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer
Not yet reported, Not yet reported The Methodist Hospital Research Institute 55 participants Est. completion 2009-06 1 siteOther conditions: Carcinoma, Renal CellView official trial listing → -
Completed NCT NCT00448201
Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Not yet reported UNC Lineberger Comprehensive Cancer Center 71 participants Est. completion 2012-05-23 1 siteOther conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00448357
Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen
Not yet reported, Not yet reported UNC Lineberger Comprehensive Cancer Center 54 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00449280
Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies
Not yet reported University of Chicago 34 participants Est. completion 2009-09 1 siteOther conditions: Advanced Solid TumorView official trial listing → -
Completed NCT NCT00449748
Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
Not yet reported M.D. Anderson Cancer Center 10 participants Est. completion 2009-10 1 siteOther conditions: Systemic MastocytosisView official trial listing → -
Completed NCT NCT00450320
Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma
Not yet reported AIDS Malignancy Consortium 7 participants Est. completion 2009-09 3 sitesOther conditions: SarcomaView official trial listing → -
Completed NCT NCT00451932
A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients
Not yet reported Astellas Pharma Inc 303 participants Est. completion 2005-09 29 sitesOther conditions: Liver TransplantationView official trial listing → -
Terminated NCT NCT00452361
Study Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft Recipient
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 31 participants Est. completion 2008-08 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00454584
An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis
Not yet reported Centocor, Inc. 903 participants Est. completion 2009-01Other conditions: PsoriasisView official trial listing → -
Completed NCT NCT00455013
A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation
Not yet reported Bristol-Myers Squibb 93 participants Est. completion 2012-08 17 sites Stand-aloneOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Completed NCT NCT00456235
Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors
Not yet reported University Hospital, Limoges 92 participants Est. completion 2011-09 17 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00456833
Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy
Not yet reported Novartis Pharmaceuticals 248 participants 14 sitesOther conditions: Non Small Cell Lung CancerView official trial listing → -
Completed NCT NCT00456885
The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women
Not yet reported Beth Israel Deaconess Medical Center 41 participants Est. completion 2010-09 1 site Stand-alonePrediabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT00457808
Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM
Not yet reported Children's Hospital Medical Center, Cincinnati 25 participants Est. completion 2006-03 1 siteOther conditions: Tuberous Sclerosis, LymphangioleiomyomatosisView official trial listing → -
Completed NCT NCT00457964
RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM
Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 36 participants Est. completion 2013-07 1 siteOther conditions: Tuberous Sclerosis, LymphangioleiomyomatosisView official trial listing → -
Completed NCT NCT00459186
The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer
Not yet reported, Not yet reported Dana-Farber Cancer Institute 19 participants Est. completion 2012-12 5 sitesOther conditions: Metastatic, Androgen Independent Prostate Cancer, Prostate CancerView official trial listing → -
Completed NCT NCT00459706
Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept
Not yet reported Pfizer 640 participants Est. completion 2009-09 113 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00459719
A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation
Not yet reported Astellas Pharma Inc 42 participants Est. completion 2009-03 5 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Status unknown NCT NCT00461357
Sirolimus Based Immunosuppression for Patients Undergoing Kidney Transplantation in the Eurotransplant Senior Program
Medical University of Vienna 48 participants Est. completion 2007-12Other conditions: Kidney Function After Transplantation, Outcome After Kidney TransplantationView official trial listing → -
Terminated NCT NCT00463723
Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following Penetrating Keratoplasty
Not yet reported, Not yet reported University Hospital FreiburgOther conditions: Penetrating KeratoplastyView official trial listing → -
Completed NCT NCT00464399
Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients
Not yet reported Novartis Pharmaceuticals 20 participants 1 siteOther conditions: De Novo Renal TransplantationView official trial listing → -
Completed NCT NCT00464555
Strategies to Improve Islet Survival
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2014-02 2 sites Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Status unknown NCT NCT00466102
Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases
Not yet reported GBG Forschungs GmbH 130 participants Est. completion 2012-12 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00467194
Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Not yet reported National Cancer Centre, Singapore 27 participants 2 sitesOther conditions: Liver CancerView official trial listing → -
Completed NCT NCT00468117
Efficacy of Islet After Kidney Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2017-07-05 10 sites Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00468403
LEA29Y (Belatacept) Emory Edmonton Protocol
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2013-04 2 sites Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Terminated NCT NCT00468442
B-Lymphocyte Immunotherapy in Islet Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 2 participants Est. completion 2011-09 1 site Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00469131
Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid
Not yet reported Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 79 participants Est. completion 2011-08 1 siteOther conditions: Hepatitis C, Liver CirrhosisView official trial listing → -
Completed NCT NCT00470665
Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 460 participants Est. completion 2004-07Other conditions: Renal Allograft RecipientsView official trial listing → -
Terminated NCT NCT00472082
Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients
Not yet reported, Not yet reported Emory University 5 participants Est. completion 2009-04 1 siteOther conditions: Kidney Transplantation, Chronic Kidney FailureView official trial listing → -
Completed NCT NCT00473499
PEPCAD III Substudy: Stem Cell Mobilization
Not yet reported, Not yet reported University Hospital, Saarland 60 participants Est. completion 2009-11 1 siteCardiovascular diseaseView official trial listing → -
Terminated NCT NCT00475605
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis
LEO Pharma 8071 participants Est. completion 2019-01-31 313 sitesOther conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT00476229
Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies
Not yet reported M.D. Anderson Cancer Center 20 participants Est. completion 2009-05 1 siteOther conditions: Lymphoma, LeukemiaView official trial listing → -
Completed NCT NCT00477581
A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus
Not yet reported AstraZeneca 102 participants Est. completion 2007-09 19 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00480610
Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment
Not yet reported Astellas Pharma Inc 226 participants Est. completion 2005-11 22 sites Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00480896
Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
Not yet reported Astellas Pharma Inc 250 participants Est. completion 2005-11 22 sites Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00481481
Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects
Not yet reported Astellas Pharma Inc 346 participants Est. completion 2009-04 56 sites Stand-aloneOther conditions: TransplantationView official trial listing → -
Completed NCT NCT00481819
A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation
Not yet reported Astellas Pharma Inc 240 participants Est. completion 2009-03 9 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00482170
Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept
Not yet reported Pfizer 421 participants Est. completion 2009-09 78 sites Stand-aloneOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00482183
Comparison Between Pioglitazone and SES With type2 DM
Not yet reported, Not yet reported Showa University 38 participants Est. completion 2007-06Cardiovascular diseaseType 2 diabetesView official trial listing → -
Completed NCT NCT00483262
Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma
Not yet reported, Not yet reported Dana-Farber Cancer Institute 63 participants Est. completion 2012-02 3 sitesOther conditions: Multiple MyelomaView official trial listing → -
Completed NCT NCT00484237
A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 80 participants Est. completion 2007-12 13 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00484809
Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children
Wyeth is now a wholly owned subsidiary of Pfizer 100 participants Est. completion 2006-02Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00488475
Observational Trial With Enbrel
Pfizer 4945 participants Est. completion 2013-04 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00489203
Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Not yet reported Fred Hutchinson Cancer Center 140 participants 2 sites Stand-aloneObstructive sleep apnea Other conditions: Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Atypical Chronic Myeloid Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Extramedullary Plasmacytoma, Graft Versus Host Disease, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Meningeal Chronic Myelogenous Leukemia, Myelodysplastic/Myeloproliferative Disease, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic LymphomaView official trial listing → -
Status unknown NCT NCT00490789
Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM
Not yet reported Cardiff University 14 participants Est. completion 2009-09 3 sitesOther conditions: Tuberous Sclerosis, LymphangioleiomyomatosisView official trial listing → -
Completed NCT NCT00492661
A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus
Not yet reported Janssen-Cilag Pty Ltd 55 participants Est. completion 2010-06 4 sites Stand-aloneOther conditions: Renal Transplantion, Kidney TransplantionView official trial listing → -
Completed NCT NCT00492869
Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation
Not yet reported, Not yet reported Novartis Pharmaceuticals 124 participants 41 sitesOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT00493194
Fibrosis in Renal Allografts
Not yet reported University Hospital, Antwerp 100 participants Est. completion 2007-07 3 sitesOther conditions: Kidney Failure, Chronic, Transplantation, Immunosuppression, Interstitial FibrosisView official trial listing → -
Completed NCT NCT00494091
Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma
Not yet reported Pfizer 82 participants Est. completion 2012-03 24 sitesOther conditions: Advanced Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT00495898
A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions
Not yet reported Cordis US Corp. 200 participants Est. completion 2009-11 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00496483
Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients
Not yet reported Asahi Kasei Therapeutics, Inc. 60 participants Est. completion 2008-03 2 sitesOther conditions: Renal FailureView official trial listing → -
Completed NCT NCT00497172
Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial
Not yet reported Cordis US Corp. 150 participants Est. completion 2009-04 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00498316
Cord Blood Expansion on Mesenchymal Stem Cells
Not yet reported M.D. Anderson Cancer Center 98 participants Est. completion 2016-10 1 siteOther conditions: Myelodysplastic Syndrome, LeukemiaView official trial listing → -
Completed NCT NCT00498966
Ph II Study of Perifosine for Patients With Carcinoma of the Kidney
Not yet reported AEterna Zentaris 50 participants Est. completion 2011-10 3 sitesOther conditions: Kidney CancerView official trial listing → -
Status unknown NCT NCT00499603
Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer
Not yet reported M.D. Anderson Cancer Center 62 participants Est. completion 2017-04 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00499889
Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients
Not yet reported M.D. Anderson Cancer Center 42 participants Est. completion 2009-11 1 site Stand-aloneOther conditions: LeukemiaView official trial listing → -
Completed NCT NCT00500370
A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
Not yet reported AstraZeneca 163 participants Est. completion 2008-02 16 sites Stand-aloneOther conditions: ObesityView official trial listing → -
Completed NCT NCT00503139
Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan
Pfizer 684 participants Est. completion 2013-04 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00504348
Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
Not yet reported, Not yet reported Tokyo Medical and Dental University 25 participants Est. completion 2011-01 11 sites Stand-aloneOther conditions: Interstitial Pneumonitis, Polymyositis, DermatomyositisView official trial listing → -
Status unknown NCT NCT00505102
Safe Renal Function In Long Term Heart Transplanted Patients
Not yet reported A.O. Ospedale Papa Giovanni XXIII 200 participants Est. completion 2009-07 2 sitesOther conditions: Kidney Diseases, Heart TransplantationView official trial listing → -
Completed NCT NCT00506922
Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT
Not yet reported, Not yet reported M.D. Anderson Cancer Center 150 participants Est. completion 2009-11 1 site Stand-aloneOther conditions: Leukemia, LymphomaView official trial listing → -
Completed NCT NCT00507793
Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 385 participants Est. completion 2002-06Other conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00510913
A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure
Not yet reported Astellas Pharma Inc 450 participants Est. completion 2000-09 18 sitesOther conditions: Graft Rejection, Kidney TransplantationView official trial listing → -
Completed NCT NCT00513474
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
Not yet reported Massachusetts General Hospital 46 participants Est. completion 2013-02-12 1 site Stand-aloneOther conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative NeoplasmsView official trial listing → -
Withdrawn NCT NCT00514982
Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2011-03-08 1 siteOther conditions: Hermanski-Pudlak Syndrome, Colitis, Cytokines, Lymphocytes, Drug EvaluationView official trial listing → -
Completed NCT NCT00516048
An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
Not yet reported AstraZeneca 58 participants Est. completion 2008-04 13 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00516152
Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT
Not yet reported University of California, San Francisco 36 participants Est. completion 2007-11 1 siteOther conditions: Chronic Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplasia, Acute Lymphocytic Leukemia, Severe Aplastic Anemia, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease, Multiple Myeloma, Advanced Myeloproliferative DiseaseView official trial listing → -
Completed NCT NCT00517283
A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
Not yet reported AstraZeneca 17 participants Est. completion 2005-06 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00518271
Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 120 participants Est. completion 2002-06Other conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00518375
Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 250 participants Est. completion 2001-05Other conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00519116
Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 150 participants Est. completion 2001-08Other conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00520130
Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System
Not yet reported, Not yet reported National Cancer Institute (NCI) 92 participants Est. completion 2018-12-31 1 site Stand-aloneOther conditions: Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Disease, Acute Leukemia, Multiple MyelomaView official trial listing → -
Completed NCT NCT00521001
Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery
Not yet reported Alliance for Clinical Trials in Oncology 49 participants Est. completion 2010-12 198 sitesOther conditions: Melanoma (Skin)View official trial listing → -
Completed NCT NCT00522184
Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study
Not yet reported Centre Hospitalier Universitaire de Nice 34 participants Est. completion 2006-11 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT00522548
Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients
Not yet reported University of Pennsylvania 37 participants Est. completion 2011-01 1 siteOther conditions: Transplants and ImplantsView official trial listing → -
Completed NCT NCT00523952
Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients
Not yet reported Astellas Pharma Inc 303 participants Est. completion 2005-09 25 sites Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00525681
Interaction Between Rimonabant and Cyclosporine and Tacrolimus
Not yet reported University of Oslo School of Pharmacy 18 participants Est. completion 2008-05 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00525876
Non-Myeloablative Allogeneic Stem Cell Transplantation
Not yet reported M.D. Anderson Cancer Center 49 participants Est. completion 2010-09 1 site Stand-aloneOther conditions: LymphomaView official trial listing → -
Completed NCT NCT00525889
Proleukin and Rapamune in Type 1 Diabetes
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 9 participants Est. completion 2013-09 3 sites Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT00529204
Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease
Not yet reported University of California, Davis 1 participants Est. completion 2010-02 1 site Stand-aloneOther conditions: Diabetes Complications, Fatty LiverView official trial listing → -
Completed NCT NCT00531440
This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.
Not yet reported Novartis Pharmaceuticals 256 participants 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00533442
Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients
Not yet reported University of Miami 170 participants Est. completion 2016-05 1 site Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00533624
Myfortic vs. Cellcept in Kidney Transplant Recipients
Not yet reported, Not yet reported University of Miami 150 participants Est. completion 2006-02 1 siteOther conditions: End Stage Renal DiseaseView official trial listing → -
Completed NCT NCT00534508
Distribution of Tacrolimus in Skin, Atopic Dermatitis
Not yet reported Astellas Pharma Inc 14 participants Est. completion 2001-07 1 siteOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00535691
Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis
Not yet reported Astellas Pharma Inc 53 participants Est. completion 2004-12 8 sitesOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00536978
Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies
Not yet reported M.D. Anderson Cancer Center 22 participants Est. completion 2010-11 1 site Stand-aloneOther conditions: Lymphoma, LeukemiaView official trial listing → -
Completed NCT NCT00538265
Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantation
Not yet reported University Hospital, Toulouse 100 participants Est. completion 2011-01 8 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00543569
A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients
Not yet reported Astellas Pharma Inc 323 participants Est. completion 2011-02 38 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Active, not recruiting NCT NCT00544115
Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders
Not yet reported City of Hope Medical Center 260 participants Est. completion 2027-03-29Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Precancerous/Nonmalignant ConditionView official trial listing → -
Active, not recruiting NCT NCT00544466
Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies
Not yet reported, Not yet reported City of Hope Medical Center 75 participants Est. completion 2026-12-02 1 site Stand-aloneOther conditions: Leukemia, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00544557
Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis
Pfizer 1715 participants Est. completion 2014-05 1 siteOther conditions: Ankylosing SpondylitisView official trial listing → -
Completed NCT NCT00545402
A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.
Not yet reported Hoffmann-La Roche 180 participants Est. completion 2011-07 16 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Status unknown NCT NCT00545493
Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis
Not yet reported, Not yet reported University Hospital, Bonn 16 participants Est. completion 2010-04 1 site Stand-aloneOther conditions: Rasmussen EncephalitisView official trial listing → -
Completed NCT NCT00546533
Study Evaluating the Efficacy and Safety of Etanercept
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 40 participants Est. completion 2005-02Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00546728
The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes
Not yet reported St. Paul Heart Clinic 50 participants Est. completion 2011-07 2 sites Stand-alonePrediabetesView official trial listing → -
Completed NCT NCT00551343
Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
Not yet reported Garvan Institute of Medical Research 20 participants Est. completion 2008-09 1 siteOther conditions: Prader-Willi SyndromeView official trial listing → -
Completed NCT NCT00552201
TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic
Not yet reported Centre Hospitalier Universitaire, Amiens 280 participants Est. completion 2008-12 10 sitesOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT00552656
Long Term Efficacy and Safety of Firebird Sirolimus-Eluting Stent In Complex Coronary Lesions
Xijing Hospital 1000 participants Est. completion 2010-08 1 siteOther conditions: Coronary DiseaseView official trial listing → -
Completed NCT NCT00552669
Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
Not yet reported Centro de estudios en Cardiologia Intervencionista 200 participants Est. completion 2007-09 3 sites Stand-aloneOther conditions: Coronary Heart Disease, Coronary RestenosisView official trial listing → -
Completed NCT NCT00553202
Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia
Not yet reported Children's Oncology Group 158 participants Est. completion 2020-03-31 52 sites Stand-aloneOther conditions: LeukemiaView official trial listing → -
Status unknown NCT NCT00554125
Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria
Not yet reported Fudan University 220 participants Est. completion 2013-08 1 siteOther conditions: Hepatocellular CarcinomaView official trial listing → -
Terminated NCT NCT00555048
Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer
Not yet reported, Not yet reported Fred Hutchinson Cancer Center 1 participants 2 sites Stand-aloneOther conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative DiseasesView official trial listing → -
Terminated NCT NCT00555321
Belatacept in Liver Transplant Recipients
Not yet reported Bristol-Myers Squibb 260 participants Est. completion 2011-06 42 sitesOther conditions: Immunosuppression in Solid Organ TransplantView official trial listing → -
Completed NCT NCT00555373
Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression
Not yet reported Pediatric Nephrology of Alabama 52 participants Est. completion 2012-11 4 sitesOther conditions: Renal TransplantView official trial listing → -
Terminated NCT NCT00555789
24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients
Not yet reported Novartis Pharmaceuticals 137 participants Est. completion 2008-03 27 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00556933
Improved Induction and Maintenance Immunosuppression in Kidney Transplantation
Not yet reported University of Nebraska 180 participants Est. completion 2011-06-01 1 site Stand-aloneOther conditions: End-stage Renal DiseaseView official trial listing → -
Completed NCT NCT00560326
Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis
Not yet reported Astellas Pharma Inc 50 participants Est. completion 2006-12 8 sites Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00560378
Long-term Safety of Protopic in Atopic Eczema
Not yet reported Astellas Pharma Inc 789 participants Est. completion 2005-06 41 sites Stand-aloneOther conditions: Dermatitis, Atopic, Eczema, AtopicView official trial listing → -
Completed NCT NCT00560417
Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide
Not yet reported Eli Lilly and Company 339 participants Est. completion 2009-12 52 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00560963
Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine
Not yet reported, Not yet reported Novartis Pharmaceuticals 21 participants Est. completion 2011-01 5 sitesOther conditions: Advanced or Metastatic Pancreatic AdenocarcinomaView official trial listing → -
Status unknown NCT NCT00563108
Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation
Not yet reported Hospital Authority, Hong Kong 60 participants Est. completion 2008-12 1 siteOther conditions: Graft vs Host Disease, Hematopoietic Stem Cell TransplantationView official trial listing → -
Status unknown NCT NCT00564538
A Study of Thymoglobulin and Tacrolimus in Liver Transplant
Not yet reported University of Nebraska 100 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: Liver Transplantation, Liver Disease, ImmunosuppressionView official trial listing → -
Completed NCT NCT00565773
Belatacept Post Depletional Repopulation to Facilitate Tolerance
Not yet reported Allan D Kirk, MD, PhD 40 participants Est. completion 2017-07-01 2 sites Stand-aloneOther conditions: Organ TransplantationView official trial listing → -
Completed NCT NCT00566813
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
Not yet reported, Not yet reported University of Illinois Chicago 10 participants Est. completion 2020-07-15 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00567554
Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer
Not yet reported GBG Forschungs GmbH 2600 participants Est. completion 2015-10 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00567762
Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
Not yet reported Astellas Pharma Inc 56 participants Est. completion 2004-09 8 sitesOther conditions: Keratoconjunctivitis, ConjunctivitisView official trial listing → -
Completed NCT NCT00567918
Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
Not yet reported Astellas Pharma Inc 52 participants Est. completion 2008-01 8 sitesOther conditions: Keratoconjunctivitis, ConjunctivitisView official trial listing → -
Status unknown NCT NCT00569101
A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis
Not yet reported Seoul National University Hospital 9 participants Est. completion 2008-03 1 site Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT00570921
Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure
Not yet reported Mara Chambers 33 participants Est. completion 2015-01 1 siteOther conditions: Breast CancerView official trial listing → -
Withdrawn NCT NCT00572689
Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes
Not yet reported Georgetown University Est. completion 2015-08 2 sites Stand-aloneOther conditions: Gestational DiabetesView official trial listing → -
Completed NCT NCT00574769
Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer
Not yet reported, Not yet reported University of Southern California 27 participants Est. completion 2017-02-17 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00577278
A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan
Not yet reported City of Hope Medical Center 41 participants Est. completion 2023-12-14 1 site Stand-aloneOther conditions: Graft Versus Host Disease, Leukemia, LymphomaView official trial listing → -
Completed NCT NCT00577824
Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)
Not yet reported AstraZeneca 181 participants Est. completion 2008-11 12 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00578266
Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia
Not yet reported Mayo Clinic 8 participants Est. completion 2016-08-16 1 siteOther conditions: Anemia, AplasticView official trial listing → -
Terminated NCT NCT00578903
Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
Not yet reported Baylor College of Medicine 22 participants Est. completion 2012-07 2 sitesOther conditions: Aplastic AnemiaView official trial listing → -
Terminated NCT NCT00579111
Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)
Not yet reported, Not yet reported Baylor College of Medicine 4 participants Est. completion 2010-10 2 sitesOther conditions: Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Multiple Myeloma, Plasma Cell Dyscrasia, Lymphoproliferative Disorders, Hematologic DiseasesView official trial listing → -
Terminated NCT NCT00579150
Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
AstraZeneca 7 participants Est. completion 2016-04 1 siteType 2 diabetes Other conditions: Birth Defects, Preterm BirthView official trial listing → -
Completed NCT NCT00579527
Phase I/II Thymus Transplantation With Immunosuppression #950
Not yet reported, Not yet reported Sumitomo Pharma Switzerland GmbH 14 participants Est. completion 2017-12-31 1 site Stand-aloneOther conditions: DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly, Complete DiGeorge Syndrome, Complete Atypical DiGeorge SyndromeView official trial listing → -
Completed NCT NCT00581100
Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 136 participants Est. completion 2009-10Other conditions: Nail Psoriasis, Plaque PsoriasisView official trial listing → -
Terminated NCT NCT00582738
Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection
Not yet reported Novartis Pharmaceuticals 43 participants Est. completion 2010-01 1 siteOther conditions: Recurrent Hepatitis CView official trial listing → -
Completed NCT NCT00585468
Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State
Not yet reported University of Utah 21 participants Est. completion 2011-07 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00585650
Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet
Not yet reported, Not yet reported University of California, Irvine 20 participants Est. completion 2008-05 3 sites Stand-aloneOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00586443
BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)
Not yet reported Herbert Hurwitz, MD 56 participants Est. completion 2014-09 1 siteOther conditions: Solid TumorsView official trial listing → -
Completed NCT NCT00587158
Oral Paricalcitol in Kidney Transplant Recipients
Not yet reported Mayo Clinic 100 participants Est. completion 2011-11 2 sitesOther conditions: Transplant; Failure, Kidney, Renal Disease, End Stage, Hyperparathyroidism, SecondaryView official trial listing → -
Terminated NCT NCT00589316
Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome
Not yet reported Fred Hutchinson Cancer Center 26 participants Est. completion 2021-10-01 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, CD45-Positive Neoplastic Cells Present, Chronic Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndrome, Refractory Anemia With Excess Blasts, Refractory Anemia With Ring Sideroblasts, Refractory Cytopenia With Multilineage Dysplasia, Refractory Cytopenia With Multilineage Dysplasia and Ring SideroblastsView official trial listing → -
Completed NCT NCT00589563
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer
Not yet reported City of Hope Medical Center 32 participants Est. completion 2012-02 2 sites Stand-aloneOther conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Secondary Myelofibrosis, Small Intestine CancerView official trial listing → -
Terminated NCT NCT00589602
T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases
Not yet reported The Cleveland Clinic 13 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Malignant Plasma Cell Neoplasms, Myelodysplastic Syndromes, Precancerous/Nonmalignant Condition, Secondary MyelofibrosisView official trial listing → -
Completed NCT NCT00590876
The Impact of Pancreatic Islet Cell Allotransplantation on Cognitive Function in Type 1 Diabetes Mellitus
Yale University 36 participants Est. completion 2011-07 2 sitesOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT00593008
Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer
Not yet reported Massachusetts General Hospital 5 participants Est. completion 2009-10 1 siteOther conditions: Pancreatic AdenocarcinomaView official trial listing → -
Completed NCT NCT00593060
Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer
Not yet reported Jeffrey W. Clark, MD 35 participants Est. completion 2010-11 2 sitesOther conditions: Colorectal Cancer, Colorectal AdenocarcinomaView official trial listing → -
Completed NCT NCT00596557
Everolimus and Low Dose CNI Compared With MMF and Full CNI Dose in Heart Transplanted Patients: One Year Follow up
Not yet reported Rabin Medical Center 20 participants Est. completion 2011-07 1 siteOther conditions: Chronic Rejection of Cardiac TransplantView official trial listing → -
Terminated NCT NCT00596947
Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant
Not yet reported University of Pennsylvania 18 participants Est. completion 2009-03 1 site Stand-aloneOther conditions: Transplants and ImplantsView official trial listing → -
Completed NCT NCT00597506
Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus
Not yet reported Herbert Hurwitz 50 participants Est. completion 2010-06 1 siteOther conditions: Colorectal AdenocarcinomaView official trial listing → -
Completed NCT NCT00598676
3 Limus Agent Eluting Stents With Different Polymer Coating
Not yet reported Deutsches Herzzentrum Muenchen 2600 participants Est. completion 2009-04 2 sitesOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00598715
Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents
Not yet reported Deutsches Herzzentrum Muenchen 450 participants Est. completion 2009-08 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00600496
A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)
Not yet reported AstraZeneca 140 participants Est. completion 2025-12-18 4 sitesOther conditions: Breast Cancer, Breast Neoplasms, Colon Cancer, Colonic Cancer, Colon Neoplasms, Lung Cancer, Melanoma, Kidney CancerView official trial listing → -
Completed NCT NCT00602693
T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer
Not yet reported Masonic Cancer Center, University of Minnesota 41 participants Est. completion 2015-04-16 1 site Stand-aloneOther conditions: Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00603239
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin
Not yet reported AstraZeneca 165 participants Est. completion 2009-07 25 sites Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT00605592
UVA Islet Cell Transplantation in Patients With Type I Diabetes
Not yet reported University of Virginia 20 participants Est. completion 2012-01 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT00606333
Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions
Not yet reported Cordis US Corp. 394 participants Est. completion 2012-10 2 sites Stand-aloneOther conditions: Coronary AtherosclerosisView official trial listing → -
Completed NCT NCT00608244
Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients
Not yet reported Asahi Kasei Therapeutics, Inc. 59 participants Est. completion 2008-06 1 site Stand-aloneOther conditions: Liver FailureView official trial listing → -
Terminated NCT NCT00608517
Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil
Not yet reported Vanderbilt-Ingram Cancer Center 6 participants Est. completion 2011-05 4 sitesOther conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Terminated NCT NCT00608894
LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis
Not yet reported Veloxis Pharmaceuticals 13 participants Est. completion 2009-07 12 sites Stand-aloneOther conditions: Autoimmune HepatitisView official trial listing → -
Completed NCT NCT00609388
Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver Transplantation
Not yet reported Medical University of Vienna 26 participants Est. completion 2010-12 1 siteOther conditions: Ischemia Reperfusion InjuryView official trial listing → -
Completed NCT NCT00610948
Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment
Not yet reported UNC Lineberger Comprehensive Cancer Center 74 participants Est. completion 2016-01 1 siteOther conditions: Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00610961
Induction Related BK Viremia in Renal Transplant Patients
University of Florida 60 participants Est. completion 2009-11 1 siteOther conditions: Disease Due to BK Polyomavirus, Transplantation Infection, Disorder Related to TransplantationView official trial listing → -
Completed NCT NCT00611351
Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer
Not yet reported University of Nebraska 5 participants Est. completion 2008-09-17 1 site Stand-aloneOther conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Secondary MyelofibrosisView official trial listing → -
Completed NCT NCT00611910
Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions
Not yet reported Deutsches Herzzentrum Muenchen 610 participants Est. completion 2011-03 4 sites Stand-aloneOther conditions: Arteriosclerosis of Arterial Coronary Artery Bypass GraftView official trial listing → -
Completed NCT NCT00612274
Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation
Not yet reported Yale University 26 participants Est. completion 2014-10 1 site Stand-aloneOther conditions: Stem Cell TransplantationView official trial listing → -
Completed NCT NCT00612794
A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes
Not yet reported AstraZeneca 30 participants Est. completion 2008-05 4 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00613132
Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG
Not yet reported Annick Desjardins 78 participants Est. completion 2013-01 1 siteObstructive sleep apnea Other conditions: GlioblastomaView official trial listing → -
Completed NCT NCT00615173
Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis
Not yet reported Sun Yat-sen University 81 participants Est. completion 2008-09 1 site Stand-aloneOther conditions: Kidney Diseases, Lupus Nephritis, Tacrolimus, Induction Phase, Maintenance PhaseView official trial listing → -
Completed NCT NCT00615667
Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)
Not yet reported Sun Yat-sen University 61 participants Est. completion 2008-09 Stand-aloneOther conditions: Kidney Diseases, Nephrotic Syndrome, TacrolimusView official trial listing → -
Completed NCT NCT00617604
A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients
Not yet reported Astellas Pharma Inc 218 participants Est. completion 2009-09 33 sites Stand-aloneOther conditions: De Novo Kidney TransplantationView official trial listing → -
Completed NCT NCT00618345
Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
Not yet reported Mayo Clinic 35 participants Est. completion 2008-08Other conditions: Multiple Myeloma and Plasma Cell NeoplasmView official trial listing → -
Completed NCT NCT00619216
Myfortic Conversion Trial in OLT Recipients With GI Intolerance
University of North Carolina, Chapel Hill 31 participants Est. completion 2009-12 1 siteOther conditions: GI DisturbanceView official trial listing → -
Completed NCT NCT00619268
Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma
Not yet reported Centre Leon Berard 160 participants Est. completion 2012-02 29 sitesOther conditions: Metastatic Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT00619398
A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients
Not yet reported Astellas Pharma Inc 172 participants Est. completion 2009-03 6 sitesOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00619528
HLA-Identical Sibling Renal Transplant Tolerance
Not yet reported Northwestern University 88 participants Est. completion 2023-09 1 site Stand-aloneOther conditions: Immunosuppression, Kidney Transplantation, Graft RejectionView official trial listing → -
Completed NCT NCT00620841
Gene Polymorphisms in Tacrolimus Drug Interactions
KU Leuven 40 participants Est. completion 2008-01 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00621101
Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects
Not yet reported University Medicine Greifswald 24 participants Est. completion 2007-06 1 site Stand-aloneOther conditions: Pharmacokinetics, Drug Interactions, Hypercholesterolemia, ImmunosuppressionView official trial listing → -
Completed NCT NCT00621699
Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects
Not yet reported University Medicine Greifswald 24 participants Est. completion 2007-11 1 site Stand-aloneOther conditions: Pharmacokinetics, Drug Interactions, Hypercholesterolemia, ImmunosuppressionView official trial listing → -
Completed NCT NCT00622258
A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Not yet reported Novartis Pharmaceuticals 13 participants Est. completion 2014-01 8 sitesOther conditions: Non-Hodgkin's LymphomaView official trial listing → -
Completed NCT NCT00622323
Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients
AstraZeneca 41 participants Est. completion 2009-09 3 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00622869
Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients
Not yet reported Novartis Pharmaceuticals 719 participants Est. completion 2012-04 91 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00622895
Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis
Not yet reported, Not yet reported Fred Hutchinson Cancer Center 3 participants Est. completion 2017-08-01 2 sites Stand-aloneOther conditions: Systemic Scleroderma, Severe Systemic SclerosisView official trial listing → -
Terminated NCT NCT00623012
Rapamycin for Prevention of Chronic Graft-Versus-Host Disease
Not yet reported, Not yet reported Yale University 2 participants Est. completion 2013-08 1 site Stand-aloneOther conditions: Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT00626483
Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia
Not yet reported Gary Archer Ph.D. 34 participants Est. completion 2016-07-06 1 site Stand-aloneOther conditions: Malignant Neoplasms BrainView official trial listing → -
Completed NCT NCT00629122
Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation
Not yet reported Weill Medical College of Cornell University 5 participants Est. completion 2009-12 1 site Stand-aloneOther conditions: Kidney Failure, ChronicView official trial listing → -
Completed NCT NCT00630344
RAD001 and Bicalutamide for Androgen Independent Prostate Cancer
Not yet reported Dana-Farber Cancer Institute 36 participants Est. completion 2012-05 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00632268
Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer
Not yet reported National Taiwan University Hospital 40 participants Est. completion 2012-12 1 siteOther conditions: Metastatic Gastric CancerView official trial listing → -
Completed NCT NCT00634244
Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Not yet reported National Cancer Institute (NCI) 92 participants Est. completion 2014-10 20 sites Stand-aloneOther conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Recurrent Adult Acute Myeloid LeukemiaView official trial listing → -
Status unknown NCT NCT00636922
Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia
Not yet reported Bayside Health 40 participants Est. completion 2014-01 1 siteOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT00637143
Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)
Not yet reported Astellas Pharma Inc 107 participants Est. completion 2006-02 13 sites Stand-aloneOther conditions: Renal Transplantation, Chronic Renal Allograft FailureView official trial listing → -
Completed NCT NCT00638794
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Cardiovascular Research Foundation, New York 8575 participants Est. completion 2013-01 8 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT00639717
Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
Not yet reported University of Michigan Rogel Cancer Center 48 participants Est. completion 2016-04 1 site Stand-aloneOther conditions: Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT00640393
Safety and Efficacy of Combining nbUVB to Etanercept in Patients
Not yet reported Innovaderm Research Inc. 99 participants Est. completion 2010-03 10 sitesOther conditions: Psoriasis VulgarisView official trial listing → -
Terminated NCT NCT00640978
Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer
Not yet reported M.D. Anderson Cancer Center 16 participants Est. completion 2010-03 1 siteOther conditions: Pancreatic CancerView official trial listing → -
Completed NCT NCT00641056
Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)
Not yet reported AstraZeneca 467 participants Est. completion 2009-11 75 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00643071
Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients
Not yet reported Astellas Pharma Inc 32 participants Est. completion 2008-05 6 sites Stand-aloneOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT00644761
PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients
Not yet reported Gilead Sciences 16 participants Est. completion 2005-05 11 sitesOther conditions: Hepatitis BView official trial listing → -
Status unknown NCT NCT00646724
Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients
Not yet reported, Not yet reported Fuzhou General Hospital 30 participants Est. completion 2014-01 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00646737
Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant
Not yet reported Novartis 18 participants Est. completion 2008-12 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00650468
A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients
Not yet reported Astellas Pharma Inc 397 participants Est. completion 2007-12 29 sites Stand-aloneOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00654355
Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
Not yet reported Wake Forest University 30 participants Est. completion 2009-09 1 site Stand-aloneOther conditions: Atopic DermatitisView official trial listing → -
No Longer Available NCT NCT00655252
Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy
Novartis Pharmaceuticals 84 sitesOther conditions: Metastatic Renal Cell CancerView official trial listing → -
Terminated NCT NCT00656266
Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation
Not yet reported Baylor College of Medicine 13 participants Est. completion 2005-11 1 site Stand-aloneOther conditions: End-stage Liver Disease, Renal Insufficiency, Renal FailureView official trial listing → -
Status unknown NCT NCT00657982
Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer
Not yet reported Sheba Medical Center 15 participants 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00658021
Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Not yet reported AstraZeneca 122 participants Est. completion 2020-04-01 53 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00658320
Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids
Not yet reported Novartis 122 participants Est. completion 2012-05 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT00659620
Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy
Not yet reported, Not yet reported Fuzhou General Hospital 20 participants Est. completion 2010-05 1 siteOther conditions: Kidney Transplant, Chronic Allograft NephropathyView official trial listing → -
Completed NCT NCT00660478
Randomized Clinical Comparison of the Endeavor and the Cypher Coronary Stents in Non-selected Angina Pectoris Patients
Not yet reported Evald Hoej Christiansen 2342 participants Est. completion 2009-10 1 siteOther conditions: Ischemic Heart DiseaseView official trial listing → -
Completed NCT NCT00663052
Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis
Not yet reported Pfizer 273 participants Est. completion 2010-01 38 sites Stand-aloneOther conditions: Plaque Psoriasis, PsoriasisView official trial listing → -
Completed NCT NCT00664963
YUKON-drug-eluting Stent Below The Knee - Randomised Double-blind Study
Not yet reported Herz-Zentrums Bad Krozingen 130 participants Est. completion 2010-04 3 sites Stand-aloneOther conditions: Arterial Occlusive DiseasesView official trial listing → -
Completed NCT NCT00666159
Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis
Not yet reported Astellas Pharma Inc 226 participants Est. completion 2003-05 12 sites Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00666302
A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis
Not yet reported Astellas Pharma Inc 413 participants Est. completion 2003-11 15 sites Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00667056
Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis
Not yet reported Astellas Pharma Inc 98 participants Est. completion 2004-12 10 sites Stand-aloneOther conditions: DermatitisView official trial listing → -
Completed NCT NCT00667160
Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis
Not yet reported Astellas Pharma Inc 426 participants Est. completion 2003-11 19 sites Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00668369
Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation
Not yet reported Hospital Clinic of Barcelona 34 participants Est. completion 2011-09 1 site Stand-aloneOther conditions: Hepatitis C Virus Infection, Liver TransplantationView official trial listing → -
Terminated NCT NCT00669890
Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML
Not yet reported New York Medical College 12 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic SyndromeView official trial listing → -
Terminated NCT NCT00670410
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma
Not yet reported Columbia University 15 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: NeuroblastomaView official trial listing → -
Completed NCT NCT00670423
A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation
Not yet reported Jennifer E. Schwartz 27 participants Est. completion 2013-10-16 1 siteOther conditions: Graft vs Host Disease, Peripheral Blood Stem Cell Transplantation, Transplantation, HomologousView official trial listing → -
Terminated NCT NCT00671112
Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma
Not yet reported Brian Hill, MD, PhD 30 participants 1 siteOther conditions: 714leukemia, LymphomaView official trial listing → -
Terminated NCT NCT00672204
Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes
Not yet reported, Not yet reported University of Minnesota 23 participants Est. completion 2012-08 1 site Stand-aloneOther conditions: Type 1 Diabetes Mellitus, HypoglycemiaView official trial listing → -
Completed NCT NCT00672243
Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme
Not yet reported Duke University 32 participants Est. completion 2009-12 1 site Stand-aloneObstructive sleep apnea Other conditions: GlioblastomaView official trial listing → -
Terminated NCT NCT00674414
Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery
Not yet reported UNICANCER 82 participants 8 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00676338
Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)
Not yet reported AstraZeneca 820 participants Est. completion 2011-01 106 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00678769
Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic Cancer
Not yet reported National Cancer Institute (NCI) 72 participants Est. completion 2015-10 2 sitesOther conditions: Malignant NeoplasmView official trial listing → -
Completed NCT NCT00678782
Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis
Not yet reported University of Padova 31 participants Est. completion 2007-12 1 siteOther conditions: Persistent Knee Joint SynovitisView official trial listing → -
Status unknown NCT NCT00678990
Heparinized Islets in Clinical Islet Transplantation
Not yet reported Corline Biomedical AB 10 participants Est. completion 2019-12 2 sitesOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00679042
Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol
Not yet reported CellTrans Inc. 21 participants Est. completion 2026-07-01 1 site Stand-aloneOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00680758
Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer Center 18 participants Est. completion 2010-12 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00681213
Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation
Not yet reported University of Miami 150 participants Est. completion 2002-12 1 site Stand-aloneOther conditions: Adult Primary Kidney TransplantationView official trial listing → -
Completed NCT NCT00682292
Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk
Not yet reported University Hospital, Lille 227 participants Est. completion 2006-11 1 siteOther conditions: Renal TransplantationView official trial listing → -
Status unknown NCT NCT00684372
BK Viremia After Renal Transplantation
Not yet reported Karolinska University Hospital 100 participants Est. completion 2009-05 1 siteOther conditions: Terminal Renal Failure, BK Virus InfectionView official trial listing → -
Completed NCT NCT00686855
Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease
Not yet reported Brigham and Women's Hospital 46 participants Est. completion 2013-03 5 sites Stand-aloneOther conditions: Oral Chronic Graft-versus-host DiseaseView official trial listing → -
Completed NCT NCT00688623
RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe
Not yet reported Novartis Pharmaceuticals 73 participants Est. completion 2016-11-07 40 sitesOther conditions: Advanced and Metastatic Silent Neuro-Endocrine Tumors, Carcinoma, Neuroendocrine, Non Functioning Neuroendocrine Tumors (NETs), Non Syndromic Neuroendocrine Tumors, Carcinoids, Non FunctioningView official trial listing → -
Completed NCT NCT00688753
RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe
Not yet reported Novartis Pharmaceuticals 92 participants Est. completion 2014-10 19 sitesOther conditions: Carcinoma, Renal Cell, Non Clear Cell Renal Carcinoma, Papillary Cell Renal Carcinoma, AdenocarcinomaView official trial listing → -
Completed NCT NCT00689832
Protopic Ointment in Children Atopic Eczema
Not yet reported Astellas Pharma Inc 487 participants Est. completion 2005-08 1 site Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00690105
Protopic Ointment in Adult Atopic Eczema of the Face
Not yet reported Astellas Pharma Inc 577 participants Est. completion 2005-07 1 site Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00691015
Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant
Not yet reported Barbara Ann Karmanos Cancer Institute 48 participants Est. completion 2014-04 1 siteOther conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative NeoplasmsView official trial listing → -
Completed NCT NCT00691145
Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis
Not yet reported Astellas Pharma Inc 350 participants Est. completion 2005-02 26 sites Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00691262
Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis
Not yet reported Astellas Pharma Inc 166 participants Est. completion 2005-02 9 sites Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT00693381
Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney Transplantation
Not yet reported Astellas Pharma Inc 152 participants Est. completion 2004-08 14 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT00693433
Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma
Not yet reported National Cancer Institute (NCI) 2 participants 2 sitesOther conditions: DS Stage I Multiple Myeloma, DS Stage II Multiple Myeloma, DS Stage III Multiple Myeloma, Refractory Multiple MyelomaView official trial listing → -
Status unknown NCT NCT00693446
A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids
Not yet reported Nantes University Hospital 118 participants Est. completion 2017-04 1 siteOther conditions: Pancreas Transplantation, Kidney TransplantationView official trial listing → -
Completed NCT NCT00693524
Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX
Not yet reported Astellas Pharma Inc 94 participants Est. completion 2004-03 8 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00694005
Choice Of Optimal Strategy For Bifurcation Lesions With Normal Side Branch
Not yet reported Seung-Jung Park 504 participants Est. completion 2015-01 11 sitesCardiovascular diseaseView official trial listing → -
Terminated NCT NCT00694408
A Pilot Trial of Pediatric Liver Transplantation Without Steroids
Not yet reported Birmingham Women's and Children's NHS Foundation Trust 15 participants Est. completion 2011-08 1 siteOther conditions: Evidence of Liver TransplantationView official trial listing → -
Status unknown NCT NCT00695344
Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart Transplant
Not yet reported Fundacion Investigacion y Desarrollo 52 participants Est. completion 2010-06 8 sitesOther conditions: Cardiac TransplantView official trial listing → -
Completed NCT NCT00697112
Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)
Pfizer 53 participants Est. completion 2012-12 8 sitesOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00697372
SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis
Not yet reported Catholic University of the Sacred Heart 150 participants Est. completion 2010-04 1 siteCardiovascular disease Other conditions: Coronary StenosisView official trial listing → -
Completed NCT NCT00699491
Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
Not yet reported, Not yet reported National Cancer Institute (NCI) 48 participants Est. completion 2018-02-14 192 sitesOther conditions: Male Breast Carcinoma, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Completed NCT NCT00700258
Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]
Pfizer 1520 participants Est. completion 2021-12-28 77 sitesOther conditions: Carcinoma, Renal Cell, Advanced, Lymphoma, Mantle-Cell, Gastrointestinal Stroma TumorsView official trial listing → -
Terminated NCT NCT00701935
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
Not yet reported AstraZeneca 80 participants Est. completion 2012-01 17 sites Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00702052
Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy
Not yet reported Novartis Pharmaceuticals 58 participants Est. completion 2012-04-20 31 sitesOther conditions: Lymphoma, Mantle- CellView official trial listing → -
Completed NCT NCT00703170
Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies
Not yet reported Washington University School of Medicine 28 participants Est. completion 2011-07 1 siteOther conditions: Resistant Solid MalignanciesView official trial listing → -
Active, not recruiting NCT NCT00706420
Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen
Not yet reported City of Hope Medical Center 17 participants Est. completion 2027-09-13 1 site Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00707031
GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
Not yet reported Sanofi 639 participants Est. completion 2010-11 18 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00707759
Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute Rejection
Not yet reported Fondo Nacional de Desarrollo Científico y Tecnológico, Chile 28 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Kidney DiseasesView official trial listing → -
Completed NCT NCT00708591
Study of Rapamycin Plus Ketoconazole in Advanced Cancers
Not yet reported University of Chicago 57 participants Est. completion 2008-12 1 siteOther conditions: Advanced CancerView official trial listing → -
Completed NCT NCT00708604
Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes
Not yet reported City of Hope Medical Center 3 participants Est. completion 2014-06 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT00709592
Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT
Not yet reported Virginia Commonwealth University 42 participants Est. completion 2017-06-28 1 site Stand-aloneOther conditions: Non-Hodgkin's Lymphoma, Leukemia, Multiple Myeloma, Acute Myeloid Leukemia, Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT00710801
Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation
University of Alberta 40 participants 1 siteOther conditions: Hepatitis C VirusView official trial listing → -
Completed NCT NCT00711490
Sirolimus to Treat Diabetic Macular Edema
Not yet reported, Not yet reported National Eye Institute (NEI) 5 participants Est. completion 2011-01 1 site Stand-aloneOther conditions: Diabetic RetinopathyView official trial listing → -
Terminated NCT NCT00712491
Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration
Not yet reported, Not yet reported Santen Inc. 20 participants Est. completion 2010-03 1 site Stand-aloneOther conditions: Age-related Macular Degeneration, Choroidal NeovascularizationView official trial listing → -
Completed NCT NCT00713284
Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic
Not yet reported California Pacific Medical Center Research Institute 29 participants Est. completion 2010-11 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00713544
A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
Not yet reported AstraZeneca 373 participants Est. completion 2009-04 49 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT00713557
Shanghai Registry of Acute Coronary Events
Shanghai Jiao Tong University School of Medicine 20000 participants 1 siteCardiovascular disease Other conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT00714025
A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy
Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 40 participants Est. completion 2012-01 1 siteOther conditions: Transitional Cell CarcinomaView official trial listing → -
Completed NCT NCT00714493
RESTART C0168Z05 Rheumatoid Arthritis Study
Not yet reported Centocor Ortho Biotech Services, L.L.C. 203 participants Est. completion 2010-06 76 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00714623
The SCRIPPS DES REAL WORLD Registry
Paul S Teirstein, MD 859 participants Est. completion 2012-04 1 siteCardiovascular disease Other conditions: Coronary Restenosis, Coronary ThrombosisView official trial listing → -
Terminated NCT NCT00714883
Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions
Not yet reported Cordis US Corp. 3 participants Est. completion 2012-10 2 sitesOther conditions: Coronary DiseaseView official trial listing → -
Completed NCT NCT00716573
Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure
Not yet reported Hospices Civils de Lyon 120 participants Est. completion 2014-04-17 1 site Stand-aloneOther conditions: Cardiac Transplantation, Chronic Renal InsufficiencyView official trial listing → -
Completed NCT NCT00717379
Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation
Not yet reported Astellas Pharma Inc 50 participants Est. completion 2008-10 6 sites Stand-aloneOther conditions: Kidney Transplantation, Kidney Failure, Chronic, Renal Insufficiency, ChronicView official trial listing → -
Completed NCT NCT00717470
A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection
Not yet reported Astellas Pharma Inc 1252 participants Est. completion 2010-03-02 110 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00717678
A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients
Not yet reported Astellas Pharma Inc 73 participants Est. completion 2010-04 5 sites Stand-aloneOther conditions: Kidney Transplantation, Transplantation Immunology, Host vs Graft ReactionView official trial listing → -
Completed NCT NCT00719264
Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer
Not yet reported Novartis Pharmaceuticals 365 participants Est. completion 2013-04-15 109 sitesOther conditions: Carcinoma, Adenocarcinoma, Renal Cell, Nephroid Carcinoma, HypernephroidView official trial listing → -
Completed NCT NCT00719745
A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients
Not yet reported Astellas Pharma Inc 74 participants Est. completion 2008-06 1 siteOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00720265
A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients
Not yet reported Astellas Pharma Inc 135 participants Est. completion 2008-03 2 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00720408
A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.
Not yet reported Astellas Pharma Inc 48 participants Est. completion 2009-09 4 sites Stand-aloneOther conditions: Liver Transplantation, Transplantation Immunology, Host vs Graft ReactionView official trial listing → -
Terminated NCT NCT00720629
Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 8 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT00724022
Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation
Not yet reported University Hospital Freiburg 600 participants Est. completion 2014-07 25 sites Stand-aloneOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Withdrawn NCT NCT00724672
A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)
Merck Sharp & Dohme LLC Est. completion 2009-07Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00726375
The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease
Not yet reported University of Michigan Rogel Cancer Center 34 participants Est. completion 2014-09 1 site Stand-aloneOther conditions: Acute Graft Versus Host DiseaseView official trial listing → -
Terminated NCT NCT00726804
Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis
Not yet reported Glostrup University Hospital, Copenhagen 7 participants Est. completion 2012-05 6 sitesOther conditions: SPONDYLOARTHRITISView official trial listing → -
Completed NCT NCT00729131
Functional Implications of TNF
National Institute of Environmental Health Sciences (NIEHS) 10 participants Est. completion 2012-02 1 siteOther conditions: BronchitisView official trial listing → -
Completed NCT NCT00729248
The Differential Effects of 3 Different Immunosuppressive
Northwestern University 12 participants Est. completion 2010-01 1 siteOther conditions: Immunosuppression, Kidney TransplantationView official trial listing → -
Completed NCT NCT00729482
RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment
Not yet reported Asan Medical Center 54 participants Est. completion 2013-03 1 siteOther conditions: Stomach NeoplasmView official trial listing → -
Terminated NCT NCT00731874
Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status
Not yet reported Weill Medical College of Cornell University 34 participants Est. completion 2013-07 1 siteOther conditions: ImmunosuppressionView official trial listing → -
Status unknown NCT NCT00733733
Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor
Not yet reported Radboud University Medical Center 180 participants Est. completion 2010-06 1 siteOther conditions: Renal Transplant Patients, Recipients of a Kidney From a Non-Heart-Beating DonorView official trial listing → -
Completed NCT NCT00736229
Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients
Not yet reported Saint Luke's Health System 40 participants Est. completion 2012-08 1 site Stand-aloneCardiovascular disease Other conditions: Hyperglycemia, Acute Coronary SyndromesView official trial listing → -
Status unknown NCT NCT00737659
CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients
Not yet reported Rabin Medical Center 138 participants Est. completion 2013-08 2 sitesOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT00745420
Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601)
Not yet reported Medical College of Wisconsin 30 participants Est. completion 2016-09 19 sites Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Completed NCT NCT00747968
The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
Not yet reported, Not yet reported University of Aarhus 8 participants Est. completion 2011-03 4 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00749424
The Study of the Crushing Technique Application Using SES in Coronary Bifurcations.
Not yet reported Cordis US Corp. 350 participants Est. completion 2009-04 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00752362
Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)
Not yet reported Sahajanand Medical Technologies Limited 280 participants 11 sites Stand-aloneOther conditions: Coronary RestenosisView official trial listing → -
Completed NCT NCT00757874
Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus
Not yet reported Deana Funaro 56 participants Est. completion 2010-01 1 site Stand-aloneOther conditions: Vulvar Lichen SclerosusView official trial listing → -
Completed NCT NCT00758602
A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.
Not yet reported Hoffmann-La Roche 210 participants Est. completion 2011-02 6 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00761644
Doxil, Bevacizumab and Temsirolimus Trial
Not yet reported M.D. Anderson Cancer Center 200 participants Est. completion 2019-03-28 1 siteOther conditions: Advanced CancerView official trial listing → -
Completed NCT NCT00762658
A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test
Not yet reported Pfizer 12 participants Est. completion 2007-12-07 1 siteOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00763490
Trial Of Double Umbilical Cord Blood Transplantation
Not yet reported University of Michigan Rogel Cancer Center 20 participants Est. completion 2015-10 1 site Stand-aloneOther conditions: Hematological MalignanciesView official trial listing → -
Completed NCT NCT00765661
Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients
Not yet reported Asahi Kasei Therapeutics, Inc. 63 participants Est. completion 2010-02 1 site Stand-aloneOther conditions: Kidney Failure, Renal FailureView official trial listing → -
Completed NCT NCT00765817
Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus
Not yet reported AstraZeneca 261 participants Est. completion 2010-01 59 sites Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT00766337
Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration
Not yet reported Santen Inc. 62 participants Est. completion 2010-03 1 site Stand-aloneOther conditions: Age-Related Macular Degeneration, Choroidal NeovascularizationView official trial listing → -
Completed NCT NCT00766649
Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMD
Not yet reported, Not yet reported National Eye Institute (NEI) 11 participants Est. completion 2012-07 1 site Stand-aloneOther conditions: Age-Related Macular DegenerationView official trial listing → -
Completed NCT NCT00766857
Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure
Not yet reported Amsterdam UMC, location VUmc 27 participants Est. completion 2012-12 1 site Stand-aloneType 2 diabetesHeart failureView official trial listing → -
Completed NCT NCT00766909
Diabetogenicity of Cyclosporine and Tacrolimus
Not yet reported University of Aarhus 18 participants Est. completion 2011-11 1 site Stand-aloneOther conditions: Complications of Transplanted Organs and Tissue, Diabetes Mellitus Nos New OnsetView official trial listing → -
Completed NCT NCT00768053
Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 108 participants Est. completion 2010-04 17 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00768651
Incretin Effect and Use After Clinical Islet Transplantation
Not yet reported University of Alberta 8 participants Est. completion 2011-12 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT00770120
S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Not yet reported SWOG Cancer Research Network 61 participants Est. completion 2014-04 129 sitesOther conditions: Malignant MesotheliomaView official trial listing → -
Completed NCT NCT00770263
Erlotinib and Temsirolimus for Solid Tumors
Not yet reported Washington University School of Medicine 46 participants Est. completion 2014-09 1 siteOther conditions: Solid TumorsView official trial listing → -
Completed NCT NCT00771745
Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients
Not yet reported University of Cincinnati 11 participants Est. completion 2010-07 1 siteOther conditions: Renal Transplant Rejection, Transplants and ImplantsView official trial listing → -
Completed NCT NCT00772148
Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients
Not yet reported Asahi Kasei Therapeutics, Inc. 58 participants Est. completion 2010-05 1 site Stand-aloneOther conditions: Liver FailureView official trial listing → -
Completed NCT NCT00775593
Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia
Not yet reported Gruppo Italiano Malattie EMatologiche dell'Adulto 60 participants Est. completion 2013-10-23 19 sitesOther conditions: LeukemiaView official trial listing → -
Completed NCT NCT00775684
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
Not yet reported University of Pennsylvania 47 participants Est. completion 2012-11 3 sites Stand-alonePrediabetesType 2 diabetesView official trial listing → -
Terminated NCT NCT00776373
Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies
Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 4 participants Est. completion 2009-12 1 siteOther conditions: ALL, Burkitt's Lymphoma, Lymphoblastic Leukemia, CMLView official trial listing → -
Withdrawn NCT NCT00777400
Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg Cells
Not yet reported, Not yet reported University of California, San Francisco Est. completion 2009-04 1 site Stand-aloneOther conditions: Autoimmune DiseasesView official trial listing → -
Completed NCT NCT00777933
Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal Transplantation
Not yet reported Samsung Medical Center 131 participants Est. completion 2008-05 1 site Stand-aloneOther conditions: Kidney Transplantation, Living DonorsView official trial listing → -
Status unknown NCT NCT00779792
Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation
Not yet reported Odense University Hospital 36 participants Est. completion 2008-11 1 siteOther conditions: Dermatitis, Contact, Dermatitis, OccupationalView official trial listing → -
Status unknown NCT NCT00780429
Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients
Fondazione IRCCS Policlinico San Matteo di Pavia 54 participants 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00780793
Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study
Not yet reported Assistance Publique - Hôpitaux de Paris 250 participants Est. completion 2011-09 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT00781716
Safety and Efficacy Study of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction (STEMI) and Analysis of Current Status of Emergency PCI Green Channel for STEMI Patients in China
Not yet reported Beijing Chao Yang Hospital 1020 participants Est. completion 2011-05 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00782275
Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma
Not yet reported Beth Israel Deaconess Medical Center 41 participants Est. completion 2015-05 3 sitesOther conditions: Renal Cell Carcinoma, Kidney CancerView official trial listing → -
Completed NCT NCT00782379
Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer
Not yet reported Northside Hospital, Inc. 20 participants Est. completion 2012-04 1 site Stand-aloneOther conditions: Leukemia, Lymphoma, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00782418
A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 27 participants Est. completion 2009-03Other conditions: The Methodology Assessment of Glucose Dependent Insulin SecretionView official trial listing → -
Completed NCT NCT00782821
Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients
Not yet reported University of Cincinnati 40 participants Est. completion 2013-03 2 sitesOther conditions: Kidney TransplantationView official trial listing → -
Withdrawn NCT NCT00783536
A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2010-06 Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00784914
A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors
Not yet reported City of Hope Medical Center 12 participants Est. completion 2010-11 1 site Stand-aloneOther conditions: Brain and Central Nervous System Tumors, Metastatic CancerView official trial listing → -
Withdrawn NCT NCT00784966
Islet After Kidney Transplant for Type 1 Diabetes
Not yet reported, Not yet reported Virginia Commonwealth University Est. completion 2017-09 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT00785330
Allo-hNHL (FluBuCy)
Not yet reported Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 84 participants Est. completion 2011-04 6 sites Stand-aloneOther conditions: Non-Hodgkin's LymphomaView official trial listing → -
Completed NCT NCT00787761
Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer
Not yet reported Northside Hospital, Inc. 24 participants Est. completion 2012-05 1 site Stand-aloneOther conditions: Myeloproliferative Disorders, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative DiseasesView official trial listing → -
Completed NCT NCT00788021
Protective Immunity Project 01
Emory University 124 participants Est. completion 2011-10 1 siteOther conditions: Kidney Transplantation, Immunity, ImmunosuppressionView official trial listing → -
Withdrawn NCT NCT00788580
S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors
Not yet reported SWOG Cancer Research NetworkOther conditions: Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00789308
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2014-08-21 3 sites Stand-aloneOther conditions: Diabetes Mellitus, Type IView official trial listing → -
Completed NCT NCT00789776
Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer
Not yet reported, Not yet reported Fred Hutchinson Cancer Center 41 participants Est. completion 2017-05 3 sites Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Previously Treated Myelodysplastic Syndrome, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Indolent Adult Non-Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Refractory Plasma Cell Myeloma, Refractory Small Lymphocytic Lymphoma, Waldenstrom MacroglobulinemiaView official trial listing → -
Completed NCT NCT00790036
Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy
Not yet reported Novartis Pharmaceuticals 742 participants Est. completion 2016-06-15 202 sitesOther conditions: Diffuse Large B-cell LymphomaView official trial listing → -
Withdrawn NCT NCT00790439
Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2009-10 Stand-aloneOther conditions: Diabetes Mellitus, Type IView official trial listing → -
Completed NCT NCT00791765
Moderate to Severe Plaque Psoriasis With Scalp Involvement
Not yet reported Amgen 124 participants Est. completion 2010-03 Stand-aloneOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00792766
Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)
Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 20 participants Est. completion 2013-09 1 siteOther conditions: Tuberous Sclerosis, AngiolipomaView official trial listing → -
Active, not recruiting NCT NCT00792948
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Not yet reported National Cancer Institute (NCI) 97 participants Est. completion 2027-01-06 157 sites Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Adult L1 Acute Lymphoblastic Leukemia, Adult L2 Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic LeukemiaView official trial listing → -
Completed NCT NCT00793221
Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent
Not yet reported Raul Moreno 207 participantsCardiovascular disease Other conditions: Coronary Occlusion, Percutaneous Coronary InterventionView official trial listing → -
Completed NCT NCT00795886
Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)
Not yet reported University of Utah 63 participants Est. completion 2010-03 1 site Stand-aloneOther conditions: Acute Lymphoblastic LeukemiaView official trial listing → -
Completed NCT NCT00796562
Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 107 participants Est. completion 2016-11 2 sitesOther conditions: MDS, Leukemias, LymphomasView official trial listing → -
Terminated NCT NCT00796705
Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 13 participants Est. completion 2010-10 16 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00796796
Temsirolimus and Radiation for Non-Small Cell Lung Cancer
Not yet reported Washington University School of Medicine 10 participants Est. completion 2011-07 1 siteOther conditions: Carcinoma, Non-Small-Cell LungView official trial listing → -
Status unknown NCT NCT00797784
The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus
Not yet reported Florida Academic Dermatology Centers 20 participants Est. completion 2011-04 1 siteOther conditions: Discoid Lupus Erythematosus (DLE)View official trial listing → -
Status unknown NCT NCT00798785
Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients
Not yet reported, Not yet reported Universitair Ziekenhuis Brussel 50 participants Est. completion 2014-12 4 sites Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00799188
CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial
Not yet reported Hospices Civils de Lyon 175 participants 1 site Stand-aloneOther conditions: Cardiac Transplantation, Skin CancerView official trial listing → -
Terminated NCT NCT00799435
Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure
Not yet reported Baylor College of Medicine 2 participants Est. completion 2012-04 1 site Stand-aloneType 2 diabetesHeart failureView official trial listing → -
Completed NCT NCT00800722
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
Not yet reported University of California, Irvine 21 participants Est. completion 2014-06 1 siteOther conditions: Port Wine StainView official trial listing → -
Completed NCT NCT00801632
Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: Kidney Transplantation, Kidney Failure, ChronicView official trial listing → -
Terminated NCT NCT00801931
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
Not yet reported, Not yet reported Columbia University 1 participants Est. completion 2009-05-05 1 site Stand-aloneOther conditions: Leukemia, Lymphoma, Neuroblastoma, Immunodeficiencies, AnemiaView official trial listing → -
Completed NCT NCT00801957
Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis
Not yet reported Astellas Pharma Inc 260 participants Est. completion 2004-11 36 sites Stand-aloneOther conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT00802815
Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis
Not yet reported Washington University School of Medicine 20 participants Est. completion 2014-05 1 site Stand-aloneOther conditions: Inclusion Body MyositisView official trial listing → -
Completed NCT NCT00803010
Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 74 participants Est. completion 2012-12 1 siteOther conditions: Acute Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT00803816
Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A
Not yet reported Carsten Heinz 12 participants Est. completion 2010-12 1 siteOther conditions: UveitisView official trial listing → -
Completed NCT NCT00803920
Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide
HealthPartners Institute 8 participants Est. completion 2008-02 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00804336
Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
Not yet reported Dana-Farber Cancer Institute 22 participants Est. completion 2015-04 3 sitesOther conditions: Neuroendocrine Tumor, Carcinoid Tumor, Pancreatic Neuroendocrine TumorView official trial listing → -
Completed NCT NCT00805961
RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
Not yet reported SCRI Development Innovations, LLC 68 participants Est. completion 2013-05 13 sitesOther conditions: Glioblastoma MultiformeView official trial listing → -
Completed NCT NCT00806520
Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control
HealthPartners Institute 16 participants Est. completion 2011-08 5 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT00807144
Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation
Not yet reported Imperial College Healthcare NHS Trust 102 participants Est. completion 2012-03 1 site Stand-aloneOther conditions: End-stage Renal Failure, Graft RejectionView official trial listing → -
Completed NCT NCT00807690
Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo
Not yet reported Oslo University Hospital Est. completion 2008-01Other conditions: VitiligoView official trial listing → -
Terminated NCT NCT00807755
Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors
Not yet reported University of California, Davis 5 participants Est. completion 2011-12 1 siteOther conditions: Lung Cancer, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Terminated NCT NCT00809185
RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes
Not yet reported Case Comprehensive Cancer Center 7 participants Est. completion 2009-03 1 siteOther conditions: Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00810602
Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant
Not yet reported, Not yet reported Pavan Reddy, MD 61 participants Est. completion 2013-07 2 sites Stand-aloneOther conditions: Hematologic Malignancies, Graft vs Host DiseaseView official trial listing → -
Completed NCT NCT00811616
A Safety and Efficacy of Supralimus™ Core™ Sirolimus Eluting Stent at MAX DDHV Institute
Not yet reported Sahajanand Medical Technologies Limited 105 participants Est. completion 2008-03 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Terminated NCT NCT00811915
Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation
Not yet reported University Hospital, Rouen 65 participants Est. completion 2014-06 8 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00812786
Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant Patients
Not yet reported University Hospital, Limoges 42 participants Est. completion 2012-05 12 sitesOther conditions: Heart TransplantView official trial listing → -
Completed NCT NCT00813124
Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)
Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2014-09 1 siteOther conditions: Stem Cell Transplantation, LeukemiaView official trial listing → -
Completed NCT NCT00814944
A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model
Not yet reported Santen Inc. 143 participants Est. completion 2009-10 1 site Stand-aloneOther conditions: Dry EyeView official trial listing → -
Completed NCT NCT00817206
Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily
Not yet reported Asahi Kasei Therapeutics, Inc. 326 participants Est. completion 2011-02 1 site Stand-aloneOther conditions: Renal FailureView official trial listing → -
Completed NCT NCT00818194
Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy Volunteers
Not yet reported Astellas Pharma Inc 18 participants Est. completion 2008-09 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Terminated NCT NCT00818961
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer
Not yet reported Northside Hospital, Inc. 36 participants Est. completion 2012-03 1 siteOther conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative DiseasesView official trial listing → -
Active, not recruiting NCT NCT00819546
RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS
Not yet reported Richard Stone, MD 29 participants Est. completion 2026-12 3 sitesOther conditions: Acute Myeloid Leukemia, Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT00820911
Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients
Not yet reported Novartis Pharmaceuticals 175 participants Est. completion 2012-07 28 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00821080
Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma
Not yet reported Massachusetts General Hospital 33 participants Est. completion 2015-02 2 sites Stand-aloneOther conditions: GlioblastomaView official trial listing → -
Completed NCT NCT00821587
Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation
Not yet reported University of Florida 39 participants Est. completion 2008-05Other conditions: Hepatitis CView official trial listing → -
Completed NCT NCT00823459
Everolimus in Treating Patients With Recurrent Low-Grade Glioma
Not yet reported Susan Chang 58 participants Est. completion 2017-11-13 1 siteOther conditions: Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma, Adult Subependymal Giant Cell Astrocytoma, Recurrent Adult Brain NeoplasmView official trial listing → -
Terminated NCT NCT00827099
Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer
Not yet reported Northside Hospital, Inc. 5 participants Est. completion 2009-11 1 siteOther conditions: Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT00827359
Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma
Not yet reported Beth Israel Deaconess Medical Center 25 participants Est. completion 2018-06 3 sitesOther conditions: Renal Cell Carcinoma, Renal CancerView official trial listing → -
Terminated NCT NCT00827567
Trial of RAD001 in Triple Negative Metastatic Breast Cancer
Not yet reported Milton S. Hershey Medical Center 6 participants Est. completion 2011-02 1 siteOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT00828503
Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
Not yet reported Marcus Saemann 40 participants Est. completion 2014-06 1 siteOther conditions: Cytomegalovirus DiseaseView official trial listing → -
Completed NCT NCT00830297
Treat-to-target Trial of Basal Insulin in Post-transplant Hyperglycemia
Not yet reported Marcus Saemann 50 participants Est. completion 2011-05 1 siteOther conditions: HyperglycemiaView official trial listing → -
Completed NCT NCT00830466
A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.
Not yet reported University of California, Irvine 22 participants Est. completion 2016-01 1 siteOther conditions: Port Wine StainView official trial listing → -
Terminated NCT NCT00831480
Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal
Not yet reported Linda C. Higgins 15 participants Est. completion 2014-12 2 sitesOther conditions: Kidney CancerView official trial listing → -
Completed NCT NCT00833079
Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis
Not yet reported Sun Pharmaceutical Industries, Inc. 500 participants Est. completion 2010-03 Stand-aloneOther conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT00833651
Protective Immunity Project 02
Emory University 97 participants Est. completion 2011-10 1 siteOther conditions: Kidney Transplant, Immunology, ImmunosuppressionView official trial listing → -
Withdrawn NCT NCT00834496
Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation
Thomas Jefferson University Est. completion 2010-01 1 siteOther conditions: Side Effects of Calcineurin Inhibitors, Renal Toxicity, Hepatic Fibrosis on Biopsy, Neurotoxicity, Post Transplant DiabetesView official trial listing → -
Completed NCT NCT00835848
Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI
Not yet reported Copenhagen University Hospital, Rigshospitalet 100 participants Est. completion 2015-05 1 siteCardiovascular diseaseView official trial listing → -
Terminated NCT NCT00836927
Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038)
Not yet reported Merck Sharp & Dohme LLC 7 participants Est. completion 2018-02-04Other conditions: Advanced CancersView official trial listing → -
Completed NCT NCT00837434
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 63 participants Est. completion 2014-01 7 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT00838539
Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors
Not yet reported Puma Biotechnology, Inc. 63 participants Est. completion 2013-12 5 sitesOther conditions: Neoplasms, Malignant CarcinomaView official trial listing → -
Terminated NCT NCT00838955
Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma
Not yet reported Loyola University 14 participants Est. completion 2017-10 1 siteOther conditions: Hodgkin's LymphomaView official trial listing → -
Completed NCT NCT00843856
Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis
Not yet reported Imperial College Healthcare NHS Trust 40 participants Est. completion 2018-09-18 1 siteOther conditions: Glomerulonephritis, MembranousView official trial listing → -
Status unknown NCT NCT00844142
Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)
Not yet reported Charite University, Berlin, Germany 80 participants Est. completion 2013-07 9 sitesOther conditions: Moderate to Severe Active Axial SpondyloarthritisView official trial listing → -
Completed NCT NCT00845182
Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
Not yet reported The University of Texas Health Science Center at San Antonio 43 participants Est. completion 2010-07 1 site Stand-aloneType 2 diabetesPrediabetes Other conditions: HealthyView official trial listing → -
Completed NCT NCT00845507
Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults
Not yet reported University of Cincinnati 54 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: Weight GainView official trial listing → -
Withdrawn NCT NCT00845559
The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults
Not yet reported Yale University Stand-alonePrediabetesCardiovascular disease Other conditions: Obesity, Insulin ResistanceView official trial listing → -
Completed NCT NCT00849147
Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)
Not yet reported Medical College of Wisconsin 55 participants Est. completion 2013-11 17 sites Stand-aloneOther conditions: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, DiffuseView official trial listing → -
Withdrawn NCT NCT00853424
A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease
Not yet reported University of British Columbia Est. completion 2010-12 Stand-aloneOther conditions: Diabetic Retinopathy, Diabetic Macular EdemaView official trial listing → -
Terminated NCT NCT00853944
Effect of Sitagliptin on Graft Function Following Islet Transplantation
Not yet reported University of British Columbia 12 participants Est. completion 2013-11-01 1 siteOther conditions: Islet TransplantationView official trial listing → -
Withdrawn NCT NCT00855114
Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery
Not yet reported Masonic Cancer Center, University of Minnesota Est. completion 2009-06 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00855439
Evaluation of Exenatide in Patients With Diabetic Neuropathy
Not yet reported University of Michigan 46 participants Est. completion 2014-05 1 site Stand-aloneType 2 diabetes Other conditions: Diabetic Peripheral NeuropathyView official trial listing → -
Status unknown NCT NCT00856505
Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation
Not yet reported, Not yet reported University Hospital Freiburg 38 participants Est. completion 2011-03 1 siteOther conditions: Hematologic DiseasesView official trial listing → -
Completed NCT NCT00856609
The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 150 participants Est. completion 2016-09-19 1 siteOther conditions: Weight Loss, ObesityView official trial listing → -
Terminated NCT NCT00857259
The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration
Not yet reported Novartis Pharmaceuticals 16 participants 12 sitesOther conditions: Choroidal Neo-Vascular Age-onset Macular Degeneration, Age-related Macular DegenerationView official trial listing → -
Completed NCT NCT00857389
Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies
Not yet reported M.D. Anderson Cancer Center 60 participants Est. completion 2019-03-09 1 site Stand-aloneOther conditions: Stem Cell Transplantation, Leukemia, LymphomaView official trial listing → -
Completed NCT NCT00859131
Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists
Not yet reported Medical University of South Carolina 200 participants Est. completion 2014-07 1 siteOther conditions: End Stage Renal DiseaseView official trial listing → -
Completed NCT NCT00859183
Oral Sirolimus for In-Stent Restenosis
Not yet reported Deutsches Herzzentrum Muenchen 300 participants Est. completion 2004-03 3 sitesOther conditions: Coronary RestenosisView official trial listing → -
Completed NCT NCT00860496
A Phase I Open-Label Study of the Effects of Tacrolimus and Cyclosporine on CP-690,555 in Healthy Volunteers
Not yet reported Pfizer 24 participants Est. completion 2009-08 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT00860574
Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia
Not yet reported Fred Hutchinson Cancer Center 96 participants 3 sites Stand-aloneOther conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic LeukemiaView official trial listing → -
Completed NCT NCT00861874
A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia
Not yet reported University of Rochester 13 participants 1 siteOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT00862979
A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients
Not yet reported Novartis Pharmaceuticals 162 participants Est. completion 2017-03-06 9 sites Stand-aloneOther conditions: Heart TransplantationView official trial listing → -
Completed NCT NCT00863655
Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
Not yet reported Novartis Pharmaceuticals 724 participants Est. completion 2014-12-04 200 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00865137
An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients
Not yet reported Astellas Pharma Inc 27 participants Est. completion 2007-12 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT00866684
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
Not yet reported Charite University, Berlin, Germany 44 participants Est. completion 2011-04-19 15 sites Stand-aloneOther conditions: Skin CancerView official trial listing → -
Completed NCT NCT00866879
Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients
Not yet reported Northwestern University 275 participants Est. completion 2019-03 1 site Stand-aloneOther conditions: Renal Transplant RejectionView official trial listing → -
Status unknown NCT NCT00868829
Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial
Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 5000 participants Est. completion 2013-03 1 siteOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT00869999
Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
Not yet reported Massachusetts General Hospital 26 participants Est. completion 2011-11 2 sitesOther conditions: Diffuse Large B-cell LymphomaView official trial listing → -
Completed NCT NCT00870194
A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin
Not yet reported AstraZeneca 255 participants Est. completion 2010-04 36 sites Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT00870831
Islet Function and Clinical Analyses of Transplant Recipients
Washington University School of Medicine 8 participants Est. completion 2010-03Other conditions: Type One Diabetes MellitusView official trial listing → -
Completed NCT NCT00873730
Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain
Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 108 participants Est. completion 2008-06 Stand-aloneOther conditions: Ankylosing SpondylitisView official trial listing → -
Withdrawn NCT NCT00874315
Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.
Not yet reported Nationwide Children's Hospital Est. completion 2012-06 4 sitesOther conditions: NeuroblastomaView official trial listing → -
Completed NCT NCT00874562
Rapamycin in Relapsed Acute Lymphoblastic Leukemia
Not yet reported Dana-Farber Cancer Institute 6 participants Est. completion 2016-04 1 siteOther conditions: Acute Lymphoblastic LeukemiaView official trial listing → -
Completed NCT NCT00876616
Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis
Not yet reported Zhi-Hong Liu, M.D. 362 participants Est. completion 2012-02 1 site Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT00877890
A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)
Not yet reported AstraZeneca 254 participants Est. completion 2010-01 41 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00879333
Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)
Not yet reported Novartis Pharmaceuticals 656 participants Est. completion 2014-01 122 sitesOther conditions: Advanced Gastric CancerView official trial listing → -
Completed NCT NCT00880282
Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment
Not yet reported National Cancer Institute (NCI) 39 participants 23 sitesOther conditions: Unspecified Childhood Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT00880815
Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant
Not yet reported M.D. Anderson Cancer Center 60 participants Est. completion 2019-05-28 1 site Stand-aloneOther conditions: CD20 Positive, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, T-Cell Non-Hodgkin LymphomaView official trial listing → -
Terminated NCT NCT00881556
Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Not yet reported Columbia University 3 participants Est. completion 2015-09 3 sites Stand-aloneObstructive sleep apneaView official trial listing → -
Completed NCT NCT00882050
Intravenous Exenatide (Byetta) During Surgery
Not yet reported, Not yet reported Thomas Jefferson University 104 participants Est. completion 2016-04 1 site Stand-aloneOther conditions: Euglycemia, Hypoglycemia, HyperglycemiaView official trial listing → -
Active, not recruiting NCT NCT00882895
Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma
Not yet reported Washington University School of Medicine 18 participants Est. completion 2028-06-01 1 site Stand-aloneOther conditions: Lymphoma, Non-HodgkinView official trial listing → -
Completed NCT NCT00885820
Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection
Not yet reported Astellas Pharma Inc 240 participants Est. completion 2006-01 12 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00886626
GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children
Not yet reported University of Minnesota 12 participants Est. completion 2011-02 1 site Stand-aloneOther conditions: Obesity, MorbidView official trial listing → -
Terminated NCT NCT00887640
Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer
Not yet reported Duke University 11 participants Est. completion 2012-08 2 sitesOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT00890253
Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation
Not yet reported Armin Goralczyk 29 participants Est. completion 2013-01 1 site Stand-aloneOther conditions: Liver Transplantation, Chronic Renal InsufficiencyView official trial listing → -
Completed NCT NCT00890500
Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.
Not yet reported Fate Therapeutics 12 participants Est. completion 2013-10 2 sitesOther conditions: Hematologic Malignancies, Allogeneic Stem Cell TransplantationView official trial listing → -
Completed NCT NCT00891696
Nutritional and Contractile Regulation of Muscle Growth
Not yet reported The University of Texas Medical Branch, Galveston 144 participants Est. completion 2015-03 1 siteOther conditions: SarcopeniaView official trial listing → -
Completed NCT NCT00894322
A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension
Not yet reported, Not yet reported AstraZeneca 65 participants Est. completion 2009-08 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00895583
Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients
Not yet reported Pfizer 254 participants Est. completion 2013-08 44 sites Stand-aloneOther conditions: Graft Rejection, Kidney Transplant, Renal Allograft Recipients, Renal TransplantView official trial listing → -
Completed NCT NCT00896012
Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal
Not yet reported University at Buffalo 58 participants Est. completion 2011-12 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00899847
Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG
Not yet reported Stanford University 9 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Transplantation, Homologous, Transplantation, Autologous, Multiple Myeloma, Blood and Marrow Transplant (BMT)View official trial listing → -
Completed NCT NCT00901849
Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1)
Not yet reported Roger Packer 21 participants Est. completion 2012-10 1 siteOther conditions: Low-grade GliomasView official trial listing → -
Completed NCT NCT00902980
Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics
Astellas Pharma Inc 264 participants Est. completion 2006-12 13 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00903175
Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
Not yet reported Novartis Pharmaceuticals 471 participants Est. completion 2015-05 84 sitesOther conditions: Renal Cell CarcinomaView official trial listing → -
Status unknown NCT NCT00903188
Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation
Not yet reported University Hospital, Antwerp 152 participants Est. completion 2015-04 5 sitesOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00905515
Optima: Optimizing Prograf Therapy in Maintenance Allografts II
Not yet reported East Carolina University 63 participants Est. completion 2008-07 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00909571
Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus
Not yet reported Astellas Pharma Inc 10 participants Est. completion 2010-03 1 site Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Terminated NCT NCT00910273
Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients
Not yet reported Pfizer 34 participants Est. completion 2011-10 4 sites Stand-aloneOther conditions: Ankylosing SpondylitisView official trial listing → -
Completed NCT NCT00912223
Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)
Not yet reported Medical College of Wisconsin 65 participants Est. completion 2016-08 21 sites Stand-aloneOther conditions: Lymphoma, Non-HodgkinView official trial listing → -
Completed NCT NCT00912340
Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer
Not yet reported Emory University 70 participants Est. completion 2017-07 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT00912678
Minimizing Immunosuppression in Old for Old Kidney Transplantation
Not yet reported University of Luebeck 90 participants Est. completion 2008-10 5 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00913458
Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis
Not yet reported Pfizer 306 participants Est. completion 2012-12 59 sites Stand-aloneOther conditions: Active Rheumatoid Arthritis, Arthritis, Rheumatoid, Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT00914940
Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
Not yet reported Fred Hutchinson Cancer Center 41 participants Est. completion 2020-05-26 2 sites Stand-aloneOther conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic SyndromesView official trial listing → -
Terminated NCT NCT00917163
SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent
Not yet reported Sahajanand Medical Technologies Limited 13 participants Est. completion 2010-05 28 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT00917267
A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects
Not yet reported AstraZeneca 691 participants Est. completion 2011-04 42 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00919035
Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients
Not yet reported Oncology Specialists, S.C. 21 participants Est. completion 2013-10 2 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT00919503
Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders
Not yet reported Fred Hutchinson Cancer Center 98 participants Est. completion 2020-06-10 6 sites Stand-aloneOther conditions: Non-Neoplastic Hematologic and Lymphocytic DisorderView official trial listing → -
Status unknown NCT NCT00920478
Targeting Synovitis in Early Rheumatoid Arthritis
Not yet reported NHS Greater Glasgow and Clyde 110 participants Est. completion 2012-09 3 sitesOther conditions: Rheumatoid Arthritis, PolyarthritisView official trial listing → -
Terminated NCT NCT00921310
Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer
Not yet reported, Not yet reported Washington University School of Medicine 12 participants Est. completion 2016-04 1 siteOther conditions: Carcinoma, Non-Small-Cell LungView official trial listing → -
Withdrawn NCT NCT00922129
Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer
Not yet reported, Not yet reported St. Joseph's Healthcare Hamilton Est. completion 2011-01 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Terminated NCT NCT00923273
Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
Not yet reported, Not yet reported National Cancer Institute (NCI) 42 participants Est. completion 2013-03-10 1 site Stand-aloneOther conditions: Carcinoma, Non-Small-Cell LungView official trial listing → -
Completed NCT NCT00923845
Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
Not yet reported National Cancer Institute (NCI) 25 participants Est. completion 2017-06-22 1 siteOther conditions: Renal Cell Carcinoma, Graft-Versus-Host Disease, Engraftment SyndromeView official trial listing → -
Terminated NCT NCT00926107
Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse
Not yet reported Hellenic Cooperative Oncology Group 9 participants Est. completion 2011-10 12 sitesOther conditions: Ovarian CancerView official trial listing → -
Completed NCT NCT00928018
Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma
Not yet reported Dana-Farber Cancer Institute 139 participants Est. completion 2014-11 5 sitesOther conditions: Non-hodgkin Lymphoma, Hodgkin LymphomaView official trial listing → -
Terminated NCT NCT00928811
Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant
Not yet reported, Not yet reported Drexel University College of Medicine 5 participants Est. completion 2010-04 1 site Stand-aloneOther conditions: End Stage Renal DiseaseView official trial listing → -
Terminated NCT NCT00930241
Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung Transplantation
Not yet reported Hannover Medical School 25 participants Est. completion 2012-07 3 sites Stand-aloneOther conditions: Lung TransplantationView official trial listing → -
Status unknown NCT NCT00930475
Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer
Not yet reported, Not yet reported Charite University, Berlin, Germany 54 participants 1 siteOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT00931255
Tacrolimus to Sirolimus Conversion for Delayed Graft Function
Not yet reported University of Maryland, Baltimore 32 participants Est. completion 2014-07 1 siteOther conditions: Kidney Transplant, Delayed Graft FunctionView official trial listing → -
Status unknown NCT NCT00931957
Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Not yet reported Tehran University of Medical Sciences 80 participants Est. completion 2013-10 1 siteOther conditions: Behcet Syndrome, Uveal DiseaseView official trial listing → -
Completed NCT NCT00933231
Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts
Not yet reported Astellas Pharma Inc 281 participants Est. completion 2018-04-03 13 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT00934791
Polycystic Liver Disease in Kidney Transplant
Not yet reported Mayo Clinic 2 participants Est. completion 2012-12 1 siteOther conditions: Polycystic Liver DiseaseView official trial listing → -
Completed NCT NCT00935298
Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation
Not yet reported The Second Artillery General Hospital 145 participants Est. completion 2011-06 5 sites Stand-aloneOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00935792
Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Not yet reported, Not yet reported Mayo Clinic 28 participants Est. completion 2015-12 2 sitesOther conditions: Lymphocytic LeukemiaView official trial listing → -
Completed NCT NCT00935961
RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer
Not yet reported Memorial Sloan Kettering Cancer Center 18 participants Est. completion 2013-08 5 sitesOther conditions: HEAD & NECK CancerView official trial listing → -
Completed NCT NCT00936065
Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis
Not yet reported Pfizer 60 participants Est. completion 2011-04 10 sites Stand-aloneOther conditions: Moderate to Severe PsoriasisView official trial listing → -
Completed NCT NCT00936702
Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Not yet reported Alliance for Clinical Trials in Oncology 46 participants Est. completion 2013-08 141 sitesOther conditions: Carcinoma of Unknown Primary OriginView official trial listing → -
Completed NCT NCT00936858
RAD001 for Patients With Radioiodine Refractory Thyroid Cancer
Not yet reported Dana-Farber Cancer Institute 50 participants Est. completion 2020-02-27 4 sitesOther conditions: Thyroid CancerView official trial listing → -
Terminated NCT NCT00938119
Care China-Diabetes
Johnson & Johnson Medical, China 1603 participants Est. completion 2012-12 46 sitesCardiovascular disease Other conditions: DiabetesView official trial listing → -
Completed NCT NCT00938860
Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C
Not yet reported Novartis Pharmaceuticals 92 participants Est. completion 2013-05 45 sitesOther conditions: Hepatitis C, Liver TransplantationView official trial listing → -
Completed NCT NCT00940381
Sirolimus and Cetuximab in Advanced Malignancies
Not yet reported M.D. Anderson Cancer Center 165 participants Est. completion 2014-05 1 site Stand-aloneOther conditions: Advanced CancerView official trial listing → -
Completed NCT NCT00941824
Pharmacokinetic Evaluation of an Intensified and Decreasing Dosing Regimen of Mycophenolate Sodium in Combination With Tacrolimus Post Kidney Transplant: The Myfortic Study
Not yet reported Centre Hospitalier Universitaire de Saint Etienne 15 participants Est. completion 2010-03 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00942682
Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors
Not yet reported Dana-Farber Cancer Institute 21 participants Est. completion 2013-03 1 siteOther conditions: Neuroendocrine Tumor, Carcinoid Tumor, Pancreatic Neuroendocrine TumorView official trial listing → -
Completed NCT NCT00942734
Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma
Not yet reported M.D. Anderson Cancer Center 49 participants Est. completion 2014-11 1 siteOther conditions: Head And Neck CancerView official trial listing → -
Status unknown NCT NCT00942747
Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma
Not yet reported Charite University, Berlin, Germany 37 participants Est. completion 2014-06 6 sitesOther conditions: Recurrent or Refractory Primary CNS LymphomaView official trial listing → -
Completed NCT NCT00943917
Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus
Not yet reported Intarcia Therapeutics 155 participants Est. completion 2011-02 50 sites Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT00946023
Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 135 participants Est. completion 2013-07-17 1 site Stand-aloneOther conditions: Lymphoma, B-cell Lymphoma, Non Hodgkin Lymphoma, Chronic Lymphocytic LeukemiaView official trial listing → -
Completed NCT NCT00947635
Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention
Not yet reported, Not yet reported University of Alberta 46 participants Est. completion 2009-06 1 siteOther conditions: Immunosuppression, Hyperlipidemias, Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT00948168
Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes
Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 34 participants Est. completion 2009-07 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT00948753
Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation
Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 38 participants Est. completion 2011-04 Stand-aloneOther conditions: Graft-versus-host Disease, Hematopoietic Stem Cell TransplantationView official trial listing → -
Completed NCT NCT00949325
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24 participants Est. completion 2012-09 1 siteOther conditions: SarcomaView official trial listing → -
Completed NCT NCT00949949
Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy
Not yet reported Mayo Clinic 38 participants Est. completion 2014-07 3 sitesOther conditions: Cholangiocarcinoma of the Gallbladder, Localized Gallbladder Cancer, Unresectable Gallbladder Cancer, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Withdrawn NCT NCT00950391
Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus
Not yet reported, Not yet reported Washington University School of Medicine Est. completion 2015-09 Stand-aloneOther conditions: Peripheral Nerve InjuryView official trial listing → -
Completed NCT NCT00950677
The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes
Not yet reported Baylor College of Medicine 16 participants Est. completion 2011-05 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT00954512
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
Not yet reported, Not yet reported Merck Sharp & Dohme LLC 15 participants Est. completion 2011-06-07Other conditions: NeoplasmsView official trial listing → -
Completed NCT NCT00955773
A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects
Not yet reported GlaxoSmithKline 64 participants Est. completion 2011-11-08 3 sitesOther conditions: CancerView official trial listing → -
Status unknown NCT NCT00956059
Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis
Not yet reported Xi'an Jiaotong University 40 participants Est. completion 2012-12 1 siteOther conditions: Focal Segmental GlomerulosclerosisView official trial listing → -
Terminated NCT NCT00956293
Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program
Not yet reported Novartis Pharmaceuticals 207 participants Est. completion 2013-03 9 sites Stand-aloneOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT00960648
Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting
Seoul National University Hospital 3056 participants Est. completion 2014-01 18 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT00960661
A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes
Not yet reported AstraZeneca 1036 participants Est. completion 2012-08 95 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00964262
A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide
Not yet reported Peptron, Inc. 34 participants Est. completion 2010-10 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT00965094
Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients
Not yet reported Novartis Pharmaceuticals 36 participants Est. completion 2013-06 3 sites Stand-aloneOther conditions: Chronic Renal FailureView official trial listing → -
Completed NCT NCT00965666
Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia
Not yet reported Children's Hospital Medical Center, Cincinnati 3 participants Est. completion 2010-10 1 site Stand-aloneOther conditions: Fanconi AnemiaView official trial listing → -
Status unknown NCT NCT00966836
Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy
Not yet reported University of Bologna 100 participants 1 siteOther conditions: Heart Transplantation, Cardiac Allograft Vasculopathy, Cytomegalovirus InfectionView official trial listing → -
Completed NCT NCT00967044
Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma
Not yet reported, Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2014-03 1 siteOther conditions: LymphomaView official trial listing → -
Completed NCT NCT00967902
Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent
Not yet reported OrbusNeich 180 participants Est. completion 2015-09 1 site Stand-aloneOther conditions: Coronary Artery LesionsView official trial listing → -
Withdrawn NCT NCT00967928
Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer
Not yet reported Accelerated Community Oncology Research Network Est. completion 2010-12Other conditions: Cervical CancerView official trial listing → -
Completed NCT NCT00968253
RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia
Not yet reported, Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2015-12 1 siteOther conditions: Leukemia, Acute Lymphocytic LeukemiaView official trial listing → -
Completed NCT NCT00968591
Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency
Not yet reported Novartis Pharmaceuticals 34 participants 3 sitesOther conditions: Hepatic InsufficiencyView official trial listing → -
Completed NCT NCT00970073
Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant
Not yet reported The Cleveland Clinic 30 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT00971789
Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes
Not yet reported National Cancer Institute (NCI) 18 participants Est. completion 2012-10 1 site Stand-aloneOther conditions: Cowden's Disease, Hamartoma Syndrome, MultipleView official trial listing → -
Withdrawn NCT NCT00972101
Infusion of Expanded Cord Blood T Cells
Not yet reported M.D. Anderson Cancer Center Est. completion 2011-09 Stand-aloneOther conditions: Stem Cell Transplantation, Leukemia, Lymphoma, Pediatric DisordersView official trial listing → -
Terminated NCT NCT00972335
Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma
Not yet reported SCRI Development Innovations, LLC 18 participants Est. completion 2014-07 7 sitesOther conditions: Intracranial MeningiomaView official trial listing → -
Status unknown NCT NCT00972660
Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease
Not yet reported Guangdong Provincial People's Hospital 52 participants Est. completion 2017-12 1 site Stand-aloneOther conditions: Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT00973076
Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055
Not yet reported AstraZeneca 19 participants Est. completion 2010-12 1 siteOther conditions: Cancer, Solid Tumors, Advanced Solid MalignanciesView official trial listing → -
Status unknown NCT NCT00973713
Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol
Not yet reported Austin Health 27 participants Est. completion 2012-03 1 siteOther conditions: CholangiocarcinomaView official trial listing → -
Terminated NCT NCT00973804
Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders
Not yet reported National Cancer Institute (NCI) 4 participants Est. completion 2013-05-20 1 siteOther conditions: Leukemia, Non-Hodgkins Lymphoma, Hodgkins Lymphoma, MDS, Multiple MyelomaView official trial listing → -
Terminated NCT NCT00975663
Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation
Not yet reported University Hospital, Limoges 180 participants Est. completion 2011-02 9 sites Stand-aloneOther conditions: Lung and Heart-lung TransplantationView official trial listing → -
Completed NCT NCT00976248
Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia
Not yet reported Dana-Farber Cancer Institute 33 participants Est. completion 2018-07 1 siteOther conditions: Waldenstrom's MacroglobulinemiaView official trial listing → -
Completed NCT NCT00976755
Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer
Not yet reported Swiss Cancer Institute 37 participants Est. completion 2019-08-08 13 sitesOther conditions: Prostate CancerView official trial listing → -
Active, not recruiting NCT NCT00977574
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
Not yet reported National Cancer Institute (NCI) 349 participants Est. completion 2027-03-06 230 sitesObstructive sleep apnea Other conditions: Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Recurrent Malignant Uterine Corpus NeoplasmView official trial listing → -
Active, not recruiting NCT NCT00977691
Haploidentical PBMC Transplant for Severe Congenital Anemias
Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 23 participants Est. completion 2026-09-10 1 site Stand-aloneOther conditions: Sickle Cell AnemiaView official trial listing → -
Completed NCT NCT00977938
The Dual Antiplatelet Therapy Study (DAPT Study)
Not yet reported Baim Institute for Clinical Research 25682 participants Est. completion 2014-06 256 sitesCardiovascular diseaseView official trial listing → -
Terminated NCT NCT00978432
Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Not yet reported Anne Beaven, MD 50 participants Est. completion 2016-03 1 siteOther conditions: Diffuse Large B-cell LymphomaView official trial listing → -
Completed NCT NCT00980460
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
Not yet reported National Cancer Institute (NCI) 236 participants Est. completion 2026-03-31 209 sitesOther conditions: PRETEXT I Hepatoblastoma, PRETEXT II Hepatoblastoma, PRETEXT III Hepatoblastoma, PRETEXT IV HepatoblastomaView official trial listing → -
Completed NCT NCT00982072
Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease
Not yet reported Imperial College Healthcare NHS Trust 52 participants Est. completion 2019-10-10 1 site Stand-aloneOther conditions: Minimal Change DiseaseView official trial listing → -
Status unknown NCT NCT00982631
A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer
Not yet reported Radboud University Medical Center 30 participants Est. completion 2012-08 1 siteOther conditions: Advanced/Recurrent Breast Cancer, Endometrial Cancer, Ovarian CancerView official trial listing → -
Terminated NCT NCT00983645
A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity
Not yet reported Loma Linda University 15 participants Est. completion 2013-03 1 siteOther conditions: Renal Transplant RejectionView official trial listing → -
Completed NCT NCT00985192
Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer
Not yet reported Translational Oncology Research International 49 participants Est. completion 2014-05 18 sitesOther conditions: Esophageal Cancer, Gastric CancerView official trial listing → -
Status unknown NCT NCT00987103
Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant Patients
Not yet reported Maastricht University Medical Center 18 participants Est. completion 2011-09 1 site Stand-aloneOther conditions: Organ TransplantationView official trial listing → -
Completed NCT NCT00992394
Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept
Not yet reported Pfizer 174 participants Est. completion 2013-04 46 sitesOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT00993343
Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation
Not yet reported Karolinska Institutet 215 participants Est. completion 2015-04 1 siteOther conditions: Graft-versus-host Disease, SurvivalView official trial listing → -
Withdrawn NCT NCT00995059
Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma
Not yet reported, Not yet reported Mayo Clinic Stand-aloneOther conditions: Multiple Myeloma, Refractory Multiple MyelomaView official trial listing → -
Terminated NCT NCT00996346
Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas
Not yet reported New Mexico Cancer Research Alliance 17 participants Est. completion 2013-11 1 siteOther conditions: SarcomaView official trial listing → -
Completed NCT NCT00997763
Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus
Not yet reported Seung-Jung Park 300 participants Est. completion 2015-08 18 sitesCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT00999258
Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients
Not yet reported Temple University 50 participants Est. completion 2011-06 1 siteOther conditions: Glomerular Filtration Rate, Chronic Allograft NephropathyView official trial listing → -
Completed NCT NCT00999362
Is T-lymphocyte Calcineurin Phosphatase Up-regulated by Treatment With Tacrolimus?
University of Aarhus 40 participants Est. completion 2009-10 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT00999882
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients
Not yet reported AstraZeneca 26 participants Est. completion 2011-12 3 sitesOther conditions: Cancer, Advanced Hepatocellular CarcinomaView official trial listing → -
Terminated NCT NCT01002339
Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation
Not yet reported Armando Torres Ramírez 134 participants Est. completion 2015-06 10 sites Stand-aloneOther conditions: Diabetes Mellitus, Adult-OnsetView official trial listing → -
Completed NCT NCT01003184
Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes
Not yet reported AstraZeneca 222 participants Est. completion 2011-12 34 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01004432
Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)
Not yet reported Janssen Biotech, Inc. 433 participants Est. completion 2013-10 117 sitesOther conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune DiseasesView official trial listing → -
Completed NCT NCT01005199
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer
Not yet reported Swiss Cancer Institute 106 participants Est. completion 2016-03 15 sitesOther conditions: Liver CancerView official trial listing → -
Terminated NCT NCT01005316
Alloantibodies in Pediatric Heart Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 290 participants Est. completion 2014-12 8 sitesOther conditions: Pediatric Heart Transplantation, Pediatric Heart Transplant RecipientsView official trial listing → -
Completed NCT NCT01005706
Sirolimus Conversions in African-American Renal Transplant Recipients
Not yet reported Medical University of South Carolina 40 participants Est. completion 2014-07 1 siteOther conditions: Absence; KidneyView official trial listing → -
Completed NCT NCT01006889
Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
Not yet reported University of Florida 24 participants Est. completion 2010-02 1 site Stand-aloneMASLDType 2 diabetesView official trial listing → -
Completed NCT NCT01007942
Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer
Not yet reported Novartis Pharmaceuticals 569 participants Est. completion 2015-06 161 sitesOther conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01008462
Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia
Not yet reported Fred Hutchinson Cancer Center 16 participants Est. completion 2018-06-30 2 sites Stand-aloneOther conditions: B-Cell Prolymphocytic Leukemia, Hypodiploidy, Loss of Chromosome 17p, Plasma Cell Leukemia, Progression of Multiple Myeloma or Plasma Cell Leukemia, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Childhood Hodgkin Lymphoma, Recurrent Childhood Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Non-Hodgkin Lymphoma, Refractory Plasma Cell Myeloma, Refractory Small Lymphocytic Lymphoma, t(14;16), t(4;14), T-Cell Prolymphocytic Leukemia, Waldenstrom MacroglobulinemiaView official trial listing → -
Completed NCT NCT01008917
Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Not yet reported University of California, San Francisco 25 participants Est. completion 2013-06-27 2 sitesOther conditions: Hepatocellular CarcinomaView official trial listing → -
Terminated NCT NCT01009203
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
Not yet reported New Mexico Cancer Research Alliance 13 participants Est. completion 2012-12 2 sitesOther conditions: Squamous Cell CarcinomaView official trial listing → -
Terminated NCT NCT01009801
Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer
Not yet reported, Not yet reported Swiss Cancer Institute 27 participants Est. completion 2015-06 8 sitesOther conditions: Liver CancerView official trial listing → -
Withdrawn NCT NCT01009879
Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants
Not yet reported University of Pittsburgh Est. completion 2012-02 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01010217
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
Not yet reported M.D. Anderson Cancer Center 176 participants Est. completion 2017-10-05 1 site Stand-aloneOther conditions: Blood Stem Cell Transplant Failure, Leukemia, Hematologic MalignanciesView official trial listing → -
Completed NCT NCT01011205
Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation
Not yet reported Astellas Pharma Inc 893 participants Est. completion 2013-01-04 72 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT01014234
Rapamycin and Regulatory T Cells in Kidney Transplantation
Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 56 participants Est. completion 2013-06 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT01015664
Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Not yet reported, Not yet reported University of Tennessee Cancer Institute 11 participants Est. completion 2012-12 1 siteOther conditions: Squamous Cell Carcinoma of the Head and NeckView official trial listing → -
Completed NCT NCT01016015
Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma
Not yet reported National Cancer Institute (NCI) 178 participants Est. completion 2014-07 24 sitesObstructive sleep apnea Other conditions: Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue SarcomaView official trial listing → -
Completed NCT NCT01018914
A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients
Not yet reported Astellas Pharma Inc 44 participants Est. completion 2010-12 3 sitesOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT01019434
Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 111 participants Est. completion 2014-03 13 sitesOther conditions: Brain and Central Nervous System TumorsView official trial listing → -
Terminated NCT NCT01020305
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer
Not yet reported, Not yet reported Sandy Srinivas 5 participants Est. completion 2012-04 1 siteOther conditions: Prostate Cancer, Prostatic Neoplasms, Castrate-resistant Prostate Cancer (CRPC), Androgen-insensitive Prostate Cancer, Hormone-refractory Prostate Cancer, Metastatic DiseaseView official trial listing → -
Completed NCT NCT01020539
Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia
Not yet reported Columbia University 18 participants Est. completion 2020-12 1 site Stand-aloneOther conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic LeukemiaView official trial listing → -
Completed NCT NCT01021527
A Study to Assess the Effects of Exenatide on Insulin Secretion Rates Using a Graded Infusion of Intravenous Glucose (0000-099)(COMPLETED)
Not yet reported Merck Sharp & Dohme LLC 12 participants Est. completion 2008-04 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01021735
Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy
Not yet reported University of Glasgow 302 participants Est. completion 2015-04 8 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT01021930
Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT
Not yet reported Harbin Medical University 70 participants Est. completion 2010-12 1 siteOther conditions: Coronary Heart Disease, Diabetes MellitusView official trial listing → -
Terminated NCT NCT01023919
Assessment of Surface Coverage of Two Types of Drug-eluting Stent in Diabetes Mellitus and Non-Diabetes Mellitus
Not yet reported Harbin Medical University 120 participants Est. completion 2010-12 1 siteCardiovascular disease Other conditions: Diabetes MellitusView official trial listing → -
Terminated NCT NCT01024179
Relationship Between Initial Plaque Characteristics and Stent Surface Coverage Patterns
Not yet reported Harbin Medical University 90 participants Est. completion 2010-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01024946
Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity
Not yet reported Memorial Sloan Kettering Cancer Center 11 participants Est. completion 2012-07 3 sitesOther conditions: Malignant Pleural MesotheliomaView official trial listing → -
Completed NCT NCT01025817
Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients
Not yet reported Novartis Pharmaceuticals 613 participants Est. completion 2013-03 50 sites Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT01026623
Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer
Not yet reported, Not yet reported National Cancer Institute (NCI) 16 participants Est. completion 2013-02 4 sitesOther conditions: Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate CancerView official trial listing → -
Completed NCT NCT01026792
Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery
Not yet reported National Cancer Institute (NCI) 38 participants Est. completion 2012-11 1 siteOther conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Carcinoma, Stage IIIA Cervical Cancer, Stage IIIB Cervical Cancer, Stage IVA Cervical Cancer, Stage IVB Cervical CancerView official trial listing → -
Completed NCT NCT01027000
Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Not yet reported Alliance for Clinical Trials in Oncology 68 participants Est. completion 2023-04 25 sites Stand-aloneOther conditions: Leukemia, LymphomaView official trial listing → -
Terminated NCT NCT01028716
Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Not yet reported Fred Hutchinson Cancer Center 46 participants Est. completion 2021-10-07 1 site Stand-aloneOther conditions: Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukaemia With Prior Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(3)(Q21Q26.2); RPN1-EVI1, Acute Myeloid Leukemia With Multilineage Dysplasia, Acute Myeloid Leukemia With t(6;9), Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, B Acute Lymphoblastic Leukemia With T(1;19)(Q23;P13.3); E2A-PBX1 (TCF3-PBX1), Ph+ ALL, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Complete Remission, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma, Myelodysplastic Syndrome, Recurrent Anaplastic Large Cell Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Recurrent Follicular Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, Secondary Acute Myeloid Leukemia, T Lymphoblastic Lymphoma, Hematopoietic Cell Transplant RecipientView official trial listing → -
Completed NCT NCT01031381
Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer
Not yet reported University of Pittsburgh 50 participants Est. completion 2014-12 1 siteOther conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal CarcinomaView official trial listing → -
Completed NCT NCT01031446
Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer
Not yet reported, Not yet reported Vanderbilt-Ingram Cancer Center 55 participants Est. completion 2017-08 4 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01031901
Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)
Not yet reported The University of Texas Health Science Center, Houston 52 participants Est. completion 2011-06 1 site Stand-aloneOther conditions: Tuberous Sclerosis, Neurofibromatoses, Angiofibroma, NeurofibromaView official trial listing → -
Withdrawn NCT NCT01033500
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients
Not yet reported University of Wisconsin, Madison Est. completion 2012-12 1 site Stand-aloneOther conditions: Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1, Kidney TransplantationView official trial listing → -
Status unknown NCT NCT01034371
Comparison of One-stop Hybrid Revascularization Versus Off-pump Coronary Artery Bypass for the Treatment of Multi-vessel Disease
Not yet reported China National Center for Cardiovascular Diseases 400 participants 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT01035034
Comparison of One-stop Hybrid Revascularization Versus Percutaneous Coronary Intervention for the Treatment of Multi-vessel Disease
Not yet reported China National Center for Cardiovascular Diseases 480 participants 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01038167
A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults
Not yet reported Vertex Pharmaceuticals Incorporated 20 participants Est. completion 2010-04 1 site Stand-aloneOther conditions: Hepatitis CView official trial listing → -
Withdrawn NCT NCT01038505
Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus
Not yet reported University of Miami Est. completion 2013-01Other conditions: Living Donor Kidney Transplants PatientsView official trial listing → -
Completed NCT NCT01042782
Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction
Not yet reported Krankenhaus Nordwest 16 participants Est. completion 2012-08 1 siteOther conditions: Advanced Gastric Cancer, Advanced Cancer of the Esophagogastric JunctionView official trial listing → -
Terminated NCT NCT01044745
Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer
Not yet reported University of Nebraska 20 participants Est. completion 2017-10-10 1 site Stand-aloneObstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blastic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Graft Versus Host Disease, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia, Waldenström MacroglobulinemiaView official trial listing → -
Withdrawn NCT NCT01047072
Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis
Not yet reported Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1 site Stand-aloneOther conditions: Systemic SclerodermaView official trial listing → -
Completed NCT NCT01047293
RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma
Not yet reported, Not yet reported University of Utah 47 participants Est. completion 2015-08 2 sitesOther conditions: Colorectal CancerView official trial listing → -
No Longer Available NCT NCT01049633
B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
National Institute of Allergy and Infectious Diseases (NIAID) 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT01049841
Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors
Not yet reported Memorial Sloan Kettering Cancer Center 23 participants Est. completion 2017-03 1 siteOther conditions: Pediatric Solid TumorsView official trial listing → -
Completed NCT NCT01049854
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
Not yet reported New York Medical College 20 participants Est. completion 2018-08 1 site Stand-aloneOther conditions: Leukemia, Lymphoma, Bone Marrow Failure, Immunodeficiencies, Histiocytosis, Sickle Cell Disease, Beta Thalassemia, Inborn Errors of MetabolismView official trial listing → -
Completed NCT NCT01050166
MRI Imaging of Labeled Human Islets Transplanted Into the Liver
Frantisek Saudek 8 participants Est. completion 2012-12-31 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT01050985
A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer
Not yet reported Georgetown University 47 participants Est. completion 2013-06 1 siteOther conditions: Advanced Solid TumorsView official trial listing → -
Completed NCT NCT01051557
Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma
Not yet reported, Not yet reported National Cancer Institute (NCI) 36 participants Est. completion 2020-09-30 1 siteObstructive sleep apnea Other conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain NeoplasmView official trial listing → -
Terminated NCT NCT01053221
Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation
Not yet reported University of Wisconsin, Madison 16 participants Est. completion 2012-08 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01053247
Study of 0416 Ointment in the Treatment of Atopic Dermatitis
Not yet reported Fougera Pharmaceuticals Inc. 793 participants Est. completion 2009-08 1 siteOther conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT01055795
Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors
Not yet reported Herbert Hurwitz 14 participants Est. completion 2012-05 1 siteOther conditions: Advanced Solid TumorsView official trial listing → -
Completed NCT NCT01055964
a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients
Not yet reported Seoul National University Hospital 80 participants 1 site Stand-aloneOther conditions: Pharmacokinetics, TacrolimusView official trial listing → -
Completed NCT NCT01056237
Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis
Not yet reported Zhi-Hong Liu, M.D. 206 participants Est. completion 2013-06 1 site Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT01056614
Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies
Not yet reported Fred Hutchinson Cancer Center 23 participants Est. completion 2016-04 1 site Stand-aloneOther conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Hematopoietic/Lymphoid Cancer, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Relapsing Chronic Myelogenous LeukemiaView official trial listing → -
Completed NCT NCT01056822
Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.
Not yet reported Novartis Pharmaceuticals 89 participants Est. completion 2013-04 19 sitesOther conditions: Prophilaxis of Acute Rejection in Patients Receiving a Renal AllograftView official trial listing → -
Completed NCT NCT01060059
Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes
AstraZeneca 888 participants Est. completion 2012-05 50 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01060098
T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
Imperial College London 48 participants Est. completion 2012-12 1 siteOther conditions: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic ArthritisView official trial listing → -
Completed NCT NCT01060475
Safety and Tolerability of LIM-0705 in Healthy Male Subjects
Not yet reported Limerick BioPharma 44 participants Est. completion 2010-06 2 sites Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01060605
Pre Transplant Rapamycin Treatment in Islet Transplantation Alone
Not yet reported IRCCS San Raffaele 11 participants Est. completion 2009-09 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Terminated NCT NCT01061606
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus
Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2012-10 20 sitesObstructive sleep apnea Other conditions: Recurrent Uterine SarcomaView official trial listing → -
Completed NCT NCT01061788
A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007
Not yet reported Jeffrey Clarke 43 participants Est. completion 2018-12-19 1 siteOther conditions: Advanced Solid Tumors, Non-small Cell Lung CancerView official trial listing → -
Terminated NCT NCT01061853
Efficacy of Topical Rapamycin to Treat Chronic Erosive Oral Lichen
Not yet reported University Hospital, Tours 76 participants Est. completion 2012-11 9 sites Stand-aloneOther conditions: Oral Lichen PlanusView official trial listing → -
Completed NCT NCT01062399
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Not yet reported, Not yet reported Radiation Therapy Oncology Group 279 participants Est. completion 2022-05-20 36 sitesOther conditions: Brain and Central Nervous System TumorsView official trial listing → -
Completed NCT NCT01062555
Calcineurin Inhibitor Sparing After Kidney Transplantation
Not yet reported, Not yet reported University of Minnesota 527 participants Est. completion 2014-04-03 1 siteOther conditions: CNI Side EffectsView official trial listing → -
Completed NCT NCT01064791
Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients
Not yet reported Novartis Pharmaceuticals 298 participants Est. completion 2012-08 44 sites Stand-aloneOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT01065662
AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies
Not yet reported Susana M. Campos, MD 11 participants Est. completion 2021-03 3 sitesOther conditions: Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Fallopian Tube Cancer, Peritoneal CancerView official trial listing → -
Completed NCT NCT01068054
Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)
Not yet reported, Not yet reported Siriraj Hospital 24 participants Est. completion 2005-05 1 siteOther conditions: Keratoconjunctivitis, VernalView official trial listing → -
Status unknown NCT NCT01068067
Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients
Not yet reported Sun Yat-sen University 60 participants 2 sites Stand-aloneOther conditions: Renal TransplantationView official trial listing → -
Active, not recruiting NCT NCT01068249
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer
Not yet reported M.D. Anderson Cancer Center 42 participants Est. completion 2028-04-30 2 sitesOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT01068353
Safety and Tolerability of Etanercept in Alzheimer's Disease
Not yet reported University of Southampton 41 participants 1 site Stand-aloneOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT01070316
Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)
Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 20 participants Est. completion 2016-04 2 sitesOther conditions: Epilepsy, Tuberous Sclerosis ComplexView official trial listing → -
Status unknown NCT NCT01072058
Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker
Not yet reported University of Sao Paulo 100 participants 1 siteOther conditions: Arthritis, Rheumatoid, Spondylitis, AnkylosingView official trial listing → -
Completed NCT NCT01072890
Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors
Not yet reported University of California, Davis 8 participants Est. completion 2012-02 1 siteOther conditions: Solid TumorsView official trial listing → -
Completed NCT NCT01074086
Phase I Study in RAD 001 Patients With Relapse AML
Not yet reported French Innovative Leukemia Organisation 31 participants Est. completion 2012-12 1 siteOther conditions: AMLView official trial listing → -
Completed NCT NCT01075321
Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma
Not yet reported, Not yet reported Mayo Clinic 58 participants Est. completion 2020-02-13 2 sitesObstructive sleep apnea Other conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Splenic Marginal Zone Lymphoma, Waldenstrom MacroglobulinemiaView official trial listing → -
Completed NCT NCT01076543
Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma
Not yet reported, Not yet reported National Cancer Institute (NCI) 110 participants Est. completion 2018-09-30 11 sitesOther conditions: AIDS-Related Hodgkin Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Lymphoplasmacytic Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Non-Hodgkin Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma, Waldenstrom MacroglobulinemiaView official trial listing → -
Completed NCT NCT01077986
Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer
Not yet reported, Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 35 participants Est. completion 2011-08 1 siteOther conditions: Metastatic Pancreatic CancerView official trial listing → -
Completed NCT NCT01078142
Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma
Not yet reported, Not yet reported Georg Hess, MD 39 participants Est. completion 2017-09-08 1 siteOther conditions: Follicular Lymphoma, Mantle Cell LymphomaView official trial listing → -
Completed NCT NCT01079143
Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients
Not yet reported Novartis Pharmaceuticals 194 participants Est. completion 2012-06 23 sitesOther conditions: Renal Interstitial FibrosisView official trial listing → -
Completed NCT NCT01079286
Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 18 participants Est. completion 2011-08 1 siteOther conditions: Renal Cell Cancer, CancerView official trial listing → -
Status unknown NCT NCT01079702
Everolimus and Capecitabine in Patients With Advanced Malignancy
Not yet reported, Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 35 participants Est. completion 2011-01 2 sitesOther conditions: Advanced MalignanciesView official trial listing → -
Terminated NCT NCT01079767
Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis
Not yet reported Federation Francophone de Cancerologie Digestive 6 participants 1 siteOther conditions: Liver CancerView official trial listing → -
Completed NCT NCT01080456
Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fasting Condition
Not yet reported Panacea Biotec Ltd 36 participants Est. completion 2007-10 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01080469
Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed Condition
Not yet reported Panacea Biotec Ltd 36 participants Est. completion 2007-10 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01080482
Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fasting Condition
Not yet reported Panacea Biotec Ltd 36 participants Est. completion 2007-10 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01080534
Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed Condition
Not yet reported Panacea Biotec Ltd 36 participants Est. completion 2007-10 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01082393
Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)
Not yet reported University Hospital, Ghent 14 participants Est. completion 2015-12-01 1 siteOther conditions: VitiligoView official trial listing → -
Completed NCT NCT01084980
Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome
Not yet reported, Not yet reported Seoul National University Hospital 20 participants Est. completion 2011-07 1 site Stand-aloneOther conditions: Minimal Change DiseaseView official trial listing → -
Active, not recruiting NCT NCT01087554
Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
Not yet reported M.D. Anderson Cancer Center 249 participants Est. completion 2026-08-18 1 site Stand-aloneOther conditions: Advanced CancerView official trial listing → -
Completed NCT NCT01087983
Lapatinib With Sirolimus or Metformin
Not yet reported M.D. Anderson Cancer Center 111 participants Est. completion 2015-09 1 site Stand-aloneOther conditions: Advanced CancersView official trial listing → -
Status unknown NCT NCT01088893
Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy
Not yet reported Organisation for Oncology and Translational Research 50 participants Est. completion 2013-03 1 siteOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT01092806
Insulin Secretion and Advagraf
Not yet reported University of Oslo School of Pharmacy 20 participants Est. completion 2010-05 1 site Stand-aloneOther conditions: Post Transplant Diabetes MellitusView official trial listing → -
Completed NCT NCT01093391
A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus
Not yet reported Scitech Produtos Medicos SA 63 participants Est. completion 2015-07 4 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01093729
A Study of HM11260C in Healthy Male Subject
Not yet reported Hanmi Pharmaceutical Company Limited 41 participants Est. completion 2010-10Other conditions: HealthyView official trial listing → -
Status unknown NCT NCT01095172
RituxiMab INDuction in Renal Transplantation
Not yet reported Guy's and St Thomas' NHS Foundation Trust 100 participants Est. completion 2022-10 6 sites Stand-aloneOther conditions: Function of Renal TransplantView official trial listing → -
Completed NCT NCT01099527
A Trial of RAD001/Capecitabine in Refractory Gastric Cancer
Not yet reported, Not yet reported Samsung Medical Center 59 participants Est. completion 2013-12 1 siteOther conditions: Metastatic Gastric CancerView official trial listing → -
Completed NCT NCT01104701
A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension
Not yet reported AstraZeneca 121 participants Est. completion 2010-12 2 sites Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT01106378
Cynergy: the CYPHER-NEVO Registry
Cordis US Corp. 14000 participants Est. completion 2011-12 3 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT01106833
Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
Not yet reported, Not yet reported Medical College of Wisconsin 151 participants Est. completion 2018-06 31 sitesOther conditions: Chronic GVHDView official trial listing → -
Completed NCT NCT01108445
Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma
Not yet reported Duke University 131 participants Est. completion 2015-04 18 sitesOther conditions: Advanced Non-clear Cell Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT01109914
Mucosal Response in Immunocompromised Host
Not yet reported Leiden University Medical Center 51 participants Est. completion 2015-03 1 site Stand-aloneOther conditions: Kidney Transplantation, ImmunityView official trial listing → -
Terminated NCT NCT01111448
Temsirolimus in Myelodysplastic Syndrome (MDS)
Not yet reported Technische Universität Dresden 20 participants Est. completion 2014-06 7 sitesOther conditions: Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT01111825
Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer
Not yet reported, Not yet reported Puma Biotechnology, Inc. 99 participants Est. completion 2016-07 12 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01114529
Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients
Not yet reported Novartis Pharmaceuticals 828 participants Est. completion 2014-10-30 77 sitesOther conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT01115803
A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors
Not yet reported Eli Lilly and Company 29 participants Est. completion 2011-06 3 sitesOther conditions: Metastases, Neoplasm, Carcinoma, Non-small Cell Lung, Renal Cell Carcinoma, Neuroendocrine TumorsView official trial listing → -
Terminated NCT NCT01116232
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
Not yet reported Barbara Ann Karmanos Cancer Institute 4 participants Est. completion 2013-06 1 site Stand-aloneOther conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative NeoplasmsView official trial listing → -
Terminated NCT NCT01118013
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant
Not yet reported Alliance for Clinical Trials in Oncology 6 participants Est. completion 2013-08 10 sites Stand-aloneOther conditions: Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative NeoplasmsView official trial listing → -
Completed NCT NCT01120028
Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
Not yet reported, Not yet reported University of Oxford 852 participants Est. completion 2020-03 20 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01121744
Supralimus-Core™ Pharmacokinetic (PK) Study
Not yet reported Sahajanand Medical Technologies Limited 20 participants Est. completion 2011-01 4 sitesCardiovascular diseaseView official trial listing → -
Terminated NCT NCT01122719
Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen
Not yet reported CID - Carbostent & Implantable Devices 16 participants Est. completion 2013-03 2 sitesOther conditions: Stable Coronary Disease, Unstable Coronary Disease, Documented Silent IschemiaView official trial listing → -
Terminated NCT NCT01125293
Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia
Not yet reported, Not yet reported Dana-Farber Cancer Institute 46 participants Est. completion 2014-08 1 siteOther conditions: Waldenstrom's MacroglobulinemiaView official trial listing → -
Completed NCT NCT01126333
Long-term Follow-up of Spare the Nephron (STN) Patients
University of Maryland, Baltimore 128 participants Est. completion 2015-06-30 1 siteOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT01127763
RAD001 Plus Carboplatin in Breast Cancer Patients
Not yet reported NYU Langone Health 25 participants Est. completion 2013-03 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01128335
Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients
Not yet reported Novartis Pharmaceuticals 200 participants Est. completion 2012-07 39 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT01131988
Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting Conditions
Not yet reported Dr. Reddy's Laboratories Limited 40 participants Est. completion 2008-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01132027
Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddys's Laboratories Limited Under Non-Fasting Conditions
Not yet reported Dr. Reddy's Laboratories Limited 40 participants Est. completion 2008-03 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Terminated NCT NCT01133678
Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
Not yet reported University of Chicago 50 participants Est. completion 2015-01 2 sitesOther conditions: Head and Neck CancerView official trial listing → -
Completed NCT NCT01134952
Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)
Not yet reported London Health Sciences Centre 11 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Hepatitis CView official trial listing → -
Terminated NCT NCT01135329
Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15 participants Est. completion 2012-05 1 site Stand-aloneOther conditions: Lymphoma, Leukemia, Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT01136395
Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation
Not yet reported University of Giessen 85 participants Est. completion 2019-06-18 1 siteOther conditions: Kidney Transplantation, Rituximab (RTx), Living Donors, Immunology, VirusView official trial listing → -
Completed NCT NCT01136798
Impact of Exenatide on Sleep in Type 2 Diabetes
Not yet reported University of Chicago 18 participants Est. completion 2016-09-01 2 sites Stand-aloneType 2 diabetes Other conditions: Sleep Disordered BreathingView official trial listing → -
Completed NCT NCT01137084
Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids
Not yet reported Shanghai Jiao Tong University School of Medicine 300 participants Est. completion 2009-12 1 siteOther conditions: Immunosuppression, Hepatocellular Carcinoma, Liver Transplantation, Post-operative ComplicationsView official trial listing → -
Completed NCT NCT01139450
Study of 0417 Ointment in the Treatment of Atopic Dermatitis
Not yet reported Fougera Pharmaceuticals Inc. 899 participants Est. completion 2009-08 1 siteOther conditions: Atopic DermatitisView official trial listing → -
Status unknown NCT NCT01140893
Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes
Not yet reported, Not yet reported University Hospital, Caen 110 participants 3 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01144338
Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus
Not yet reported AstraZeneca 14752 participants Est. completion 2017-04-24 629 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01145950
Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®
Not yet reported LG Life Sciences 36 participants Est. completion 2011-01 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01147627
Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients
Not yet reported Sun Yat-sen University 416 participants Est. completion 2012-12 25 sitesType 2 diabetes Other conditions: Newly DiagnosedView official trial listing → -
Status unknown NCT NCT01148628
Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors
Not yet reported Southern Europe New Drug Organization 54 participants Est. completion 2011-12 3 sitesOther conditions: Advanced Solid TumorsView official trial listing → -
Completed NCT NCT01148680
Trial Comparing Metabolic Efficiency of Islet Graft to Intensive Insulin Therapy for Type 1 Diabetes's Treatment
Not yet reported University Hospital, Grenoble 50 participants Est. completion 2018-09 9 sitesOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT01149382
Immune Response to Influenza Vaccine in Islet Cell Transplant Recipients
University of Alberta 61 participants Est. completion 2011-12 1 siteOther conditions: TransplantView official trial listing → -
Terminated NCT NCT01149434
Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers
Not yet reported, Not yet reported University of Utah 19 participants Est. completion 2012-08 1 siteOther conditions: Cancer, Neuroendocrine, Ovarian Cancer, Colon CancerView official trial listing → -
Completed NCT NCT01150097
Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients
Not yet reported Novartis Pharmaceuticals 284 participants Est. completion 2013-05-03 57 sites Stand-aloneOther conditions: Liver Transplant RecipientView official trial listing → -
Completed NCT NCT01152801
Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer
Not yet reported Novartis Pharmaceuticals 64 participants Est. completion 2013-12 7 sitesOther conditions: Metastatic Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT01152840
Study of RAD001 in Adenoid Cystic Carcinoma
Not yet reported Seoul National University Hospital 33 participants Est. completion 2012-12 1 siteOther conditions: Adenoid Cystic CarcinomaView official trial listing → -
Completed NCT NCT01154075
Medication Adherence in Children Who Had a Liver Transplant
Icahn School of Medicine at Mount Sinai 401 participants Est. completion 2015-06 5 sitesOther conditions: Pediatric Recipients of a Liver TransplantView official trial listing → -
Completed NCT NCT01154335
Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer
Not yet reported SCRI Development Innovations, LLC 18 participants Est. completion 2013-05 2 sitesOther conditions: Metastatic Colorectal CancerView official trial listing → -
Status unknown NCT NCT01154387
Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection
Not yet reported, Not yet reported Tolera Therapeutics, Inc 85 participants Est. completion 2013-06 12 sites Stand-aloneOther conditions: End Stage Renal Disease, Renal TransplantView official trial listing → -
Completed NCT NCT01157858
Everolimus and LongActing Octreotide Trial in Polycystic Livers
Not yet reported Radboud University Medical Center 44 participants Est. completion 2012-07 1 siteOther conditions: Polycystic Liver DiseaseView official trial listing → -
Completed NCT NCT01159080
Treatment of the optImuM Dose of calcineUrin Inhibitor and Mycophenolate Sodium in Kidney Recipients
Not yet reported Asan Medical Center 350 participants Est. completion 2016-11-30 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01160276
Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft Recipients
Not yet reported Assistance Publique - Hôpitaux de Paris 17 participants Est. completion 2012-01 1 siteOther conditions: Renal Replacement TherapiesView official trial listing → -
Completed NCT NCT01161459
Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid
Not yet reported Zhi-Hong Liu, M.D. 100 participants Est. completion 2013-10 1 siteOther conditions: Idiopathic Membranous NephropathyView official trial listing → -
Completed NCT NCT01162005
Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children
Not yet reported Seoul National University Hospital 77 participants Est. completion 2013-10 1 site Stand-aloneOther conditions: Nephrotic SyndromeView official trial listing → -
Completed NCT NCT01163357
Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma
Not yet reported City of Hope Medical Center 18 participants Est. completion 2024-05-20 1 site Stand-aloneOther conditions: Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell MyelomaView official trial listing → -
Withdrawn NCT NCT01163929
A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer
Not yet reported University of Kansas Est. completion 2012-03Other conditions: Breast CancerView official trial listing → -
Completed NCT NCT01164176
Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer
Not yet reported Yonsei University 40 participants Est. completion 2014-10 7 sitesOther conditions: Head and Neck CancerView official trial listing → -
Terminated NCT NCT01166724
Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosuppression-
Not yet reported The Cleveland Clinic 12 participants Est. completion 2014-12 1 siteOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT01167530
Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer
Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 26 participants Est. completion 2017-02-09 1 siteOther conditions: Non-small Cell Lung Cancer, Locally Advanced DiseaseView official trial listing → -
Completed NCT NCT01168219
Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia
Not yet reported National Cancer Institute (NCI) 68 participants Est. completion 2020-02-01 17 sites Stand-aloneOther conditions: Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With Maturation, Adult Acute Myeloid Leukemia With Minimal Differentiation, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL, Adult Acute Myeloid Leukemia Without Maturation, Adult Acute Myelomonocytic Leukemia, Adult Erythroleukemia, Adult Pure Erythroid Leukemia, Alkylating Agent-Related Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts, Recurrent Adult Acute Myeloid Leukemia, Secondary Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT01169701
24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients
Not yet reported Novartis Pharmaceuticals 71 participants Est. completion 2014-03 9 sites Stand-aloneOther conditions: Renal TransplantView official trial listing → -
Withdrawn NCT NCT01170052
Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)
Not yet reported, Not yet reported Charite University, Berlin, Germany 20 participants Est. completion 2014-04 3 sitesOther conditions: Mantle Cell LymphomaView official trial listing → -
Completed NCT NCT01170715
Psoriasis Inflammation and Systemic Co Morbidities
Not yet reported Rockefeller University 29 participants Est. completion 2013-09-09 1 site Stand-aloneOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT01172418
Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols
Not yet reported University of Miami 200 participants Est. completion 2010-05 1 siteOther conditions: Transplant; Failure, KidneyView official trial listing → -
Completed NCT NCT01172769
Efficacy Study of Temsirolimus to Treat Head and Neck Cancer
Not yet reported Hannover Medical School 42 participants Est. completion 2012-03 7 sitesOther conditions: Head and Neck Squamous Cell CarcinomaView official trial listing → -
Status unknown NCT NCT01174810
Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
Not yet reported University College, London 40 participants Est. completion 2013-03 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT01175096
Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor
Not yet reported, Not yet reported Guangdong Provincial People's Hospital 20 participants Est. completion 2012-01 1 siteOther conditions: Neuroendocrine Tumors, Carcinoid TumorView official trial listing → -
Completed NCT NCT01177397
Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Not yet reported, Not yet reported Celgene 226 participants Est. completion 2016-12-09 16 sitesOther conditions: Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Glioblastoma Multiforme, Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Neuroendocrine Tumors of Non-Pancreatic Origin, Hormone Receptor-Positive Breast CancerView official trial listing → -
Completed NCT NCT01181271
Tandem Auto-Allo Transplant for Lymphoma
Not yet reported Massachusetts General Hospital 42 participants Est. completion 2016-02 2 sites Stand-aloneOther conditions: Diffuse, Large B-Cell, Lymphoma, Lymphoma, Low-Grade, T-Cell Lymphoma, Mantle-Cell Lymphoma, Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Lymphoma, Small LymphocyticView official trial listing → -
Completed NCT NCT01181986
The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes
Not yet reported Carl T. Hayden VA Medical Center 76 participants Est. completion 2012-12 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01182168
Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies
Not yet reported Memorial Sloan Kettering Cancer Center 12 participants Est. completion 2016-03 1 siteOther conditions: Bladder Cancer, Renal Pelvis Cancer, Ureter CancerView official trial listing → -
Withdrawn NCT NCT01182883
A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors
Not yet reported National Cancer Institute (NCI) Est. completion 2012-04-04Other conditions: Brain Stem Neoplasms, Glioma, PinealomaView official trial listing → -
Completed NCT NCT01183247
An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens
Not yet reported University Hospital, Basel, Switzerland 63 participants Est. completion 2010-06 1 siteOther conditions: Comparative Study, Immunosuppressive AgentsView official trial listing → -
Completed NCT NCT01183663
Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)
Not yet reported M.D. Anderson Cancer Center 180 participants Est. completion 2016-05 1 siteOther conditions: Advanced CancersView official trial listing → -
Completed NCT NCT01184885
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 7 participants Est. completion 2013-04 2 sites Stand-aloneOther conditions: Lymphoid Malignancies (New or Relapsed), Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Lymphoblastic Lymphoma, Mantle Cell Lymphoma, Adult T-cell Leukemia/LymphomaView official trial listing → -
Completed NCT NCT01184898
Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 36 participants Est. completion 2016-02 2 sites Stand-aloneOther conditions: AMLView official trial listing → -
Terminated NCT NCT01185366
Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma
Not yet reported M.D. Anderson Cancer Center 73 participants Est. completion 2019-09-09 4 sitesOther conditions: Kidney CancerView official trial listing → -
Completed NCT NCT01186107
Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients
Not yet reported Seung-Jung Park 256 participants Est. completion 2013-07 11 sitesCardiovascular disease Other conditions: DiabetesView official trial listing → -
Completed NCT NCT01187953
Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx
Not yet reported Asahi Kasei Therapeutics, Inc. 543 participants Est. completion 2014-03 86 sites Stand-aloneOther conditions: Renal FailureView official trial listing → -
Completed NCT NCT01188655
Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
Pfizer 89 participants Est. completion 2010-03Other conditions: Spondylitis, AnkylosingView official trial listing → -
Completed NCT NCT01188798
Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies
Not yet reported St. Jude Children's Research Hospital 6 participants Est. completion 2012-02 1 siteOther conditions: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Chronic Myelocytic Leukemia, Hodgkin's Disease, Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT01190670
A Study to Evaluate the Drug Interaction of ASP015K and Tacrolimus
Not yet reported Astellas Pharma Inc 40 participants Est. completion 2010-09 1 site Stand-aloneOther conditions: Healthy, Pharmacokinetics of ASP015K and TacrolimusView official trial listing → -
Completed NCT NCT01195194
Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity.
Not yet reported Josep M Grinyo 61 participants Est. completion 2013-06 2 sites Stand-aloneOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Completed NCT NCT01196819
Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial
Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 458 participants Est. completion 2016-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01197170
Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance
Not yet reported M.D. Anderson Cancer Center 277 participants Est. completion 2021-01-13 1 siteOther conditions: Solid Tumors, Advanced CancerView official trial listing → -
Terminated NCT NCT01198158
Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Not yet reported National Cancer Institute (NCI) 77 participants Est. completion 2017-12-16 524 sitesOther conditions: Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7, Stage IV Renal Cell Cancer AJCC v7View official trial listing → -
Completed NCT NCT01198184
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors
Not yet reported National Cancer Institute (NCI) 18 participants Est. completion 2013-10 2 sitesOther conditions: Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Renal Cell Cancer, Stage III Endometrial Carcinoma, Stage III Renal Cell Cancer, Stage IV Endometrial Carcinoma, Stage IV Renal Cell Cancer, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT01200693
Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis
Not yet reported Catholic University of the Sacred Heart 80 participants Est. completion 2012-03 1 siteCardiovascular disease Other conditions: Coronary StenosisView official trial listing → -
Terminated NCT NCT01202058
An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)
Not yet reported Cordis US Corp. 156 participants Est. completion 2012-10 3 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01203709
Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis
Not yet reported Tuen Mun Hospital 20 participants Est. completion 2013-02 1 site Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT01203722
Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies
Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87 participants Est. completion 2024-05-28 1 siteOther conditions: Hematologic MalignanciesView official trial listing → -
Completed NCT NCT01206569
Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis
Not yet reported Chinese University of Hong Kong 2 participants Est. completion 2012-02 1 site Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT01207141
rATG Induction and Tacrolimus Monotherapy in Pediatric Liver Transplantation
University of Pittsburgh 110 participants Est. completion 2019-05 1 siteOther conditions: Liver Transplantation, Thymoglobulin, RejectionView official trial listing → -
Completed NCT NCT01207297
Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis
Not yet reported Zhejiang University 40 participants Est. completion 2010-06Other conditions: SLE, Lupus Nephritis, Renal Insufficiency, End-stage Renal DiseaseView official trial listing → -
Completed NCT NCT01208337
Safety and Efficacy of Alemtuzumab in Pediatric Intestinal Transplantation
Not yet reported University of Pittsburgh 23 participants Est. completion 2014-11Other conditions: Evidence of Liver Transplantation, Rejection, ALEMTUZUMABView official trial listing → -
Completed NCT NCT01208649
Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)
Not yet reported Ruhr University of Bochum 13 participants Est. completion 2010-09 1 siteMASLDView official trial listing → -
Completed NCT NCT01208896
Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma
Not yet reported University Hospital, Bordeaux 32 participants Est. completion 2017-09-28 26 sites Stand-aloneOther conditions: Lymphoma, Follicular, Stem Cell TransplantationView official trial listing → -
Completed NCT NCT01210482
Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)
Pfizer 1050 participants Est. completion 2018-05-31 1 siteOther conditions: Renal Cell CarcinomaView official trial listing → -
Terminated NCT NCT01215136
First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma
Not yet reported Matthew Galsky 36 participants Est. completion 2018-04-24 11 sitesOther conditions: Transitional Cell Carcinoma, Bladder Carcinoma, Urothelial CarcinomaView official trial listing → -
Status unknown NCT NCT01216826
Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma
Not yet reported Sidnei Epelman 20 participants Est. completion 2014-12 1 siteObstructive sleep apneaView official trial listing → -
Status unknown NCT NCT01216839
Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas
Not yet reported Sidnei Epelman 20 participants Est. completion 2013-12 1 siteOther conditions: Refractory or Relapsed RMS and Soft Tissue SarcomasView official trial listing → -
Active, not recruiting NCT NCT01217931
Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial
Not yet reported M.D. Anderson Cancer Center 180 participants Est. completion 2028-01-31 1 siteOther conditions: Kidney CancerView official trial listing → -
Completed NCT NCT01218555
Study of Everolimus (RAD001) in Combination With Lenalidomide
Not yet reported Emory University 44 participants Est. completion 2020-11-05 2 sitesOther conditions: Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine TumorsView official trial listing → -
Terminated NCT NCT01220297
Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT
Not yet reported Stanford University 3 participants Est. completion 2011-08 1 site Stand-aloneOther conditions: Hematologic Diseases, Acute-graft-versus-host Disease, Leukemia, Non-Hodgkin Lymphoma (NHL), Hodgkin LymphomaView official trial listing → -
Completed NCT NCT01220856
Reparixin in Pancreatic Islet Transplantation
Not yet reported Dompé Farmaceutici S.p.A 9 participants Est. completion 2013-04-30 2 sitesOther conditions: Pancreatic Islet Transplantation in Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT01222039
Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.
Not yet reported, Not yet reported Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 19 participants Est. completion 2014-06 4 sites Stand-aloneOther conditions: Graft Versus Host Disease, Chronic and Expanded Graft Versus Host Disease, Immune System DiseasesView official trial listing → -
Completed NCT NCT01222715
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
Not yet reported National Cancer Institute (NCI) 87 participants Est. completion 2015-06 184 sitesObstructive sleep apnea Other conditions: Recurrent Adult Soft Tissue SarcomaView official trial listing → -
Completed NCT NCT01223027
Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
Not yet reported Novartis Pharmaceuticals 564 participants Est. completion 2014-06 199 sitesOther conditions: Metastatic Renal Cell CarcinomaView official trial listing → -
Terminated NCT NCT01223755
Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency
Not yet reported, Not yet reported Mario Negri Institute for Pharmacological Research 41 participants Est. completion 2012-07 1 site Stand-aloneOther conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)View official trial listing → -
Completed NCT NCT01224028
A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients
Not yet reported Astellas Pharma Inc 40 participants Est. completion 2011-06 1 site Stand-aloneOther conditions: IgA NephropathyView official trial listing → -
Completed NCT NCT01224041
Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate
Not yet reported Astellas Pharma Inc 78 participants Est. completion 2011-06 5 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01224418
A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate
Not yet reported Astellas Pharma Inc 50 participants Est. completion 2009-08 2 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Suspended NCT NCT01226056
Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets
Not yet reported, Not yet reported Southern Europe New Drug Organization 45 participants Est. completion 2012-12 1 siteOther conditions: Advanced Solid TumorsView official trial listing → -
Status unknown NCT NCT01226355
NOYA CoCr Biodegradable Coating Sirolimus-Eluting Coronary Stent System
Not yet reported Medfavour (Beijing) Medical Co., Ltd 300 participants Est. completion 2014-11 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01229943
Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery
Not yet reported National Cancer Institute (NCI) 150 participants Est. completion 2018-01-03 394 sitesOther conditions: Advanced Pancreatic Neuroendocrine Tumor, Locally Advanced Pancreatic Neuroendocrine Tumor, Pancreatic Gastrinoma, Pancreatic Neuroendocrine Tumor G1, Pancreatic Neuroendocrine Tumor G2, Pancreatic VipomaView official trial listing → -
Terminated NCT NCT01230502
Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation
Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2012-06 1 site Stand-aloneOther conditions: Liver TransplantView official trial listing → -
Completed NCT NCT01231399
Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer
Not yet reported, Not yet reported City of Hope Medical Center 6 participants Est. completion 2016-07 3 sitesOther conditions: Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach, Mixed Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer, Stage IV Esophageal Cancer, Stage IV Gastric CancerView official trial listing → -
Status unknown NCT NCT01233167
Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation
Not yet reported Sir Run Run Shaw Hospital 5232 participants Est. completion 2013-05Cardiovascular diseaseView official trial listing → -
Completed NCT NCT01233570
Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease
Not yet reported University of Aberdeen 20 participants 1 site Stand-aloneOther conditions: Crohn DiseaseView official trial listing → -
Withdrawn NCT NCT01234974
IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus
Not yet reported Milton S. Hershey Medical Center Est. completion 2013-12 1 siteOther conditions: Multiple MyelomaView official trial listing → -
Completed NCT NCT01236378
Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant Recipients
Not yet reported Pfizer 24 participants Est. completion 2011-04 2 sites Stand-aloneOther conditions: Transplant Rejection, Renal TransplantationView official trial listing → -
Completed NCT NCT01237197
Exenatide in Extreme Pediatric Obesity
Not yet reported University of Minnesota 26 participants Est. completion 2012-10 2 sites Stand-aloneOther conditions: ObesityView official trial listing → -
Completed NCT NCT01237314
The Impact of Food on Blood Sugar in People With Type 2 Diabetes
HealthPartners Institute 46 participants Est. completion 2013-05 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT01239368
Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma
Not yet reported, Not yet reported National Cancer Institute (NCI) 34 participants Est. completion 2017-08-16 2 sitesOther conditions: Myeloma, Plasma-Cell, Myeloma-Multiple, MyelomatosisView official trial listing → -
Completed NCT NCT01239472
Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant
Not yet reported Andre Barreto Pereira 30 participants Est. completion 2015-06 1 siteOther conditions: Renal Transplant Rejection, ImmunosuppressionView official trial listing → -
Status unknown NCT NCT01239563
Thymoglobulin Induction in Kidney Transplant Recipients
Not yet reported University of Oxford 40 participants Est. completion 2016-05 2 sitesOther conditions: Kidney Transplantation, Ischemia-Reperfusion InjuryView official trial listing → -
Completed NCT NCT01241591
A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis
Not yet reported Pfizer 1101 participants Est. completion 2013-01 122 sitesOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT01242306
Comparison of Endothelial Dysfunction (BMS vs SES) in the Same Patient With Multiple Coronary Artery Lesions
Not yet reported, Not yet reported Azienda Ospedaliera San Camillo Forlanini 25 participants Est. completion 2009-12 1 siteOther conditions: Endothelial DysfunctionView official trial listing → -
Withdrawn NCT NCT01244659
A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment
Not yet reported EMS Est. completion 2014-12 1 site Stand-aloneOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT01244906
Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant
Not yet reported Northside Hospital, Inc. 26 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Hematologic NeoplasmsView official trial listing → -
Completed NCT NCT01246206
Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT
Not yet reported Barbara Ann Karmanos Cancer Institute 21 participants Est. completion 2013-10 1 site Stand-aloneOther conditions: Hematological MalignanciesView official trial listing → -
Status unknown NCT NCT01246817
Temsirolimus-RCC-imaging
Not yet reported Radboud University Medical Center 51 participants 1 siteOther conditions: Renal Cell CancerView official trial listing → -
Completed NCT NCT01248403
A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy
Not yet reported Krankenhaus Nordwest 300 participants Est. completion 2019-10 1 siteOther conditions: Advanced Gastric Cancer, Esophagogastric Junction CancerView official trial listing → -
Completed NCT NCT01248494
PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer
Not yet reported Vanderbilt-Ingram Cancer Center 72 participants Est. completion 2016-05 6 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01251575
Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
Not yet reported Fred Hutchinson Cancer Center 77 participants Est. completion 2019-02-11 5 sites Stand-aloneOther conditions: Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Diffuse Large B-Cell Lymphoma, Adult Myelodysplastic Syndrome, Adult Non-Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia, Childhood Diffuse Large B-Cell Lymphoma, Childhood Myelodysplastic Syndrome, Childhood Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia in Remission, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid Cell Neoplasm, Mantle Cell Lymphoma, Plasma Cell Myeloma, Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, T-Cell Prolymphocytic Leukemia, Waldenstrom Macroglobulinemia, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Hodgkin LymphomaView official trial listing → -
Terminated NCT NCT01255163
A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
Not yet reported National Institute on Aging (NIA) 57 participants Est. completion 2016-11-18 1 site Stand-aloneOther conditions: Alzheimer's Disease, Mild Cognitive ImpairmentView official trial listing → -
Status unknown NCT NCT01255956
Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA)
Not yet reported Medical University of Warsaw 200 participants Est. completion 2012-07 4 sitesOther conditions: In-Stent RestenosisView official trial listing → -
Completed NCT NCT01256294
Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients
Not yet reported Novartis 71 participants Est. completion 2011-05 2 sites Stand-aloneOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT01256385
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Not yet reported National Cancer Institute (NCI) 86 participants Est. completion 2013-12 24 sitesOther conditions: Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Laryngeal Verrucous Carcinoma, Recurrent Lip and Oral Cavity Squamous Cell Carcinoma, Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma, Recurrent Oral Cavity Verrucous Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Squamous Cell Carcinoma, Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary, Stage IV Hypopharyngeal Squamous Cell Carcinoma, Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma, Stage IVA Laryngeal Squamous Cell Carcinoma, Stage IVA Laryngeal Verrucous Carcinoma, Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma, Stage IVA Major Salivary Gland Carcinoma, Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Stage IVA Oral Cavity Verrucous Carcinoma, Stage IVA Oropharyngeal Squamous Cell Carcinoma, Stage IVB Laryngeal Squamous Cell Carcinoma, Stage IVB Laryngeal Verrucous Carcinoma, Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma, Stage IVB Major Salivary Gland Carcinoma, Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Stage IVB Oral Cavity Verrucous Carcinoma, Stage IVB Oropharyngeal Squamous Cell Carcinoma, Stage IVC Laryngeal Squamous Cell Carcinoma, Stage IVC Laryngeal Verrucous Carcinoma, Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma, Stage IVC Major Salivary Gland Carcinoma, Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Stage IVC Oral Cavity Verrucous Carcinoma, Stage IVC Oropharyngeal Squamous Cell Carcinoma, Tongue CarcinomaView official trial listing → -
Completed NCT NCT01256398
Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2021-11-15 101 sites Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1View official trial listing → -
Completed NCT NCT01262703
Safety Study of a Bioresorbable Coronary Stent
Not yet reported REVA Medical, Inc. 49 participants Est. completion 2018-12 1 site Stand-aloneCardiovascular disease Other conditions: Myocardial Ischemia, Coronary Artery Stenosis, Coronary Disease, Coronary RestenosisView official trial listing → -
Completed NCT NCT01265537
A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf
Not yet reported University of British Columbia 30 participants Est. completion 2019-10-11 1 site Stand-aloneOther conditions: Acute Graft Rejection, DiabetesView official trial listing → -
Completed NCT NCT01266057
Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer
Not yet reported M.D. Anderson Cancer Center 143 participants Est. completion 2021-02-11 1 site Stand-aloneOther conditions: Advanced CancersView official trial listing → -
Completed NCT NCT01266148
SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance
Not yet reported Novartis Pharmaceuticals 115 participants Est. completion 2012-12 6 sitesOther conditions: Renal Function and Chronic Allograft VasculopathyView official trial listing → -
Completed NCT NCT01266837
Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)
Not yet reported iOMEDICO AG 64 participants Est. completion 2017-10-31 8 sitesOther conditions: Metastatic Renal Cell Carcinoma, Failure of Exactly One Prior VEGF-targeted TherapyView official trial listing → -
Terminated NCT NCT01268995
Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation
Not yet reported Medical University of Vienna 32 participants Est. completion 2010-12 1 site Stand-aloneOther conditions: New Onset Diabetes Mellitus After Renal TransplantationView official trial listing → -
Withdrawn NCT NCT01269684
Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients
Not yet reported Novartis Pharmaceuticals Est. completion 2008-08 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01270321
Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer
Not yet reported Emory University 42 participants Est. completion 2019-02 3 sitesOther conditions: Thyroid CancerView official trial listing → -
Completed NCT NCT01270997
Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients
Not yet reported Hanwha Chemical 294 participants Est. completion 2012-05 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT01272141
A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer
Not yet reported Emory University 5 participants Est. completion 2014-01 3 sitesOther conditions: Breast Neoplasms, Breast Cancer, Cancer of the BreastView official trial listing → -
Completed NCT NCT01274234
OCT Evaluation of Healing of COMBO Stent
Not yet reported, Not yet reported Prof. Stephen Lee 61 participants Est. completion 2012-06 1 site Stand-aloneOther conditions: Coronary Restenosis, Coronary ThrombosisView official trial listing → -
Completed NCT NCT01276314
Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions
Not yet reported Chang Gung Memorial Hospital 135 participants Est. completion 2015-05 1 site Stand-aloneOther conditions: Drug HypersensitivityView official trial listing → -
Terminated NCT NCT01276834
Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation
Not yet reported Dianet Dialysis Centers 13 participants Est. completion 2012-07 1 siteOther conditions: Renal TransplantationView official trial listing → -
Terminated NCT NCT01278745
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 362 participants Est. completion 2015-10 24 sites Stand-aloneOther conditions: Cardiac Allograft Vasculopathy, Heart Transplant RecipientsView official trial listing → -
Terminated NCT NCT01279616
A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease
Not yet reported Nationwide Children's Hospital 8 participants Est. completion 2015-01 1 site Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Withdrawn NCT NCT01280669
Intravitreal Sirolimus as Therapeutic Approach to Uveitis
Not yet reported Stanford University Est. completion 2024-12 1 site Stand-aloneOther conditions: Uveitis, Intermediate Uveitis, Posterior Uveitis, PanuveitisView official trial listing → -
Completed NCT NCT01281514
A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer
Not yet reported Fox Chase Cancer Center 21 participants Est. completion 2018-01-08 1 siteOther conditions: Fallopian Tube Cancer, Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial CancerView official trial listing → -
Completed NCT NCT01281917
Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma
Not yet reported University of Wisconsin, Madison 40 participants Est. completion 2014-06 18 sitesOther conditions: Non-Hodgkins LymphomaView official trial listing → -
Completed NCT NCT01282697
Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors
Not yet reported University Hospital, Strasbourg, France 42 participants Est. completion 2013-02-20 9 sitesOther conditions: Refractory Solid Tumors in ChildrenView official trial listing → -
Status unknown NCT NCT01283789
Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer
Not yet reported University of Kansas Medical Center 23 participants Est. completion 2017-04 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Status unknown NCT NCT01287715
Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis
Not yet reported Erasmus Medical Center 50 participants Est. completion 2013-09 10 sites Stand-aloneOther conditions: Juvenile Idiopathic ArthritisView official trial listing → -
Completed NCT NCT01288521
Pharmacogenetics to Predict Drug Interactions in Kidney Transplant Recipients
Not yet reported Sony Tuteja 8 participants Est. completion 2011-09 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Withdrawn NCT NCT01288664
Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis
Not yet reported Sun Yat-sen University Est. completion 2012-12 1 site Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Status unknown NCT NCT01289301
Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant
Not yet reported Hannover Medical School 124 participants Est. completion 2018-10 4 sitesOther conditions: Disorder Related to Renal Transplantation, Immunosuppression Related Infectious Disease, Virus DiseasesView official trial listing → -
Status unknown NCT NCT01289730
Etanercept (Enbrel) in Undifferentiated Spondyloarthritis
Not yet reported Charite University, Berlin, Germany 8 participants Est. completion 2012-05 2 sites Stand-aloneOther conditions: SpondyloarthritisView official trial listing → -
Status unknown NCT NCT01289743
Etanercept (Enbrel) in Ankylosing Spondylitis
Not yet reported Charite University, Berlin, Germany 24 participants Est. completion 2012-05 2 sites Stand-aloneOther conditions: Ankylosing SpondylitisView official trial listing → -
Terminated NCT NCT01292525
Protocol Calcineurin Inhibitor (CNI) Weaning
Not yet reported Nantes University Hospital 16 participants Est. completion 2015-05 1 site Stand-aloneOther conditions: Function of Renal TransplantView official trial listing → -
Completed NCT NCT01294020
Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®
Not yet reported Astellas Pharma Europe Ltd. 81 participants Est. completion 2025-11-03 16 sites Stand-aloneOther conditions: Intestine Transplantation, Kidney Transplantation, Lung Transplantation, Liver Transplantation, Heart TransplantationView official trial listing → -
Terminated NCT NCT01294397
Effects of Denosumab on the Pharmacokinetics of Etanercept
Not yet reported Amgen 19 participants Est. completion 2016-01 2 sites Stand-aloneOther conditions: Postmenopausal, Osteopenia, Rheumatoid Arthritis, OsteoporosisView official trial listing → -
Completed NCT NCT01294748
Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease
Not yet reported Micell Technologies 184 participants Est. completion 2016-08 28 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01295151
SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.
Not yet reported Julia Brown 122 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01298713
Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer
Not yet reported ARCAGY/ GINECO GROUP 111 participants Est. completion 2018-09-12 1 siteOther conditions: Breast Neoplasms, mTor ProteinView official trial listing → -
Completed NCT NCT01303874
Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)
Not yet reported University of Leeds 112 participants Est. completion 2010-11-05 1 site Stand-aloneOther conditions: Rheumatoid Arthritis, Inflammatory ArthritisView official trial listing → -
Terminated NCT NCT01303965
Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)
Not yet reported, Not yet reported Sherif S. Farag 14 participants Est. completion 2017-07-28 1 site Stand-aloneOther conditions: Multiple MyelomaView official trial listing → -
Completed NCT NCT01304836
A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids
Not yet reported Astellas Pharma Inc 1166 participants Est. completion 2013-05-22 100 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
No Longer Available NCT NCT01309022
Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
National Institute of Allergy and Infectious Diseases (NIAID) 3 sitesOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT01309477
The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS)
Not yet reported Sun Yat-sen University 20 participants Est. completion 2011-10 1 site Stand-aloneOther conditions: Nephrotic SyndromeView official trial listing → -
Terminated NCT NCT01312064
De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab Induction
Not yet reported National Taiwan University Hospital 2 participants Est. completion 2012-04 1 siteOther conditions: Renal InsufficiencyView official trial listing → -
Completed NCT NCT01313208
Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)
Not yet reported Amgen 210 participants Est. completion 2013-05 47 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01313221
Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis
Not yet reported Amgen 310 participants Est. completion 2013-05 24 sites Stand-aloneOther conditions: PsoriasisView official trial listing → -
Terminated NCT NCT01313390
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer
Not yet reported, Not yet reported University College, London 4 participants Est. completion 2011-04 1 siteOther conditions: Head and Neck CancerView official trial listing → -
Terminated NCT NCT01313559
Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 6 participants Est. completion 2012-11-29 2 sitesOther conditions: Castrate Resistant Prostate Cancer, Chemotherapy Naive Prostate Cancer, Prostate CancerView official trial listing → -
Terminated NCT NCT01316133
A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients
Not yet reported Astellas Pharma Korea, Inc. 37 participants Est. completion 2016-04-08 7 sites Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT01317615
RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation
Not yet reported Novartis Pharmaceuticals 49 participants Est. completion 2015-03 9 sitesOther conditions: Carcinoma, Large Cell, Neuroendocrine TumorsView official trial listing → -
Terminated NCT NCT01318915
Research Study of ATG and Rituximab in Renal Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2017-08-25 6 sites Stand-aloneOther conditions: Renal Transplant RecipientsView official trial listing → -
Completed NCT NCT01320579
Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis
Not yet reported BioCis Pharma Ltd 159 participants Est. completion 2012-06 7 sitesOther conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT01323920
Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors
Not yet reported Dana-Farber Cancer Institute 35 participants Est. completion 2013-11 1 site Stand-aloneOther conditions: Leukemia, Lymphoma, Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT01324492
Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor
Not yet reported Novartis Pharmaceuticals 16 participants Est. completion 2014-06 4 sitesOther conditions: Lung Neuroendocrine NeoplasmView official trial listing → -
Terminated NCT NCT01324934
Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids
Not yet reported Neovii Biotech 40 participants Est. completion 2011-01 10 sitesOther conditions: Renal Transplant RejectionView official trial listing → -
Completed NCT NCT01325571
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis
Not yet reported Astellas Pharma Inc 83 participants Est. completion 2014-05 9 sites Stand-aloneOther conditions: Myasthenia GravisView official trial listing → -
Withdrawn NCT NCT01326468
Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Est. completion 2016-12Other conditions: Head and Neck CancerView official trial listing → -
Completed NCT NCT01327573
Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation
Not yet reported Sanjay Kulkarni 16 participants Est. completion 2015-02 1 site Stand-aloneOther conditions: Kidney; Complications, AllograftView official trial listing → -
Completed NCT NCT01328834
Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis
Not yet reported Sun Yat-sen University 20 participants Est. completion 2011-10 1 site Stand-aloneOther conditions: Nephritis, LupusView official trial listing → -
Completed NCT NCT01331135
Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
Not yet reported Emory University 18 participants Est. completion 2017-08-09 1 site Stand-aloneObstructive sleep apnea Other conditions: Ewing's Sarcoma, Astrocytoma, Atypical Teratoid/Rhabdoid Tumor, Ependymoma, Germ Cell Tumor, Glioma, Medulloblastoma, Rhabdoid Tumor, Retinoblastoma, Clear Cell Sarcoma, Renal Cell Carcinoma, Wilms Tumor, Hepatoblastoma, NeuroblastomaView official trial listing → -
Completed NCT NCT01332201
Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®
Not yet reported Astellas Pharma Inc 17 participants Est. completion 2013-11 8 sitesOther conditions: Heart Transplantation, Lung Transplantation, Pancreas (Including SPK) TransplantationView official trial listing → -
Completed NCT NCT01333085
Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Surgery
Not yet reported, Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 49 participants Est. completion 2013-05 5 sitesOther conditions: Head and Neck CancerView official trial listing → -
Status unknown NCT NCT01333410
Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo
Not yet reported Mahidol University 30 participants Est. completion 2013-12 1 siteOther conditions: VitiligoView official trial listing → -
Completed NCT NCT01334073
Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid Tumors
Not yet reported University Hospital, Bordeaux 19 participants Est. completion 2015-01 2 sitesOther conditions: Malignant Advanced Solid Tumors, Carcinoma, Renal CellView official trial listing → -
Completed NCT NCT01334333
Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients
Not yet reported University of British Columbia 46 participants Est. completion 2018-03-01 1 site Stand-aloneOther conditions: Renal Disease, Renal TransplantView official trial listing → -
Withdrawn NCT NCT01335074
Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
Not yet reported, Not yet reported Philipps University Marburg 1 siteOther conditions: Hepatocellular CarcinomaView official trial listing → -
Completed NCT NCT01336296
Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients
Not yet reported University of Cincinnati 61 participants Est. completion 2014-04 1 siteOther conditions: Kidney Transplant RecipientsView official trial listing → -
Completed NCT NCT01338090
89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors
University Medical Center Groningen 14 participants Est. completion 2012-03 1 siteOther conditions: Neuroendocrine TumorsView official trial listing → -
Completed NCT NCT01338987
Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation
Not yet reported National Cancer Institute (NCI) 76 participants Est. completion 2020-11-19 3 sites Stand-aloneOther conditions: Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic LeukemiaView official trial listing → -
Completed NCT NCT01339468
A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation
Not yet reported Astellas Pharma Inc 100 participants Est. completion 2014-05-27 1 site Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT01341301
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 25 participants Est. completion 2014-08-07 1 site Stand-aloneOther conditions: Hematologic MalignancyView official trial listing → -
Status unknown NCT NCT01341834
Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors
Not yet reported National Cancer Centre, Singapore 49 participants Est. completion 2018-12 1 siteOther conditions: Nasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid TumourView official trial listing → -
Terminated NCT NCT01342016
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients
Not yet reported Astellas Pharma Inc 84 participants Est. completion 2013-05 12 sites Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Status unknown NCT NCT01342042
The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 36 participants Est. completion 2011-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01342289
Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 127 participants Est. completion 2018-03 1 site Stand-aloneOther conditions: Hodgkin's Lymphoma, Leukemia, Myelodysplastic Syndrome(MDS), Multiple Myeloma, Non Hodgkin's LymphomaView official trial listing → -
Completed NCT NCT01343498
Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors
Not yet reported SCRI Development Innovations, LLC 33 participants Est. completion 2014-01 2 sitesOther conditions: Malignant Solid TumourView official trial listing → -
Completed NCT NCT01345227
Bone Marrow as an Alternative Site for Islet Transplantation
Not yet reported Ospedale San Raffaele 8 participants Est. completion 2011-10 1 siteOther conditions: Type 1 Diabetes, Postpancreatectomy HyperglycemiaView official trial listing → -
Completed NCT NCT01346397
Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation
Russian Academy of Medical Sciences 170 participants Est. completion 2016-05 1 siteOther conditions: Acute Graft Rejection, Chronic Allograft Nephropathy, Polyomavirus-related Transplant NephropathyView official trial listing → -
Terminated NCT NCT01347866
Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
Not yet reported Pfizer 105 participants Est. completion 2015-12 18 sitesOther conditions: Advanced CancerView official trial listing → -
Completed NCT NCT01349101
A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 78 participants Est. completion 2022-12-07 1 site Stand-aloneOther conditions: Hematological MalignanciesView official trial listing → -
Completed NCT NCT01350245
Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 28 participants Est. completion 2014-05 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Biphenotypic Leukemia, Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Plasma Cell Neoplasms, Lymphoma, Hodgkin's Disease, Aplastic AnemiaView official trial listing → -
Status unknown NCT NCT01353053
Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection
Federal University of São Paulo 82 participants 1 siteOther conditions: Disorder of Transplanted Kidney, Cytomegalovirus InfectionsView official trial listing → -
Completed NCT NCT01353417
Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft Rejection
Sandoz 102 participants Est. completion 2015-08-31 1 siteOther conditions: Chronic Kidney InsufficiencyView official trial listing → -
Completed NCT NCT01353625
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.
Not yet reported Celgene 118 participants Est. completion 2021-03-12 17 sitesObstructive sleep apnea Other conditions: Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer, Chronic Lymphocytic Leukemia, Neoplasm MetastasisView official trial listing → -
Completed NCT NCT01354301
Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate
Not yet reported Hospital do Rim e Hipertensão 300 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Cytomegalovirus Infection, Renal Transplant Failure, Transplant; Complication, RejectionView official trial listing → -
Completed NCT NCT01356758
Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
University of Aarhus 126 participants Est. completion 2015-11 1 siteOther conditions: Psoriasis, Atopic Dermatitis, AtherosclerosisView official trial listing → -
Completed NCT NCT01358578
Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis
Not yet reported Novartis Pharmaceuticals 1306 participants Est. completion 2013-07 152 sites Stand-aloneOther conditions: Chronic Plaque PsoriasisView official trial listing → -
Completed NCT NCT01363752
A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
Not yet reported Astellas Pharma Inc 853 participants Est. completion 2013-09-18 58 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01364584
Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes
Not yet reported University of Colorado, Denver 23 participants Est. completion 2014-12 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01364844
Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors
Not yet reported Daiichi Sankyo 42 participants Est. completion 2013-11 3 sitesOther conditions: Solid Tumor, Colorectal Cancer, Endometrial CancerView official trial listing → -
Terminated NCT NCT01365468
Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)
Not yet reported Novartis Pharmaceuticals 9 participants Est. completion 2015-04 2 sitesOther conditions: Plexiform Neurofibroma Associated With Neurofibromatosis Type 1View official trial listing → -
Completed NCT NCT01367457
INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus
Pfizer 243 participants Est. completion 2015-04 16 sitesOther conditions: Carcinoma, Renal Cell, Lymphoma, Mantle-CellView official trial listing → -
Completed NCT NCT01368627
The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions
Not yet reported Sahajanand Medical Technologies Limited 1274 participants Est. completion 2011-12 7 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01369082
Extended Follow-Up After Islet Transplantation in T1D
National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2017-07 8 sitesOther conditions: Type 1 Diabetes (T1D), Islet TransplantationView official trial listing → -
Terminated NCT NCT01369433
A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols
Not yet reported AVEO Pharmaceuticals, Inc. 225 participants Est. completion 2015-10 49 sitesOther conditions: Solid TumorsView official trial listing → -
Completed NCT NCT01371331
A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation
Not yet reported Astellas Pharma Europe Ltd. 52 participants Est. completion 2015-02-03 10 sites Stand-aloneOther conditions: Kidney Transplantation, Heart Transplantation, Liver TransplantationView official trial listing → -
Terminated NCT NCT01371344
A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients
Not yet reported Astellas Pharma Europe Ltd. 47 participants Est. completion 2017-04-02 12 sites Stand-aloneOther conditions: Heart Transplantation, Kidney Transplantation, Liver TransplantationView official trial listing → -
Status unknown NCT NCT01372930
Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction
Not yet reported Xijing Hospital 200 participants 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01374750
Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)
Not yet reported Seoul National University Hospital 45 participants Est. completion 2016-05 1 siteOther conditions: Hepatocellular CarcinomaView official trial listing → -
Active, not recruiting NCT NCT01375829
Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Not yet reported National Cancer Institute (NCI) 22 participants Est. completion 2027-03-19 2 sitesOther conditions: Adult Solid NeoplasmView official trial listing → -
Terminated NCT NCT01376310
GSK1120212 Rollover Study
Not yet reported Novartis Pharmaceuticals 159 participants Est. completion 2018-01-18 19 sitesOther conditions: CancerView official trial listing → -
Terminated NCT NCT01378377
Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus
Not yet reported EMD Serono 33 participants Est. completion 2012-02-23 3 sitesOther conditions: Advanced Solid TumorView official trial listing → -
Completed NCT NCT01379209
Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
Not yet reported, Not yet reported Regimmune Corporation 68 participants Est. completion 2017-04 6 sites Stand-aloneOther conditions: Graft Versus Host DiseaseView official trial listing → -
Terminated NCT NCT01379521
Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC
Not yet reported Novartis Pharmaceuticals 65 participants Est. completion 2015-06 5 sitesOther conditions: Hepatocellular CarcinomaView official trial listing → -
Status unknown NCT NCT01379729
Bet Cell Therapy in Diabetes Type 1
Not yet reported Universitair Ziekenhuis Brussel 10 participants Est. completion 2018-05 2 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT01380535
Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)
Not yet reported Mallinckrodt 60 participants Est. completion 2015-03 32 sites Stand-aloneOther conditions: Chronic Graft Versus Host DiseaseView official trial listing → -
Withdrawn NCT NCT01383668
Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer
Not yet reported Mayo Clinic Est. completion 2013-02-08 Stand-aloneOther conditions: Recurrent Non-small Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer, Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT01384513
A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 40 participants Est. completion 2022-11-16 1 site Stand-aloneObstructive sleep apnea Other conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Aplastic Anemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Essential Thrombocythemia, Juvenile Myelomonocytic Leukemia, Mastocytosis, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Polycythemia Vera, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Anemia, Refractory Anemia With Ringed Sideroblasts, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Waldenström MacroglobulinemiaView official trial listing → -
Terminated NCT NCT01387659
Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations
Not yet reported The University of Texas Medical Branch, Galveston 2 participants Est. completion 2012-10 1 siteOther conditions: Diabetes, ImmunosuppressionView official trial listing → -
Completed NCT NCT01388387
Pharmacogenetic Study of Tacrolimus in Hepatic Transplant (CYPTAC'H)
Not yet reported Rennes University Hospital 154 participants Est. completion 2018-07-31 1 site Stand-aloneOther conditions: Hepatic TransplantationView official trial listing → -
Completed NCT NCT01388517
Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba
Not yet reported Universidad Autonoma de San Luis Potosí 39 participants Est. completion 2011-01 1 siteOther conditions: Pityriasis AlbaView official trial listing → -
Completed NCT NCT01388608
Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept
University Hospital Muenster 28 participants Est. completion 2013-04 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01389427
Escalating Doses of Torisel in Combination With Three Chemotherapies Regimens: R-CHOP, R-FC or R-DHA for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL).
Not yet reported, Not yet reported The Lymphoma Academic Research Organisation 41 participants Est. completion 2015-09 11 sitesOther conditions: Mantle Cell Lymphoma RefractoryView official trial listing → -
Completed NCT NCT01390402
Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG
Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: Leukemia, Chronic Myelogenous LeukemiaView official trial listing → -
Completed NCT NCT01390818
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors
Not yet reported EMD Serono 146 participants Est. completion 2015-04 8 sitesOther conditions: Locally Advanced Solid Tumor, Metastatic Solid Tumor, Breast Cancer, Non Small Cell Lung Cancer, Melanoma, Colorectal CancerView official trial listing → -
Completed NCT NCT01392183
Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)
Not yet reported M.D. Anderson Cancer Center 69 participants Est. completion 2019-09-08 1 siteOther conditions: Kidney CancerView official trial listing → -
Withdrawn NCT NCT01394913
Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis
Not yet reported EMS Est. completion 2014-06 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Active, not recruiting NCT NCT01396408
A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours
Not yet reported Canadian Cancer Trials Group 137 participants Est. completion 2026-12-31 17 sitesOther conditions: Advanced Rare TumoursView official trial listing → -
Status unknown NCT NCT01399242
Efficacy of Certican® in Combination With Myfortic® in Renal
Not yet reported Hospital Universitário São José 40 participants Est. completion 2013-06 1 siteOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Completed NCT NCT01400516
Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial
Not yet reported Brigham and Women's Hospital 26 participants Est. completion 2016-07-28 3 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01404325
Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients
Not yet reported Novartis Pharmaceuticals 130 participants Est. completion 2017-01-05 9 sitesOther conditions: Lung TransplantationView official trial listing → -
Completed NCT NCT01405287
Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT
Not yet reported OrbusNeich 60 participants Est. completion 2014-01 6 sitesCardiovascular disease Other conditions: Atherosclerosis, Acute Coronary Syndrome (ACS)View official trial listing → -
Completed NCT NCT01410162
Advagraf/Prograf Conversion Trial
Not yet reported Norman Muirhead 53 participants Est. completion 2014-12 1 siteOther conditions: Renal Transplant, Kidney Pancreas TransplantView official trial listing → -
Completed NCT NCT01410448
Everolimus in de Novo Kidney Transplant Recipients
Not yet reported Novartis Pharmaceuticals 383 participants Est. completion 2015-12 22 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01410747
A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations
Astellas Pharma Inc 1484 participants Est. completion 2020-01-31 8 sitesOther conditions: Lupus NephritisView official trial listing → -
Terminated NCT NCT01411215
A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
Pfizer 160 participants Est. completion 2013-01 15 sitesOther conditions: Rheumatoid Arthritis, Ankylosing SpondylitisView official trial listing → -
Terminated NCT NCT01412515
A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma
Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 11 participants Est. completion 2011-05 1 siteOther conditions: Kaposi SarcomaView official trial listing → -
Terminated NCT NCT01413685
Calcineurin Activity in Renal Recipients
Not yet reported Assistance Publique - Hôpitaux de Paris 23 participants Est. completion 2010-07 1 siteOther conditions: Renal Transplant RejectionView official trial listing → -
Completed NCT NCT01414660
Evolution of Interleukin 7, Fat Mass and Metabolic Profile Before and After Transplantation
University Hospital, Lille 49 participants Est. completion 2018-02 5 sitesOther conditions: Immunodeficiency Secondary to Organ TransplantationView official trial listing → -
Completed NCT NCT01416649
Impact of Exenatide on Sleep Duration
University of Chicago 8 participants Est. completion 2021-04-21 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT01418131
Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis
Not yet reported The University of Western Australia 21 participants Est. completion 2016-11 4 sitesOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT01419639
Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2
Not yet reported NYU Langone Health 10 participants Est. completion 2013-12 1 siteOther conditions: Neurofibromatosis Type IIView official trial listing → -
Terminated NCT NCT01420081
A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer
Not yet reported Pfizer 67 participants Est. completion 2015-12-25 51 sitesOther conditions: Endometrial NeoplasmsView official trial listing → -
Status unknown NCT NCT01423708
Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study
Not yet reported Azienda Ospedaliera di Padova 117 participants Est. completion 2014-01 7 sites Stand-aloneOther conditions: Liver Failure, Liver Diseases, Liver Cirrhosis, Liver NeoplasmsView official trial listing → -
Completed NCT NCT01427946
Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer
Not yet reported, Not yet reported Infinity Pharmaceuticals, Inc. 47 participants Est. completion 2014-10 5 sitesOther conditions: Non-small Cell Lung CancerView official trial listing → -
Status unknown NCT NCT01428973
Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens
Not yet reported University of Liege 200 participants Est. completion 2024-12 13 sites Stand-aloneOther conditions: Graft-Versus-Host Disease, Hematological MalignanciesView official trial listing → -
Completed NCT NCT01429038
Mesenchymal Stem Cells After Renal or Liver Transplantation
Not yet reported, Not yet reported University of Liege 40 participants Est. completion 2019-03-11 1 site Stand-aloneOther conditions: Liver Failure, Kidney FailureView official trial listing → -
Completed NCT NCT01429844
Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation
Not yet reported Universitätsklinikum Hamburg-Eppendorf 274 participants Est. completion 2010-08 14 sitesOther conditions: Bronchiolitis Obliterans, ImmunosuppressionView official trial listing → -
Completed NCT NCT01430065
Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy Volunteers
Not yet reported Astellas Pharma Inc 24 participants Est. completion 2009-06 1 site Stand-aloneOther conditions: Pharmacokinetics of ASP015K, Drug Interactions, Healthy SubjectsView official trial listing → -
Completed NCT NCT01435291
AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation
Not yet reported Centre Hospitalier Universitaire de Nice 45 participants Est. completion 2013-07 4 sites Stand-aloneOther conditions: Renal TransplantationView official trial listing → -
Status unknown NCT NCT01436019
Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis
Blood Transfusion Centre of Slovenia 100 participants Est. completion 2012-12 1 siteOther conditions: Juvenile Idiopathic ArthritisView official trial listing → -
Terminated NCT NCT01436305
Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 19 participants Est. completion 2015-04 3 sites Stand-aloneOther conditions: Kidney Transplantation, Renal TransplantationView official trial listing → -
Completed NCT NCT01438710
Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Not yet reported Veloxis Pharmaceuticals 44 participants Est. completion 2015-07 10 sites Stand-aloneOther conditions: Renal Failure, TremorsView official trial listing → -
Completed NCT NCT01444898
Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
Not yet reported Children's Hospital Los Angeles 10 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: Prader-Willi SyndromeView official trial listing → -
Completed NCT NCT01445106
A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors
Not yet reported National Cancer Institute (NCI) 28 participants Est. completion 2011-05-09 1 siteOther conditions: Solid TumorsView official trial listing → -
Terminated NCT NCT01445236
Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance
Not yet reported Hospital Clinic of Barcelona 25 participants Est. completion 2013-01 1 siteOther conditions: Liver TransplantationView official trial listing → -
Status unknown NCT NCT01446484
Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection
Not yet reported, Not yet reported Pirogov Russian National Research Medical University 30 participants Est. completion 2014-11 2 sites Stand-aloneOther conditions: End-Stage Renal Disease, Kidney FailureView official trial listing → -
Terminated NCT NCT01451489
The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis
Not yet reported Nanjing University School of Medicine 70 participants Est. completion 2016-10-29 1 siteOther conditions: FSGSView official trial listing → -
Completed NCT NCT01452451
Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Not yet reported Hanmi Pharmaceutical Company Limited 72 participants 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT01453218
Safety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction
Not yet reported Hospital Vall d'Hebron 30 participants Est. completion 2020-02 1 siteOther conditions: Renal InsufficiencyView official trial listing → -
Status unknown NCT NCT01455649
Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults
Not yet reported Deise de Boni Monteiro de Carvalho 30 participants Est. completion 2013-11 1 siteOther conditions: Kidney Transplant, ImmunosuppressionView official trial listing → -
Withdrawn NCT NCT01455909
A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes
Not yet reported Intarcia Therapeutics Est. completion 2014-07 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01460979
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma
Not yet reported AGO Study Group 47 participants Est. completion 2015-11 18 sitesOther conditions: Genital Diseases, Female, Ovarian Diseases, Ovarian Neoplasms, Endometrial NeoplasmsView official trial listing → -
Completed NCT NCT01462214
Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer
Not yet reported, Not yet reported Hans J. van der Vliet, MD, PhD 96 participants Est. completion 2017-01 13 sitesOther conditions: Metastatic Renal Cell CancerView official trial listing → -
Completed NCT NCT01467011
Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation
R. Mark Ghobrial, MD 25 participants Est. completion 2013-12 1 siteOther conditions: End Stage Liver DiseaseView official trial listing → -
Terminated NCT NCT01467505
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Not yet reported Vertex Pharmaceuticals Incorporated 61 participants Est. completion 2014-04 22 sites Stand-aloneOther conditions: Hepatitis CView official trial listing → -
Completed NCT NCT01467986
Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma
Not yet reported University of Regensburg 130 participants Est. completion 2020-09-30 1 siteOther conditions: Neuroblastoma RecurrentView official trial listing → -
Completed NCT NCT01469572
Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases
Not yet reported Emory University 13 participants Est. completion 2018-10 1 siteOther conditions: Neuroendocrine TumorsView official trial listing → -
Completed NCT NCT01469884
Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients
Not yet reported Irmandade Santa Casa de Misericórdia de Porto Alegre 30 participants Est. completion 2015-04 1 siteOther conditions: Renal Allograft, Hepatitis CView official trial listing → -
Completed NCT NCT01471067
Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies
Not yet reported M.D. Anderson Cancer Center 33 participants Est. completion 2017-04-25 1 site Stand-aloneOther conditions: Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplantation Infection, Transplantation, Bone MarrowView official trial listing → -
Completed NCT NCT01471444
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
Not yet reported M.D. Anderson Cancer Center 256 participants Est. completion 2020-12-14 1 site Stand-aloneOther conditions: Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation InfectionView official trial listing → -
Completed NCT NCT01472705
Everolimus- Versus Biolimus-Eluting Stents in All-Comers
University of Freiburg 814 participants Est. completion 2011-11 1 siteCardiovascular diseaseView official trial listing → -
Terminated NCT NCT01473732
Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity
Not yet reported Montefiore Medical Center 2 participants Est. completion 2012-08 1 siteOther conditions: Chronic Allograft Injury, Calcineurin Inhibitor ToxicityView official trial listing → -
Completed NCT NCT01476488
Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients
Not yet reported, Not yet reported Seoul National University Hospital 1 siteOther conditions: Kidney Transplantation, Pediatric Patients, Maintenance With TacrolimusView official trial listing → -
Completed NCT NCT01476839
Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma
Not yet reported City of Hope Medical Center 25 participants Est. completion 2024-05-31 1 site Stand-aloneOther conditions: Recurrent Adult Hodgkin LymphomaView official trial listing → -
Completed NCT NCT01479881
A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus
Not yet reported Tibotec Pharmaceuticals, Ireland 29 participants Est. completion 2011-12 1 site Stand-aloneOther conditions: Hepatitis C VirusView official trial listing → -
Completed NCT NCT01482156
Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
Not yet reported Novartis Pharmaceuticals 46 participants Est. completion 2015-02 10 sitesOther conditions: Advanced Solid Tumors, Metastatic Breast Cancer, Metastatic Renal Cell CarcinomaView official trial listing → -
Terminated NCT NCT01485055
Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
Not yet reported Nationwide Children's Hospital 11 participants Est. completion 2016-09-26 3 sites Stand-aloneOther conditions: Graft Versus Host Disease, Steroid Refractory GVHD, Acute GVH DiseaseView official trial listing → -
Terminated NCT NCT01488253
Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants
Not yet reported The Korean Society of Blood and Marrow Transplantation 3 participants Est. completion 2014-10 1 site Stand-aloneOther conditions: Acute Leukemia in Remission, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Accelerated-PhaseView official trial listing → -
Completed NCT NCT01488487
Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
Not yet reported UNC Lineberger Comprehensive Cancer Center 24 participants Est. completion 2015-03 3 sitesOther conditions: Advanced Adult Hepatocellular CarcinomaView official trial listing → -
Withdrawn NCT NCT01490047
Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas
Not yet reported Ludwig Institute for Cancer Research 1 siteOther conditions: Solid Tumors, LymphomasView official trial listing → -
Completed NCT NCT01490723
Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)
Not yet reported M.D. Anderson Cancer Center 20 participants Est. completion 2019-04-24 1 site Stand-aloneOther conditions: Leukemia, LymphomaView official trial listing → -
Completed NCT NCT01490749
Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer
Not yet reported Emory University 17 participants Est. completion 2019-02 3 sitesOther conditions: Esophageal Cancer, Neoplasms, EsophagealView official trial listing → -
Completed NCT NCT01491672
Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma
Not yet reported Novartis Pharmaceuticals 134 participants Est. completion 2015-05 17 sitesOther conditions: Metastatic Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT01491958
Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation
Not yet reported Ohio State University Comprehensive Cancer Center 40 participants Est. completion 2016-06-27 1 site Stand-aloneOther conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic SyndromeView official trial listing → -
Withdrawn NCT NCT01492894
Kidney Allograft Dysfunction Without Reversible Causes
Not yet reported University of Minnesota Est. completion 2011-10 1 siteOther conditions: Kidney Graft DysfunctionView official trial listing → -
Terminated NCT NCT01495247
Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer
Not yet reported, Not yet reported Novartis Pharmaceuticals 18 participants Est. completion 2014-05-19 3 sitesOther conditions: Inoperable Locally Advanced Breast Cancer, Metastatic Breast Cancer (MBC)View official trial listing → -
Completed NCT NCT01501084
Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women
Not yet reported University of California, Los Angeles 34 participants Est. completion 2013-02 1 siteOther conditions: ObesityView official trial listing → -
Completed NCT NCT01507038
Safety and Efficacy of YH14617 in Diabetes Mellitus
Not yet reported Yuhan Corporation 84 participants Est. completion 2015-02 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT01507519
Study Safety and Performance of the Biomime Stent in Patients With Single, De Novo, Non-Complex Coronary Lesions
Not yet reported Meril Life Sciences Pvt. Ltd. 30 participants Est. completion 2011-03 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT01509300
HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors
Not yet reported, Not yet reported Asan Medical Center 10 participants Est. completion 2014-03 1 site Stand-aloneOther conditions: Acute Leukemia, Myelodysplastic Syndrome, Solid TumorsView official trial listing → -
Completed NCT NCT01510119
Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma
Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 40 participants Est. completion 2017-01-05 3 sitesOther conditions: Metastatic Clear Cell Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT01511003
A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)
Not yet reported Astellas Pharma Inc 128 participants Est. completion 2015-05-11 4 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT01514149
Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy
Not yet reported ConjuChem 73 participants Est. completion 2013-03 22 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01514448
Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib
Not yet reported Novartis Pharmaceuticals 29 participants Est. completion 2016-04-01 13 sitesOther conditions: Metastatic Renal Cell Carcinoma (mRCC)View official trial listing → -
Completed NCT NCT01516723
Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions
Not yet reported R&D Cardiologie 330 participants Est. completion 2020-12-31 4 sites Stand-aloneCardiovascular disease Other conditions: Coronary Disease, Coronary StenosisView official trial listing → -
Completed NCT NCT01517074
Sirolimus Injections for Autoimmune Scleritis
Not yet reported, Not yet reported National Eye Institute (NEI) 5 participants Est. completion 2014-04 1 site Stand-aloneOther conditions: ScleritisView official trial listing → -
Completed NCT NCT01517243
Phase II Study of Alternating Sunitinib and Temsirolimus
Not yet reported Dartmouth-Hitchcock Medical Center 37 participants Est. completion 2018-08-20 2 sitesOther conditions: Metastatic Renal Cell CarcinomaView official trial listing → -
Terminated NCT NCT01517984
Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 52 participants Est. completion 2015-05 11 sites Stand-aloneOther conditions: Kidney Transplant RecipientsView official trial listing → -
Terminated NCT NCT01518153
Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)
Not yet reported M.D. Anderson Cancer Center 16 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: Leukemia, Lymphoma, Myeloma, Myeloproliferative DiseasesView official trial listing → -
Terminated NCT NCT01522742
Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study
Massachusetts General Hospital 29 participants Est. completion 2016-01 1 siteOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT01522820
Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
Not yet reported Roswell Park Cancer Institute 18 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Estrogen Receptor Negative, Estrogen Receptor Positive, Glioblastoma, Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Metastatic Renal Cell Cancer, Recurrent Adult Brain Neoplasm, Recurrent Bladder Carcinoma, Recurrent Breast Carcinoma, Recurrent Colorectal Carcinoma, Recurrent Esophageal Carcinoma, Recurrent Gastric Carcinoma, Recurrent Hepatocellular Carcinoma, Recurrent Lung Carcinoma, Recurrent Melanoma, Recurrent Ovarian Carcinoma, Recurrent Prostate Carcinoma, Recurrent Renal Cell Carcinoma, Recurrent Uterine Corpus Carcinoma, Resectable Hepatocellular Carcinoma, Sarcoma, Stage IA Breast Cancer, Stage IA Ovarian Cancer, Stage IA Uterine Corpus Cancer, Stage IB Breast Cancer, Stage IB Ovarian Cancer, Stage IB Uterine Corpus Cancer, Stage IC Ovarian Cancer, Stage II Uterine Corpus Cancer, Stage IIA Breast Cancer, Stage IIA Lung Carcinoma, Stage IIA Ovarian Cancer, Stage IIB Breast Cancer, Stage IIB Esophageal Cancer, Stage IIB Lung Carcinoma, Stage IIB Ovarian Cancer, Stage IIB Skin Melanoma, Stage IIC Ovarian Cancer, Stage IIC Skin Melanoma, Stage IIIA Breast Cancer, Stage IIIA Esophageal Cancer, Stage IIIA Lung Carcinoma, Stage IIIA Ovarian Cancer, Stage IIIA Skin Melanoma, Stage IIIA Uterine Corpus Cancer, Stage IIIB Breast Cancer, Stage IIIB Esophageal Cancer, Stage IIIB Ovarian Cancer, Stage IIIB Skin Melanoma, Stage IIIB Uterine Corpus Cancer, Stage IIIC Breast Cancer, Stage IIIC Esophageal Cancer, Stage IIIC Ovarian Cancer, Stage IIIC Skin Melanoma, Stage IIIC Uterine Corpus Cancer, Stage IV Bladder Urothelial Carcinoma, Stage IV Esophageal Cancer, Stage IV Ovarian Cancer, Stage IV Prostate Cancer, Stage IV Skin Melanoma, Stage IVA Uterine Corpus Cancer, Stage IVB Uterine Corpus CancerView official trial listing → -
Status unknown NCT NCT01525719
Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma
Not yet reported Ratchavithi Hospital 40 participants Est. completion 2014-06Other conditions: CholangiocarcinomaView official trial listing → -
Completed NCT NCT01526096
Stem Cell Transplantation for Patients With Multiple Myeloma
Not yet reported University of Chicago 30 participants Est. completion 2024-08-28 1 site Stand-aloneOther conditions: MyelomaView official trial listing → -
Completed NCT NCT01526356
Topical Rapamycin to Erase Angiofibromas in TSC
Not yet reported The University of Texas Health Science Center, Houston 179 participants Est. completion 2014-08 10 sitesOther conditions: Angiofibromas, Tuberous SclerosisView official trial listing → -
Completed NCT NCT01529138
Study of Axitinib and Temsirolimus in Solid Tumors
Not yet reported Emory University 13 participants Est. completion 2014-03 1 site Stand-aloneOther conditions: CancerView official trial listing → -
Completed NCT NCT01529554
Controlled Level EVERolimus in Acute Coronary Syndromes
Not yet reported, Not yet reported University of Zurich 150 participants Est. completion 2021-11-29 8 sitesOther conditions: Acute Coronary SyndromesView official trial listing → -
Terminated NCT NCT01529593
Temsirolimus in Combination With Metformin in Patients With Advanced Cancers
Not yet reported M.D. Anderson Cancer Center 34 participants Est. completion 2025-03-14 1 siteOther conditions: Advanced CancersView official trial listing → -
Completed NCT NCT01529827
Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Not yet reported Roswell Park Cancer Institute 94 participants Est. completion 2019-08-29 1 site Stand-aloneObstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Aplastic Anemia, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Congenital Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia, Hepatosplenic T-cell Lymphoma, Juvenile Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Paroxysmal Nocturnal Hemoglobinuria, Peripheral T-cell Lymphoma, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Secondary Myelofibrosis, Severe Combined Immunodeficiency, Severe Congenital Neutropenia, Shwachman-Diamond Syndrome, Splenic Marginal Zone Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Waldenstrom Macroglobulinemia, Wiskott-Aldrich SyndromeView official trial listing → -
Terminated NCT NCT01532635
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4 participants Est. completion 2013-05 1 site Stand-aloneOther conditions: Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia, ALL, Acute Myelogenous Leukemia, AML, Chronic Lymphocytic Leukemia, CLL, Lymphoma, Hodgkin's Lymphoma, Non-hodgkin's Lymphoma, MyelomaView official trial listing → -
Terminated NCT NCT01534143
High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant
Not yet reported Barbara Ann Karmanos Cancer Institute 1 participants Est. completion 2013-05 1 site Stand-aloneOther conditions: Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple MyelomaView official trial listing → -
Completed NCT NCT01535547
Drug Interaction Study of Isavuconazole and Tacrolimus
Not yet reported Astellas Pharma Inc 24 participants Est. completion 2012-01 1 site Stand-aloneOther conditions: Pharmacokinetics of Isavuconazole, Pharmacokinetics of Tacrolimus, Healthy VolunteersView official trial listing → -
Completed NCT NCT01536054
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Not yet reported Roswell Park Cancer Institute 7 participants Est. completion 2015-04-21 1 site Stand-aloneOther conditions: Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity CancerView official trial listing → -
Completed NCT NCT01536535
Predicting Response to Standardized Pediatric Colitis Therapy
Not yet reported Connecticut Children's Medical Center 431 participants Est. completion 2018-04-30 29 sites Stand-aloneOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT01541176
Absence of Steroid in Renal Transplantation and Digital Fibrosis Observation
Not yet reported Nantes University Hospital 193 participants Est. completion 2018-08 8 sitesOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT01541384
Medication Adherence in Kidney Transplant Recipients Using Automated Reminders and Provider Notification
Not yet reported University of Pennsylvania 120 participants Est. completion 2015-09 1 site Stand-aloneOther conditions: Medication AdherenceView official trial listing → -
Terminated NCT NCT01543204
Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
Not yet reported Amgen 64 participants Est. completion 2015-05-29 47 sites Stand-aloneOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT01543373
Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS
Not yet reported CID - Carbostent & Implantable Devices 38 participants Est. completion 2014-04 6 sites Stand-aloneOther conditions: Stable Angina, Unstable Angina, NSTEMIView official trial listing → -
Completed NCT NCT01544491
Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients
Not yet reported Novartis Pharmaceuticals 106 participants Est. completion 2018-09-24 31 sites Stand-aloneOther conditions: Prevention of Acute Rejection in Paediatric Recipients of a Renal TransplantView official trial listing → -
Terminated NCT NCT01544842
Tacrolimus Ointment in Oral Lichen Planus
Not yet reported University of Oulu 28 participants Est. completion 2015-07 2 sitesOther conditions: Oral Lichen PlanusView official trial listing → -
Completed NCT NCT01548807
Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy
Not yet reported Abramson Cancer Center at Penn Medicine 19 participants Est. completion 2017-01-04 1 siteOther conditions: Prostate Cancer Patients With Detectable PSA Following ProstatectomyView official trial listing → -
Status unknown NCT NCT01550445
Steroid Withdrawal Immunosuppression After Renal Transplantation
Not yet reported Ajou University School of Medicine 30 participants Est. completion 2012-07 1 siteOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Completed NCT NCT01551212
Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients
Not yet reported Novartis Pharmaceuticals 339 participants Est. completion 2017-08-08 15 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT01554618
Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes
Not yet reported AstraZeneca 84 participants Est. completion 2021-05-05 35 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01556126
Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
Not yet reported CID - Carbostent & Implantable Devices 1191 participants Est. completion 2018-12 23 sites Stand-aloneCardiovascular disease Other conditions: Stable Angina, Unstable AnginaView official trial listing → -
Completed NCT NCT01557322
Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)
Pfizer 1754 participants Est. completion 2012-09Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01560572
Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen
Not yet reported University Medical Center Groningen 305 participants Est. completion 2016-04 3 sites Stand-aloneOther conditions: Renal Insufficiency, Kidney TransplantationView official trial listing → -
Terminated NCT NCT01561404
Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise
Not yet reported Josep M Cruzado 3 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: Disorder Related to Renal Transplantation, Exercise, Aerobic, Muscle StrengthView official trial listing → -
Terminated NCT NCT01564095
TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion
Not yet reported, Not yet reported Ludwig-Maximilians - University of Munich 25 participants Est. completion 2013-07 7 sites Stand-aloneOther conditions: Terminal Liver Disease, Ischemia Reperfusion Injury, Graft Dysfunction, Graft Failure, Poor Graft QualityView official trial listing → -
Completed NCT NCT01565616
Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease
Not yet reported Emory University 22 participants Est. completion 2016-06-30 8 sites Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Completed NCT NCT01566279
A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03)
Not yet reported UMC Utrecht 73 participants Est. completion 2016-11 3 sitesOther conditions: Unspecified Adult Solid Tumor, Protocol SpecificView official trial listing → -
Completed NCT NCT01567488
Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET
Not yet reported Grupo Espanol de Tumores Neuroendocrinos 43 participants Est. completion 2017-06-07 1 siteOther conditions: Gastrointestinal NeoplasmsView official trial listing → -
Status unknown NCT NCT01567930
Temsirolimus as Second-line Therapy in HCC
Not yet reported University of Tennessee Cancer Institute 25 participants Est. completion 2013-03 1 siteOther conditions: Unresectable or Metastatic Hepatocellular CarcinomaView official trial listing → -
Terminated NCT NCT01570348
Crohn's Allogeneic Transplant Study
Not yet reported Fred Hutchinson Cancer Center 2 participants Est. completion 2019-10-30 1 site Stand-aloneOther conditions: Crohn DiseaseView official trial listing → -
Completed NCT NCT01571817
Pancreatic Islet Transplantation Into the Gastric Submucosa
Not yet reported Andrew Posselt 1 participants Est. completion 2014-12 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT01572662
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
Not yet reported M.D. Anderson Cancer Center 201 participants Est. completion 2022-08-11 1 site Stand-aloneOther conditions: Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Myeloproliferative Diseases, Non-Hodgkins Lymphoma, Hodgkins Lymphoma, Multiple Myeloma, Myelodysplastic SyndromeView official trial listing → -
Withdrawn NCT NCT01573806
Pharmacology of Exenatide in Pediatric Sepsis
Not yet reported, Not yet reported Seattle Children's Hospital Est. completion 2014-10 1 siteOther conditions: Septic Shock, Inflammation, Glucose Homeostasis, Organ Dysfunction, Health-related Quality of LifeView official trial listing → -
Completed NCT NCT01575301
DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
Not yet reported University of Dundee 411 participants Est. completion 2015-12-11 4 sitesOther conditions: DiabetesView official trial listing → -
Completed NCT NCT01578850
Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening
Not yet reported Pfizer 491 participants Est. completion 2015-03 62 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01580514
Myocardial Protection of Exenatide in AMI
Not yet reported Kyunghee University Medical Center 127 participants Est. completion 2011-08 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT01580865
Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis
Not yet reported Ramathibodi Hospital 84 participants Est. completion 2017-03 1 site Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Terminated NCT NCT01582009
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
Not yet reported, Not yet reported Roswell Park Cancer Institute 26 participants Est. completion 2015-12 2 sitesOther conditions: Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell CancerView official trial listing → -
Completed NCT NCT01582191
Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer
Not yet reported M.D. Anderson Cancer Center 123 participants Est. completion 2025-10-22 1 siteOther conditions: Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm, Refractory Malignant NeoplasmView official trial listing → -
Withdrawn NCT NCT01586845
Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation
Not yet reported Aurinia Pharmaceuticals Inc. Est. completion 2015-12Other conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT01591070
Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis
Not yet reported Pusan National University Hospital 104 participants Est. completion 2011-05 1 site Stand-aloneOther conditions: Seborrheic DermatitisView official trial listing → -
Completed NCT NCT01594268
A Prospective, Open Label Study of CERtican in KIdney Transplantation
Not yet reported Novartis Pharmaceuticals 54 participants Est. completion 2013-10 4 sitesOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT01595841
Sirolimus Use in Angioplasty for Vascular Access Extension
Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 17 participants Est. completion 2022-03 1 site Stand-aloneOther conditions: End Stage Renal Disease, Venous StenosisView official trial listing → -
Completed NCT NCT01595984
Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)
Not yet reported Centre Hospitalier Universitaire, Amiens 88 participants Est. completion 2024-03-05 2 sitesOther conditions: Kidney FailureView official trial listing → -
Completed NCT NCT01596062
Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)
Not yet reported Novartis Pharmaceuticals 16 participants Est. completion 2013-03 3 sitesOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT01596140
Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer
Not yet reported M.D. Anderson Cancer Center 27 participants Est. completion 2020-06-01 1 siteOther conditions: Advanced Cancer, Solid TumorView official trial listing → -
Completed NCT NCT01597778
Double Cord Versus Haploidentical (BMT CTN 1101)
Not yet reported Medical College of Wisconsin 368 participants Est. completion 2020-09-11 39 sites Stand-aloneOther conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma, Follicular Lymphoma, Hodgkin Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin LymphomaView official trial listing → -
Completed NCT NCT01598987
Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.
Not yet reported Novartis Pharmaceuticals 56 participants Est. completion 2016-06 32 sites Stand-aloneOther conditions: Renal Function, Liver TransplantView official trial listing → -
Completed NCT NCT01601821
Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids
Not yet reported Pfizer 245 participants Est. completion 2008-03 4 sitesOther conditions: InflammationView official trial listing → -
Completed NCT NCT01602913
Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine
GlaxoSmithKline 1 participants Est. completion 2012-05Other conditions: Depression, PostpartumView official trial listing → -
Completed NCT NCT01604629
Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF
Not yet reported Spanish Clinical Pharmacology Society 120 participants Est. completion 2015-09 31 sites Stand-aloneOther conditions: SpondylarthropathiesView official trial listing → -
Status unknown NCT NCT01608412
A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus
Not yet reported Hospital de Clinicas de Porto Alegre 120 participants Est. completion 2014-07 1 siteOther conditions: Kidney Transplant RecipientsView official trial listing → -
Terminated NCT NCT01609673
Study of Everolimus in de Novo Renal Transplant Recipients
Not yet reported Helady Pinheiro, MD, PhD 1 participants Est. completion 2013-05 4 sitesOther conditions: End Stage Renal Failure With Renal TransplantView official trial listing → -
Completed NCT NCT01611116
Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia
Not yet reported Goethe University 33 participants Est. completion 2017-04-26 5 sitesOther conditions: Acute Myeloblastic LeukemiaView official trial listing → -
Withdrawn NCT NCT01612299
Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients
Not yet reported University of Kentucky Est. completion 2013-12 1 site Stand-aloneOther conditions: Renal TransplantView official trial listing → -
Status unknown NCT NCT01613963
Causes of Visual Loss in Retinal Disease
Royal Surrey County Hospital NHS Foundation Trust 2000 participants Est. completion 2012-12 2 sitesOther conditions: Uveitis, ScleritisView official trial listing → -
Completed NCT NCT01614197
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Not yet reported Therapeutic Advances in Childhood Leukemia Consortium 16 participants Est. completion 2020-09-04 32 sitesOther conditions: Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma, Peripheral T-cell LymphomaView official trial listing → -
Completed NCT NCT01614665
A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time
Not yet reported Astellas Pharma Europe Ltd. 44 participants Est. completion 2021-04-21 10 sites Stand-aloneOther conditions: Heart Transplantation, Kidney Transplantation, Liver TransplantationView official trial listing → -
Completed NCT NCT01614795
Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma
Not yet reported National Cancer Institute (NCI) 46 participants Est. completion 2014-04-01 76 sitesObstructive sleep apnea Other conditions: Childhood Alveolar Soft Part Sarcoma, Childhood Epithelioid Sarcoma, Childhood Malignant Peripheral Nerve Sheath Tumor, Childhood Synovial Sarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal TumorView official trial listing → -
Withdrawn NCT NCT01616186
Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC)
Not yet reported Andrea Harzstark Est. completion 2016-04Other conditions: Locally Metastatic Malignant NeoplasmView official trial listing → -
Status unknown NCT NCT01619761
NK Cells in Cord Blood Transplantation
Not yet reported M.D. Anderson Cancer Center 13 participants Est. completion 2021-11 1 site Stand-aloneOther conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, ISS Stage II Plasma Cell Myeloma, ISS Stage III Plasma Cell Myeloma, Myelodysplastic Syndrome, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Refractory Small Lymphocytic Lymphoma, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia, Therapy-Related Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT01620307
Rapamune Improves Outcomes of Severe H1N1 Pneumonia
Not yet reported Chang Gung Memorial Hospital 38 participants Est. completion 2011-12Other conditions: H1N1 Pneumonia, HypoxemiaView official trial listing → -
Terminated NCT NCT01621477
T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant
Not yet reported St. Jude Children's Research Hospital 34 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Chronic Myelocytic Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Hodgkin or Non-Hodgkin Lymphoma, Sarcoma, MyeloidView official trial listing → -
Completed NCT NCT01624766
Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers
Not yet reported M.D. Anderson Cancer Center 57 participants Est. completion 2021-02-24 1 siteOther conditions: Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm, Refractory Malignant NeoplasmView official trial listing → -
Completed NCT NCT01624948
Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients
Not yet reported University of California, San Francisco 40 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: BK Virus InfectionView official trial listing → -
Completed NCT NCT01625156
Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery
Not yet reported National Cancer Institute (NCI) 11 participants Est. completion 2015-10 2 sitesOther conditions: Adult Solid NeoplasmView official trial listing → -
Completed NCT NCT01625377
A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients
Not yet reported Novartis Pharmaceuticals 188 participants Est. completion 2015-03 14 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT01626170
Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma
Children's Oncology Group 20 participants 1 siteObstructive sleep apneaView official trial listing → -
Terminated NCT NCT01628913
Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors
Not yet reported Novartis Pharmaceuticals 62 participants Est. completion 2014-09 26 sitesOther conditions: Pancreatic Neuroendocrine Tumors (pNET)View official trial listing → -
Terminated NCT NCT01629511
Allogeneic Stem Cell Transplant for CLL
Not yet reported, Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2018-04-25 1 site Stand-aloneOther conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Richter SyndromeView official trial listing → -
Status unknown NCT NCT01631058
Renal Transplantation in the Elderly - nEverOld Study
Not yet reported University of Sao Paulo General Hospital 90 participants Est. completion 2019-06 2 sites Stand-aloneOther conditions: Chronic Renal Failure (CRF), Graft Failure, Transplant; Failure, Kidney, Renal Transplant RejectionView official trial listing → -
Completed NCT NCT01632605
The Vienna RAP Pilot Study
Not yet reported Medical University of Vienna 8 participants Est. completion 2012-04 1 site Stand-aloneOther conditions: ADPKDView official trial listing → -
Status unknown NCT NCT01635686
Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers
Not yet reported Daewoong Pharmaceutical Co. LTD. 38 participants Est. completion 2013-06 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01637012
Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease
Not yet reported Balton Sp.zo.o. 60 participants Est. completion 2013-09 5 sitesCardiovascular disease Other conditions: Stable Angina, Unstable AnginaView official trial listing → -
Terminated NCT NCT01637090
Everolimus in Treating Cutaneous T-cell Lymphoma
Not yet reported Adam Lerner 3 participants Est. completion 2015-05 1 siteOther conditions: Cutaneous T-Cell LymphomaView official trial listing → -
Completed NCT NCT01637194
Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer
Not yet reported Fox Chase Cancer Center 12 participants Est. completion 2011-07 1 siteOther conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Colon Cancer, Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Lymphoepithelioma of the Oropharynx, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Stage IV Adenoid Cystic Carcinoma of the Oral Cavity, Stage IV Basal Cell Carcinoma of the Lip, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Lymphoepithelioma of the Oropharynx, Stage IV Mucoepidermoid Carcinoma of the Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Stage IVA Colon Cancer, Stage IVA Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVA Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Colon Cancer, Stage IVB Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVB Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVC Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Tongue CancerView official trial listing → -
Completed NCT NCT01640743
Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation
Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 58 participants Est. completion 2014-04 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01642186
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
Not yet reported Memorial Sloan Kettering Cancer Center 28 participants Est. completion 2021-07-16 6 sitesOther conditions: Fibrolamellar Carcinoma, Fibrolamellar Liver CancerView official trial listing → -
Completed NCT NCT01646177
A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)
Not yet reported Eli Lilly and Company 1346 participants Est. completion 2019-07-22 101 sitesOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT01646385
Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry
Pfizer 6393 participants Est. completion 2012-08Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01647945
FK506 (Tacrolimus) in Pulmonary Arterial Hypertension
Not yet reported Edda Spiekerkoetter 23 participants Est. completion 2014-08 1 siteOther conditions: Pulmonary Arterial HypertensionView official trial listing → -
Terminated NCT NCT01648465
Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors
Not yet reported Hellenic Cooperative Oncology Group 25 participants Est. completion 2019-08-06 12 sitesOther conditions: Gastrointestinal Tumors, Pancreatic Tumors, Gastrointestinal Neuroendocrine Tumors, Pancreatic Neuroendocrine TumorsView official trial listing → -
Completed NCT NCT01649427
Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients
Not yet reported Novartis Pharmaceuticals 73 participants Est. completion 2015-08-20 5 sites Stand-aloneOther conditions: Pharmacokinetics Study in de Novo Kidney TransplantationView official trial listing → -
Completed NCT NCT01649609
Using mTOR Inhibitors in the Prevention of BK Nephropathy
Not yet reported Columbia University 40 participants Est. completion 2016-12 2 sitesOther conditions: BK Viremia, BK NephropathyView official trial listing → -
Completed NCT NCT01649960
Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial
Not yet reported Mayo Clinic 13 participants Est. completion 2015-12 1 siteOther conditions: Aging, CADView official trial listing → -
Completed NCT NCT01650545
Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients
Not yet reported, Not yet reported University of Maryland, Baltimore 21 participants Est. completion 2019-11 1 site Stand-aloneOther conditions: Disorder Related to Lung Transplantation, Bronchiolitis Obliterans, Decreased Immunologic Activity, Chronic Rejection of Lung TransplantView official trial listing → -
Completed NCT NCT01651390
Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.
Not yet reported Biotronik AG 231 participants Est. completion 2016-07 14 sitesCardiovascular disease Other conditions: Coronary RestenosisView official trial listing → -
Withdrawn NCT NCT01652014
Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies
Not yet reported University of Medicine and Dentistry of New Jersey Est. completion 2017-01 1 site Stand-aloneObstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blastic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Testicular Lymphoma, Waldenström MacroglobulinemiaView official trial listing → -
Completed NCT NCT01652716
Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
Not yet reported AstraZeneca 377 participants Est. completion 2014-08 58 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01652729
Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus
Not yet reported AstraZeneca 365 participants Est. completion 2014-04 60 sites Stand-aloneOther conditions: Diabetes Type 2View official trial listing → -
Completed NCT NCT01653041
Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors
Not yet reported Hospital do Rim e Hipertensão 47 participants Est. completion 2015-04 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT01653067
STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma
Not yet reported Mathias Witzens-Harig 88 participants Est. completion 2018-07 9 sitesOther conditions: Diffuse Large B-Cell LymphomaView official trial listing → -
Completed NCT NCT01653847
Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens
Not yet reported Northwestern University 88 participants Est. completion 2020-05 1 siteOther conditions: End Stage Renal Failure With Renal TransplantView official trial listing → -
Completed NCT NCT01653899
Caspase Inhibition in Islet Transplantation
Not yet reported, Not yet reported University of Alberta 12 participants Est. completion 2016-06 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT01655563
Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation
Not yet reported The Hospital for Sick Children 75 participants Est. completion 2016-02 1 site Stand-aloneOther conditions: Heart Transplantation, Liver Transplantation, Kidney TransplantationView official trial listing → -
Completed NCT NCT01656135
Reference Group Trial for The ONE Study
Not yet reported University of Regensburg 70 participants Est. completion 2015-12 8 sitesOther conditions: End-stage Renal Failure, Kidney Graft RejectionView official trial listing → -
Terminated NCT NCT01658007
Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma
Not yet reported Children's Hospital Medical Center, Cincinnati 3 participants Est. completion 2017-01 1 site Stand-aloneOther conditions: Relapsed Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Lymphoblastic LymphomaView official trial listing → -
Withdrawn NCT NCT01658176
Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer
Not yet reported Pfizer Est. completion 2015-04Other conditions: Breast NeoplasmsView official trial listing → -
Active, not recruiting NCT NCT01659606
Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
Not yet reported Boston Children's Hospital 40 participants Est. completion 2034-12 13 sites Stand-aloneOther conditions: Dyskeratosis Congenita, Hoyeraal Hreidarsson Syndrome, Revesz Syndrome, Aplastic AnemiaView official trial listing → -
Completed NCT NCT01661283
SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors
Not yet reported Sarcoma Alliance for Research through Collaboration 25 participants Est. completion 2017-12 12 sitesOther conditions: Malignant Peripheral Nerve Sheath Tumors, MPNST, SarcomaView official trial listing → -
Terminated NCT NCT01663766
Phase I Study of Milatuzumab for Graft Versus Host Disease
Not yet reported Gilead Sciences 12 participants Est. completion 2015-03 1 site Stand-aloneOther conditions: GVHD (Acute or Chronic), Acute Myeloid or Lymphoblastic Leukemia (AML or ALL), Myelodysplastic Syndrome, Chronic Myelogenous Leukemia (CML), Multiple Myeloma (MM), Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell), Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (CLL or SLL)View official trial listing → -
Completed NCT NCT01664624
Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes
Not yet reported AstraZeneca 40 participants Est. completion 2012-11 2 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01664910
CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies
Not yet reported, Not yet reported M.D. Anderson Cancer Center 27 participants Est. completion 2023-06-28 1 site Stand-aloneOther conditions: Hematopoietic and Lymphoid Cell NeoplasmView official trial listing → -
Completed NCT NCT01665677
Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
Not yet reported Mehdi Hamadani 69 participants Est. completion 2021-07-09 2 sitesOther conditions: Graft vs Host DiseaseView official trial listing → -
Completed NCT NCT01666951
Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant
Not yet reported Veloxis Pharmaceuticals 36 participants Est. completion 2013-05 13 sites Stand-aloneOther conditions: Renal FailureView official trial listing → -
Completed NCT NCT01668485
Mechanisms of Glucose Counterregulation in Pancreatic Islet Transplantation
Not yet reported University of Giessen 36 participants Est. completion 2011-11 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT01668784
Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)
Not yet reported Bristol-Myers Squibb 821 participants Est. completion 2021-07-19 168 sitesOther conditions: Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT01670175
Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors
Not yet reported University of California, San Francisco 21 participants Est. completion 2016-09 1 site Stand-aloneOther conditions: Malignant Solid Tumor, Childhood Solid TumorView official trial listing → -
Completed NCT NCT01672151
Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia
First Affiliated Hospital of Suzhou Medical College 35 participants Est. completion 2012-08 1 siteOther conditions: Immune Thrombocytopenic PurpuraView official trial listing → -
Active, not recruiting NCT NCT01674140
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer
Not yet reported SWOG Cancer Research Network 1939 participants Est. completion 2030-01 1458 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01674803
Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)
Not yet reported Foundation of Cardiovascular Research and Education Enschede 3514 participants Est. completion 2020-08-25 1 siteCardiovascular disease Other conditions: Acute Coronary Syndrome, Angina Pectoris, Angina, Unstable, Coronary Stenosis, Coronary RestenosisView official trial listing → -
Completed NCT NCT01678664
Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors
Not yet reported Federation Francophone de Cancerologie Digestive 74 participants Est. completion 2019-04 18 sitesOther conditions: Neuroendocrine Tumors, Hepatic Metastases, MetastasesView official trial listing → -
Completed NCT NCT01678937
Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents
Northwestern University 31 participants Est. completion 2008-09 1 siteOther conditions: Liver Transplant Rejection, ImmunosuppressionView official trial listing → -
Status unknown NCT NCT01680250
Sirolimus for Massive Polycystic Liver
Not yet reported, Not yet reported Seoul National University Hospital 44 participants Est. completion 2015-08 1 site Stand-aloneOther conditions: Polycystic Kidney DiseasesView official trial listing → -
Completed NCT NCT01680861
Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium
Not yet reported Gaetano Ciancio 32 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: Transplant; Failure, KidneyView official trial listing → -
Completed NCT NCT01680952
Study to Evaluate the Safety and Efficacy of Extended Release Tacrolimus (Advagraf®) + Sirolimus (Rapamune®), Versus Extended Release Tacrolimus (Advagraf®) + Mycophenolate Mofetil in Kidney Transplant Patients
Not yet reported Yonsei University 158 participants Est. completion 2016-01 7 sites Stand-aloneOther conditions: Kidney Transplant PatientsView official trial listing → -
Completed NCT NCT01681134
A Comparison of the Effects of Extended Release Tacrolimus (Advagraf®) vs. Immediate Release Tacrolimus (Prograf®) on Kidney Function in Healthy Male Volunteers
Not yet reported Astellas Pharma Canada, Inc. 19 participants Est. completion 2012-10 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Status unknown NCT NCT01681381
Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization
Not yet reported Essen Technology (Beijing) Co., Ltd. 2790 participants Est. completion 2018-09 1 siteOther conditions: Ischemic Heart Disease, Myocardial Ischemia, Coronary Artery Lesions,Primary, Coronary Disease, Acute Coronary Syndrome, Furcation Lesion of Coronary ArteryView official trial listing → -
Completed NCT NCT01684449
Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma
Not yet reported, Not yet reported Grupo Espanol de Investigacion en Sarcomas 28 participants Est. completion 2013-12 9 sitesOther conditions: Advanced Soft Tissue SarcomaView official trial listing → -
Completed NCT NCT01684982
Everolimus Stent in Myocardial Infarction
Not yet reported San Giuseppe Moscati Hospital 500 participants Est. completion 2012-06 1 siteCardiovascular diseaseView official trial listing → -
Terminated NCT NCT01685411
Busulfan and Cyclophosphamide Followed By ALLO BMT
Not yet reported Masonic Cancer Center, University of Minnesota 5 participants Est. completion 2020-02-10 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic SyndromeView official trial listing → -
Status unknown NCT NCT01686191
Genetic Predictors of Renal Dysfunction Following Heart Transplantation
University of Colorado, Denver 300 participants Est. completion 2025-12 1 siteOther conditions: Heart Transplantation, Chronic Renal InsufficiencyView official trial listing → -
Completed NCT NCT01687075
CRE8 in All Comers Patients
Not yet reported Tel-Aviv Sourasky Medical Center 215 participants Est. completion 2014-08 1 site Stand-aloneOther conditions: Consecutive Subjects Who Are Suitable for a Coronary, Angioplasty of de Novo Lesion(s) in Native Coronary, Arteries Should be Screened for Eligibility., A Total Number of 200 Patients Fulfilling the Selection, Criteria and Willing to Sign the Informed Consent Should, be Enrolled in the Trial.View official trial listing → -
Completed NCT NCT01687179
Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis
Not yet reported Brigham and Women's Hospital 14 participants Est. completion 2015-08 1 site Stand-aloneOther conditions: LymphangioleiomyomatosisView official trial listing → -
Completed NCT NCT01687673
Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Not yet reported University of California, San Francisco 29 participants Est. completion 2020-01-09 2 sitesOther conditions: Hepatocellular CarcinomaView official trial listing → -
Completed NCT NCT01690299
Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
Not yet reported Amgen 250 participants Est. completion 2016-04-04 82 sites Stand-aloneOther conditions: Psoriasis, Psoriatic ArthritisView official trial listing → -
Terminated NCT NCT01691014
Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents
Pfizer 79 participants Est. completion 2015-01 13 sitesOther conditions: Rheumatoid Arthritis (RA)View official trial listing → -
Completed NCT NCT01692899
Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice
Pfizer 780 participants Est. completion 2011-09Other conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01698541
Generic Tacrolimus in the Elderly - Prograf® vs Tacni®
Not yet reported University of Oslo School of Pharmacy 28 participants Est. completion 2013-11 1 site Stand-aloneOther conditions: End Stage Renal DiseaseView official trial listing → -
Status unknown NCT NCT01699360
The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients
Not yet reported Central South University 600 participants Est. completion 2013-12 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01701986
Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma
Not yet reported, Not yet reported M.D. Anderson Cancer Center 64 participants Est. completion 2024-06-05 1 site Stand-aloneOther conditions: Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin LymphomaView official trial listing → -
Status unknown NCT NCT01702051
Extending Indication for Islet Autotransplantation in Pancreatic Surgery
Ospedale San Raffaele 150 participants Est. completion 2025-10 1 siteOther conditions: DiabetesView official trial listing → -
Completed NCT NCT01702181
A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis
Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 92 participants Est. completion 2013-12 12 sitesOther conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT01702207
Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular Risk
Not yet reported University of Saskatchewan 36 participants Est. completion 2017-12 1 siteCardiovascular disease Other conditions: Immunosuppression, Kidney TransplantationView official trial listing → -
Completed NCT NCT01707004
Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2017-10-07 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT01707849
The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation
Not yet reported Hospital Vall d'Hebron 18 participants Est. completion 2016-08 1 site Stand-aloneOther conditions: Hepatitis C Recurrence After Liver TransplantView official trial listing → -
Terminated NCT NCT01709136
Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity
Not yet reported, Not yet reported University of Pittsburgh 3 participants Est. completion 2010-01 Stand-aloneOther conditions: HypertensionView official trial listing → -
Completed NCT NCT01712828
Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males
Not yet reported Celgene 31 participants Est. completion 2013-01-01 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01713400
Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 54 participants Est. completion 2018-06-14 1 site Stand-aloneOther conditions: Graft vs. Host DiseaseView official trial listing → -
Completed NCT NCT01714440
Genomics of Kidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 1552 participants Est. completion 2017-01 5 sitesOther conditions: KidneyTransplant Recipients, Simultaneous Kidney/Pancreas Recipients, Kidney Transplant DonorView official trial listing → -
Completed NCT NCT01722682
Bone Marrow vs Liver as Site for Islet Transplantation
Not yet reported, Not yet reported Ospedale San Raffaele 9 participants Est. completion 2017-12 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT01724060
Effects of Obesity Treatments on Food Preferences and Metabolism
Imperial College London 80 participants Est. completion 2017-10 2 sitesType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT01725620
Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®
Not yet reported LG Life Sciences 48 participants Est. completion 2014-04 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT01729494
Belatacept Early Steroid Withdrawal Trial
Not yet reported University of Cincinnati 316 participants Est. completion 2019-12 8 sitesOther conditions: Renal TransplantationView official trial listing → -
Status unknown NCT NCT01730209
Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex
Not yet reported, Not yet reported Erasmus Medical Center 60 participants Est. completion 2016-11 1 siteOther conditions: Tuberous Sclerosis Complex, TSC Related Cognitive Disability, TSC Related Autism, TSC Related Learning ProblemsView official trial listing → -
Completed NCT NCT01731158
Sequential Therapy in Metastatic Renal Cell Carinoma
Not yet reported Central European Society for Anticancer Drug Research 22 participants Est. completion 2016-09 13 sitesOther conditions: Metastatic Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT01734512
PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
Not yet reported University of California, San Francisco 65 participants Est. completion 2024-07-31 18 sitesOther conditions: Pediatric Recurrent Progressive Low-grade Gliomas, Pediatric Progressive Low-grade GliomasView official trial listing → -
Completed NCT NCT01742624
Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation
Not yet reported Astellas Pharma Korea, Inc. 60 participants Est. completion 2012-06 3 sitesOther conditions: de Novo Kidney TransplantationView official trial listing → -
Completed NCT NCT01742676
A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients
Not yet reported Astellas Pharma Korea, Inc. 100 participants Est. completion 2013-04 1 siteOther conditions: Renal Transplantation, Kidney Transplantation, Stable Renal RecipientsView official trial listing → -
Completed NCT NCT01743131
Abatacept as GVHD Prophylaxis Phase 2
Not yet reported Boston Children's Hospital 186 participants Est. completion 2024-03-30 14 sites Stand-aloneOther conditions: Graft vs Host Disease, MalignancyView official trial listing → -
Completed NCT NCT01744067
The Effects of Omega-3 Fatty Acids in Renal Transplantation
Not yet reported Oslo University Hospital 132 participants Est. completion 2015-12 2 sitesOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Status unknown NCT NCT01744470
Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)
Not yet reported University Hospital, Tours 286 participants Est. completion 2015-03 16 sites Stand-aloneOther conditions: De Novo Transplant DiseaseView official trial listing → -
Completed NCT NCT01745159
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
Not yet reported Astellas Pharma China, Inc. 125 participants Est. completion 2013-11 4 sites Stand-aloneOther conditions: Moderate/Severe Atopic DermatitisView official trial listing → -
Completed NCT NCT01746680
Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis
Not yet reported Chong Kun Dang Pharmaceutical 111 participants Est. completion 2015-06 1 site Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT01749111
Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis
Not yet reported Hospital Israelita Albert Einstein 3 participants Est. completion 2016-08 1 siteOther conditions: Acute Myelogenous Leukemia, Acute Lymphoid Leukemia, Myeloproliferative Disease, Myelodysplastic Syndrome, Chronic Myeloid Leukemia, Chronic Myelomonocytic LeukemiaView official trial listing → -
Terminated NCT NCT01749293
Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation
Not yet reported University of Illinois Chicago 3 participants Est. completion 2014-05-15 1 site Stand-aloneOther conditions: Hematologic MalignanciesView official trial listing → -
Completed NCT NCT01751997
Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors
Not yet reported, Not yet reported Byung-Sik Cho 116 participants Est. completion 2019-12-31 1 site Stand-aloneOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT01754389
Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant
Not yet reported Dana-Farber Cancer Institute 138 participants Est. completion 2016-11 4 sites Stand-aloneOther conditions: Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT01756118
A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia
Not yet reported Goethe University 24 participants Est. completion 2020-02-07 1 siteOther conditions: Acute Lymphoblastic Leukemia, Leukemia, Myelocytic, Acute, Chronic Myelogenous Leukemia With Crisis of Blast CellsView official trial listing → -
Status unknown NCT NCT01758107
Study of Cyclosporine Withdrawal Regimen in Thai Renal Transplant Recipients
Not yet reported Chulalongkorn University 30 participants Est. completion 2015-10 1 site Stand-aloneOther conditions: Renal TransplantView official trial listing → -
Terminated NCT NCT01758575
Clinical Evaluation of the Underlying Mechanisms of Targeted Therapy Related Toxicities
Amsterdam UMC, location VUmc 8 participants Est. completion 2017-04 1 siteOther conditions: Advanced or Metastatic Solid MalignancyView official trial listing → -
Terminated NCT NCT01760356
Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients
UDA Centro Nacional Hepato-Bilio-Pancreático 141 participants Est. completion 2021-05-17 1 siteOther conditions: End Stage Liver Disease, Rejection, Infection, Malignancy, Toxicity, DiabetesView official trial listing → -
Completed NCT NCT01760655
Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 62 participants Est. completion 2022-12-05 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM, Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214, Aplastic Anemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Follicular Lymphoma, Hodgkin Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Myeloid Leukemia, Non-Hodgkin Lymphoma, Plasma Cell Myeloma, Polycythemia Vera, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid LeukemiaView official trial listing → -
Suspended NCT NCT01762410
Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors
Not yet reported Piramal Enterprises Limited 60 participants Est. completion 2016-03 4 sitesOther conditions: Advanced Refractory Solid TumorsView official trial listing → -
Completed NCT NCT01763580
A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome
Not yet reported Astellas Pharma Korea, Inc. 144 participants Est. completion 2017-08-21 1 site Stand-aloneOther conditions: MCNS, Minimal Change Nephrotic Syndrome (MCNS)View official trial listing → -
Completed NCT NCT01764321
Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors
UCB Pharma SA 1723 participants Est. completion 2020-06-16 122 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01764581
Randomized Controlled Trial of ImmuKnow in Liver Transplantation
Not yet reported University of Bologna 206 participants Est. completion 2012-03 Stand-aloneOther conditions: Liver DiseaseView official trial listing → -
Terminated NCT NCT01764997
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
Not yet reported Sanofi 776 participants Est. completion 2015-01 257 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT01766518
The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)
Not yet reported Chong Kun Dang Pharmaceutical 120 participants Est. completion 2014-05 3 sites Stand-aloneOther conditions: Evidence of Liver TransplantationView official trial listing → -
Completed NCT NCT01768845
Unrelated Umbilical Cord Blood (UBC)Transplantation
Not yet reported West Virginia University 34 participants Est. completion 2021-04-06 1 site Stand-aloneOther conditions: Chronic Myelogenous Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Severe Aplastic AnemiaView official trial listing → -
Completed NCT NCT01771705
NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients
Not yet reported University of California, San Francisco 40 participants Est. completion 2017-04-17 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT01773395
GVAX vs. Placebo for MDS/AML After Allo HSCT
Not yet reported Dana-Farber Cancer Institute 123 participants Est. completion 2021-11-24 4 sitesOther conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic LeukemiaView official trial listing → -
Terminated NCT NCT01773460
Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane
Not yet reported GBG Forschungs GmbH 3 participants Est. completion 2014-07 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01776788
Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients
Not yet reported The First Affiliated Hospital of Xiamen University 156 participants Est. completion 2015-02 1 site Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT01777204
Gastrointestinal Transit and Motility in Renal Transplant Recipients
Universidade Estadual de Ciências da Saúde de Alagoas 20 participants Est. completion 2013-01 1 siteOther conditions: Change of Transit or Circulation, Effects of Immunosuppressant TherapyView official trial listing → -
Completed NCT NCT01780844
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Not yet reported Astellas Pharma Global Development, Inc. 149 participants Est. completion 2017-01-27 42 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01780948
Pharmacokinetic of Everolimus and Atorvastatin Co-administration
Not yet reported Chulalongkorn University 18 participants Est. completion 2013-01 1 siteOther conditions: Difference of 12-hour AUCView official trial listing → -
Withdrawn NCT NCT01781442
A Post Marketing Surveillance As Required By Philippine Food And Drug Administration
Pfizer Est. completion 2015-06Other conditions: Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT01782729
An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis
Not yet reported Janssen-Cilag Ltd.,Thailand 30 participants Est. completion 2008-11 1 site Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Terminated NCT NCT01783015
Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
Not yet reported Pfizer 16 participants Est. completion 2014-08 15 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT01783717
Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage
Not yet reported Huashan Hospital 10 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: Hypothalamic Obesity, Diabetes MellitusView official trial listing → -
Terminated NCT NCT01784861
VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors
Not yet reported, Not yet reported Washington University School of Medicine 23 participants Est. completion 2020-08-19 2 sitesOther conditions: Adenocarcinoma, Pancreatic NeoplasmsView official trial listing → -
Completed NCT NCT01785810
Phase II Maraviroc for GVHD Prevention
Not yet reported Abramson Cancer Center at Penn Medicine 37 participants Est. completion 2018-07-12 1 site Stand-aloneOther conditions: Hematologic MalignancyView official trial listing → -
Completed NCT NCT01788150
Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System
Not yet reported Svelte Medical Systems, Inc. 159 participants Est. completion 2019-05-31 18 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT01788501
Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease
Not yet reported, Not yet reported Seoul National University Hospital 50 participants Est. completion 2017-03-01 3 sites Stand-aloneOther conditions: Graft vs Host DiseaseView official trial listing → -
Completed NCT NCT01789255
Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies
Not yet reported National Cancer Institute (NCI) 12 participants Est. completion 2014-03 1 site Stand-aloneObstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Graft Versus Host Disease, Intraocular Lymphoma, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Ringed Sideroblasts, Refractory Chronic Lymphocytic Leukemia, Refractory Cytopenia With Multilineage Dysplasia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Central Nervous System Hodgkin Lymphoma, Secondary Central Nervous System Non-Hodgkin Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Testicular Lymphoma, Waldenström MacroglobulinemiaView official trial listing → -
Completed NCT NCT01789619
Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients
UMC Utrecht 9 participants Est. completion 2014-01 1 siteOther conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT01790568
Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant
Not yet reported University of Michigan Rogel Cancer Center 26 participants Est. completion 2017-10-31 1 site Stand-aloneOther conditions: Graft vs Host Disease, Hematologic Neoplasms, Non-Neoplastic Hematologic and Lymphocytic DisorderView official trial listing → -
Terminated NCT NCT01790594
Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 46 participants Est. completion 2016-08 5 sites Stand-aloneOther conditions: Simultaneous Kidney and Pancreas TransplantationView official trial listing → -
Completed NCT NCT01791088
Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery
Not yet reported University of Chicago 56 participants Est. completion 2018-08-17 1 site Stand-aloneOther conditions: Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol SpecificView official trial listing → -
Status unknown NCT NCT01793519
Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis
Not yet reported Georgetown University 290 participants Est. completion 2024-08-30 2 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT01793636
A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer
Not yet reported Queen Mary University of London 49 participants Est. completion 2015-11 9 sitesOther conditions: Metastatic Clear Cell Renal CarcinomaView official trial listing → -
Terminated NCT NCT01797315
Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol
Not yet reported University Hospital of Berlin 40 participants Est. completion 2013-06Other conditions: Renal Transplant Patients at High-risk for Skin CancerView official trial listing → -
Completed NCT NCT01797341
Prograf-Advagraf Cross Over Conversion Study
Not yet reported University Health Network, Toronto 13 participants Est. completion 2014-02 1 site Stand-aloneOther conditions: Kidney-Pancreas TransplantationView official trial listing → -
Completed NCT NCT01797523
A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma
Not yet reported M.D. Anderson Cancer Center 62 participants Est. completion 2026-02-04 6 sitesOther conditions: Endometrial CancerView official trial listing → -
Completed NCT NCT01798264
Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
Not yet reported Intarcia Therapeutics 44 participants Est. completion 2009-05 3 sites Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT01798446
A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus
Not yet reported Seoul National University Hospital 41 participants Est. completion 2016-12 1 siteOther conditions: Renal Cell Carcinoma, Nonclear Cell, Temsirolimus ResistanceView official trial listing → -
Status unknown NCT NCT01799460
Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy
Shanghai University of Traditional Chinese Medicine 80 participants Est. completion 2013-08 1 siteOther conditions: Idiopathic Membranous NephropathyView official trial listing → -
Completed NCT NCT01801137
The Efficacy of RAD 001 as Second Line Therapy in Patients With Transitional Cell Carcinoma TCC of the Urothelium
Not yet reported Hopital Foch 54 participants Est. completion 2014-10 1 siteOther conditions: Urothelial CancerView official trial listing → -
Completed NCT NCT01802268
Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients
Not yet reported Helio Tedesco Silva Junior 320 participants Est. completion 2012-10 6 sitesOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT01804374
Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma
Not yet reported Italian Sarcoma Group 38 participants Est. completion 2014-12 1 siteObstructive sleep apneaView official trial listing → -
Withdrawn NCT NCT01807767
Myfortic in High MELD Liver Transplantation
Not yet reported Medical College of Wisconsin Est. completion 2015-08 1 site Stand-aloneOther conditions: High Model for End-Stage Liver Disease (MELD) ScoreView official trial listing → -
Completed NCT NCT01809860
A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects
Not yet reported Astellas Pharma Global Development, Inc. 22 participants Est. completion 2012-01 1 site Stand-aloneOther conditions: Healthy Subjects, Pharmacokinetics of Isavuconazole, Pharmacokinetics of SirolimusView official trial listing → -
Completed NCT NCT01810588
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation
Not yet reported Weill Medical College of Cornell University 270 participants Est. completion 2026-03-24 2 sites Stand-aloneOther conditions: Hematologic MalignanciesView official trial listing → -
Completed NCT NCT01812954
Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis
Jochen Schmitt. 1 participants Est. completion 2014-06Other conditions: PsoriasisView official trial listing → -
Completed NCT NCT01817959
Study to Assess Efficacy & Safety of Reparixin in Pancreatic Islet Transplantation
Not yet reported Dompé Farmaceutici S.p.A 51 participants Est. completion 2017-12 9 sitesOther conditions: Islet Transplantation in Diabetes Mellitus Type 1View official trial listing → -
Withdrawn NCT NCT01818648
Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome
Not yet reported Mayo Clinic Est. completion 2014-01 Stand-aloneOther conditions: Short Bowel SyndromeView official trial listing → -
Completed NCT NCT01820572
A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based
Not yet reported Bristol-Myers Squibb 446 participants Est. completion 2019-10-24 117 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT01824368
Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.
Not yet reported, Not yet reported Red de Terapia Celular 10 participants Est. completion 2016-04 1 site Stand-aloneOther conditions: Liver Transplantation, ImmunosuppressionView official trial listing → -
Completed NCT NCT01824693
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia
Not yet reported Children's Oncology Group 30 participants Est. completion 2017-12-31 50 sites Stand-aloneOther conditions: Juvenile Myelomonocytic LeukemiaView official trial listing → -
Completed NCT NCT01827267
Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer
Not yet reported Puma Biotechnology, Inc. 62 participants Est. completion 2017-10-06 21 sitesOther conditions: HER2-mutant Non-Small Cell Lung CancerView official trial listing → -
Completed NCT NCT01827618
Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy
Not yet reported The University of Texas Health Science Center at San Antonio 29 participants Est. completion 2014-04 1 siteOther conditions: Invasive Bladder Cancer Stage IIView official trial listing → -
Completed NCT NCT01828879
An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis
Not yet reported Janssen-Cilag Ltd.,Thailand 74 participants Est. completion 2009-12 2 sites Stand-aloneOther conditions: Dermatitis, AtopicView official trial listing → -
Completed NCT NCT01830010
A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies
Not yet reported Novartis Pharmaceuticals 23 participants Est. completion 2018-08-21 8 sites Stand-aloneOther conditions: Hematological MalignanciesView official trial listing → -
Status unknown NCT NCT01837043
Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function
Not yet reported Nair, Vinay, D.O. 90 participants Est. completion 2017-06 1 siteOther conditions: Delayed Graft Function, Kidney TransplantView official trial listing → -
Completed NCT NCT01839929
A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF
Not yet reported Astellas Pharma Korea, Inc. 138 participants Est. completion 2013-02 4 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT01841008
Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control
Not yet reported, Not yet reported Centre Hospitalier Universitaire de Nice 35 participants Est. completion 2014-06 2 sites Stand-aloneOther conditions: Pigmentation Disorders, VitiligoView official trial listing → -
Completed NCT NCT01842139
Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission
Not yet reported University of Chicago 7 participants Est. completion 2018-03 1 site Stand-aloneOther conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)View official trial listing → -
Completed NCT NCT01842269
Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients
Not yet reported Chong Kun Dang Pharmaceutical 156 participants Est. completion 2015-04 11 sitesOther conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT01842594
A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma
Not yet reported Shin Kong Wu Ho-Su Memorial Hospital 13 participants Est. completion 2015-01 1 site Stand-aloneOther conditions: SarcomaView official trial listing → -
Completed NCT NCT01843127
A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.
Not yet reported Gilead Sciences 24 participants Est. completion 2013-09 3 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT01843348
12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients
Not yet reported Novartis Pharmaceuticals 612 participants Est. completion 2016-03-23 27 sites Stand-aloneOther conditions: Kidney Transplantation, Renal TransplantationView official trial listing → -
Withdrawn NCT NCT01843998
Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)
Not yet reported Stefan Schieke MD Est. completion 2015-12 1 site Stand-aloneOther conditions: Cutaneous T-cell Lymphoma (CTCL)View official trial listing → -
Completed NCT NCT01850979
Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops
Not yet reported University of Sao Paulo General Hospital 24 participants Est. completion 2011-11 1 siteOther conditions: Sjogren Syndrome, Dry Eye SyndromeView official trial listing → -
Completed NCT NCT01853423
Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream
Not yet reported Le Bonheur Children's Hospital 11 participants Est. completion 2016-07 1 siteOther conditions: Facial AngiofibromaView official trial listing → -
Completed NCT NCT01854606
Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma
Not yet reported Novartis Pharmaceuticals 31 participants Est. completion 2016-06-01 15 sitesOther conditions: CD79 Mutant or ABC-subtype Diffuse Large B-Cell LymphomaView official trial listing → -
Completed NCT NCT01855490
Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes
Not yet reported Yale University 17 participants Est. completion 2013-10 1 site Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Terminated NCT NCT01856257
Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 71 participants Est. completion 2016-04 3 sites Stand-aloneOther conditions: Primary Renal Allograft Candidate, Kidney TransplantationView official trial listing → -
Completed NCT NCT01857193
Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer
Not yet reported Novartis Pharmaceuticals 132 participants Est. completion 2020-04-16 13 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT01857895
Feasibility Study of Exenatide by Continuous Subcutaneous Infusion
Not yet reported GlaxoSmithKline 10 participants Est. completion 2013-11-01 1 site Stand-aloneOther conditions: ObesityView official trial listing → -
Completed NCT NCT01858740
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children
Not yet reported Fred Hutchinson Cancer Center 20 participants Est. completion 2023-07-30 1 site Stand-aloneOther conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome With Excess Blasts-2, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Refractory Adult Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic LeukemiaView official trial listing → -
Completed NCT NCT01860183
Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis
Not yet reported Clinical Hospital Merkur 76 participants Est. completion 2016-06-01 1 siteOther conditions: Kidney Transplantation, Kidney FailureView official trial listing → -
Completed NCT NCT01860963
Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls
Not yet reported Stanford University 310 participants Est. completion 2013-06 1 siteOther conditions: Anal Squamous Intraepithelial Lesion (ASIL), HPV DNAView official trial listing → -
Withdrawn NCT NCT01864070
Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease
Not yet reported M.D. Anderson Cancer CenterOther conditions: Liver CancerView official trial listing → -
Completed NCT NCT01865747
A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma
Not yet reported Exelixis 658 participants Est. completion 2021-01-15 205 sitesOther conditions: Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT01870908
Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients
Astellas Pharma Inc 664 participants Est. completion 2015-03 7 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT01871441
Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4 participants Est. completion 2016-10-20 1 site Stand-aloneOther conditions: Malignant NeoplasmView official trial listing → -
Status unknown NCT NCT01874002
Prospective Registry to Asses the Long-term Safety and Performance of the Combo Stent
Robbert J de Winter 1000 participants Est. completion 2019-03 9 sitesCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT01875224
Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression
Not yet reported University of Arizona 32 participants Est. completion 2016-08 1 siteOther conditions: New Onset Diabetes After Transplant, Kidney TransplantationView official trial listing → -
Terminated NCT NCT01875237
Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene
Not yet reported, Not yet reported M.D. Anderson Cancer Center 3 participants Est. completion 2017-03-07 1 site Stand-aloneOther conditions: Leukemia, Myeloma, Myeloproliferative DiseasesView official trial listing → -
Completed NCT NCT01875991
Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept
Not yet reported Amgen 217 participants Est. completion 2014-03-04 37 sites Stand-aloneOther conditions: Rheumatoid Arthritis, Plaque PsoriasisView official trial listing → -
Terminated NCT NCT01878786
A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys
Not yet reported, Not yet reported Matthew Cooper 25 participants Est. completion 2017-12 1 site Stand-aloneOther conditions: Delayed Graft FunctionView official trial listing → -
Status unknown NCT NCT01879358
Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent
Not yet reported Odense University Hospital 2314 participants Est. completion 2021-02-01 1 siteCardiovascular disease Other conditions: Ischemic Heart DiseaseView official trial listing → -
Completed NCT NCT01882322
A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects
Not yet reported Astellas Pharma Korea, Inc. 36 participants Est. completion 2017-01-03 1 site Stand-aloneOther conditions: de Novo Liver Transplant SubjectsView official trial listing → -
Completed NCT NCT01884480
Renal Function and Pharmacogenetics in Renal Transplant Recipients Converted From Tac BID to Tac OD
Unity Health Toronto 60 participants Est. completion 2014-09 1 siteOther conditions: Real Function Post Conversion From Prograf to Advagraf, Examin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversionView official trial listing → -
Completed NCT NCT01884571
Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)
Not yet reported Emory University 31 participants Est. completion 2016-01 3 sites Stand-aloneOther conditions: Amyotrophic Lateral Sclerosis (ALS)View official trial listing → -
Active, not recruiting NCT NCT01885689
Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia
Not yet reported City of Hope Medical Center 72 participants Est. completion 2026-09-21 1 site Stand-aloneOther conditions: Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Myelodysplastic Syndrome, Secondary Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Therapy-Related Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT01887171
Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus
Not yet reported Republican Scientific and Practical Center for Organ and Tissue Transplantation 86 participants Est. completion 2014-07 1 site Stand-aloneOther conditions: Early Allograft Dysfunction, Ischemic Reperfusion Injury, Liver Transplantation, HyperfibrinolysisView official trial listing → -
Completed NCT NCT01888432
Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants
Not yet reported Novartis Pharmaceuticals 285 participants Est. completion 2018-04-21 42 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT01889758
Pharmacokinetic Studies of Tacrolimus in Transplant Patients
Not yet reported University of Cincinnati 78 participants Est. completion 2016-01 2 sitesOther conditions: Kidney Transplant Recipients, Liver Transplant RecipientsView official trial listing → -
Completed NCT NCT01891864
Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel
Not yet reported Sandoz 531 participants Est. completion 2015-03 74 sites Stand-aloneOther conditions: Chronic Stable Plaque PsoriasisView official trial listing → -
Completed NCT NCT01895049
Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria
Not yet reported Helio Tedesco Silva Junior 171 participants Est. completion 2017-03-07 1 site Stand-aloneOther conditions: Kidney Transplantation, CytomegalovirusView official trial listing → -
Completed NCT NCT01901185
Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept
Not yet reported Amgen 77 participants Est. completion 2013-12-30 13 sites Stand-aloneOther conditions: Rheumatoid Arthritis, Psoriatic ArthritisView official trial listing → -
Withdrawn NCT NCT01903317
Evaluation of Vitamin D Levels in Psoriasis Patients
University of California, Irvine Est. completion 2015-07 1 siteOther conditions: PsoriasisView official trial listing → -
Terminated NCT NCT01903473
Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
Not yet reported University of Liege 19 participants Est. completion 2022-09-12 2 sitesOther conditions: Chronic Graft-Versus-Host Disease, Acute Graft-Versus-Host Disease, Steroid Refractory Graft-Versus-Host DiseaseView official trial listing → -
Completed NCT NCT01904045
PEL-1235_REN-0176-I (Pelicon)
Technical University of Munich 51 participants Est. completion 2018-08 1 siteOther conditions: Immunosuppression After Kidney TransplantationView official trial listing → -
Completed NCT NCT01904136
Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia
Not yet reported, Not yet reported M.D. Anderson Cancer Center 54 participants Est. completion 2022-02-28 1 site Stand-aloneOther conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Gene Mutations, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Therapy-Related Acute Myeloid LeukemiaView official trial listing → -
Active, not recruiting NCT NCT01909245
Islet Cell Transplant for Type 1 Diabetes
Not yet reported City of Hope Medical Center 10 participants Est. completion 2027-08-31 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT01910077
Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg
Not yet reported Chong Kun Dang Pharmaceutical 50 participants Est. completion 2013-11 1 site Stand-aloneOther conditions: ImmunosuppressionView official trial listing → -
Completed NCT NCT01911546
Role of Everolimus in Highly Sensitized Patients
Not yet reported Joseph Kahwaji, MD, MPH 20 participants Est. completion 2016-01-19 1 site Stand-aloneOther conditions: Highly-sensitized Kidney Transplant RecipientsView official trial listing → -
Completed NCT NCT01920061
A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)
Not yet reported Pfizer 110 participants Est. completion 2020-01-08 29 sitesOther conditions: NeoplasmView official trial listing → -
Completed NCT NCT01921218
Belatacept Therapy for the Failing Renal Allograft
Not yet reported Andrew B Adams 13 participants Est. completion 2019-12-12 1 siteOther conditions: Failing Renal AllograftView official trial listing → -
Status unknown NCT NCT01922492
Effect of Islet Autotransplantation Compared to Oral Antidiabetic Drug.
Not yet reported Seoul National University Hospital 28 participants Est. completion 2017-12 1 siteOther conditions: Partial Pancreatectomy Due to Benign Pancreatic NeoplasmView official trial listing → -
Status unknown NCT NCT01925027
Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography Study
Not yet reported Lepu Medical Technology (Beijing) Co., Ltd. 45 participants Est. completion 2016-11 5 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT01927120
In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 20 participants Est. completion 2017-03-09 1 site Stand-aloneOther conditions: Graft-Versus-Host-DiseaseView official trial listing → -
Status unknown NCT NCT01927588
Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients
Not yet reported Fundação Pró Rim 50 participants Est. completion 2015-11 Stand-aloneOther conditions: Cytomegalovirus InfectionsView official trial listing → -
Completed NCT NCT01932372
Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis
Pfizer 9968 participants Est. completion 2021-08-24 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01935128
Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction
Not yet reported University of Toledo Health Science Campus 55 participants Est. completion 2020-07 1 site Stand-aloneOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT01936519
Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.
Not yet reported Milton S. Hershey Medical Center 24 participants Est. completion 2019-07-31 1 siteOther conditions: Immunosuppression, Renal FailureView official trial listing → -
Completed NCT NCT01938625
A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation
Not yet reported Janssen R&D Ireland 35 participants Est. completion 2015-07-28 6 sites Stand-aloneOther conditions: Hepatitis C, ChronicView official trial listing → -
Status unknown NCT NCT01939249
Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent
Not yet reported Biotronik AG 585 participants Est. completion 2020-01 45 sitesCardiovascular diseaseView official trial listing → -
Terminated NCT NCT01939418
Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer
Not yet reported, Not yet reported National Cancer Center, Korea 23 participants Est. completion 2017-07-30 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT01950819
Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)
Not yet reported Novartis Pharmaceuticals 2037 participants Est. completion 2018-01-17 184 sites Stand-aloneChronic kidney disease Other conditions: End Stage Renal Disease (ESRD), Hemodialysis, Renal Replacement Therapy, Renal TransplantationView official trial listing → -
Completed NCT NCT01951885
Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention
Not yet reported Case Comprehensive Cancer Center 101 participants Est. completion 2021-08-11 1 site Stand-aloneOther conditions: Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma, Hodgkins Disease, Chronic Lymphocytic Leukemia, Multiple MyelomaView official trial listing → -
Completed NCT NCT01955187
Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy
Not yet reported Hospital Universitario 12 de Octubre 86 participants Est. completion 2019-06-26 1 site Stand-aloneOther conditions: MEMBRANOUS NEPHROPATHYView official trial listing → -
Completed NCT NCT01958190
Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus
Not yet reported Foundation for Liver Research 196 participants Est. completion 2021-05-20 3 sites Stand-aloneOther conditions: Liver DiseaseView official trial listing → -
Completed NCT NCT01962922
Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.
Not yet reported Asahi Kasei Therapeutics, Inc. 50 participants Est. completion 2015-08 3 sitesOther conditions: Renal FailureView official trial listing → -
Completed NCT NCT01964014
Once-a-day Immunosuppression(CISECON_a_day)
Not yet reported Ajou University School of Medicine 160 participants Est. completion 2015-10 7 sites Stand-aloneOther conditions: Chronic Renal DiseaseView official trial listing → -
Status unknown NCT NCT01967186
Intraportal or Intramuscular Site for Islets in Simultaneous Islet and Kidney Transplantation
Not yet reported The Nordic Network For Clinical Islet Transplantation 36 participants Est. completion 2016-07Other conditions: Type 1 Diabetes, End Stage Renal DiseaseView official trial listing → -
Completed NCT NCT01969149
Exenatide for Stress Hyperglycemia
Not yet reported, Not yet reported Centre Hospitalier Universitaire de Besancon 110 participants Est. completion 2016-12 1 site Stand-aloneOther conditions: Stress HyperglycemiaView official trial listing → -
Completed NCT NCT01971242
Trial of Exenatide for Parkinson's Disease
Not yet reported University College, London 60 participants Est. completion 2016-08 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01971346
The Immunological Basis for Treatment Resistance to Anti-TNF Treatments
Not yet reported University of Michigan 50 participants Est. completion 2017-11-01 1 siteOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT01971684
ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP
Boston Children's Hospital 120 participants Est. completion 2017-04 29 sitesOther conditions: Immune ThrombocytopeniaView official trial listing → -
Status unknown NCT NCT01974674
Allogeneic Islet Transplantation for the Treatment of Type 1 Diabetes
Not yet reported Assistance Publique - Hôpitaux de Paris 19 participants Est. completion 2022-01 1 site Stand-aloneOther conditions: Patients With Type 1 DiabetesView official trial listing → -
Completed NCT NCT01977781
Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease
Not yet reported Massachusetts Eye and Ear Infirmary 40 participants Est. completion 2014-09 1 site Stand-aloneOther conditions: Ocular GVHDView official trial listing → -
Status unknown NCT NCT01981304
Effects of a rapamycIn-eluting carboNized Stent With a Completely biodEgradable polymeR Coating
University of Roma La Sapienza 50 participants Est. completion 2016-12Cardiovascular diseaseView official trial listing → -
Completed NCT NCT01981473
Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab
Pfizer 605 participants Est. completion 2014-12 54 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT01982682
Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 41 participants Est. completion 2017-03-27 1 site Stand-aloneOther conditions: Hematopoietic/Lymphoid CancerView official trial listing → -
Status unknown NCT NCT01983761
Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation
Not yet reported, Not yet reported Targazyme, Inc. 25 participants 4 sitesOther conditions: Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplantation Infection, Myelodysplastic Syndrome (MDS), Non-Hodgkin's Lymphoma (NHL), Hodgkin's LymphomaView official trial listing → -
Completed NCT NCT01989689
Etanercept and Vascular Function in Psoriasis
Not yet reported Emory University 24 participants Est. completion 2013-09 1 site Stand-aloneOther conditions: PSORIASISView official trial listing → -
Terminated NCT NCT01991938
Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
Not yet reported Verastem, Inc. 75 participants Est. completion 2016-12 5 sitesOther conditions: Non Hematologic Cancers, Metastatic Cancer, LymphomaView official trial listing → -
Withdrawn NCT NCT01997255
Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)
Not yet reported Baylor College of Medicine Est. completion 2016-04 1 siteOther conditions: Sturge Weber SyndromeView official trial listing → -
Status unknown NCT NCT01998789
Everolimus Post Orthotopic Liver Transplant
Not yet reported Tomoaki Kato 50 participants Est. completion 2019-02 1 site Stand-aloneOther conditions: Orthotopic Liver TransplantView official trial listing → -
Completed NCT NCT02004860
Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis
Not yet reported University Hospital, Rouen 120 participants Est. completion 2017-10 1 siteOther conditions: Severe Seborrheic DermatitisView official trial listing → -
Completed NCT NCT02004964
Screening of Subjects With Type I Diabetes to Determine Eligibility for Islet Transplantation
Rodolfo Alejandro 40 participants Est. completion 2018-11-06 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT02010320
Computer Guided Doing of Tacrolimus in Renal Transplantation
Not yet reported University of Oslo School of Pharmacy 80 participants Est. completion 2014-07 1 site Stand-aloneOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT02014103
Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients
Not yet reported University of Cincinnati 71 participants Est. completion 2015-08 1 siteOther conditions: Complication of TransplantView official trial listing → -
Completed NCT NCT02016625
Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus
Not yet reported Boehringer Ingelheim 32 participants Est. completion 2014-04 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT02017860
Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.
Not yet reported Novartis Pharmaceuticals 4 participants Est. completion 2019-04-25 4 sitesOther conditions: NeoplasmsView official trial listing → -
Completed NCT NCT02019693
A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer
Not yet reported National Cancer Institute (NCI) 20 participants Est. completion 2021-12-17 1 siteOther conditions: Kidney CancerView official trial listing → -
Terminated NCT NCT02023905
Everolimus With and Without Temozolomide in Adult Low Grade Glioma
Not yet reported University of California, San Francisco 27 participants Est. completion 2021-09-30 1 siteOther conditions: Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas, Mixed OligoastrocytomasView official trial listing → -
Completed NCT NCT02027870
EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III)
JW Medical Systems Ltd 625 participants Est. completion 2019-11-07 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02028364
Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women
Not yet reported Jules Bordet Institute 55 participants Est. completion 2021-08-09 5 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02029638
BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 4 participants Est. completion 2017-09-06 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Withdrawn NCT NCT02031211
TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial
Not yet reported Stanford University Est. completion 2016-10 1 site Stand-aloneOther conditions: CRPS, Chronic Regional Pain SyndromeView official trial listing → -
Status unknown NCT NCT02036554
Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients
Not yet reported Seoul St. Mary's Hospital 234 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: Kidney; Complications, AllograftView official trial listing → -
Withdrawn NCT NCT02038478
Allograft for Sickle Cell Disease and Thalassemia
Not yet reported University of Texas Southwestern Medical Center Est. completion 2021-05 1 site Stand-aloneOther conditions: Sickle Cell Disease and ThalassemiaView official trial listing → -
Completed NCT NCT02040584
A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.
Not yet reported Novartis Pharmaceuticals 217 participants Est. completion 2016-02-10 20 sitesOther conditions: Liver TransplantView official trial listing → -
Completed NCT NCT02048384
A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22 participants Est. completion 2019-09 2 sitesOther conditions: Metastatic Pancreatic AdenocarcinomaView official trial listing → -
Completed NCT NCT02049047
Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy
Not yet reported Armando Santoro, MD 41 participants Est. completion 2019-01 1 siteOther conditions: Thymoma and Thymic CarcinomaView official trial listing → -
Withdrawn NCT NCT02053545
Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion
Not yet reported, Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago Est. completion 2017-05-11 1 site Stand-aloneOther conditions: Leukemia, Lymphoma, MDSView official trial listing → -
Status unknown NCT NCT02055079
Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease
Not yet reported Medical University of Vienna 68 participants Est. completion 2019-12 1 site Stand-aloneOther conditions: Polycystic Kidney, Type 1 Autosomal Dominant Disease, Polycystic Kidney, Type 2 Autosomal Dominant DiseaseView official trial listing → -
Completed NCT NCT02056587
Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment
Not yet reported Kidney Cancer Research Bureau 37 participants Est. completion 2013-10 3 sitesOther conditions: Metastatic Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT02057172
Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
Not yet reported Hanmi Pharmaceutical Company Limited 254 participants Est. completion 2014-12 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02057484
A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant
Astellas Pharma Europe Ltd. 2300 participants Est. completion 2017-10-17 145 sitesOther conditions: Liver Transplant, Kidney TransplantView official trial listing → -
Status unknown NCT NCT02057965
Mesenchymal Stromal Cell Therapy in Renal Recipients
Not yet reported Leiden University Medical Center 70 participants Est. completion 2022-01 1 siteOther conditions: Renal Transplant Rejection, FibrosisView official trial listing → -
Completed NCT NCT02057978
EXCEL-II Stent Vesus EXCEL Stent to Treat the Patients With de Novo Coronary Artery Lesions.
JW Medical Systems Ltd 419 participants Est. completion 2019-12-25 1 siteCardiovascular disease Other conditions: Myocardial Ischemia, Coronary Disease, Heart Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Vascular DiseasesView official trial listing → -
Withdrawn NCT NCT02058875
Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring
Not yet reported University of Saskatchewan Est. completion 2015-10 2 sitesCardiovascular disease Other conditions: Cardiovascular Outcomes, Kidney Transplant Recipients, Kidney TransplantationView official trial listing → -
Completed NCT NCT02058940
Intravenous Exenatide in Patients With Acute Brain Injury
Not yet reported University of North Carolina, Chapel Hill 8 participants Est. completion 2017-08 1 site Stand-aloneOther conditions: Brain InjuriesView official trial listing → -
Status unknown NCT NCT02059564
A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
Not yet reported Hanmi Pharmaceutical Company Limited 44 participants Est. completion 2014-12 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT02061397
Safety of Simvastatin in LAM and TSC
Not yet reported, Not yet reported University of Pennsylvania 10 participants Est. completion 2019-12-13 1 site Stand-aloneOther conditions: Lymphangioleiomyomatosis, Tuberous Sclerosis ComplexView official trial listing → -
Status unknown NCT NCT02061800
CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant
Not yet reported, Not yet reported Diane George 14 participants Est. completion 2026-07 1 site Stand-aloneOther conditions: Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS), Juvenile Myelomonocytic Leukemia (JMML), Acute Lymphoblastic Leukemia (ALL), Lymphoma (Hodgkin's and Non-Hodgkin's)View official trial listing → -
Withdrawn NCT NCT02062892
Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients
Not yet reported University of Colorado, Denver Est. completion 2014-06 Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT02064777
Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation
Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 60 participants Est. completion 2014-09 1 site Stand-aloneOther conditions: Pediatric Liver TransplantationView official trial listing → -
Completed NCT NCT02068170
Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital
KU Leuven 178 participants Est. completion 2015-06 1 siteOther conditions: Delirium, QT-prolongationView official trial listing → -
Completed NCT NCT02073565
HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt
Not yet reported OrbusNeich 572 participants Est. completion 2021-12 50 sites Stand-aloneOther conditions: Coronary Arteriosclerosis, Non ST Segment Elevation Acute Coronary SyndromeView official trial listing → -
Status unknown NCT NCT02075242
TO Compare the Triple Drug Therapy and Dual Therapy .
Not yet reported Asan Medical Center 170 participants Est. completion 2016-01 1 site Stand-aloneOther conditions: HEPATITISView official trial listing → -
Status unknown NCT NCT02075697
Spanish Registry of Systemic Treatments in Psoriasis
Fundación Academia Española de Dermatología 3500 participants Est. completion 2025-10 13 sitesOther conditions: PsoriasisView official trial listing → -
Status unknown NCT NCT02076516
Pilot Evaluation Of CORACTO® (THE PILOT-SECRET TRIAL)
Not yet reported Alvimedica 100 participants Est. completion 2015-05 5 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02077556
Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients
Not yet reported National Taiwan University Hospital 14 participants Est. completion 2019-01-15 1 site Stand-aloneOther conditions: Drug Interaction PotentiationView official trial listing → -
Terminated NCT NCT02080195
Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)
Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 participants Est. completion 2017-03-29 1 site Stand-aloneOther conditions: Lupus Erythematosus, Graft-versus-host DiseaseView official trial listing → -
Enrolling by invitation NCT NCT02081755
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Not yet reported Baylor Research Institute 336 participants Est. completion 2027-03 9 sites Stand-aloneOther conditions: Carcinoma, HepatocellularView official trial listing → -
Completed NCT NCT02083991
Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation
Not yet reported Vastra Gotaland Region 224 participants Est. completion 2017-12 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT02084251
Clinical Trial for PB-119 in Healthy Subjects (Phase I)
Not yet reported PegBio Co., Ltd. 70 participants Est. completion 2014-11 1 site Stand-aloneOther conditions: Type II DiabetesView official trial listing → -
Completed NCT NCT02084446
Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant
Not yet reported Ronaldo de Matos Esmeraldo, MD 120 participants Est. completion 2017-07 1 site Stand-aloneOther conditions: Transplantation Infection, Cytomegalovirus InfectionsView official trial listing → -
Completed NCT NCT02084654
Exenatide and Weight Loss for Diabetes Prevention
Not yet reported Stanford University 66 participants Est. completion 2013-02Other conditions: Pre Diabetes, Insulin ResistanceView official trial listing → -
Terminated NCT NCT02085629
The ONE Study M Reg Trial
Not yet reported, Not yet reported University of Regensburg 8 participants Est. completion 2018-12-03 1 site Stand-aloneOther conditions: Renal Failure, End StageView official trial listing → -
Completed NCT NCT02088931
Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation
Not yet reported University of California, San Francisco 3 participants Est. completion 2016-12-31 1 site Stand-aloneOther conditions: Late Complication From Kidney TransplantView official trial listing → -
Status unknown NCT NCT02091973
MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney Transplantation
Not yet reported Chulalongkorn University 50 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: microRNA ProfilesView official trial listing → -
Completed NCT NCT02092467
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Not yet reported Pfizer 4372 participants Est. completion 2020-07-22 345 sitesOther conditions: Arthritis, RheumatoidView official trial listing → -
Status unknown NCT NCT02095418
Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept
Not yet reported Samsung Medical Center 152 participants Est. completion 2018-02 5 sites Stand-aloneOther conditions: DiabetesView official trial listing → -
Completed NCT NCT02096107
Novartis Everolimus Transition
Not yet reported Medical University of South Carolina 60 participants Est. completion 2017-05 1 siteOther conditions: Graft Dysfunction, Interstitial FibrosisView official trial listing → -
Terminated NCT NCT02102997
Deutsches Dual Therapy Stent Register
OrbusNeich 130 participants Est. completion 2017-11 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02103855
Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients
Not yet reported Indiana University 6 participants Est. completion 2016-03 1 site Stand-aloneOther conditions: NephrotoxicityView official trial listing → -
Completed NCT NCT02105155
Conversion Prograf® to Advagraf® at D7 Versus D90 After Liver Transplantation
Not yet reported Assistance Publique - Hôpitaux de Paris 90 participants Est. completion 2016-10-17 1 site Stand-aloneOther conditions: Immunosuppression After Liver TransplantationView official trial listing → -
Active, not recruiting NCT NCT02105766
Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 56 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Sickle Cell Disease, Thalassemia, Stem Cell Transplantation, Graft vs Host DiseaseView official trial listing → -
Completed NCT NCT02106507
ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate
Not yet reported Memorial Sloan Kettering Cancer Center 9 participants Est. completion 2021-06-28 1 siteOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT02107833
Study to Evaluate the Safety and Pharmacokinetics of Oral OPRX-106 (TNFR-Fc Fusion Protein) in Healthy Volunteers
Not yet reported Protalix 18 participants Est. completion 2014-12 1 siteOther conditions: Human VolunteerView official trial listing → -
Status unknown NCT NCT02108301
Hepatitis C in Renal Transplant Recipients
Not yet reported Prof. Dr. Alice Schmidt 30 participants 1 site Stand-aloneOther conditions: Chronic Hepatitis C-virus Infection, Renal TransplantationView official trial listing → -
Status unknown NCT NCT02109913
Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane
Not yet reported Amsterdam UMC, location VUmc 175 participants Est. completion 2021-01 28 sitesOther conditions: Hormone Receptor Positive Malignant Neoplasm of Breast, Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT02110069
A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
Not yet reported Boston Children's Hospital 4 participants Est. completion 2020-10-27 7 sites Stand-aloneOther conditions: Kaposiform Hemangioendothelioma (KHE), Kasabach-Merritt Syndrome, Tufted AngiomaView official trial listing → -
Status unknown NCT NCT02112097
ASIS for Enbrel in Plaque Psoriasis
Not yet reported, Not yet reported ASIS Corporation 60 participants Est. completion 2017-06 2 sitesOther conditions: Plaque Psoriasis.View official trial listing → -
Status unknown NCT NCT02112981
BioMime Vs. Xience Randomised Control Clinical Study
Not yet reported Meril Life Sciences Pvt. Ltd. 256 participants Est. completion 2019-12-01 15 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Withdrawn NCT NCT02113891
Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation
Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris Est. completion 2017-11 Stand-aloneOther conditions: Subclinical Acute Antibody-mediated Rejection in Kidney TransplantationView official trial listing → -
Completed NCT NCT02115113
REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy
Not yet reported Novartis Pharmaceuticals 78 participants Est. completion 2016-09-30 14 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT02115750
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
Not yet reported Coherus Oncology, Inc. 647 participants Est. completion 2016-05 141 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT02116504
Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients
Not yet reported Assistance Publique - Hôpitaux de Paris 156 participants Est. completion 2017-11 1 siteOther conditions: Rheumatoid Arthritis, Juvenile Idiopathic ArthritisView official trial listing → -
Completed NCT NCT02117596
Calcineurin Inhibitor Based Immunosuppression Withdrawal
Not yet reported Pediatric Nephrology of Alabama 52 participants Est. completion 2012-11 4 sitesOther conditions: Renal TransplantView official trial listing → -
Status unknown NCT NCT02118376
Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status
Not yet reported Shanghai 10th People's Hospital 20 participants Est. completion 2014-12 1 site Stand-aloneOther conditions: ObesityView official trial listing → -
Completed NCT NCT02118896
Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant
Not yet reported Astellas Pharma Europe Ltd. 850 participants Est. completion 2009-10-07 105 sitesOther conditions: Heart Transplantation, Liver Transplantation, Kidney TransplantationView official trial listing → -
Completed NCT NCT02120157
Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35 participants Est. completion 2020-10-01 9 sites Stand-aloneOther conditions: Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival, Transplantation, Bone MarrowView official trial listing → -
Completed NCT NCT02120469
Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer
Not yet reported City of Hope Medical Center 27 participants Est. completion 2020-03-03 3 sitesOther conditions: Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor-negative, Stage IV Breast Cancer, Triple-negative Breast CarcinomaView official trial listing → -
Completed NCT NCT02122081
Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
Not yet reported Sumithira Vasu 33 participants Est. completion 2022-09-06 1 site Stand-aloneOther conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT02122406
Depression and Anxiety in Rheumatoid Arthritis
University of Pavia 200 participants Est. completion 2015-12 1 siteOther conditions: Rheumatoid Arthritis, Depression, AnxietyView official trial listing → -
Completed NCT NCT02123108
Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation
Not yet reported University of California, Los Angeles 59 participants Est. completion 2015-01 1 site Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT02123823
BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer
Not yet reported Boehringer Ingelheim 164 participants Est. completion 2021-12-14 38 sitesOther conditions: NeoplasmsView official trial listing → -
Completed NCT NCT02126176
Protopic Adherence and Efficacy in Korean Eczema Patient
Pusan National University Hospital 50 participants Est. completion 2016-03 1 siteOther conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT02127541
New Imaging Procedure for the Localisation of Insulinoma
Not yet reported University Hospital, Basel, Switzerland 52 participants Est. completion 2017-11 1 siteOther conditions: Endogenous Hyperinsulinaemic HypoglycaemiaView official trial listing → -
Completed NCT NCT02129582
Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies
Not yet reported Case Comprehensive Cancer Center 14 participants Est. completion 2020-03-05 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Myelofibrosis, Myeloproliferative SyndromeView official trial listing → -
Completed NCT NCT02129881
The ONE Study UK Treg Trial
Not yet reported, Not yet reported Guy's and St Thomas' NHS Foundation Trust 15 participants Est. completion 2017-03-23 2 sites Stand-aloneOther conditions: End-stage Renal FailureView official trial listing → -
Withdrawn NCT NCT02130817
Belatacept in Kidney Transplantation of Moderately Sensitized Patients
Not yet reported University of Wisconsin, Madison Est. completion 2015-10-09 1 site Stand-aloneOther conditions: End Stage Renal Disease, Antibody Mediated RejectionView official trial listing → -
Status unknown NCT NCT02132234
Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Not yet reported Jagiellonian University 100 participants 1 site Stand-aloneOther conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, HypertensionView official trial listing → -
Status unknown NCT NCT02133287
To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization
Not yet reported Beijing AmsinoMed Medical Device Co., Ltd 2000 participants Est. completion 2022-11 1 siteOther conditions: Ischemic Heart Disease, Myocardial Ischemia, Coronary Disease, Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT02134210
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)
Not yet reported Coherus Oncology, Inc. 521 participants Est. completion 2016-05-12 100 sitesOther conditions: Plaque PsoriasisView official trial listing → -
Completed NCT NCT02137239
Regimen Optimization Study
Not yet reported Bristol-Myers Squibb 58 participants Est. completion 2019-05-02 20 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT02142036
N-of-1 Trial: Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy
Not yet reported Oslo University Hospital 50 participants Est. completion 2018-08 2 sitesOther conditions: Metastatic CancerView official trial listing → -
Completed NCT NCT02143479
A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year
Astellas Pharma S.A.S. 398 participants Est. completion 2017-05-03 18 sitesOther conditions: Liver TransplantationView official trial listing → -
Active, not recruiting NCT NCT02143726
Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer
Not yet reported Alliance for Clinical Trials in Oncology 35 participants Est. completion 2028-08-06 21 sitesOther conditions: Refractory Hurthle Cell Thyroid CancerView official trial listing → -
Status unknown NCT NCT02144857
Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
Not yet reported University of Athens 200 participants Est. completion 2023-12-31 1 siteOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT02145403
Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies
Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 53 participants Est. completion 2020-10-16 1 site Stand-aloneOther conditions: Hematologic Malignancies, Relapse, Graft-Versus-Host DiseaseView official trial listing → -
Completed NCT NCT02147938
A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)
Astellas Pharma S.A.S. 578 participants Est. completion 2017-05-15 26 sitesOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT02152007
Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)
Not yet reported TransDerm, Inc. 15 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: Pachyonychia CongenitaView official trial listing → -
Completed NCT NCT02152345
Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients
Not yet reported Columbia University 57 participants Est. completion 2016-12-31 1 siteOther conditions: Implant or Graft; RejectionView official trial listing → -
Completed NCT NCT02152943
Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients
Not yet reported M.D. Anderson Cancer Center 37 participants Est. completion 2020-12-14 5 sitesOther conditions: Advanced Malignant Solid Neoplasm, Estrogen Receptor Positive, HER2/Neu Positive, Postmenopausal, Premenopausal, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Refractory Breast Carcinoma, Refractory Hormone Receptor Positive Breast Carcinoma, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7View official trial listing → -
Status unknown NCT NCT02154854
Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)
Not yet reported University Hospital, Tours 104 participants Est. completion 2015-03 11 sites Stand-aloneOther conditions: De Novo Transplant DiseaseView official trial listing → -
Completed NCT NCT02155920
Everolimus for Children With Recurrent or Progressive Ependymoma
Not yet reported University of Texas Southwestern Medical Center 11 participants Est. completion 2023-07-14 4 sitesOther conditions: Recurrent Childhood EpendymomaView official trial listing → -
Completed NCT NCT02158052
Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease
Not yet reported Massachusetts General Hospital 2 participants Est. completion 2021-06-22 1 site Stand-aloneOther conditions: Multiple Myeloma, AmyloidosisView official trial listing → -
Completed NCT NCT02159651
A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia
Astellas Pharma Inc 179 participants Est. completion 2019-12-23 8 sitesOther conditions: Interstitial Pneumonia Associated With Polymyositis/DermatomyositisView official trial listing → -
Completed NCT NCT02160054
Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)
Astellas Pharma Inc 289 participants Est. completion 2016-03-31 30 sitesOther conditions: the Maintenance Phase After Kidney TransplantationView official trial listing → -
Completed NCT NCT02160990
Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying
Not yet reported Mayo Clinic 20 participants Est. completion 2015-03 1 site Stand-aloneOther conditions: ObesityView official trial listing → -
Completed NCT NCT02161237
Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney Transplantation
Not yet reported Astellas Pharma Inc 73 participants Est. completion 2016-12-22 2 sitesOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT02162550
Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
Not yet reported Phoenix VA Health Care System 148 participants Est. completion 2019-09 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02166177
Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients
Not yet reported, Not yet reported Guy's and St Thomas' NHS Foundation Trust 9 participants Est. completion 2018-01-22 1 site Stand-aloneOther conditions: End-stage Liver DiseaseView official trial listing → -
Completed NCT NCT02167958
Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source
Not yet reported Rafic Farah, MD 28 participants Est. completion 2019-09-21 1 site Stand-aloneOther conditions: Leukemia, MDS, Myelofibrosis, LymphomaView official trial listing → -
Completed NCT NCT02170324
GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men
Not yet reported Xiang Guang-da 20 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT02178683
Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression
Not yet reported Colorado Blood Cancer Institute 50 participants Est. completion 2018-12 1 siteOther conditions: Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT02183454
MASCOT - Post Marketing Registry
OrbusNeich 2500 participants Est. completion 2017-05-31 1 siteCardiovascular disease Other conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT02184416
Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting
Pfizer 554 participants Est. completion 2022-09-30 110 sitesOther conditions: Metastatic Renal Cell Carcinoma (mRCC)View official trial listing → -
Status unknown NCT NCT02188550
Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
Not yet reported Sinai Hospital of Baltimore 20 participants 1 siteOther conditions: Ovarian Cancer, Endometrial CancerView official trial listing → -
Terminated NCT NCT02188719
Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 15 participants Est. completion 2019-06-18 3 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT02192164
Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis
Pfizer 126 participants Est. completion 2016-05 8 sitesOther conditions: Plaque PsoriasisView official trial listing → -
Status unknown NCT NCT02195414
NeoVas Bioresorbable Coronary Scaffold First-in-Man Study
Not yet reported Lepu Medical Technology (Beijing) Co., Ltd. 31 participants Est. completion 2019-09 2 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT02196467
Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients
Not yet reported, Not yet reported CHU de Quebec-Universite Laval 10 participants Est. completion 2024-01 2 sitesOther conditions: Duchenne Muscular DystrophyView official trial listing → -
Completed NCT NCT02198300
DES Versus BiOSS LIM - POLBOS II Study
Not yet reported Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland 202 participants Est. completion 2015-03 1 siteCardiovascular diseaseView official trial listing → -
Terminated NCT NCT02199041
Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen
Not yet reported St. Jude Children's Research Hospital 24 participants Est. completion 2017-05-23 1 site Stand-aloneOther conditions: Hematological MalignanciesView official trial listing → -
Completed NCT NCT02201212
Everolimus for Cancer With TSC1 or TSC2 Mutation
Not yet reported Dana-Farber Cancer Institute 30 participants Est. completion 2019-06 2 sitesOther conditions: TSC1, TSC2, Tuberous Sclerosis Complex, MTORView official trial listing → -
Completed NCT NCT02202837
Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice
Pfizer 157 participants Est. completion 2017-04-24 35 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02206035
A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant
Not yet reported William R. Drobyski, MD 45 participants Est. completion 2018-09 1 site Stand-aloneOther conditions: Hematopoietic Stem Cell TransplantationView official trial listing → -
Completed NCT NCT02208037
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 279 participants Est. completion 2017-10 30 sites Stand-aloneOther conditions: Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Hodgkin's LymphomaView official trial listing → -
Status unknown NCT NCT02208128
Molecular Determinants for Therapy Response on Renal Cell Carcinoma
Not yet reported Heidelberg University 4 participants Est. completion 2018-02 1 siteOther conditions: Renal Cell CarcinomaView official trial listing → -
Status unknown NCT NCT02208791
Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant
Not yet reported University of Sao Paulo General Hospital 45 participants Est. completion 2017-07 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT02213068
Belatacept 3 Month Post Transplant Conversion Study
Not yet reported Lorenzo Gallon 28 participants Est. completion 2020-09 1 site Stand-aloneOther conditions: Transplant; Failure, Kidney, EBVView official trial listing → -
Terminated NCT NCT02214706
Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical Sirolimus
Not yet reported Erasmus Medical Center 17 participants Est. completion 2016-12 1 site Stand-aloneOther conditions: Port-Wine StainView official trial listing → -
Completed NCT NCT02215720
Temsirolimus and Cetuximab in Patients With Advanced or Metastatic Solid Tumors
Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 45 participants Est. completion 2016-05-04 1 siteOther conditions: Patients With Advanced or Metastatic Solid TumorsView official trial listing → -
Status unknown NCT NCT02216058
Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease
Not yet reported Medfavour (Beijing) Medical Co., Ltd 2000 participants Est. completion 2020-06 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02217410
CCFZ533X2201 - PoC Study in de Novo Renal Transplantation
Not yet reported, Not yet reported Novartis Pharmaceuticals 59 participants Est. completion 2017-11-29 14 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT02220985
Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD
Not yet reported Fred Hutchinson Cancer Center 84 participants Est. completion 2025-05-01 2 sites Stand-aloneOther conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Undifferentiated Leukemia, Allogeneic Hematopoietic Stem Cell Transplant Recipient, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blastic Plasmacytoid Dendritic Cell Neoplasm, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Donor, Lymphoblastic Lymphoma, Myelodysplastic Syndrome With Excess Blasts, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome With Excess Blasts-2, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in RemissionView official trial listing → -
Completed NCT NCT02221583
Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy
Not yet reported University of Cincinnati 26 participants Est. completion 2015-02 1 site Stand-aloneOther conditions: End Stage Renal DiseaseView official trial listing → -
Completed NCT NCT02224872
Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18 participants Est. completion 2021-12 2 sites Stand-aloneOther conditions: Severe Aplastic Anemia, Bone Marrow Failure SyndromesView official trial listing → -
Completed NCT NCT02229383
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
Not yet reported AstraZeneca 464 participants Est. completion 2016-08-29 123 sites Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT02229396
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
Not yet reported AstraZeneca 695 participants Est. completion 2017-12-28 133 sites Stand-aloneOther conditions: Diabetes MellitusView official trial listing → -
Status unknown NCT NCT02233049
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication
Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 250 participants Est. completion 2018-10 1 siteOther conditions: Diffuse Intrinsic Pontine GliomaView official trial listing → -
Completed NCT NCT02236975
First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis
Not yet reported, Not yet reported Sino Medical Sciences Technology Inc. 168 participants Est. completion 2019-03 12 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02238496
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Not yet reported Andrew B Lassman, MD 10 participants Est. completion 2021-02-14 2 sitesOther conditions: Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Mixed GliomaView official trial listing → -
Completed NCT NCT02240407
Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease
Not yet reported University of Florida 2 participants Est. completion 2021-08-26 1 site Stand-aloneOther conditions: Pompe DiseaseView official trial listing → -
Completed NCT NCT02240719
Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer
Not yet reported University of California, Davis 20 participants Est. completion 2018-04-09 1 siteOther conditions: Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Chronic Lymphocytic Leukemia, Multiple MyelomaView official trial listing → -
Completed NCT NCT02241564
Malignancies in Transplanted Patients
Uppsala University 95 participants Est. completion 2017-06 1 siteOther conditions: NeoplasmsView official trial listing → -
Terminated NCT NCT02244164
Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.
Not yet reported Erasme University Hospital 5 participants Est. completion 2023-02-13 1 siteType 2 diabetes Other conditions: Incretinomimetics, PancreasView official trial listing → -
Completed NCT NCT02246127
Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor
Not yet reported Grupo Espanol de Tumores Neuroendocrinos 141 participants Est. completion 2021-07-12 37 sitesOther conditions: Neuroendocrine TumorsView official trial listing → -
Completed NCT NCT02248012
Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)
Not yet reported Haukeland University Hospital 38 participants Est. completion 2019-12-01 1 siteOther conditions: Neuroendocrine CarcinomaView official trial listing → -
Completed NCT NCT02248571
Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
Not yet reported iOMEDICO AG 85 participants Est. completion 2017-09-30 1 siteOther conditions: Breast Cancer Recurrent, HER2/Neu-negative Carcinoma of Breast, Hormone Receptor Positive Malignant Neoplasm of BreastView official trial listing → -
Completed NCT NCT02248597
Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases
Not yet reported Wake Forest University Health Sciences 27 participants Est. completion 2023-01-18 1 site Stand-aloneOther conditions: Graft Versus Host Disease, Hematopoietic/Lymphoid CancerView official trial listing → -
Status unknown NCT NCT02251691
Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant
Not yet reported National Taiwan University Hospital 90 participants Est. completion 2020-03-31 1 siteOther conditions: Adherence to Medication RegimeView official trial listing → -
Completed NCT NCT02251821
JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis
Not yet reported Fred Hutchinson Cancer Center 61 participants Est. completion 2026-01-22 1 site Stand-aloneOther conditions: Primary Myelofibrosis, Secondary MyelofibrosisView official trial listing → -
Completed NCT NCT02251938
A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program
Not yet reported Santen Inc. 60 participants Est. completion 2017-11-27 25 sites Stand-aloneOther conditions: Non-Infectious Uveitis of the Posterior Segment of the EyeView official trial listing → -
Completed NCT NCT02252055
The ONE Study ATDC Trial
Not yet reported, Not yet reported Nantes University Hospital 11 participants Est. completion 2018-11-14 1 site Stand-aloneOther conditions: Renal Failure, End StageView official trial listing → -
Status unknown NCT NCT02254668
Intracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography
Not yet reported University of Zurich 278 participants Est. completion 2023-02 1 siteOther conditions: Intimal Proliferation, ImmunosuppressionView official trial listing → -
Status unknown NCT NCT02258282
Safety and Efficacy of Etanercept in Patients With Psoriasis
Not yet reported Chengdu PLA General Hospital 80 participants Est. completion 2022-12 1 site Stand-aloneOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT02258451
Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer
Not yet reported Bayer 283 participants Est. completion 2022-10-28 92 sitesOther conditions: Breast NeoplasmsView official trial listing → -
Completed NCT NCT02264665
OPALINE : A Study Of Morbidity And Mortality At 2 Years
Pfizer 144 participants Est. completion 2019-11-18 35 sitesOther conditions: Pancreatic Neuroendocrine Tumor, Well Differentiated and ProgressiveView official trial listing → -
Completed NCT NCT02266888
B Cell Induction in Pediatric Lung Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 45 participants Est. completion 2019-06-30 7 sites Stand-aloneOther conditions: Lung TransplantView official trial listing → -
Terminated NCT NCT02268201
A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule
Not yet reported Astellas Pharma China, Inc. 17 participants Est. completion 2015-03-31 7 sites Stand-aloneOther conditions: Kidney Transplant RecipientsView official trial listing → -
Completed NCT NCT02274662
Expanded Access Protocol Thymus Transplantation
Not yet reported Sumitomo Pharma Switzerland GmbH 11 participants Est. completion 2023-08 Stand-aloneOther conditions: Poor Thymic Function, Immunodeficiency, Athymia, Immunoreconstitution, Thymus Transplantation, Low T Cell NumbersView official trial listing → -
Completed NCT NCT02274792
Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis
Not yet reported Amgen 132 participants Est. completion 2015-11 45 sites Stand-aloneOther conditions: Plaque PsoriasisView official trial listing → -
Completed NCT NCT02278952
Tacrolimus Adjustment by NFAT-related Gene Expression in Lung Allograft Recipients.
University of California, San Francisco 50 participants Est. completion 2018-01 1 siteOther conditions: Transplantation, LungView official trial listing → -
Terminated NCT NCT02282904
Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 7 participants Est. completion 2019-12-10 1 site Stand-aloneOther conditions: Chronic Granulomatous DiseaseView official trial listing → -
Completed NCT NCT02283658
Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
Not yet reported Mayo Clinic 20 participants Est. completion 2018-06-21 2 sitesOther conditions: Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Serous Surface Papillary Adenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Germ Cell Tumor, Recurrent Primary Peritoneal Carcinoma, Undifferentiated Ovarian CarcinomaView official trial listing → -
Completed NCT NCT02284464
Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients
Not yet reported Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 230 participants Est. completion 2019-12 5 sites Stand-aloneOther conditions: Other Complication of Kidney Transplant, Renal Transplant RejectionView official trial listing → -
Completed NCT NCT02288273
Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
Not yet reported AstraZeneca 239 participants Est. completion 2015-08 29 sites Added to GLP-1Type 2 diabetesView official trial listing → -
Status unknown NCT NCT02291770
Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells
Not yet reported Guangdong Provincial People's Hospital 130 participants Est. completion 2019-12 1 siteOther conditions: Chronic Graft-Versus-Host DiseaseView official trial listing → -
Completed NCT NCT02291913
Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer
Not yet reported SCRI Development Innovations, LLC 48 participants Est. completion 2019-01-31 8 sitesOther conditions: Breast CancerView official trial listing → -
Status unknown NCT NCT02294006
Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs
Not yet reported Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 26 participants Est. completion 2021-10 1 siteOther conditions: Well Differentiated Pancreatic Endocrine TumorView official trial listing → -
Completed NCT NCT02294032
The Role of B Cells in Kidney Allograft Dysfunction
Loma Linda University 180 participants Est. completion 2023-04-24 1 siteOther conditions: Kidney; Complications, Allograft, Transplantation InfectionView official trial listing → -
Completed NCT NCT02294552
Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT
Not yet reported Ivan S Moiseev 200 participants Est. completion 2017-11 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Lymphoma, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia, Immune System DiseasesView official trial listing → -
Completed NCT NCT02297126
A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program
Not yet reported Indiana University 4465 participants Est. completion 2019-05-03 1 siteOther conditions: Adverse Drug ReactionView official trial listing → -
Status unknown NCT NCT02300571
Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant
Fondazione del Piemonte per l'Oncologia 60 participants Est. completion 2018-01 2 sitesOther conditions: Hematological MalignanciesView official trial listing → -
Completed NCT NCT02303730
Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes
Not yet reported Fudan University 76 participants Est. completion 2017-11 5 sites Stand-aloneType 2 diabetes Other conditions: Non-alcoholic Fatty Liver DiseaseView official trial listing → -
Status unknown NCT NCT02305472
NeoVas Bioresorbable Coronary Scaffold Registry Study
Not yet reported Lepu Medical Technology (Beijing) Co., Ltd. 825 participants Est. completion 2020-09 27 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT02311010
Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism
Not yet reported Université Catholique de Louvain 150 participants Est. completion 2015-01 1 siteOther conditions: Kidney DiseasesView official trial listing → -
Status unknown NCT NCT02313051
Everolimus trIal for Advanced prememopausaL Breast Cancer Patients
Not yet reported Chinese Academy of Medical Sciences 200 participants Est. completion 2017-12 1 siteOther conditions: Metastatic Breast CancerView official trial listing → -
Completed NCT NCT02313220
Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight
Not yet reported Uppsala University 50 participants Est. completion 2016-03 1 site Stand-aloneOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT02314312
Efficacy and Safety of Everolimus in de Novo Kidney Transplant Recipients of ECD or AKI Donors
Not yet reported Mahidol University 48 participants Est. completion 2015-06Other conditions: Transplantation of Kidney, Expanded Criteria Donor, ECDView official trial listing → -
Completed NCT NCT02314403
Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)
Not yet reported Massachusetts General Hospital 2 participants Est. completion 2021-07 1 site Stand-aloneOther conditions: Kidney Failure, Chronic, Renal InsufficiencyView official trial listing → -
Terminated NCT NCT02315625
Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery
Not yet reported National Cancer Institute (NCI) 16 participants Est. completion 2019-05-22 1 siteOther conditions: Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors of the Gastrointestinal Tract and PancreasView official trial listing → -
Completed NCT NCT02318030
CNTRP POSITIVE Study
The Hospital for Sick Children 600 participants Est. completion 2020-04 1 siteOther conditions: Transplant, Adaptive Immunity, EBV, Medication Adherence, PTLDView official trial listing → -
Active, not recruiting NCT NCT02321501
Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer
Not yet reported M.D. Anderson Cancer Center 37 participants Est. completion 2026-12-31 1 siteOther conditions: ALK Positive, Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, ROS1 Gene Rearrangement, Stage IIIB Lung Non-Small Cell Cancer AJCC v7, Stage IV Lung Non-Small Cell Cancer AJCC v7View official trial listing → -
Completed NCT NCT02322580
An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients
Universitaire Ziekenhuizen KU Leuven 56 participants Est. completion 2016-11Other conditions: PsoriasisView official trial listing → -
Completed NCT NCT02325960
A Comparison of Exenatide and Insulin Glargine
Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 44 participants Est. completion 2016-10 1 siteType 2 diabetesView official trial listing → -
Completed NCT NCT02328222
ESTEROID WITHDRAWAL STUDY, SAFETY AND EFFICACY IN RENAL TRANPLANTATION
Not yet reported Unidad de Investigacion Medica en Enfermedades Renales 71 participants Est. completion 2011-06 1 siteOther conditions: END STAGE RENAL DISEASEView official trial listing → -
Completed NCT NCT02328755
Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia
Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 37 participants Est. completion 2019-03-25 1 site Stand-aloneOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT02328963
Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A
Not yet reported University Hospital, Bordeaux 186 participants Est. completion 2018-10-10 9 sites Stand-aloneOther conditions: Transplantation Infection, Cytomegalovirus InfectionView official trial listing → -
Completed NCT NCT02329808
Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics
Radboud University Medical Center 93 participants Est. completion 2021-12-03 1 siteOther conditions: Hematologic Diseases, Oncology Problem, Kidney Diseases, Transplantation InfectionView official trial listing → -
Completed NCT NCT02330380
Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation
University Hospitals Cleveland Medical Center 26 participants Est. completion 2016-12 1 siteOther conditions: Psoriasis, InflammationView official trial listing → -
Completed NCT NCT02332902
Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T
Not yet reported The University of Texas Health Science Center, Houston 24 participants Est. completion 2016-03 1 siteOther conditions: Neurofibromatosis 1View official trial listing → -
Suspended NCT NCT02333162
Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant
Not yet reported University of Chicago 30 participants Est. completion 2028-12-01 1 site Stand-aloneOther conditions: Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Hematologic MalignancyView official trial listing → -
Completed NCT NCT02333565
Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas
Not yet reported Assistance Publique Hopitaux De Marseille 20 participants Est. completion 2023-05-24 1 siteOther conditions: Recurrent Meningiomas, Resistant MeningiomasView official trial listing → -
Completed NCT NCT02334488
Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function
Not yet reported Poitiers University Hospital 329 participants Est. completion 2020-07-03 14 sites Stand-aloneChronic kidney diseaseView official trial listing → -
Completed NCT NCT02336854
Tacrobell tab_Phase1_PK
Not yet reported Chong Kun Dang Pharmaceutical 50 participants Est. completion 2015-03-19Other conditions: Immunosuppressant(Organ Transplantation, RA)View official trial listing → -
Status unknown NCT NCT02337036
Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant Patients
Not yet reported Assistance Publique - Hôpitaux de Paris 80 participants Est. completion 2020-12 1 site Stand-aloneOther conditions: Liver Transplantation, ChildView official trial listing → -
Completed NCT NCT02339246
Pharmacokinetic Comparison Of All FK-506 Formulations
Not yet reported Veloxis Pharmaceuticals 32 participants Est. completion 2015-03 1 siteOther conditions: Renal FailureView official trial listing → -
Completed NCT NCT02341274
Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteeers
Not yet reported Indiana University 24 participants Est. completion 2018-01-20 1 siteOther conditions: BioequivalenceView official trial listing → -
Completed NCT NCT02342145
Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major
Not yet reported Zhongming Zhang 205 participants Est. completion 2022-08-20 3 sites Stand-aloneOther conditions: Beta-Thalassemia Major, Graft-versus-host Disease (GVHD)View official trial listing → -
Completed NCT NCT02342782
Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma
Not yet reported City of Hope Medical Center 20 participants Est. completion 2024-11-18 1 site Stand-aloneOther conditions: Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma, Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Cutaneous T-Cell Non-Hodgkin LymphomaView official trial listing → -
Status unknown NCT NCT02344641
Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients
Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 234 participants Est. completion 2016-12 Stand-aloneType 2 diabetesHeart failureView official trial listing → -
Completed NCT NCT02345850
Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 346 participants Est. completion 2020-10-05 28 sitesOther conditions: Acute Leukemia, MyelodysplasiaView official trial listing → -
Completed NCT NCT02346240
Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)
Not yet reported UCB Biopharma S.P.R.L. 559 participants Est. completion 2018-12-17 70 sitesOther conditions: Psoriasis, Plaque PsoriasisView official trial listing → -
Terminated NCT NCT02346877
Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis
Not yet reported Amgen 19 participants Est. completion 2015-10 15 sitesOther conditions: Persistence to EnbrelView official trial listing → -
Status unknown NCT NCT02356146
First Tacrolimus Dose Trough Level is Better Than CYP3A5 Genotyping in Tacrolimus Dose Prediction
Chulalongkorn University 60 participants Est. completion 2015-06 1 siteOther conditions: Kidney Transplantation RecipientsView official trial listing → -
Completed NCT NCT02356159
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
Not yet reported, Not yet reported National Cancer Institute (NCI) 34 participants Est. completion 2025-03-25 2 sites Stand-aloneOther conditions: Myelodysplastic Syndromes, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Leukemia, Multiple MyelomaView official trial listing → -
Status unknown NCT NCT02360423
Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions
Not yet reported CID S.p.A. 430 participants Est. completion 2021-04 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT02360709
Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions
CID S.p.A. 800 participants Est. completion 2021-04 1 siteCardiovascular diseaseView official trial listing → -
Withdrawn NCT NCT02365415
Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement
Not yet reported Boston Children's Hospital Est. completion 2018-04 1 site Stand-aloneOther conditions: Peripheral Pulmonary Stenosis, In-stent StenosisView official trial listing → -
Completed NCT NCT02366728
DC Migration Study for Newly-Diagnosed GBM
Not yet reported Mustafa Khasraw, MBChB, MD, FRCP, FRACP 64 participants Est. completion 2020-10-31 1 site Stand-aloneOther conditions: Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma MultiformeView official trial listing → -
Completed NCT NCT02371434
The ONE Study nTreg Trial (ONEnTreg13)
Not yet reported, Not yet reported Prof. Dr. Petra Reinke 17 participants Est. completion 2017-11-01 1 site Stand-aloneOther conditions: Immunosuppressive Treatment of Living-donor Renal TransplantationView official trial listing → -
Completed NCT NCT02373202
A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)
Not yet reported Sanofi 91 participants Est. completion 2016-11 40 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02373813
Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission
Not yet reported Amgen 371 participants Est. completion 2019-12-06 136 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02376478
On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection
Medical University of Vienna 222 participants Est. completion 2011-01Other conditions: Psoriasis, Inflammatory Bowel DiseasesView official trial listing → -
Completed NCT NCT02376790
Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis
Not yet reported Amgen 851 participants Est. completion 2018-07-06 138 sites Stand-aloneOther conditions: Psoriatic ArthritisView official trial listing → -
Completed NCT NCT02376985
Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT
Not yet reported Comprehensive Support Project for Oncology Research 174 participants Est. completion 2018-10-16 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02377193
Simulect Versus ATG in Sensitized Renal Transplant Patient
Not yet reported University Hospital, Toulouse 60 participants Est. completion 2017-01 1 site Stand-aloneOther conditions: Renal Transplant RejectionView official trial listing → -
Terminated NCT NCT02377609
To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks
Astellas Pharma Europe Ltd. 108 participants Est. completion 2014-09 6 sitesOther conditions: Validation, Dried Blood Spot, Transplant PatientsView official trial listing → -
Status unknown NCT NCT02377791
Impact of CYP3A5 Gene Polymorphisms on Tacrolimus Concentrations and Outcomes in Thai Transplant Recipients
Mahidol University 170 participants Est. completion 2015-10Other conditions: Kidney TransplantView official trial listing → -
Status unknown NCT NCT02382575
Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic Syndrome
Not yet reported Nilratan Sircar Medical College 120 participants Est. completion 2023-12 1 siteOther conditions: Nephrotic SyndromeView official trial listing → -
Completed NCT NCT02384018
Mesenchymal Stem Cell and Islet Co-transplantation
Not yet reported Medical University of South Carolina 3 participants Est. completion 2017-11-21 1 siteOther conditions: Chronic Pancreatitis, DiabetesView official trial listing → -
Completed NCT NCT02384837
Effect of TCFA on Neointimal Coverage After PCI at 9 Months Follow-up
General Hospital of Chinese Armed Police Forces 33 participants Est. completion 2016-11 1 siteOther conditions: Unrecognized ConditionView official trial listing → -
Completed NCT NCT02385279
Study Comparing the MiStent SES Versus the XIENCE EES Stent
Not yet reported ECRI bv 1398 participants Est. completion 2021-02-04 20 sites Stand-aloneOther conditions: Coronary StenosisView official trial listing → -
Status unknown NCT NCT02392780
Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease
Not yet reported moshe yeshurun 10 participants 1 site Stand-aloneOther conditions: Acute-graft-versus-host DiseaseView official trial listing → -
Status unknown NCT NCT02398955
Biomime Stent in All-comers PCI Patients Registry
Azienda Ospedaliero Universitaria Maggiore della Carita 250 participants Est. completion 2016-12 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02400632
MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions
Not yet reported Scitech Produtos Medicos SA 60 participants Est. completion 2019-12-30 3 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02402140
Influence of Pharmaceutical Care on the Intraindividual Variability of Tacrolimus Concentrations
Not yet reported Hospital do Rim e Hipertensão 128 participants Est. completion 2014-12Other conditions: Renal Transplant Graft FailureView official trial listing → -
Completed NCT NCT02404376
COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial
Not yet reported Hospital Universitari Vall d'Hebron Research Institute 378 participants Est. completion 2020-06 6 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02406326
An Evaluation of BioMime™ - Sirolimus Eluting Coronary Stent in a Multi- Centre Study.
Meril Life Sciences Pvt. Ltd. 250 participants Est. completion 2016-12-27 11 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02407054
A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer
Not yet reported Eli Lilly and Company 142 participants Est. completion 2020-04-16 36 sitesOther conditions: Prostate Cancer MetastaticView official trial listing → -
Completed NCT NCT02407509
Phase I Trial of VS-6766 Alone and in Combination With Everolimus
Not yet reported Royal Marsden NHS Foundation Trust 104 participants Est. completion 2025-10-15 3 sitesOther conditions: Solid Tumours, Multiple Myeloma, Lung Cancer, Ovarian CancerView official trial listing → -
Withdrawn NCT NCT02409147
Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center
Not yet reported University of Nebraska Est. completion 2018-07-24 Stand-aloneOther conditions: Uterus TransplantView official trial listing → -
Approved For Marketing NCT NCT02411604
Expanded Access Study for Renal Transplant Patients With Envarsus XR ™
Asahi Kasei Therapeutics, Inc.Other conditions: Renal FailureView official trial listing → -
Status unknown NCT NCT02415452
Researches of Retinal Artery Lesions and Acute Coronary Syndrome
Capital Medical University 660 participants Est. completion 2018-01Other conditions: Acute Coronary SyndromeView official trial listing → -
Status unknown NCT NCT02416674
Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects
Not yet reported Brigham and Women's Hospital 10 participants Est. completion 2025-02 1 site Stand-aloneOther conditions: Abdominal Wall DefectView official trial listing → -
Completed NCT NCT02417142
Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia
Not yet reported University of Massachusetts, Worcester 70 participants Est. completion 2020-07 1 site Stand-aloneOther conditions: Schizophrenia, Schizoaffective DisorderView official trial listing → -
Completed NCT NCT02420613
Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma
Not yet reported M.D. Anderson Cancer Center 18 participants Est. completion 2025-03-28 1 siteOther conditions: Diffuse Intrinsic Pontine GliomaView official trial listing → -
Terminated NCT NCT02423954
Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
Not yet reported, Not yet reported Western Regional Medical Center 33 participants Est. completion 2017-11-01 1 siteOther conditions: Advanced Cancer, Pancreatic Cancer, Renal Cell Cancer, Non Small Cell Lung Cancer, Colorectal Carcinoma, Endometrial, UterineView official trial listing → -
Status unknown NCT NCT02426502
Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients
Not yet reported University of British Columbia 76 participants Est. completion 2024-12 3 sites Stand-aloneOther conditions: End-Stage Renal DiseaseView official trial listing → -
Completed NCT NCT02428296
Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation
Not yet reported National Human Genome Research Institute (NHGRI) 39 participants Est. completion 2018-02-14 1 site Stand-aloneOther conditions: PIK3CA-Related Overgrowth Spectrum (PROS), Growth Disorder, GeneticsView official trial listing → -
Completed NCT NCT02432053
A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India
Not yet reported Astellas Pharma Inc 92 participants Est. completion 2013-05 7 sitesOther conditions: Kidney Transplantation, Liver TransplantationView official trial listing → -
Completed NCT NCT02432833
Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients
Not yet reported Chiesi Farmaceutici S.p.A. 428 participants Est. completion 2017-01-24 1 site Stand-aloneOther conditions: End Stage Renal DiseaseView official trial listing → -
Completed NCT NCT02432976
Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients
Not yet reported, Not yet reported Centre Hospitalier Universitaire de Besancon 64 participants Est. completion 2017-01 1 site Stand-aloneOther conditions: Quality of LifeView official trial listing → -
Completed NCT NCT02435901
HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity
Not yet reported, Not yet reported Northwell Health 29 participants Est. completion 2019-12 1 site Stand-aloneOther conditions: Sickle Cell Disease, Beta Thalassemia-MajorView official trial listing → -
Completed NCT NCT02438982
Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome
Not yet reported Nilratan Sircar Medical College 120 participants Est. completion 2016-09 1 siteOther conditions: Nephrotic SyndromeView official trial listing → -
Completed NCT NCT02440464
Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 57 participants Est. completion 2020-10-01 15 sites Stand-aloneOther conditions: Multiple MyelomaView official trial listing → -
Completed NCT NCT02441075
70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014
Not yet reported Nationwide Children's Hospital 13 participants Est. completion 2016-01 1 siteOther conditions: Hematopoietic Stem Cell Transplant, GVHDView official trial listing → -
Completed NCT NCT02441543
Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus
Istituto Clinico Humanitas 45 participants Est. completion 2018-05 1 siteOther conditions: SOLID TUMORView official trial listing → -
Completed NCT NCT02441803
Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)
Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2021-09-22 1 site Stand-aloneOther conditions: LeukemiaView official trial listing → -
Completed NCT NCT02443818
Sirolimus Effect on Hypertrophic Syndromes Related Gene PIK3CA
Not yet reported Centre Hospitalier Universitaire Dijon 16 participants Est. completion 2016-11 11 sitesOther conditions: Segmental Overgrowth Disorders Due to PIK3CAView official trial listing → -
Completed NCT NCT02444143
A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients
Not yet reported University of Illinois Chicago 20 participants Est. completion 2017-06-09 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT02446964
Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia
Not yet reported City of Hope Medical Center 31 participants Est. completion 2025-05-20 1 site Stand-aloneOther conditions: Adult Acute Lymphoblastic Leukemia in Complete Remission, Acute Myeloid Leukemia in Remission, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Childhood Acute Lymphoblastic Leukemia in Complete RemissionView official trial listing → -
Withdrawn NCT NCT02447055
Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma
Not yet reported Washington University School of Medicine Est. completion 2016-06 Stand-aloneOther conditions: Multiple Myeloma, Myeloma-MultipleView official trial listing → -
Status unknown NCT NCT02448524
Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System)
Not yet reported Micell Technologies 428 participants Est. completion 2022-11 16 sites Stand-aloneOther conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT02449564
The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors
Not yet reported Samsung Medical Center 5 participants Est. completion 2017-11-03 1 site Stand-aloneOther conditions: Solid TumorView official trial listing → -
Completed NCT NCT02449603
Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes
Not yet reported Xijing Hospital 150 participants Est. completion 2018-04 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT02451696
A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD
Not yet reported NYU Langone Health 15 participants Est. completion 2017-12-28 1 siteOther conditions: Epilepsy, Tuberous Sclerosis Complex, Focal Cortical DysplasiaView official trial listing → -
Completed NCT NCT02451748
IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA
Not yet reported University of Illinois Chicago 32 participants Est. completion 2017-12 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT02453867
Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients
Not yet reported Klemens Budde 400 participants Est. completion 2019-07 Stand-aloneOther conditions: Immunosuppression After Renal TransplantationView official trial listing → -
Completed NCT NCT02454478
Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)
Not yet reported Eisai Co., Ltd. 7 participants Est. completion 2017-05-29 3 sitesOther conditions: Carcinoma, Renal CellView official trial listing → -
Status unknown NCT NCT02456025
Topical Tacrolimus in Vernal Keratoconjunctivitis
Not yet reported The Eye Center and The Eye Foundation for Research in Ophthalmology 20 participants Est. completion 2016-12 1 siteOther conditions: Vernal KeratoconjunctivitisView official trial listing → -
Status unknown NCT NCT02456363
Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis
Not yet reported Chung Shan Medical University 300 participants Est. completion 2019-12 1 site Stand-aloneOther conditions: Ankylosing SpondylitisView official trial listing → -
Completed NCT NCT02456857
Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative
Not yet reported M.D. Anderson Cancer Center 17 participants Est. completion 2023-05-24 1 siteOther conditions: Invasive Breast Carcinoma, Triple-Negative Breast CarcinomaView official trial listing → -
Completed NCT NCT02457221
A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis
Not yet reported Astellas Pharma China, Inc. 314 participants Est. completion 2018-09-10 35 sites Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Status unknown NCT NCT02459977
The Usefulness of Tacrolimus Without Basiliximab in Well Matched Living Renal Transplantation in Korea
Not yet reported Asan Medical Center 40 participants 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT02464878
Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
Not yet reported Massachusetts General Hospital 2 participants Est. completion 2022-12 1 siteOther conditions: Kidney Transplant, Type 1 DiabetesView official trial listing → -
Completed NCT NCT02466997
Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC
Not yet reported University Hospital, Bordeaux 42 participants Est. completion 2018-09-30 4 sites Stand-aloneOther conditions: VitiligoView official trial listing → -
Terminated NCT NCT02479490
PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI
Not yet reported Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 8 participants Est. completion 2017-09 4 sitesOther conditions: Metastatic Renal CancerView official trial listing → -
Completed NCT NCT02481453
Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis
Not yet reported, Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 44 participants Est. completion 2018-01-22 1 siteOther conditions: Inclusion Body Myositis (IBM)View official trial listing → -
Completed NCT NCT02482974
Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients
Ege University 66 participants Est. completion 2016-07 1 siteOther conditions: Liver Transplant RecipientsView official trial listing → -
Completed NCT NCT02486302
A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
Pfizer 1534 participants Est. completion 2017-12-11 180 sitesOther conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Plaque PsoriasisView official trial listing → -
Completed NCT NCT02486315
Treatment of Coronary ARtery bIfurcation Narrowing by AXxess Stent Implantation
Clinica Mediterranea 326 participants Est. completion 2015-06Cardiovascular diseaseView official trial listing → -
Status unknown NCT NCT02489760
Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study
Not yet reported Chung Shan Medical University 30 participants Est. completion 2016-10 1 site Stand-aloneOther conditions: Ankylosing SpondylitisView official trial listing → -
Status unknown NCT NCT02492308
Induction With SVF Derived MSC in Living-related Kidney Transplantation
Not yet reported, Not yet reported Fuzhou General Hospital 120 participants Est. completion 2017-12 2 sitesOther conditions: Living-relative Kidney TransplantationView official trial listing → -
Status unknown NCT NCT02492490
Effect of SVF Derived MSC in DCD Renal Transplantation
Not yet reported, Not yet reported Fuzhou General Hospital 120 participants Est. completion 2016-11 1 site Stand-aloneOther conditions: UremiaView official trial listing → -
Status unknown NCT NCT02493465
Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study
Not yet reported Instituto de Urologia e Nefrologia 50 participants Est. completion 2017-07 1 siteOther conditions: Left Ventricular HypertrophyView official trial listing → -
Completed NCT NCT02494570
A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa
Not yet reported Aadi Bioscience, Inc. 34 participants Est. completion 2022-04 9 sites Stand-aloneOther conditions: Malignant PEComaView official trial listing → -
Completed NCT NCT02495077
Effects of Inhibiting Early Inflammation in Kidney Transplant Patients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 290 participants Est. completion 2021-07-23 15 sites Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Status unknown NCT NCT02496494
The Effects of Conversion From Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant Recipients
Not yet reported Kyungpook National University Hospital 50 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: CYCLOSPORINE/TACROLIMUSView official trial listing → -
Terminated NCT NCT02498977
Liver Immunosuppression Free Trial
Not yet reported King's College London 116 participants Est. completion 2021-12-31 2 sitesOther conditions: Transplantation, LiverView official trial listing → -
Completed NCT NCT02500212
Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients
Not yet reported Chiesi Farmaceutici S.p.A. 75 participants Est. completion 2016-06 7 sites Stand-aloneOther conditions: Organ or Tissue Transplant; ComplicationsView official trial listing → -
Status unknown NCT NCT02501850
The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
Not yet reported Hospital Universitari Vall d'Hebron Research Institute 40 participants Est. completion 2015-10 1 site Added to GLP-1Type 2 diabetesView official trial listing → -
Completed NCT NCT02503059
Etanercept Survival in Elderly Population
Fundación Pública Andaluza Progreso y Salud 70 participants Est. completion 2015-02 5 sitesOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT02504047
Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood Units
Not yet reported University of Calgary 40 participants Est. completion 2019-02 5 sites Stand-aloneOther conditions: Hematologic NeoplasmsView official trial listing → -
Completed NCT NCT02504359
Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
Not yet reported OHSU Knight Cancer Institute 11 participants Est. completion 2020-09-09 2 sites Stand-aloneOther conditions: Plasma Cell Leukemia, Recurrent Plasma Cell MyelomaView official trial listing → -
Completed NCT NCT02509468
suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS
Not yet reported University Hospital, Tours 63 participants Est. completion 2019-03 12 sites Stand-aloneOther conditions: Vascular MalformationView official trial listing → -
Completed NCT NCT02517918
Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma
Not yet reported Institut Bergonié 23 participants Est. completion 2021-11-16 3 sites Stand-aloneObstructive sleep apnea Other conditions: Solid TumorView official trial listing → -
Terminated NCT NCT02523768
Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment
Not yet reported Centre Hospitalier Universitaire de Saint Etienne 117 participants Est. completion 2020-02-24 15 sitesOther conditions: Glomerulonephritis, IgANView official trial listing → -
Withdrawn NCT NCT02524639
Sirolimus for the Treatment of Hyperinsulinism
Not yet reported, Not yet reported Children's Hospital of Philadelphia Est. completion 2018-05-29 1 site Stand-aloneOther conditions: HyperinsulinismView official trial listing → -
Status unknown NCT NCT02528292
Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis
Barts & The London NHS Trust 24 participants Est. completion 2018-04 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Withdrawn NCT NCT02528877
Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis
Not yet reported City of Hope Medical Center 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia in Remission, Primary Myelofibrosis, Primary Myelofibrosis, Prefibrotic Stage, Secondary Acute Myeloid Leukemia, Secondary MyelofibrosisView official trial listing → -
Completed NCT NCT02531932
Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer
Not yet reported Amy Tiersten 64 participants Est. completion 2024-10-19 3 sitesOther conditions: Breast CancerView official trial listing → -
Terminated NCT NCT02539459
Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus
Not yet reported Fox Chase Cancer Center 20 participants Est. completion 2018-08-20 8 sitesOther conditions: Sporadic Angiomyolipomas (AMLs)View official trial listing → -
Completed NCT NCT02540395
Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation
Not yet reported Prof. Dr. Petra Reinke 184 participants Est. completion 2020-10-31 8 sites Stand-aloneOther conditions: Disorder Related to Renal Transplantation, Effects of Immunosuppressant TherapyView official trial listing → -
Completed NCT NCT02541916
Liver Immune Tolerance Marker Utilization Study
Not yet reported University of Toronto 69 participants Est. completion 2021-05-31 1 site Stand-aloneOther conditions: Immunosuppression, Immune ToleranceView official trial listing → -
Completed NCT NCT02542007
Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions
Not yet reported OrbusNeich 440 participants Est. completion 2021-06-10 15 sites Stand-aloneOther conditions: Coronary ArteriosclerosisView official trial listing → -
Status unknown NCT NCT02545972
Once-a-day Tacrolimus Conversion Study: The OneTAC Trial
Not yet reported Newark Beth Israel Medical Center 100 participants Est. completion 2019-02 1 site Stand-aloneHeart failureView official trial listing → -
Completed NCT NCT02545985
First-in-man Sirolimus-eluting Prolim® Stent Registry
Not yet reported Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland 204 participants Est. completion 2015-06Other conditions: Sirolimus-eluting Stainless Steel Coronary Stent Prolim®View official trial listing → -
Withdrawn NCT NCT02548468
Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Est. completion 2017-03-16 Stand-aloneOther conditions: Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides and Sezary Syndrome, Stage IIB Mycosis Fungoides and Sezary Syndrome, Stage IIIA Mycosis Fungoides and Sezary Syndrome, Stage IIIB Mycosis Fungoides and Sezary Syndrome, Stage IVA Mycosis Fungoides and Sezary Syndrome, Stage IVB Mycosis Fungoides and Sezary SyndromeView official trial listing → -
Completed NCT NCT02551718
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
Not yet reported University of Washington 34 participants Est. completion 2021-05-13 1 siteOther conditions: Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Refractory Acute Leukemia of Ambiguous LineageView official trial listing → -
Completed NCT NCT02554955
A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant Participants
Not yet reported Hoffmann-La Roche 36 participants Est. completion 2007-12 14 sites Stand-aloneOther conditions: Heart TransplantationView official trial listing → -
Completed NCT NCT02555787
Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients
Astellas Pharma Europe Ltd. 4430 participants Est. completion 2022-09-30 129 sitesOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT02556931
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 117 participants Est. completion 2021-04 1 site Stand-aloneOther conditions: Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Chronic Myeloid Leukemia, Chronic Myeloproliferative Disorders, Multiple Myeloma, Plasma Cell Neoplasm, Plasma Cell Dyscrasia, Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia, Plasma Cell LeukemiaView official trial listing → -
Not yet recruiting NCT NCT02558452
European Transplant Registry of Senior Renal Transplant Recipients on Advagraf
Klemens Budde 1000 participants Est. completion 2028-01Other conditions: Graft Failure, Death, Acute Rejection of Renal Transplant, Infections, Bone Disease, Post Transplant Diabetes Mellitus, Quality of Life, HLA Antibody Production, Cardiovascular Risk Factors, Non-HLA Antibody ProductionView official trial listing → -
Terminated NCT NCT02560012
Personalized Targeted Inhibitors Treatment in Renal Cell Cancer
Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2017-07-27 1 siteOther conditions: Carcinoma, Renal CellView official trial listing → -
Status unknown NCT NCT02560376
68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis
Not yet reported Peking Union Medical College Hospital 100 participants Est. completion 2016-12 1 siteOther conditions: Insulinoma, NesidioblastosisView official trial listing → -
Status unknown NCT NCT02561767
Effect of BM-MSCs in DCD Kidney Transplantation
Not yet reported, Not yet reported First Affiliated Hospital, Sun Yat-Sen University 120 participants Est. completion 2017-10 1 site Stand-aloneOther conditions: Kidney Transplantation, Acute Kidney Tubular NecrosisView official trial listing → -
Withdrawn NCT NCT02563782
Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD
Not yet reported Astellas Institute for Regenerative Medicine Est. completion 2017-05-05 1 siteOther conditions: Age-Related Macular DegenerationView official trial listing → -
Completed NCT NCT02566304
Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 35 participants Est. completion 2024-02-13 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Aplastic Anemia, Chronic Myelomonocytic Leukemia, Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Malignant Neoplasm, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Plasma Cell Myeloma, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Ring Sideroblasts, Refractory Cytopenia With Multilineage Dysplasia, Refractory Cytopenia With Multilineage Dysplasia and Ring SideroblastsView official trial listing → -
Withdrawn NCT NCT02569125
Open Label Study of Everolimus (RAD001) in Patients With Segmental Overgrowth Syndrome
Not yet reported Jochen Roessler Est. completion 2016-02 4 sitesOther conditions: Segmental Overgrowth SyndromeView official trial listing → -
Completed NCT NCT02570750
The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis
Pfizer 183 participants Est. completion 2016-12-05 30 sitesOther conditions: Chronic Plaque PsoriasisView official trial listing → -
Completed NCT NCT02576366
Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus
Not yet reported Universitaire Ziekenhuizen KU Leuven 24 participants Est. completion 2017-12 1 siteOther conditions: Drug Interactions, Kidney TransplantationView official trial listing → -
Completed NCT NCT02579031
A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
Not yet reported Insel Gruppe AG, University Hospital Bern 1300 participants Est. completion 2020-05 10 sitesCardiovascular disease Other conditions: Acute Coronary SyndromeView official trial listing → -
Enrolling by invitation NCT NCT02579044
Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Not yet reported, Not yet reported Boston Children's Hospital 80 participants Est. completion 2027-03 1 siteOther conditions: ProgeriaView official trial listing → -
Completed NCT NCT02581436
Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR
Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 70 participants Est. completion 2018-02-01 1 site Stand-aloneOther conditions: Disorder Related to Renal Transplantation, Renal Transplant Rejection, Acute Graft RejectionView official trial listing → -
Completed NCT NCT02582775
MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs
Not yet reported Masonic Cancer Center, University of Minnesota 17 participants Est. completion 2023-07-26 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Completed NCT NCT02583893
Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 39 participants Est. completion 2023-05-17 1 site Stand-aloneOther conditions: Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid LeukemiaView official trial listing → -
Status unknown NCT NCT02584075
Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function
Not yet reported Beijing Chao Yang Hospital 100 participants Est. completion 2018-01 Stand-aloneOther conditions: Coronary Endothelial FunctionView official trial listing → -
Status unknown NCT NCT02584582
The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate
Not yet reported, Not yet reported Hvidovre University Hospital 10 participants Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Terminated NCT NCT02584647
PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
Not yet reported, Not yet reported Gulam Manji 39 participants Est. completion 2024-10-01 5 sites Stand-aloneOther conditions: Sarcoma, Malignant Peripheral Nerve Sheath TumorsView official trial listing → -
Completed NCT NCT02587052
A 1-year Comparison of Generic Tacrolimus (Tacni) and Prograf in Renal Transplant Patients - a Retrospective Matched Pair Analysis, GenTac
Vastra Gotaland Region 186 participants Est. completion 2016-12 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT02588339
Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 42 participants Est. completion 2021-07-13 1 site Stand-aloneOther conditions: Graft Versus Host Disease, GVHDView official trial listing → -
Completed NCT NCT02596828
Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma
Not yet reported University of Regensburg 4 participants Est. completion 2021-04 1 siteOther conditions: PineoblastomaView official trial listing → -
Withdrawn NCT NCT02597283
Coronary Bifurcation Lesions Treated With Biguard Stent System
Not yet reported Nanjing First Hospital, Nanjing Medical University Est. completion 2015-12 Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02599324
Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors
Not yet reported, Not yet reported Pharmacyclics LLC. 263 participants Est. completion 2021-08-20 65 sitesOther conditions: Metastatic Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Advanced Gastric Adenocarcinoma, Metastatic Colorectal AdenocarcinomaView official trial listing → -
Completed NCT NCT02601703
To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)
Not yet reported Glenmark Pharmaceuticals Ltd. India 1110 participants Est. completion 2016-10 60 sites Stand-aloneOther conditions: Atopic DermatitisView official trial listing → -
Status unknown NCT NCT02602873
Study of Tacrolimus Used for Pediatric Patients With Nephrotic Syndrome Based on Pharmacogenomics and Metabonomics
Guangzhou Women and Children's Medical Center 150 participants Est. completion 2020-08 1 siteOther conditions: Nephrotic SyndromeView official trial listing → -
Completed NCT NCT02602925
Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity
Not yet reported Radboud University Medical Center 120 participants Est. completion 2018-07-20 6 sites Stand-aloneOther conditions: PsoriasisView official trial listing → -
Completed NCT NCT02608606
Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors
Not yet reported Pontificia Universidad Catolica de Chile 20 participants Est. completion 2016-03 1 siteOther conditions: Evidence of Liver Transplantation, Effects of Immunosuppressant TherapyView official trial listing → -
Status unknown NCT NCT02616848
Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers
Not yet reported Istituti Ospitalieri di Cremona 1 participants 1 siteOther conditions: Triple Negative Breast CancerView official trial listing → -
Withdrawn NCT NCT02619669
Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer
Not yet reported Gary Schwartz Est. completion 2019-06-14 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02620189
Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα
Queen Mary University of London 60 participants Est. completion 2017-05-24 8 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02621489
Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
Not yet reported Karolinska Institutet 38 participants Est. completion 2022-10 1 siteOther conditions: Atherosclerosis, Diabetes, RestenosisView official trial listing → -
Completed NCT NCT02623140
BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX
Not yet reported Odense University Hospital 3150 participants Est. completion 2023-10-01 1 siteOther conditions: Ischaemic Heart DiseaseView official trial listing → -
Terminated NCT NCT02627573
Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT
Not yet reported St. Petersburg State Pavlov Medical University 32 participants Est. completion 2019-04-03 1 site Stand-aloneOther conditions: Leukemia, Chronic Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL NegativeView official trial listing → -
Completed NCT NCT02627690
Nephrologic Prognosis 10 Years After Diabetes Cell Therapy
University Hospital, Lille 45 participants Est. completion 2021-11-29 1 siteOther conditions: Islet TransplantationView official trial listing → -
Active, not recruiting NCT NCT02629120
High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 45 participants Est. completion 2028-12-30 1 siteOther conditions: Chronic Granulomatous Disease TransplantView official trial listing → -
Completed NCT NCT02630628
Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis
Not yet reported The University of Hong Kong 130 participants Est. completion 2024-12-27 1 site Stand-aloneOther conditions: Lupus NephritisView official trial listing → -
Completed NCT NCT02635386
EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)
Not yet reported Woman's 119 participants Est. completion 2020-10-09 1 site Stand-aloneOther conditions: Polycystic Ovary Syndrome, ObesityView official trial listing → -
Completed NCT NCT02638259
Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis
Not yet reported Sandoz 376 participants Est. completion 2017-06-12 92 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT02641990
Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects
Not yet reported Intarcia Therapeutics 28 participants Est. completion 2016-02 2 sites Stand-aloneOther conditions: Healthy Adult Premenopausal Female VolunteersView official trial listing → -
Completed NCT NCT02644395
Thiazide Diuretics for Hypertension in Kidney Transplant Recipients Using Tacrolimus
Not yet reported Erasmus Medical Center 49 participants Est. completion 2016-12-19 1 siteOther conditions: Hypertension, Kidney TransplantationView official trial listing → -
Completed NCT NCT02646319
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations
Not yet reported Mayo Clinic 2 participants Est. completion 2018-04-24 2 sitesOther conditions: Advanced Malignant Neoplasm, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma, Malignant Uterine Neoplasm, Recurrent Bladder Carcinoma, Recurrent Breast Carcinoma, Recurrent Cervical Carcinoma, Recurrent Head and Neck Carcinoma, Recurrent Malignant Neoplasm, Recurrent Ovarian Carcinoma, Recurrent Prostate Carcinoma, Recurrent Renal Cell Carcinoma, Solid Neoplasm, Stage III Bladder Cancer, Stage III Prostate Cancer, Stage III Renal Cell Cancer, Stage IIIA Breast Cancer, Stage IIIA Cervical Cancer, Stage IIIA Ovarian Cancer, Stage IIIB Breast Cancer, Stage IIIB Cervical Cancer, Stage IIIB Ovarian Cancer, Stage IIIC Breast Cancer, Stage IIIC Ovarian Cancer, Stage IV Breast Cancer, Stage IV Ovarian Cancer, Stage IV Prostate Cancer, Stage IV Renal Cell Cancer, Stage IVA Bladder Cancer, Stage IVA Cervical Cancer, Stage IVB Bladder Cancer, Stage IVB Cervical CancerView official trial listing → -
Completed NCT NCT02652468
TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma
Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2021-09-17 1 site Stand-aloneOther conditions: LymphomaView official trial listing → -
Terminated NCT NCT02653196
A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors
Not yet reported Montefiore Medical Center 1 participants Est. completion 2017-08 1 site Stand-aloneOther conditions: Neuroepithelial Tumor, Solid Tumor, Allogeneic Hematopoietic Stem Cell TransplantationView official trial listing → -
Completed NCT NCT02656082
Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
Not yet reported University of Leeds 25 participants Est. completion 2017-12-31 1 site Stand-aloneOther conditions: Lupus Erythematosus, Discoid, Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Chronic CutaneousView official trial listing → -
Completed NCT NCT02660684
Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor
Not yet reported Astellas Pharma Korea, Inc. 39 participants Est. completion 2010-02 3 sites Stand-aloneOther conditions: Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT02661035
Allo HSCT Using RIC for Hematological Diseases
Not yet reported Masonic Cancer Center, University of Minnesota 156 participants Est. completion 2023-05-29 1 site Stand-aloneOther conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Plasma Cell Leukemia, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Leukemia, Lymphoblastic Lymphoma, Burkitt's Lymphoma, Non-Hodgkin's Lymphoma, Multiple Myeloma, Myeloproliferative Syndromes, Hematological DiseasesView official trial listing → -
Status unknown NCT NCT02663323
Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System
Not yet reported Meril Life Sciences Pvt. Ltd. 64 participants Est. completion 2020-07-05 4 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02663622
Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)
Not yet reported Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 44 participants Est. completion 2021-05-18 4 sites Stand-aloneOther conditions: Graft Versus Host Disease, Hematopoietic Stem Cell Transplantation, LeukemiaView official trial listing → -
Completed NCT NCT02664441
Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity
Not yet reported Seattle Children's Hospital 42 participants Est. completion 2020-07-31 3 sitesOther conditions: Hypothalamic ObesityView official trial listing → -
Status unknown NCT NCT02671318
Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence
Not yet reported Hospital do Rim e Hipertensão 250 participants Est. completion 2020-08 1 siteOther conditions: Cytomegalovirus InfectionsView official trial listing → -
Status unknown NCT NCT02675153
To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture
Not yet reported The Second Hospital of Nanjing Medical University 15 participants Est. completion 2020-10 1 site Stand-aloneOther conditions: Crohn's DiseasesView official trial listing → -
Terminated NCT NCT02678143
Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease
Not yet reported Washington University School of Medicine 1 participants Est. completion 2021-11-16 1 site Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Withdrawn NCT NCT02680717
Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea
Not yet reported Medical College of Wisconsin Est. completion 2017-05Other conditions: SclerodermaView official trial listing → -
Completed NCT NCT02681016
Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCE
Not yet reported Meshalkin Research Institute of Pathology of Circulation 610 participants Est. completion 2017-07 1 site Stand-aloneCardiovascular disease Other conditions: Ischemic Heart Disease, Coronary Atherosclerosis, Coronary Artery StenosisView official trial listing → -
Completed NCT NCT02683291
Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients
Not yet reported Associação Médico Espírita de Botucatu 48 participants Est. completion 2016-01 Stand-aloneOther conditions: Disorder Related to Renal Transplantation, Cytomegalovirus InfectionsView official trial listing → -
Completed NCT NCT02685852
Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia
Not yet reported University of Minnesota 11 participants Est. completion 2019-07-22 1 site Stand-aloneOther conditions: Hyperinsulinemic HypoglycemiaView official trial listing → -
Status unknown NCT NCT02687958
Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin
Not yet reported Gruppo Oncologico Italiano di Ricerca Clinica 30 participants Est. completion 2023-12 5 sitesOther conditions: Neuroendocrine CarcinomaView official trial listing → -
Completed NCT NCT02688829
The First-In-Man Pilot Study of Firehawk
Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 21 participants Est. completion 2015-01Other conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT02688881
Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors
Not yet reported Samsung Medical Center 6 participants Est. completion 2021-02-24 1 site Stand-aloneOther conditions: Refractory Solid TumorsView official trial listing → -
Completed NCT NCT02689479
11C-5-HTP PET in Clinical Islet Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 8 participants Est. completion 2014-09 2 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT02690883
Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy
Not yet reported Nanfang Hospital, Southern Medical University 92 participants Est. completion 2019-12-30 Stand-aloneOther conditions: Diabetic NephropathiesView official trial listing → -
Status unknown NCT NCT02690987
Gut Hormones in Obesity, Nicotine and Alcohol Dependence
Not yet reported Imperial College London 95 participants Est. completion 2020-08 1 site Stand-aloneOther conditions: Obesity, Smoking Cessation, AlcoholismView official trial listing → -
Completed NCT NCT02693158
The Direct III Post Market Study
Svelte Medical Systems, Inc. 440 participants Est. completion 2020-01 8 sitesCardiovascular diseaseView official trial listing → -
Withdrawn NCT NCT02694770
A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD
Not yet reported AbGenomics B.V Taiwan Branch Est. completion 2018-02 2 sitesOther conditions: Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell TransplantationView official trial listing → -
Status unknown NCT NCT02695459
Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin
Not yet reported The Netherlands Cancer Institute 39 participants Est. completion 2021-08 3 sitesOther conditions: Neuroendocrine CarcinomasView official trial listing → -
Status unknown NCT NCT02698852
A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)
Not yet reported Sino Medical Sciences Technology Inc. 1000 participants Est. completion 2025-12 1 siteCardiovascular diseaseView official trial listing → -
Withdrawn NCT NCT02702960
Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Est. completion 2018-01-03 1 site Stand-aloneOther conditions: Fibrolamellar Hepatocellular Carcinoma, Hepatocellular Carcinoma (Fibrolamellar Variant), Hepatocellular CarcinomaView official trial listing → -
Completed NCT NCT02706678
Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients
Not yet reported Astellas Pharma China, Inc. 105 participants Est. completion 2012-08-01 9 sites Stand-aloneOther conditions: Renal Transplant RecipientsView official trial listing → -
Status unknown NCT NCT02707822
The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration
National Taiwan University Hospital 440 participants Est. completion 2018-12 1 siteOther conditions: Kidney Transplantation, Liver TransplantationView official trial listing → -
Completed NCT NCT02711202
Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation
Not yet reported Institute for Clinical and Experimental Medicine 20 participants Est. completion 2009-03Other conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT02711826
Treg Therapy in Subclinical Inflammation in Kidney Transplantation
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 32 participants Est. completion 2023-08-04 6 sites Stand-aloneOther conditions: Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant, Living Kidney DonorView official trial listing → -
Status unknown NCT NCT02722772
Efficacy of Intra-Articular Injection of Etanercept for Moderate and Severe Knee Osteoarthritis
Not yet reported First Affiliated Hospital of Harbin Medical University 60 participants Est. completion 2017-08 1 site Stand-aloneOsteoarthritisView official trial listing → -
Completed NCT NCT02723591
To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients
Not yet reported Astellas Pharma Global Development, Inc. 599 participants Est. completion 2019-06-14 30 sitesOther conditions: Kidney TransplantationView official trial listing → -
Terminated NCT NCT02723786
Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation
Not yet reported GlaxoSmithKline 7 participants Est. completion 2018-03-06 4 sites Stand-aloneOther conditions: Kidney Transplantation (Status Post)View official trial listing → -
Completed NCT NCT02723877
PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)
Not yet reported, Not yet reported PIQUR Therapeutics AG 41 participants Est. completion 2018-10-03 5 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Withdrawn NCT NCT02723981
COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials
Not yet reported IHF GmbH - Institut für Herzinfarktforschung Est. completion 2018-12 10 sites Stand-aloneOther conditions: Stable Angina, Unstable Angina, STEMI, NSTEMI, Coronary DiseaseView official trial listing → -
Completed NCT NCT02727608
Complement Inhibitor Eculizumab in Clinical Islet Transplantation
Not yet reported Uppsala University 3 participants Est. completion 2018-06 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Terminated NCT NCT02730715
Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients
University of Pennsylvania 30 participants Est. completion 2020-04 1 siteOther conditions: KIDNEY TRANSPLANTATIONView official trial listing → -
Status unknown NCT NCT02730923
Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)
Not yet reported, Not yet reported Centre Leon Berard 72 participants Est. completion 2024-12 12 sitesOther conditions: Endometrial Carcinoma, Metastatic Carcinoma, Hormone Receptor Positive TumorView official trial listing → -
Completed NCT NCT02732119
Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor.
Not yet reported, Not yet reported Novartis Pharmaceuticals 104 participants Est. completion 2020-02-25 25 sitesOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02735031
Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes
Not yet reported, Not yet reported Radboud University Medical Center 10 participants Est. completion 2018-04-09 1 siteOther conditions: Diabetes Mellitus, Type 1, HypoglycemiaView official trial listing → -
Completed NCT NCT02736227
Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation
Not yet reported Northwestern University 28 participants Est. completion 2021-03 1 site Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Withdrawn NCT NCT02741102
Uterine Transplant in Absolute Uterine Infertility (AUIF)
Not yet reported, Not yet reported Brigham and Women's Hospital Est. completion 2028-06 1 site Stand-aloneOther conditions: Female InfertilityView official trial listing → -
Completed NCT NCT02741323
Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 97 participants Est. completion 2022-05-10 10 sites Stand-aloneOther conditions: HIV Infections, Kidney DiseasesView official trial listing → -
Completed NCT NCT02742051
A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40 participants Est. completion 2020-03-14 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT02743247
Identification of Drug-drug Interaction Between Tacrolimus and Mycophenolate Mofetil in Healthy Adults
Not yet reported Seoul National University Hospital 18 participants Est. completion 2016-04 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT02744378
Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus
Not yet reported University of Peradeniya 68 participants Est. completion 2015-12Other conditions: Oral Lichen PlanusView official trial listing → -
Completed NCT NCT02749370
Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast
Not yet reported Amgen 80 participants Est. completion 2017-12-06 22 sites Stand-aloneOther conditions: Plaque PsoriasisView official trial listing → -
Status unknown NCT NCT02752529
The Establishment of Multiple Point Prediction Model About Tacrolimus Metabolic Differences Based on Genetic Network After Liver Transplantation and the Application of Multicenter
Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 415 participants 1 site Stand-aloneOther conditions: Cirrhosis, LiverView official trial listing → -
Completed NCT NCT02753309
A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
Not yet reported The University of Texas Health Science Center at San Antonio 33 participants Est. completion 2021-03-02 1 siteOther conditions: Bladder CancerView official trial listing → -
Status unknown NCT NCT02759822
Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias
Leonardo Javier Arcuri 30 participants 1 siteOther conditions: Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-LymphomaView official trial listing → -
Completed NCT NCT02766439
Rhupus Syndrome and Efficacy of Etanercept Treatment
Yang Beibei 6 participants Est. completion 2015-03Other conditions: Rhupus Syndrome, EtanerceptView official trial listing → -
Completed NCT NCT02766465
Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Not yet reported Medical College of Wisconsin 138 participants Est. completion 2023-08-02 35 sites Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Status unknown NCT NCT02768116
The Study of Active Transfer of Plaque Technique for Non-Left Main Coronary Bifurcation Lesions
Not yet reported Beijing Anzhen Hospital 316 participants Est. completion 2021-12 Stand-aloneOther conditions: Coronary Heart DiseaseView official trial listing → -
Status unknown NCT NCT02776202
HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen
Not yet reported National Guard Health Affairs 15 participants Est. completion 2019-12 1 site Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Completed NCT NCT02776644
Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan
Pfizer 1349 participants Est. completion 2017-12-30Other conditions: Renal Cell CarcinomaView official trial listing → -
Status unknown NCT NCT02779114
RETRO (REduction of Therapy in RA Patients in Ongoing Remission)
Not yet reported University of Erlangen-Nürnberg Medical School 318 participants Est. completion 2018-06 12 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Active, not recruiting NCT NCT02782546
Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation
Not yet reported Washington University School of Medicine 60 participants Est. completion 2028-02-13 1 site Stand-aloneOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT02787551
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
Not yet reported Sanofi 514 participants Est. completion 2018-11-17 124 sites Added to GLP-1Type 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT02790515
Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
Not yet reported St. Jude Children's Research Hospital 170 participants Est. completion 2026-07-01 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myeloid Sarcoma, Chronic Myeloid Leukemia (CML), Juvenile Myelomonocytic Leukemia (JMML), Myelodysplastic Syndrome (MDS), Non-Hodgkin Lymphoma (NHL)View official trial listing → -
Completed NCT NCT02794402
Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI
Not yet reported Uppsala University 44 participants Est. completion 2016-11 2 sitesOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT02794610
Ocular Penetration of Topical Tacrolimus Eye Drops
Not yet reported The Eye Center and The Eye Foundation for Research in Ophthalmology 10 participants Est. completion 2016-07 1 site Stand-aloneOther conditions: Ocular Penetration of Topical TacrolimusView official trial listing → -
Status unknown NCT NCT02799888
Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation
Not yet reported Affiliated Hospital to Academy of Military Medical Sciences 40 participants Est. completion 2017-04 1 site Stand-aloneOther conditions: Graft-versus-host Disease, Hematopoietic Stem Cell TransplantationView official trial listing → -
Status unknown NCT NCT02803905
Islet Transplant Alone in OMENtum
Not yet reported Lorenzo Piemonti 12 participants Est. completion 2024-12 1 siteOther conditions: Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1View official trial listing → -
Status unknown NCT NCT02805842
Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus
Not yet reported Rabin Medical Center 60 participants Est. completion 2018-08 1 siteOther conditions: Medication AdherenceView official trial listing → -
Status unknown NCT NCT02808065
Validation of Population Pharmacokinetic Model Derived From Healthy Volunteer in Kidney Transplant Recipients
Seoul National University Hospital 40 participants Est. completion 2016-10 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Active, not recruiting NCT NCT02811861
Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
Not yet reported Eisai Inc. 1069 participants Est. completion 2027-03-31 183 sitesOther conditions: Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT02812940
Single-centre Study of Everolimus as GvHD Prophylaxis After Post-Transplantation Cyclophosphamide After Allogeneic SCT
Not yet reported University of Cologne 19 participants Est. completion 2020-12 1 siteOther conditions: Graft-versus-Host DiseaseView official trial listing → -
Completed NCT NCT02820259
Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)
Rennes University Hospital 42 participants Est. completion 2017-04-07 1 siteOther conditions: Biliary Concentration of TacrolimusView official trial listing → -
Completed NCT NCT02821026
Omental Islet Transplant
Not yet reported, Not yet reported University of Alberta 4 participants Est. completion 2019-11-13 1 site Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT02821507
Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma
Not yet reported Leiden University Medical Center 70 participants Est. completion 2021-12 7 sites Stand-aloneObstructive sleep apneaView official trial listing → -
Terminated NCT NCT02829424
Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis
Not yet reported Assistance Publique Hopitaux De Marseille 78 participants Est. completion 2024-02-10 1 siteOther conditions: PsoriasisView official trial listing → -
Withdrawn NCT NCT02833506
Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Not yet reported Roswell Park Cancer Institute Est. completion 2019-08-15 1 site Stand-aloneOther conditions: Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Cancer, Stage IIIA Primary Peritoneal Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Cancer, Stage IIIB Primary Peritoneal Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Cancer, Stage IIIC Primary Peritoneal Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Cancer, Stage IV Primary Peritoneal CancerView official trial listing → -
Completed NCT NCT02833805
NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21 participants Est. completion 2021-07 1 site Stand-aloneOther conditions: Severe Aplastic Anemia, Aplastic Anemia, Bone Marrow Failure, ImmunosuppressionView official trial listing → -
Status unknown NCT NCT02836847
Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma
Not yet reported Shanghai Jiao Tong University School of Medicine 152 participants Est. completion 2020-12 1 siteOther conditions: Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder CancerView official trial listing → -
Status unknown NCT NCT02837003
3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation
Teikyo University 1500 participants Est. completion 2019-03 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT02837978
The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term Treatment
Not yet reported Qiang Shu 150 participants Est. completion 2022-12-30 1 site Stand-aloneOther conditions: Arthritis, RheumatoidView official trial listing → -
Status unknown NCT NCT02839941
Iguratimod in Kidney Transplant Recipients
Not yet reported The First Affiliated Hospital with Nanjing Medical University 60 participants Est. completion 2019-07 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT02842749
Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China
Not yet reported Novartis Pharmaceuticals 61 participants Est. completion 2024-02-22 5 sitesOther conditions: Pancreatic Neuroendocrine TumorsView official trial listing → -
Completed NCT NCT02843399
Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy
AstraZeneca 15498 participants Est. completion 2016-12-15 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT02843841
Polyclonal Antilymphocyte Globulin (ATG) & Intestinal Immune Barrier After Kidney Transplantation
Not yet reported Centre Hospitalier Universitaire de Besancon 63 participants Est. completion 2017-03-01 1 siteOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Status unknown NCT NCT02844270
Galaxy Rapamycin Drug-Eluting Bioresorbable Coronary Stent System First-in-man Study
Not yet reported Shanghai Bio-heart Biological Technology Co., Ltd. 45 participants Est. completion 2021-12Other conditions: Heart DiseasesView official trial listing → -
Status unknown NCT NCT02847403
Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients
Not yet reported Azienda Ospedaliero-Universitaria di Parma 40 participants Est. completion 2021-10-31 2 sites Stand-aloneOther conditions: Dysglycemia, Cognitive DeficitView official trial listing → -
Status unknown NCT NCT02853994
Safety and Efficacy of the DEVOIR Sirolimus-Coated Coronary Balloon in the Real-world Clinical Practice
MINVASYS 500 participants Est. completion 2018-09Other conditions: CADView official trial listing → -
Status unknown NCT NCT02854696
Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes
Not yet reported University Hospital, Grenoble 42 participants Est. completion 2023-12 11 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT02860923
Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
Not yet reported University Hospital, Bordeaux 42 participants Est. completion 2018-09-30 11 sites Stand-aloneOther conditions: Craniopharyngiomas, Hypothalamic ObesityView official trial listing → -
Active, not recruiting NCT NCT02861417
Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
Not yet reported M.D. Anderson Cancer Center 204 participants Est. completion 2028-08-31 1 site Stand-aloneOther conditions: Hematopoietic and Lymphoid Cell Neoplasm, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, Lymphoproliferative Disorder, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent High Risk Myelodysplastic Syndrome, Recurrent Hodgkin Lymphoma, Recurrent Myelodysplastic Syndrome, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell MyelomaView official trial listing → -
Completed NCT NCT02864706
SCHEDULE Follow Up Visit 5-7 yr
Not yet reported Novartis Pharmaceuticals 95 participants Est. completion 2017-09-25 6 sitesOther conditions: Heart TransplantationView official trial listing → -
Completed NCT NCT02866682
Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients
Not yet reported University of California, Los Angeles 176 participants Est. completion 2021-06-11 1 siteOther conditions: Renal Transplant RejectionView official trial listing → -
Completed NCT NCT02867800
Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
Not yet reported Monica Bhatia 24 participants Est. completion 2023-12-30 7 sites Stand-aloneOther conditions: Sickle Cell Disease, Graft Versus Host DiseaseView official trial listing → -
Completed NCT NCT02869087
The DESappear Study: Drug Eluting Scaffold
Not yet reported Elixir Medical Corporation 21 participants Est. completion 2021-04-30 11 sites Stand-aloneOther conditions: Peripheral Vascular DiseaseView official trial listing → -
Completed NCT NCT02870140
Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent
Not yet reported ECRI bv 1435 participants Est. completion 2020-08-26 23 sites Stand-aloneOther conditions: Coronary StenosisView official trial listing → -
Completed NCT NCT02870985
BIOTRONIK Orsiro Pre-Marketing Registration
Not yet reported Biotronik (Beijing) Medical Device Ltd. 440 participants Est. completion 2021-12 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02874924
Effect of mTOR Inhibition and Other Metabolism Modulating Interventions on the Elderly
Not yet reported The University of Texas Health Science Center at San Antonio 34 participants Est. completion 2018-09 1 siteOther conditions: AgingView official trial listing → -
Terminated NCT NCT02877082
Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients
Not yet reported Emory University 5 participants Est. completion 2017-07 1 site Stand-aloneOther conditions: Acute Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Graft Versus Host Disease, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Myeloproliferative Neoplasm, Small Lymphocytic LymphomaView official trial listing → -
Completed NCT NCT02877628
Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation
Rennes University Hospital 110 participants Est. completion 2018-12 1 siteOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT02880293
Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor
Not yet reported Memorial Sloan Kettering Cancer Center 44 participants Est. completion 2023-11-20 1 site Stand-aloneOther conditions: Hematologic MalignancyView official trial listing → -
Status unknown NCT NCT02882113
Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After Conversion
Not yet reported Seoul National University Hospital 60 participants Est. completion 2018-12 1 site Stand-aloneOther conditions: Liver DysfunctionView official trial listing → -
Completed NCT NCT02882828
PK Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®)
Not yet reported University Hospital, Limoges 134 participants Est. completion 2020-03 9 sites Stand-aloneOther conditions: AllograftView official trial listing → -
Completed NCT NCT02885610
Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
Not yet reported RemeGen Co., Ltd. 249 participants Est. completion 2019-07-09 1 site Stand-aloneOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT02890069
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
Not yet reported Novartis Pharmaceuticals 298 participants Est. completion 2022-02-22 25 sitesOther conditions: Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell CarcinomaView official trial listing → -
Completed NCT NCT02890160
A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II
Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 430 participants Est. completion 2024-10-03 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02891603
A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression
Not yet reported, Not yet reported H. Lee Moffitt Cancer Center and Research Institute 40 participants Est. completion 2022-04-18 2 sites Stand-aloneOther conditions: Graft Vs Host Disease, GVHDView official trial listing → -
Completed NCT NCT02892266
Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 124 participants Est. completion 2018-11-24 13 sitesOther conditions: Solid Organ Transplant Recipients, Parent(s)/Guardian of Referenced Transplant RecipientsView official trial listing → -
Completed NCT NCT02894606
Influence of Thymoglobuline on Phenotypic and Functional Profiles of B Lymphocytes in Renal Transplant Recipients
University Hospital, Brest 49 participants Est. completion 2018-05-22 2 sitesOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT02895672
GLP-1/Basal Insulin Combination Therapy
Albany College of Pharmacy and Health Sciences 150 participants Est. completion 2016-12Type 2 diabetesView official trial listing → -
Status unknown NCT NCT02908035
Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)
Not yet reported Mercator MedSystems, Inc. 100 participants Est. completion 2021-09 8 sitesOther conditions: Chronic Limb IschemiaView official trial listing → -
Withdrawn NCT NCT02909335
De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study
Not yet reported Rennes University Hospital Est. completion 2021-11 Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT02913261
Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation
Not yet reported Novartis Pharmaceuticals 310 participants Est. completion 2021-04-23 103 sitesOther conditions: Corticosteroid Refractory Acute Graft vs Host DiseaseView official trial listing → -
Completed NCT NCT02915107
The SORT OUT IX STEMI OCT Trial
Not yet reported Odense University Hospital 80 participants Est. completion 2023-09-01 3 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT02915783
A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease
Not yet reported Eisai Inc. 41 participants Est. completion 2021-11-02 8 sitesOther conditions: Non Clear Cell Renal Cell Carcinoma (nccRCC)View official trial listing → -
Status unknown NCT NCT02916680
Pancreatic Islet Transplantation in the Anterior Chamber of the Human Eye - a Pilot Study
Not yet reported University Hospital, Basel, Switzerland 4 participants Est. completion 2025-04 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT02917096
Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
Not yet reported City of Hope Medical Center 18 participants Est. completion 2023-08-31 1 site Stand-aloneOther conditions: Primary Myelofibrosis, Secondary MyelofibrosisView official trial listing → -
Completed NCT NCT02918292
Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)
Not yet reported Medical College of Wisconsin 32 participants Est. completion 2021-08-17 28 sites Stand-aloneOther conditions: Severe Aplastic AnemiaView official trial listing → -
Completed NCT NCT02921789
Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients
Not yet reported Astellas Pharma Global Development, Inc. 67 participants Est. completion 2021-05-18 23 sites Stand-aloneOther conditions: Kidney Transplantation, Primary Focal Segmental Glomerulosclerosis (FSGS)View official trial listing → -
Status unknown NCT NCT02929030
Clinical Performance of Nano Plus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease
Xijing Hospital 2500 participants Est. completion 2022-01 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT02936505
Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.
Not yet reported Vastra Gotaland Region 249 participants Est. completion 2026-10-30 5 sites Stand-aloneOther conditions: Lung Transplantation, AllograftsView official trial listing → -
Withdrawn NCT NCT02939365
Precision Medicine Offers Belatacept Monotherapy
Not yet reported University of California, San Francisco Est. completion 2022-12Other conditions: TransplantationView official trial listing → -
Completed NCT NCT02941224
First-in-human Evaluation of the SELUTION DCB, a Novel Sirolimus Coated Balloon in Peripheral Arteries
Not yet reported M.A. Med Alliance S.A. 50 participants Est. completion 2019-09 4 sites Stand-aloneOther conditions: Patients With Peripheral Artery Disease in the SFA or PAView official trial listing → -
Completed NCT NCT02953873
Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients
Not yet reported Medical University of South Carolina 25 participants Est. completion 2018-12-14 1 siteOther conditions: ImmunosuppressionView official trial listing → -
Terminated NCT NCT02954159
Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC
Not yet reported Medical College of Wisconsin 4 participants Est. completion 2019-01-31 1 siteOther conditions: Ulcerative ColitisView official trial listing → -
Completed NCT NCT02954198
Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients
Not yet reported Medical University of South Carolina 40 participants Est. completion 2018-12-27 1 siteOther conditions: ImmunosuppressionView official trial listing → -
Terminated NCT NCT02956005
Envarsus XR in African American Renal Transplant Recipients
Not yet reported Georgetown University 18 participants Est. completion 2018-09 1 siteOther conditions: Renal Transplant RecipientsView official trial listing → -
Status unknown NCT NCT02957552
Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation
Not yet reported University Hospital Tuebingen 7 participants Est. completion 2021-12 1 site Stand-aloneOther conditions: Pediatric Liver TransplantationView official trial listing → -
Completed NCT NCT02959918
Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid
Not yet reported Selecta Biosciences, Inc. 152 participants Est. completion 2019-01 13 sitesOther conditions: Gout Chronic, HyperuricemiaView official trial listing → -
Completed NCT NCT02960035
A Study of the MASEI in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis
Not yet reported Sun Yat-sen University 96 participants Est. completion 2018-10 1 site Stand-aloneOther conditions: SpondyloarthropathyView official trial listing → -
Completed NCT NCT02960646
Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2023-02-13 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Aplastic Anemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Plasma Cell Myeloma, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma, Therapy-Related Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT02961608
Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day.
Not yet reported Hospital Universitari de Bellvitge 25 participants Est. completion 2018-09 1 site Stand-aloneOther conditions: Kidney Transplant; ComplicationsView official trial listing → -
Active, not recruiting NCT NCT02962414
Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment
Not yet reported Novartis Pharmaceuticals 206 participants Est. completion 2026-12-30 67 sitesOther conditions: Tuberous Sclerosis ComplexView official trial listing → -
Completed NCT NCT02962492
An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes
Not yet reported University at Buffalo 70 participants Est. completion 2021-10-24 1 siteOther conditions: Evaluate Ketogenic StressView official trial listing → -
Terminated NCT NCT02963103
A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen
Not yet reported Astellas Pharma Korea, Inc. 13 participants Est. completion 2012-10 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT02970630
Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study
Not yet reported Chiesi Farmaceutici S.p.A. 28 participants Est. completion 2018-02-22 6 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT02972671
Trial of MiStent Compared to Xience in Japan
Not yet reported Micell Technologies 120 participants Est. completion 2022-04-30 10 sites Stand-aloneOther conditions: Coronary (Artery); DiseaseView official trial listing → -
Completed NCT NCT02973204
Circulating Tumor Cells and Tumor DNA in HCC and NET
University of Aarhus 167 participants Est. completion 2020-01-08 1 siteOther conditions: Carcinoma, Hepatocellular, Neuroendocrine TumorsView official trial listing → -
Completed NCT NCT02974244
Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
AstraZeneca 7000 participants Est. completion 2014-10-28 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT02974686
Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation
Not yet reported Washington University School of Medicine 1 participants Est. completion 2019-09 1 siteOther conditions: Kidney Transplant Rejection, Gastrointestinal Disorder, FunctionalView official trial listing → -
Completed NCT NCT02975882
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Not yet reported Children's Oncology Group 33 participants Est. completion 2024-12-31 21 sites Stand-aloneOther conditions: Childhood Solid Neoplasm, Recurrent Malignant Solid Neoplasm, Recurrent Primary Central Nervous System Neoplasm, Refractory Malignant Solid Neoplasm, Refractory Primary Central Nervous System NeoplasmView official trial listing → -
Active, not recruiting NCT NCT02979873
Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 84 participants Est. completion 2030-06-30 1 site Stand-aloneOther conditions: Severe Aplastic AnemiaView official trial listing → -
Completed NCT NCT02986139
Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis
Not yet reported Amgen 111 participants Est. completion 2017-10-09 30 sites Stand-aloneOther conditions: Arthritis, Rheumatoid; Arthritis, PsoriaticView official trial listing → -
Terminated NCT NCT02987959
Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas
Not yet reported Fox Chase Cancer Center 6 participants Est. completion 2020-07-24 1 siteOther conditions: Soft-tissue SarcomaView official trial listing → -
Completed NCT NCT02988466
Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT
Not yet reported Masonic Cancer Center, University of Minnesota 78 participants Est. completion 2025-03-24 1 site Stand-aloneOther conditions: Hematologic MalignanciesView official trial listing → -
Terminated NCT NCT02995330
Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3 participants Est. completion 2021-06-16 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT02999776
Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis
Not yet reported Pantec Biosolutions AG 30 participants Est. completion 2018-06 1 site Stand-aloneOther conditions: Psoriatic PlaqueView official trial listing → -
Status unknown NCT NCT03005236
AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation
Not yet reported University Hospital Birmingham NHS Foundation Trust 40 participants Est. completion 2019-10 Stand-aloneOther conditions: Kidney Transplant Failure and RejectionView official trial listing → -
Status unknown NCT NCT03008083
Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation
Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 2446 participants Est. completion 2022-10 1 siteOther conditions: Drug-Eluting Stents, Percutaneous Coronary InterventionView official trial listing → -
Status unknown NCT NCT03008148
Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM
Not yet reported, Not yet reported Johnpro Biotech, Inc. 288 participants Est. completion 2025-04 2 sitesOther conditions: GlioblastomaView official trial listing → -
Terminated NCT NCT03014297
Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression
Not yet reported Lowell Anthony, MD 17 participants Est. completion 2018-11-16 1 siteOther conditions: Neuroendocrine Tumors, EverolimusView official trial listing → -
Terminated NCT NCT03016260
RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis
TcLand Expression S.A. 250 participants Est. completion 2019-12-20 8 sitesOther conditions: RheumatoId ArthritisView official trial listing → -
Status unknown NCT NCT03016715
Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study
Not yet reported Premier Specialists, Australia 8 participants 1 site Stand-aloneObstructive sleep apnea Other conditions: Weber-Cockayne SyndromeView official trial listing → -
Completed NCT NCT03017352
Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases
Not yet reported Filip Krag Knop 108 participants Est. completion 2019-06 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03020589
Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients
Not yet reported University of North Carolina, Chapel Hill 97 participants Est. completion 2022-06-28 1 site Stand-aloneOther conditions: Renal TransplantView official trial listing → -
Completed NCT NCT03026465
Vessel Injury in Relation With Strut Thickness Assessed by OCT
Not yet reported Fundacion Investigacion Interhospitalaria Cardiovascular 50 participants Est. completion 2018-07-27 3 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03027856
The BIFSORB Pilot Study II
Not yet reported Aarhus University Hospital Skejby 20 participants Est. completion 2024-12-31 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Terminated NCT NCT03031470
Pilot Study of Reparixin for Early Allograft Dysfunction Prevention in Liver Transplantation
Not yet reported Dompé Farmaceutici S.p.A 40 participants Est. completion 2017-03-31 7 sitesOther conditions: Ischemia-reperfusion Injury in Liver Transplant, Early Allograft DysfunctionView official trial listing → -
Active, not recruiting NCT NCT03032406
CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer
Not yet reported Abramson Cancer Center at Penn Medicine 53 participants Est. completion 2027-01-01 1 siteOther conditions: Breast Cancer Stage IIBView official trial listing → -
Completed NCT NCT03032783
A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 51 participants Est. completion 2025-12-02 1 site Stand-aloneOther conditions: Hematopoietic and Lymphoid Cell NeoplasmView official trial listing → -
Status unknown NCT NCT03040934
Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)
Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 196 participants Est. completion 2023-10 1 siteOther conditions: Drug-Eluting Stents, Percutaneous Coronary Intervention, Tomography, Optical CoherenceView official trial listing → -
Suspended NCT NCT03042637
Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome
Southeast Renal Research Institute Est. completion 2021-12 1 siteOther conditions: Nephrotic SyndromeView official trial listing → -
Completed NCT NCT03045913
Genoss DES Prospective Multicenter Registry
Young Jin Youn, MD, PhD 2000 participants Est. completion 2022-12-31 17 sitesCardiovascular disease Other conditions: Myocardial IschemiaView official trial listing → -
Withdrawn NCT NCT03047200
Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression
Not yet reported Baylor Research Institute Est. completion 2017-01 1 siteOther conditions: Islet Cell Transplantation, Type 1 DiabetesView official trial listing → -
Active, not recruiting NCT NCT03047213
Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations
Not yet reported National Cancer Institute (NCI) 17 participants Est. completion 2026-11-12 20 sitesOther conditions: Locally Advanced Bladder Urothelial Carcinoma, Metastatic Transitional Cell Carcinoma, Metastatic Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7, Stage IV Bladder Urothelial Carcinoma AJCC v7View official trial listing → -
Completed NCT NCT03047733
Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo
Not yet reported Ajou University School of Medicine 12 participants Est. completion 2016-12-31 1 site Stand-aloneOther conditions: Dermatologic Disease, VitiligoView official trial listing → -
Completed NCT NCT03047980
Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
Not yet reported, Not yet reported Anne Comi, MD 10 participants Est. completion 2020-10-27 2 sites Stand-aloneOther conditions: Sturge-Weber SyndromeView official trial listing → -
Active, not recruiting NCT NCT03049189
Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients
Not yet reported ITM Solucin GmbH 324 participants Est. completion 2029-11 52 sitesOther conditions: Neuroendocrine TumorsView official trial listing → -
Terminated NCT NCT03060980
Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin
Not yet reported Intarcia Therapeutics 245 participants Est. completion 2018-01-26 101 sites Stand-aloneType 2 diabetesView official trial listing → -
Status unknown NCT NCT03062813
Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)
Not yet reported Guangdong Provincial People's Hospital 112 participants Est. completion 2020-03-31 1 site Stand-aloneOther conditions: Hepatitis B Virus Associated Nephrotic SyndromeView official trial listing → -
Terminated NCT NCT03063229
Energy Balance Following Islet Transplantation
Not yet reported University of Edinburgh 2 participants Est. completion 2019-10-23 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Terminated NCT NCT03065387
Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation
Not yet reported M.D. Anderson Cancer Center 84 participants Est. completion 2026-04-23 1 siteOther conditions: Advanced Malignant Solid Neoplasm, EGFR Gene Amplification, EGFR Gene Mutation, ERBB2 Gene Amplification, ERBB2 Gene Mutation, ERBB3 Gene Mutation, ERBB4 Gene Mutation, KRAS Gene Mutation, Metastatic Malignant Solid Neoplasm, Refractory Malignant Solid NeoplasmView official trial listing → -
Withdrawn NCT NCT03066466
Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT
Not yet reported Loyola University Est. completion 2021-02-28 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic SyndromeView official trial listing → -
Status unknown NCT NCT03067324
Quality Control of Pancreatic Islet Intended to Islet Graft Cells Intended to Stabilot Islet Graft Protocol
University Hospital, Grenoble 40 participants Est. completion 2021-07-01 8 sitesOther conditions: Pancreatic Islet Quality ControlView official trial listing → -
Completed NCT NCT03070301
A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors
Not yet reported Memorial Sloan Kettering Cancer Center 21 participants Est. completion 2024-01-31 5 sitesOther conditions: Neuroendocrine TumorsView official trial listing → -
Completed NCT NCT03072485
Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers
Not yet reported Anne Chang 10 participants Est. completion 2019-02-22 1 siteOther conditions: AgingView official trial listing → -
Completed NCT NCT03076151
Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation
Not yet reported University Hospital, Limoges 30 participants Est. completion 2019-07-31 5 sites Stand-aloneOther conditions: Transplantation, Kidney, PharmacokineticView official trial listing → -
Completed NCT NCT03083769
Functional Genetic Variants Affecting Tacrolimus Trough Levels and Side Effects in Chinese Renal Transplantation.
Southern Medical University, China 1502 participants Est. completion 2019-08-01 2 sitesOther conditions: TransplantationView official trial listing → -
Completed NCT NCT03083782
Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus
Not yet reported Thomas Jefferson University 12 participants Est. completion 2017-06-30 1 site Stand-aloneOther conditions: Venous Thromboembolism, Pharmacokinetics, HealthyView official trial listing → -
Terminated NCT NCT03088709
Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide
Not yet reported Loyola University 5 participants Est. completion 2022-01-31 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome, Non-hodgkin Lymphoma, Chronic Lymphocytic LeukemiaView official trial listing → -
Completed NCT NCT03091465
Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib
Spanish Oncology Genito-Urinary Group 530 participants Est. completion 2017-04-17 57 sitesOther conditions: Metastatic Renal Cell CarcinomaView official trial listing → -
Withdrawn NCT NCT03095547
Drug/Drug Interactions With F901318
Not yet reported F2G Ltd Est. completion 2017-10 Stand-aloneOther conditions: Invasive AspergillosisView official trial listing → -
Completed NCT NCT03096782
Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma
Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2022-09-20 1 site Stand-aloneOther conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chemotherapy-Related Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Hodgkin Lymphoma, Langerhans Cell Histiocytosis, Minimal Residual Disease, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts, Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Myelodysplastic Syndrome, Small Lymphocytic Lymphoma, Therapy-Related Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT03099122
A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant
Not yet reported Sanofi 115 participants Est. completion 2019-11-12 1 site Stand-aloneOther conditions: End-stage Renal DiseaseView official trial listing → -
Completed NCT NCT03100734
Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel
Biogen 585 participants Est. completion 2018-11-30 1 siteOther conditions: Rheumatoid Arthritis, Axial SpondyloarthritisView official trial listing → -
Status unknown NCT NCT03105466
Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea
Not yet reported Zhongshan Ophthalmic Center, Sun Yat-sen University 50 participants Est. completion 2020-02 1 site Stand-aloneOther conditions: Corneal TransplantationView official trial listing → -
Active, not recruiting NCT NCT03114865
A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance
Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44 participants Est. completion 2026-12-30 1 siteOther conditions: Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma, Pre B-Cell Acute Lymphoblastic LeukaemiaView official trial listing → -
Active, not recruiting NCT NCT03118492
Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis
Not yet reported City of Hope Medical Center 22 participants Est. completion 2027-04-29 1 site Stand-aloneOther conditions: Secondary MyelofibrosisView official trial listing → -
Withdrawn NCT NCT03120000
PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma
Not yet reported PIQUR Therapeutics AG Est. completion 2019-12 4 sitesOther conditions: Primary Central Nervous System LymphomaView official trial listing → -
Active, not recruiting NCT NCT03121014
Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes
Not yet reported University of Illinois Chicago 38 participants Est. completion 2026-11 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Myelodysplastic SyndromesView official trial listing → -
Completed NCT NCT03125772
Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics
Not yet reported Fortis Escorts Heart Institute 1830 participants Est. completion 2016-05 1 siteType 2 diabetes Other conditions: Coronary Heart DiseaseView official trial listing → -
Completed NCT NCT03128359
High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant
Not yet reported City of Hope Medical Center 38 participants Est. completion 2021-09-15 1 site Stand-aloneOther conditions: Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Graft Versus Host Disease, Hodgkin Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, Secondary Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT03129126
The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis
Not yet reported Lipella Pharmaceuticals, Inc. 13 participants Est. completion 2023-09-29 9 sites Stand-aloneOther conditions: Hemorrhagic CystitisView official trial listing → -
Completed NCT NCT03131934
Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant
Not yet reported University College, London 4 participants Est. completion 2026-03-12 2 sites Stand-aloneOther conditions: Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic MalignancyView official trial listing → -
Completed NCT NCT03140449
Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis
Not yet reported National Taiwan University Hospital 52 participants Est. completion 2017-04-25Other conditions: Facial AngiofibromaView official trial listing → -
Completed NCT NCT03140462
Influence of Genetic Polymorphism of Donor on Tacrolimus Concentration in Liver Transplant
National Taiwan University Hospital 96 participants Est. completion 2020-12-31 2 sitesOther conditions: Liver TransplantationView official trial listing → -
Status unknown NCT NCT03147157
The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation
Not yet reported The First Hospital of Jilin University 120 participants Est. completion 2025-04 Stand-aloneOther conditions: Liver Transplantation, Graft Versus Host Disease, Graft Rejection, Drug-Related Side Effects and Adverse ReactionsView official trial listing → -
Active, not recruiting NCT NCT03150914
Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial
Not yet reported University of Cincinnati 60 participants Est. completion 2025-06-30 8 sitesOther conditions: LAM, LymphangioleiomyomatosisView official trial listing → -
Completed NCT NCT03151005
The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
Not yet reported Xinqiao Hospital of Chongqing 70 participants Est. completion 2021-04-23 1 site Stand-aloneOther conditions: Polycystic Ovary Syndrome (PCOS), Overweight, ObesityView official trial listing → -
Completed NCT NCT03152019
Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT)
Not yet reported Hospices Civils de Lyon 50 participants Est. completion 2018-11-08 3 sitesOther conditions: Hemorrhagic Hereditary Telangiectasia (HHT)View official trial listing → -
Active, not recruiting NCT NCT03155620
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
Not yet reported National Cancer Institute (NCI) 1377 participants Est. completion 2027-01-06 172 sitesObstructive sleep apnea Other conditions: Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Histiocytic Sarcoma, Juvenile Xanthogranuloma, Langerhans Cell Histiocytosis, Malignant Glioma, Recurrent Ependymoma, Recurrent Ewing Sarcoma, Recurrent Glioma, Recurrent Hepatoblastoma, Recurrent Langerhans Cell Histiocytosis, Recurrent Malignant Germ Cell Tumor, Recurrent Malignant Solid Neoplasm, Recurrent Medulloblastoma, Recurrent Neuroblastoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Peripheral Primitive Neuroectodermal Tumor, Recurrent Primary Central Nervous System Neoplasm, Recurrent Rhabdoid Tumor, Recurrent Soft Tissue Sarcoma, Refractory Ewing Sarcoma, Refractory Glioma, Refractory Hepatoblastoma, Refractory Langerhans Cell Histiocytosis, Refractory Malignant Germ Cell Tumor, Refractory Malignant Solid Neoplasm, Refractory Medulloblastoma, Refractory Neuroblastoma, Refractory Non-Hodgkin Lymphoma, Refractory Peripheral Primitive Neuroectodermal Tumor, Refractory Primary Central Nervous System Neoplasm, Refractory Rhabdoid Tumor, Rhabdoid Tumor, Stage III Soft Tissue Sarcoma AJCC v7, Stage IV Soft Tissue Sarcoma AJCC v7, Wilms TumorView official trial listing → -
Completed NCT NCT03158389
NCT Neuro Master Match - N²M² (NOA-20)
Not yet reported, Not yet reported University Hospital Heidelberg 228 participants Est. completion 2023-02-22 13 sitesOther conditions: Glioblastoma, AdultView official trial listing → -
Completed NCT NCT03160261
Effect of Exenatide on Cortisol Secretion
Not yet reported University of Tartu 10 participants Est. completion 2017-12-28 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03161340
Immunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation Failure
Not yet reported Mehdi Yousefi 121 participants Est. completion 2018-06-20 2 sitesOther conditions: Recurrent Implantation FailureView official trial listing → -
Completed NCT NCT03162237
Safety and Efficacy Study of Islets Xenotransplantation
Not yet reported Wei Wang,MD 20 participants Est. completion 2018-12 1 site Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Completed NCT NCT03167411
Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
Not yet reported Theracos 20 participants Est. completion 2017-06-29 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT03171831
Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major
Not yet reported First Affiliated Hospital of Guangxi Medical University 30 participants Est. completion 2022-04-01 1 site Stand-aloneOther conditions: Thalassemia MajorView official trial listing → -
Status unknown NCT NCT03173820
Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients
Not yet reported Khon Kaen University 120 participants Est. completion 2018-06-30 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT03174171
Open-label Study on Treatment of Primary Aldosteronism With Everolimus
Not yet reported University Hospital, Basel, Switzerland 12 participants Est. completion 2018-06-25 1 siteOther conditions: Primary AldosteronismView official trial listing → -
Completed NCT NCT03176381
Tissue Predictors of Abiraterone Benefit
Tianjin Medical University Second Hospital 110 participants Est. completion 2023-11-01 1 siteOther conditions: Metastatic Castration-resistant Prostate CancerView official trial listing → -
Withdrawn NCT NCT03178955
Circadian RA Study in Rheumatoid Arthritis Subjects
University of California, Davis Est. completion 2019-08-16 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT03182192
GLP1R-imaging in Hypoglycemia
Not yet reported Radboud University Medical Center 12 participants Est. completion 2024-07-01 2 sitesOther conditions: HypoglycemiaView official trial listing → -
Status unknown NCT NCT03182231
GLP1-imaging Before and After Bariatric Surgery
Not yet reported, Not yet reported Radboud University Medical Center 12 participants Est. completion 2023-07-01 2 sitesType 2 diabetes Other conditions: Bariatric Surgery CandidateView official trial listing → -
Status unknown NCT NCT03182296
Visualizing Beta Cells in Patients With a History of Gestational Diabetes
Not yet reported Radboud University Medical Center 24 participants Est. completion 2026-01-01 1 siteOther conditions: Gestational DiabetesView official trial listing → -
Status unknown NCT NCT03185221
Cordimax China Post Market Surveillance
Not yet reported Shandong Branden Med.Device Co.,Ltd 3660 participants Est. completion 2020-06-20 1 siteOther conditions: Coronary Artery StenosisView official trial listing → -
Completed NCT NCT03188068
Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma
Not yet reported West China Hospital 30 participants Est. completion 2021-12-31 1 siteOther conditions: Kaposiform Hemangioendothelioma, Kasabach Merritt PhenomenonView official trial listing → -
Completed NCT NCT03189953
68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH
Not yet reported, Not yet reported Radboud University Medical Center 56 participants Est. completion 2021-05Other conditions: InsulinomaView official trial listing → -
Completed NCT NCT03190174
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Not yet reported, Not yet reported Sarcoma Oncology Research Center, LLC 34 participants Est. completion 2021-12-02 1 siteOther conditions: Ewing Sarcoma, PEComa, Epithelioid Sarcoma, Desmoid Tumor, Chordoma, Non Small Cell Lung Cancer, Urothelial Carcinoma, Melanoma, Renal Cell Carcinoma, Squamous Cell Carcinoma, Hepatocellular Carcinoma, Classical Hodgkin Lymphoma, Colorectal Cancer, MTOR Activating MutationView official trial listing → -
Active, not recruiting NCT NCT03192397
Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
Not yet reported, Not yet reported Roswell Park Cancer Institute 35 participants Est. completion 2027-05-21 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Complete Remission, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Chronic Myelomonocytic Leukemia in Remission, Graft Versus Host Disease, Hodgkin Lymphoma, Minimal Residual Disease, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma, Plasma Cell Myeloma, Severe Aplastic Anemia, Waldenstrom MacroglobulinemiaView official trial listing → -
Status unknown NCT NCT03192657
Basiliximab Treating Interstitial Pneumonia of CADM
Not yet reported RenJi Hospital 100 participants Est. completion 2020-06 1 site Stand-aloneOther conditions: Lung; Disease, Interstitial, With Fibrosis, DermatomyositisView official trial listing → -
Completed NCT NCT03193203
Pharmacokinetics, Safety, and Tolerability Study of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Male Subjects
Not yet reported Samsung Bioepis Co., Ltd. 50 participants Est. completion 2017-08-07 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT03194321
Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients
Not yet reported Cedars-Sinai Medical Center 20 participants Est. completion 2020-10-27 1 site Stand-aloneOther conditions: End Stage Renal DiseaseView official trial listing → -
Completed NCT NCT03198949
A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)
Not yet reported Yonsei University 23 participants Est. completion 2020-09-11 1 siteOther conditions: Epilepsy and Focal Cortical Dysplasia IIView official trial listing → -
Status unknown NCT NCT03199664
Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo
Not yet reported South Valley University 100 participants Est. completion 2018-12-01 1 siteOther conditions: VitiligoView official trial listing → -
Status unknown NCT NCT03204136
Tacrolimus Versus Methotrexate as Rescue Therapy for Refractory Inflammatory Bowel Disease
Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, China 60 participants Est. completion 2019-12-01 1 siteOther conditions: Inflammatory Bowel DiseasesView official trial listing → -
Status unknown NCT NCT03216447
A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant
Not yet reported Chang Gung Memorial Hospital 150 participants Est. completion 2025-09-30 1 site Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT03216967
Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.
Not yet reported University Hospital, Strasbourg, France 130 participants Est. completion 2024-08-01 15 sitesOther conditions: BK Virus Nephropathy After Kidney TransplantationView official trial listing → -
Status unknown NCT NCT03217669
Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy
Not yet reported Chao Huang 15 participants Est. completion 2025-08-01 2 sites Stand-aloneOther conditions: Advanced Solid Tumor, Non-small Cell Lung Cancer (NSCLC)View official trial listing → -
Completed NCT NCT03222687
Tacrolimus in Children With Henoch-Schönlein Purpura Nephritis
Not yet reported Shandong University 25 participants Est. completion 2017-05-31 Stand-aloneOther conditions: Henoch-Schönlein Purpura NephritisView official trial listing → -
Status unknown NCT NCT03225417
Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.
Not yet reported, Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 142 participants Est. completion 2024-12-31 8 sites Stand-aloneOther conditions: Hematopoietic Stem Cell Transplantation, Multiple MyelomaView official trial listing → -
Terminated NCT NCT03228576
Prospective Cohort of Kidney Transplanted Patients Receiving an Extended Releasing Tacrolimus-Everolimus Association
Poitiers University Hospital 16 participants Est. completion 2018-12-18 9 sitesOther conditions: Kidney Transplant, ImmunosuppressionView official trial listing → -
Completed NCT NCT03229265
Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer
Not yet reported The Rogosin Institute 8 participants Est. completion 2019-08-07 1 site Stand-aloneOther conditions: Hyperkalemia, Kidney TransplantView official trial listing → -
Completed NCT NCT03232112
Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?
Not yet reported Anders Fink-Jensen, MD, DMSci 152 participants Est. completion 2020-10-05 1 siteAlcohol use disorder Other conditions: Addiction, AlcoholView official trial listing → -
Completed NCT NCT03234348
MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction
Not yet reported Hospital Clinic of Barcelona 151 participants Est. completion 2019-10-31 11 sites Stand-aloneCardiovascular disease Other conditions: Acute Coronary Syndrome, StentView official trial listing → -
Status unknown NCT NCT03234673
The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo
Not yet reported Assiut University 30 participants Est. completion 2019-01 Stand-aloneOther conditions: Vitiligo VulgarisView official trial listing → -
Status unknown NCT NCT03239015
Efficacy and Safety of Precision Therapy in Refractory Tumor
Not yet reported Baodong Qin 300 participants Est. completion 2023-12-31 1 siteOther conditions: Rare Tumor, Refractory TumorView official trial listing → -
Status unknown NCT NCT03239119
The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 456 participants Est. completion 2019-01-15Type 2 diabetesView official trial listing → -
Withdrawn NCT NCT03240822
Human Penile Tissue Allotransplantation for Devastating Penile and Concomitant Genital Trauma
Not yet reported Wake Forest University Health Sciences Est. completion 2025-12 Stand-aloneOther conditions: Urologic Injuries, Genital Diseases, Male, AmputationView official trial listing → -
Completed NCT NCT03241043
Study to Evaluate Pharmacokinetic and Bioavailability of Envarsus® vs. Advagraf® in Liver Transplant Recipients
Not yet reported Universitätsklinikum Hamburg-Eppendorf 20 participants Est. completion 2019-04 1 siteOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT03245151
Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
Not yet reported, Not yet reported Eisai Inc. 64 participants Est. completion 2022-09-30 50 sitesOther conditions: Recurrent and Refractory Solid TumorsView official trial listing → -
Terminated NCT NCT03246906
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation
Not yet reported Fred Hutchinson Cancer Center 150 participants Est. completion 2025-05-03 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm, Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Recurrent Waldenstrom Macroglobulinemia, Hematologic and Lymphocytic Disorder, Blastic Plasmacytoid Dendritic Cell NeoplasmView official trial listing → -
Active, not recruiting NCT NCT03247088
Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
Not yet reported, Not yet reported M.D. Anderson Cancer Center 74 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid LeukemiaView official trial listing → -
Active, not recruiting NCT NCT03249831
A Blood Stem Cell Transplant for Sickle Cell Disease
Not yet reported City of Hope Medical Center 3 participants Est. completion 2027-01-25 1 site Stand-aloneOther conditions: Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies, Thalassemia, Anemia, Sickle CellView official trial listing → -
Completed NCT NCT03256864
Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant Recipient
Not yet reported Chang Gung Memorial Hospital 10 participants Est. completion 2020-05-30 1 site Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Status unknown NCT NCT03259256
Islet Allotransplantation for Type 1 Diabetic Patients
Not yet reported Second Affiliated Hospital of Guangzhou Medical University 5 participants Est. completion 2019-06-30 1 site Stand-aloneOther conditions: Type 1 DiabeticView official trial listing → -
Completed NCT NCT03263052
Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological AE and Improve QOL
University of Illinois Chicago 40 participants Est. completion 2020-01-01 1 siteOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Completed NCT NCT03263260
Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent
Scitech Produtos Medicos SA 2504 participants Est. completion 2024-01-21 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT03263559
Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)
Not yet reported Medical College of Wisconsin 95 participants Est. completion 2025-01-29 32 sites Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Active, not recruiting NCT NCT03266393
Envarsus XR® in Adolescent Renal Transplant Recipients
Not yet reported University of California, Los Angeles 28 participants Est. completion 2023-03-31 1 site Stand-aloneOther conditions: Kidney Transplantation, Renal Transplantation, Grafting, KidneyView official trial listing → -
Completed NCT NCT03270462
CNS Study of Patients Switching From Tacrolimus to Envarsus
Not yet reported University of Colorado, Denver 20 participants Est. completion 2020-06-02 1 siteOther conditions: Renal Transplant PatientsView official trial listing → -
Completed NCT NCT03270748
Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies
Not yet reported Gruppo Italiano Trapianto di Midollo Osseo 78 participants Est. completion 2022-11-20 33 sites Stand-aloneOther conditions: Myeloid MalignanciesView official trial listing → -
Completed NCT NCT03273088
Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects
Not yet reported AryoGen Pharmed Co. 34 participants Est. completion 2017-03-15 1 site Stand-aloneOther conditions: Phase 1, BioequivalenceView official trial listing → -
Status unknown NCT NCT03277430
Uterus Transplantation From Live Donors and From Deceased Donors - Clinical Study
Not yet reported Institute for Clinical and Experimental Medicine 20 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Mayer Rokitansky Kuster Hauser Syndrome, Mullerian Aplasia, Uterus; Absence, Congenital, Infertility, Female, Uterus Absence, Acquired, Absolute Uterine Factor InfertilityView official trial listing → -
Completed NCT NCT03285802
Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation
Not yet reported, Not yet reported Greater Baltimore Medical Center 1 participants Est. completion 2019-02-12 1 siteOther conditions: Uterine CancerView official trial listing → -
Status unknown NCT NCT03287076
Trial of EXenatide in Acute Ischaemic Stroke
Not yet reported Neuroscience Trials Australia 350 participants Est. completion 2021-12-31 15 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT03287167
Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease
Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 1720 participants Est. completion 2023-07-30 1 siteOther conditions: Coronary Disease, Drug Eluting Stent, Percutaneous Coronary Intervention, Dual Antiplatelet TherapyView official trial listing → -
Completed NCT NCT03289650
Extended Release Tacrolimus vs. Twice-Daily Tacrolimus
Not yet reported Lorenzo Gallon 29 participants Est. completion 2021-02-23 1 siteOther conditions: End Stage Renal Disease, Rejection of Renal TransplantView official trial listing → -
Status unknown NCT NCT03292445
Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation
Not yet reported Samuel Strober 24 participants Est. completion 2024-02-14 2 sites Stand-aloneOther conditions: Immune ToleranceView official trial listing → -
Enrolling by invitation NCT NCT03292861
The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients
Not yet reported Cedars-Sinai Medical Center 60 participants Est. completion 2026-03-31 2 sitesOther conditions: Heart TransplantationView official trial listing → -
Withdrawn NCT NCT03298958
Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer
Not yet reported The University of Texas Health Science Center at San Antonio Est. completion 2022-05-01 1 siteOther conditions: Bladder CancerView official trial listing → -
Completed NCT NCT03304678
Discovery of Sirolimus Sensitive Biomarkers in Blood
Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 33 participants Est. completion 2025-03-14 1 siteOther conditions: LymphangioleiomyomatosisView official trial listing → -
Withdrawn NCT NCT03315052
Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects
Not yet reported Montefiore Medical Center Est. completion 2022-01 Stand-aloneOther conditions: Acute Cellular Graft Rejection, Liver Transplant RejectionView official trial listing → -
Completed NCT NCT03315858
NFAT-regulated Gene Expression After Tacrolimus
Medical University of Graz 40 participants Est. completion 2021-11-29 1 siteOther conditions: NFAT Regulated Gene Expression in Tacrolimus Treated PatientsView official trial listing → -
Terminated NCT NCT03320642
GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease
Not yet reported Incyte Corporation 84 participants Est. completion 2022-02-17 17 sites Stand-aloneOther conditions: Hematologic MalignanciesView official trial listing → -
Completed NCT NCT03327454
Benepali® PEN Patient Satisfaction Survey
Biogen 500 participants Est. completion 2018-06-21 38 sitesOther conditions: Rheumatoid Arthritis, SpondyloarthropathiesView official trial listing → -
Completed NCT NCT03328104
Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma
Not yet reported Emory University 8 participants Est. completion 2023-06-29 4 sitesOther conditions: Lymphoblastic Leukemia, Lymphoblastic LymphomaView official trial listing → -
Completed NCT NCT03331289
Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
Not yet reported The University of Texas Health Science Center at San Antonio 107 participants Est. completion 2022-11-04 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT03333694
Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)
Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2018-11-01 8 sitesOther conditions: Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)View official trial listing → -
Active, not recruiting NCT NCT03334617
Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy
Not yet reported AstraZeneca 528 participants Est. completion 2026-09-11 45 sitesOther conditions: Non-Small Cell Lung CancerView official trial listing → -
Completed NCT NCT03347357
Pharmacokinetics of Tacrolimus in Children
Not yet reported Shandong University 28 participants Est. completion 2017-09-30 Stand-aloneOther conditions: Nephrotic SyndromeView official trial listing → -
Completed NCT NCT03350191
A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients
Not yet reported Sanofi 13 participants Est. completion 2018-06-07 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT03352622
Pharmacogenomic in Colombian Patients With Rheumatoid Arthritis
Not yet reported Universidad de Antioquia 372 participants Est. completion 2020-09-17 1 siteOther conditions: Pharmacological ActionView official trial listing → -
Completed NCT NCT03352869
Research of Exenatide for Overweight/Obese PCOS Patients With IGR
Not yet reported RenJi Hospital 183 participants Est. completion 2018-07-31 1 site Stand-aloneOther conditions: Polycystic Ovary Syndrome, Overweight and Obesity, Disorder of Glucose RegulationView official trial listing → -
Completed NCT NCT03355794
A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
Not yet reported Children's Hospital Medical Center, Cincinnati 19 participants Est. completion 2022-07-31 7 sitesOther conditions: Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma, Bithalamic High Grade Glioma, Brainstem Glioma, Glioblastoma, Anaplastic AstrocytomaView official trial listing → -
Status unknown NCT NCT03358082
Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo
Not yet reported, Not yet reported Sohag University 100 participants Est. completion 2019-02-01 1 siteOther conditions: Vitiligo, TacrolimusView official trial listing → -
Terminated NCT NCT03363763
Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex
Not yet reported Aucta Pharmaceuticals, Inc 24 participants Est. completion 2023-03-24 8 sitesOther conditions: Angiofibroma of Face, Tuberous SclerosisView official trial listing → -
Status unknown NCT NCT03365141
Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo
Not yet reported The Catholic University of Korea 12 participants Est. completion 2018-09-15 1 site Stand-aloneOther conditions: Vitiligo, Treatment, Intralesional Injection, CorticosteroidView official trial listing → -
Status unknown NCT NCT03365869
A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis
Not yet reported Peking University People's Hospital 72 participants Est. completion 2019-06-30Other conditions: Systemic SclerosisView official trial listing → -
Completed NCT NCT03373227
Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen
Not yet reported Baylor Research Institute 50 participants Est. completion 2023-12-30 1 siteOther conditions: Heart Transplant Rejection, Graft Failure, Compliance, PatientView official trial listing → -
Active, not recruiting NCT NCT03373903
Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly
Not yet reported Restorbio Inc. 652 participants Est. completion 2018-07 1 siteOther conditions: Respiratory Tract InfectionsView official trial listing → -
Terminated NCT NCT03380936
Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients
Not yet reported University of Colorado, Denver 4 participants Est. completion 2019-10-16 1 siteOther conditions: Kidney Transplant RejectionView official trial listing → -
Status unknown NCT NCT03383068
Research of Intensive Metabolic Intervention Before Pregnancy in PCOS
Not yet reported RenJi Hospital 160 participants Est. completion 2020-06-30 1 site Stand-alonePrediabetes Other conditions: PCOSView official trial listing → -
Completed NCT NCT03383380
Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome
Not yet reported, Not yet reported Children's Hospital of Fudan University 30 participants Est. completion 2023-11-30 2 sitesOther conditions: Activated PI3K-delta Syndrome, Immunodeficiency PrimaryView official trial listing → -
Active, not recruiting NCT NCT03386305
Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant
Not yet reported, Not yet reported Albert Einstein Healthcare Network 35 participants Est. completion 2021-12-31 1 siteOther conditions: Post Liver TransplantView official trial listing → -
Completed NCT NCT03386539
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
Not yet reported Boston Children's Hospital 211 participants Est. completion 2023-05-17 25 sites Stand-aloneChronic kidney disease Other conditions: Pediatric Heart Transplantation, Immunosuppression, Cardiac Allograft Vasculopathy, Heart Transplant Failure and Rejection, Post-transplant Lymphoproliferative Disorder, Heart Transplant InfectionView official trial listing → -
Completed NCT NCT03388008
Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation
Not yet reported Washington University School of Medicine 27 participants Est. completion 2022-08-31 2 sites Stand-aloneOther conditions: Lung Transplant Rejection, Antibody-mediated RejectionView official trial listing → -
Completed NCT NCT03399994
Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES
Not yet reported Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS 137 participants Est. completion 2022-07-26 6 sitesCardiovascular disease Other conditions: DiabetesView official trial listing → -
Status unknown NCT NCT03408210
Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia
Not yet reported Affiliated Hospital to Academy of Military Medical Sciences 191 participants Est. completion 2022-08 1 site Stand-aloneOther conditions: Myelodysplastic Syndromes, Acute LeukemiaView official trial listing → -
Status unknown NCT NCT03408223
Total Marrow and Lymphoid Irradiation and Chemotherapy for High-Risk Acute Leukemia
Not yet reported Affiliated Hospital to Academy of Military Medical Sciences 100 participants Est. completion 2022-12 1 site Stand-aloneOther conditions: Acute LeukemiaView official trial listing → -
Completed NCT NCT03410654
Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.
Not yet reported Yale University 28 participants Est. completion 2024-07-01 1 site Stand-aloneOther conditions: Kidney Transplant; ComplicationsView official trial listing → -
Completed NCT NCT03413722
Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Calcineurin Inhibitors (CNIs) to Everolimus
University of Kansas Medical Center 30 participants Est. completion 2022-10-01 1 siteOther conditions: End Stage Renal DiseaseView official trial listing → -
Completed NCT NCT03415750
Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants
Not yet reported Edoardo Melilli 20 participants Est. completion 2020-05 1 site Stand-aloneOther conditions: Hypertrophy, Left VentricularView official trial listing → -
Terminated NCT NCT03419624
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients
Not yet reported Universitätsklinikum Hamburg-Eppendorf 13 participants Est. completion 2019-08-05 4 sites Stand-aloneType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT03423225
To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients
Not yet reported Kim, Seoung-Hoon 31 participants Est. completion 2017-12-14 Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Status unknown NCT NCT03425071
Monitoring Concentration and Pharmacodynamic Effects of Tacrolimus in Peripheral Blood Lymphocytes of Kidney Transplant Recipients
University of Sao Paulo General Hospital 45 participants Est. completion 2018-12 1 siteOther conditions: Kidney Transplantation, RejectionView official trial listing → -
Completed NCT NCT03426969
Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis
Not yet reported M.D. Anderson Cancer Center 3 participants Est. completion 2020-09-21 1 site Stand-aloneOther conditions: Primary Myelofibrosis, Secondary MyelofibrosisView official trial listing → -
Completed NCT NCT03433183
SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors
Not yet reported Sarcoma Alliance for Research through Collaboration 21 participants Est. completion 2023-10-01 5 sites Stand-aloneOther conditions: Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1View official trial listing → -
Terminated NCT NCT03436732
Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma
Not yet reported National Cancer Institute (NCI) 5 participants Est. completion 2019-04-30 1 siteOther conditions: MesotheliomaView official trial listing → -
Completed NCT NCT03437577
Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients
Not yet reported, Not yet reported University of Minnesota 18 participants Est. completion 2020-03-31 1 site Stand-aloneOther conditions: Kidney Transplant Failure and RejectionView official trial listing → -
Status unknown NCT NCT03438773
Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients
Not yet reported California Institute of Renal Research 50 participants Est. completion 2023-12 1 siteOther conditions: Kidney Transplant; Complications, Kidney Transplant Failure and RejectionView official trial listing → -
Completed NCT NCT03439462
Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer
Not yet reported, Not yet reported Aadi Bioscience, Inc. 60 participants Est. completion 2022-08-26 6 sites Stand-aloneOther conditions: Colorectal Cancer MetastaticView official trial listing → -
Completed NCT NCT03441958
ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma
Not yet reported, Not yet reported Ciusss de L'Est de l'Île de Montréal 19 participants Est. completion 2025-10-17 1 site Stand-aloneOther conditions: Multiple MyelomaView official trial listing → -
Completed NCT NCT03444064
PolyTreg Immunotherapy in Islet Transplantation
Not yet reported University of Alberta 11 participants Est. completion 2024-12-17 1 siteOther conditions: Diabetes, Diabetes Mellitus, Type 1View official trial listing → -
Active, not recruiting NCT NCT03451851
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants
Not yet reported Janssen Research & Development, LLC 120 participants Est. completion 2026-12-18 39 sitesOther conditions: PsoriasisView official trial listing → -
Status unknown NCT NCT03454724
Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease.
Not yet reported Meril Life Sciences Pvt. Ltd. 484 participants Est. completion 2024-12-01 Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03461445
Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients
Not yet reported University of California, Davis 64 participants Est. completion 2023-07-31 1 site Stand-aloneOther conditions: Kidney Transplant; Complications, Toxicity, Drug Toxicity, NeurotoxicityView official trial listing → -
Completed NCT NCT03464435
A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis
Not yet reported Zhongshan Ophthalmic Center, Sun Yat-sen University 20 participants Est. completion 2018-02-01 Stand-aloneOther conditions: Vernal KeratoconjunctivitisView official trial listing → -
Completed NCT NCT03465410
OPTImization of the Dose of tacroliMUS by Bayesian Prediction
Not yet reported NURIA LLOBERAS BLANCH 96 participants Est. completion 2020-09-21 2 sites Stand-aloneOther conditions: KIDNEY TRANSPLANTATIONView official trial listing → -
Completed NCT NCT03465969
A Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant Patients
Not yet reported Astellas Pharma Europe Ltd. 80 participants Est. completion 2018-09-14 4 sitesOther conditions: Kidney Transplantation, Liver TransplantationView official trial listing → -
Active, not recruiting NCT NCT03467386
Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia
Not yet reported City of Hope Medical Center 56 participants Est. completion 2027-04-12 1 site Stand-aloneOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT03468478
Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation
Not yet reported Hospital do Rim e Hipertensão 1209 participants Est. completion 2021-08-23 1 site Stand-aloneOther conditions: Kidney Transplant InfectionView official trial listing → -
Completed NCT NCT03471234
Latin America Real World Study With Inspiron Drug Eluting Stent - INSPIRON LATITUDE
Scitech Produtos Medicos SA 299 participants Est. completion 2022-08-02 2 sitesCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT03475563
BiOSS Study (BiOSS LIM C Stent Registry in Bifurcated Lesions)
Hospital Universitari Vall d'Hebron Research Institute 100 participants Est. completion 2019-12-30 3 sitesCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT03478215
Mesenchymal Stromal Cells in Living Donor Kidney Transplantation
Not yet reported The Methodist Hospital Research Institute 24 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: Renal Transplantation, Mesenchymal Stem CellsView official trial listing → -
Completed NCT NCT03480360
Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression
Not yet reported Dartmouth-Hitchcock Medical Center 21 participants Est. completion 2025-10-17 1 siteOther conditions: Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Myelodysplasia, Myeloproliferative Disorder, Myelofibrosis, Lymphoma, Lymphoma, Non-Hodgkin, Plasma Cell DisorderView official trial listing → -
Terminated NCT NCT03484234
Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-VII: Sirolimus-eluting (Ultimaster) vs. Everolimus-Eluting Stents (Xience)
Not yet reported Seung-Jung Park 36 participants Est. completion 2019-09-06 2 sitesCardiovascular disease Other conditions: Coronary StenosisView official trial listing → -
Completed NCT NCT03492580
A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
Janssen Research & Development, LLC 714582 participants Est. completion 2018-06-25 1 siteType 2 diabetesCardiovascular diseaseView official trial listing → -
No Longer Available NCT NCT03493165
Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)
The University of Texas Health Science Center at San AntonioOther conditions: Uterine SarcomaView official trial listing → -
Status unknown NCT NCT03500848
Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation
Not yet reported, Not yet reported Southern Medical University, China 130 participants Est. completion 2023-05-31 3 sites Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT03507205
Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents
Seoul National University Hospital 17286 participants Est. completion 2017-11-30 37 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT03511560
Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation
Not yet reported Columbia University 50 participants Est. completion 2021-07-17 1 site Stand-aloneOther conditions: Renal Transplant Rejection, Kidney Transplant Failure and RejectionView official trial listing → -
Completed NCT NCT03512431
Dose Adjustment of Tacrolimus Based on Home Sampling in Renal Transplant Recipients
Oslo University Hospital 27 participants Est. completion 2018-11-01 1 siteOther conditions: Renal Transplant RejectionView official trial listing → -
Terminated NCT NCT03512756
A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer
Not yet reported, Not yet reported Tyme, Inc 130 participants Est. completion 2021-12-28 20 sites Stand-aloneOther conditions: Pancreatic CancerView official trial listing → -
Active, not recruiting NCT NCT03513939
A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation
Not yet reported, Not yet reported Sernova Biotherapeutics Inc. 17 participants Est. completion 2026-10 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Completed NCT NCT03522298
Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma
Not yet reported Kazia Therapeutics Limited 30 participants Est. completion 2023-03-30 6 sitesOther conditions: Glioblastoma, AdultView official trial listing → -
Completed NCT NCT03525834
Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.
Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2020-09-25 5 sitesOther conditions: Renal AngiomyolipomaView official trial listing → -
Completed NCT NCT03527238
Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine
Not yet reported University of Florida 62 participants Est. completion 2021-08-31 3 sites Stand-aloneOther conditions: Liver Transplant, Kidney TransplantView official trial listing → -
Withdrawn NCT NCT03531281
Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
Not yet reported City of Hope Medical Center Est. completion 2022-12-30 1 site Stand-aloneOther conditions: Hematopoietic and Lymphoid Cell Neoplasm, Hematopoietic Cell Transplantation RecipientView official trial listing → -
Completed NCT NCT03535051
Efficiency of Fractional-Laser Resurfacing Followed by Topical Tacrolimus 0.03% Cream vs Tacrolimus Alone in Vitiligo
Not yet reported Kasr El Aini Hospital 27 participants Est. completion 2017-02-01 Stand-aloneOther conditions: Stable VitiligoView official trial listing → -
Status unknown NCT NCT03540472
Tacrolimus Treatment for Refractory PRCA
Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2020-06-10 1 site Stand-aloneOther conditions: Pure Red Cell AplasiaView official trial listing → -
Terminated NCT NCT03544242
Nitrite Infusion in Islet Cell Transplantation
Not yet reported University of Alabama at Birmingham 4 participants Est. completion 2019-06-27 1 siteOther conditions: DiabetesView official trial listing → -
Status unknown NCT NCT03548272
BiOSS LIM C vs 2nd Generation DES in Non-LM Bifurcations
Not yet reported Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland 518 participants Est. completion 2020-06 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT03549663
Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)
Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 108 participants Est. completion 2021-10 1 site Stand-aloneOther conditions: Idiopathic Membranous NephropathyView official trial listing → -
Terminated NCT NCT03555448
Once Daily Immunosuppression Regimen
Not yet reported Washington University School of Medicine 51 participants Est. completion 2023-11-10 1 siteOther conditions: Kidney Transplant; ComplicationsView official trial listing → -
Status unknown NCT NCT03557203
Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis
National Taiwan University Hospital 10 participants Est. completion 2019-05-31 1 siteOther conditions: Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, TacrolimusView official trial listing → -
Completed NCT NCT03558373
The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients
Chiesi Farmaceutici S.p.A. 158 participants Est. completion 2020-02-26 12 sitesOther conditions: Kidney TransplantView official trial listing → -
Status unknown NCT NCT03571438
Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors
Not yet reported University Hospital, Grenoble 100 participants Est. completion 2024-09-30 1 siteOther conditions: Kidney CancerView official trial listing → -
Completed NCT NCT03577431
Liver Transplantation With Tregs at MGH
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 9 participants Est. completion 2026-02-05 1 site Stand-aloneOther conditions: Liver TransplantView official trial listing → -
Status unknown NCT NCT03580239
Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency
Not yet reported Tianjin Medical University Second Hospital 120 participants Est. completion 2023-12-01 4 sitesOther conditions: Prostate CancerView official trial listing → -
Completed NCT NCT03582878
Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney Transplantation
Not yet reported Institute for Clinical and Experimental Medicine 238 participants Est. completion 2019-01-01 1 site Stand-aloneOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03583307
Efficacy and Safety of Sirolimus to Vascular Anomalies
Not yet reported West China Hospital 126 participants Est. completion 2021-02-19 1 site Stand-aloneOther conditions: Vascular AnomalyView official trial listing → -
Withdrawn NCT NCT03585946
Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis
Massachusetts General Hospital Est. completion 2040-12-31Other conditions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Drug ReactionView official trial listing → -
Status unknown NCT NCT03587922
FANTOM Post Market Clinical Trial
Not yet reported REVA Medical, Inc. 1500 participants Est. completion 2025-05-01 10 sitesCardiovascular diseaseView official trial listing → -
Terminated NCT NCT03591380
CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients
Not yet reported University of Wisconsin, Madison 3 participants Est. completion 2021-12-03 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Withdrawn NCT NCT03596970
Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients.
Not yet reported Novartis Pharmaceuticals Est. completion 2020-12Other conditions: Liver TransplantationView official trial listing → -
Terminated NCT NCT03600948
BIOFLOW-SV All Comers Registry
Biotronik AG 261 participants Est. completion 2021-10-06 2 sitesOther conditions: de Novo, Symptomatic Ischemic Heart Disease, Restenoses, CoronaryView official trial listing → -
Terminated NCT NCT03600961
BIOFLOW-SV Portugal Registry
Biotronik AG 173 participants Est. completion 2021-12-21 4 sitesOther conditions: Ischemic Heart DiseaseView official trial listing → -
Status unknown NCT NCT03601208
Mitra v Fingerprick Tacrolimus Creatinine
Not yet reported Nottingham University Hospitals NHS Trust 100 participants Est. completion 2019-01 Stand-aloneOther conditions: Transplant;Failure,KidneyView official trial listing → -
Withdrawn NCT NCT03602898
Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation
Not yet reported Fred Hutchinson Cancer Center Est. completion 2023-09-17 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid System Neoplasm, Myelodysplastic Syndrome, Myelofibrosis, Myeloproliferative Neoplasm, Recurrent Acute Myeloid Leukemia, Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Refractory Acute Myeloid Leukemia, Therapy-Related Acute Myeloid LeukemiaView official trial listing → -
Status unknown NCT NCT03603548
Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial
Not yet reported Medical University of Warsaw 200 participants Est. completion 2023-07-09 1 site Stand-aloneOther conditions: Liver Transplant Rejection, ImmunosuppressionView official trial listing → -
Withdrawn NCT NCT03605654
Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants
Not yet reported, Not yet reported Medeor Therapeutics, Inc. Est. completion 2026-10Other conditions: Kidney Transplant RejectionView official trial listing → -
Completed NCT NCT03605927
CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease
Not yet reported H. Lee Moffitt Cancer Center and Research Institute 45 participants Est. completion 2023-07-25 3 sites Stand-aloneOther conditions: Graft-versus-host-disease, GVHD, GVHD, AcuteView official trial listing → -
Terminated NCT NCT03610347
Paclitaxel Eluting Balloon After Bare Metal Stent Implantation vs. Drug-Eluting Stent in St Elevation Myocardial Infarction
Not yet reported Fundacion Investigacion Interhospitalaria Cardiovascular 199 participants Est. completion 2020-03-31 16 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT03614221
Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis
Not yet reported Chang Gung Memorial Hospital 22 participants Est. completion 2021-12-06 2 sites Stand-aloneOther conditions: Atopic DermatitisView official trial listing → -
Status unknown NCT NCT03616132
A First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System
Not yet reported Lifetech Scientific (Shenzhen) Co., Ltd. 15 participants Est. completion 2023-03-30 2 sites Stand-aloneOther conditions: Single Coronary Vessel DiseaseView official trial listing → -
Completed NCT NCT03618355
Trial of eRapa in Prostate Cancer Patients
Not yet reported Rapamycin Holdings, Inc. dba Emtora Biosciences 15 participants Est. completion 2019-12-02 1 site Stand-aloneOther conditions: Prostate CancerView official trial listing → -
Status unknown NCT NCT03621501
Direct Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel Disease
Not yet reported Erasmus Medical Center 1525 participants Est. completion 2026-10-31 1 siteOther conditions: Acute Coronary SyndromeView official trial listing → -
Completed NCT NCT03623217
Quality of Life Questionnaire Validation for Patients With Changed Tacrolimus Dosing After Kidney Transplantation
Astellas Pharma Korea, Inc. 56 participants Est. completion 2017-10-17 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT03626714
Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study
Not yet reported Auritec Pharmaceuticals 8 participants Est. completion 2019-01-05 1 site Stand-aloneOther conditions: Organ Transplant Rejection, PsoriasisView official trial listing → -
Completed NCT NCT03634020
DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System
Not yet reported Elixir Medical Corporation 44 participants Est. completion 2021-03-08 7 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Terminated NCT NCT03636373
Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout
Not yet reported Rutgers, The State University of New Jersey 5 participants Est. completion 2021-08-13 1 site Stand-aloneOther conditions: Gout AttackView official trial listing → -
Terminated NCT NCT03640026
Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients
Not yet reported Centre Hospitalier Departemental Vendee 61 participants Est. completion 2025-11-10 2 sites Stand-aloneOther conditions: Kidney Failure, ChronicView official trial listing → -
Completed NCT NCT03644485
Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients
Not yet reported Astellas Pharma China, Inc. 284 participants Est. completion 2022-07-15 14 sites Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT03644667
Tocilizumab in Cardiac Transplantation
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 385 participants Est. completion 2025-03-25 20 sites Stand-aloneOther conditions: Heart TransplantView official trial listing → -
Completed NCT NCT03645057
ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis
Not yet reported University of Rochester 92 participants Est. completion 2021-08-01 1 siteOther conditions: Atopic DermatitisView official trial listing → -
Terminated NCT NCT03645408
The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers
Not yet reported Boston Medical Center 8 participants Est. completion 2021-07-01 1 site Stand-aloneAlcohol use disorderView official trial listing → -
Terminated NCT NCT03654040
Liver Transplantation With Tregs at UCSF
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 42 participants Est. completion 2023-03-06 1 site Stand-aloneOther conditions: Liver TransplantView official trial listing → -
Completed NCT NCT03654794
Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells
Rennes University Hospital 26 participants Est. completion 2017-07-06 1 siteOther conditions: HemochromatosisView official trial listing → -
Completed NCT NCT03656926
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
Not yet reported Zambon SpA 169 participants Est. completion 2024-03-12 40 sitesOther conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft DysfunctionView official trial listing → -
Completed NCT NCT03657342
Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)
Not yet reported Zambon SpA 62 participants Est. completion 2024-04-16 39 sitesOther conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft DysfunctionView official trial listing → -
Terminated NCT NCT03660930
Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas
Not yet reported, Not yet reported University of Washington 19 participants Est. completion 2024-07-31 1 site Stand-aloneOther conditions: Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue SarcomaView official trial listing → -
Completed NCT NCT03663335
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients
Not yet reported Novartis Pharmaceuticals 418 participants Est. completion 2021-10-29 74 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Active, not recruiting NCT NCT03663933
Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation
Not yet reported National Cancer Institute (NCI) 71 participants Est. completion 2030-04-03 2 sites Stand-aloneOther conditions: Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders, Immune System Diseases, Common Variable ImmunodeficiencyView official trial listing → -
Completed NCT NCT03665766
Effect of Cyclosporine A Versus Tacrolimus on Response to Antiviral Therapy After Hepatitis C Genotype -4 Recurrence Post Liver Transplantation
Ain Shams University 126 participants Est. completion 2018-04-02Other conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT03666208
Sirolimus Coated Angioplasty Balloon in the Salvage of Thrombosed Arteriovenous Graft
Not yet reported Singapore General Hospital 20 participants Est. completion 2019-09-02 1 site Stand-aloneOther conditions: End Stage Renal Failure on Dialysis, Arteriovenous Graft OcclusionView official trial listing → -
Terminated NCT NCT03670030
A Study to testABI-009 in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System
Not yet reported Robert Ramirez 5 participants Est. completion 2021-02-26 1 siteOther conditions: Neuroendocrine TumorsView official trial listing → -
Status unknown NCT NCT03671733
Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients
Not yet reported Xiangya Hospital of Central South University 150 participants Est. completion 2022-09-01 1 site Stand-aloneOther conditions: ObesityView official trial listing → -
Status unknown NCT NCT03672110
Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen
Not yet reported Technische Universität Dresden 400 participants Est. completion 2025-12 1 site Stand-aloneOther conditions: Renal Failure, Renal Insufficiency, Renal Disease, Renal Insufficiency, ChronicView official trial listing → -
Completed NCT NCT03673527
Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin
Not yet reported LEO Pharma 24 participants Est. completion 2019-02-11 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT03674411
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
Not yet reported Masonic Cancer Center, University of Minnesota 22 participants Est. completion 2026-12-01 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Biphenotypic/Undifferentiated Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia, Relapsed Large Cell Lymphoma, Mantle Cell Lymphoma, Hodgkin Lymphoma, Burkitt Lymphoma, Relapsed T-Cell Lymphoma, Lymphoplasmacytic LymphomaView official trial listing → -
Completed NCT NCT03680092
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation
Not yet reported Dimitrios Tzachanis, MD PhD 43 participants Est. completion 2023-06-15 1 siteOther conditions: GVHD, Hematologic NeoplasmsView official trial listing → -
Status unknown NCT NCT03688191
Study of Sirolimus in CTD-TP in China
Not yet reported Peking Union Medical College Hospital 20 participants Est. completion 2019-09-30 1 site Stand-aloneOther conditions: Connective Tissue Diseases, ThrombocytopeniaView official trial listing → -
Terminated NCT NCT03689075
Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation
Not yet reported Imperial College Healthcare NHS Trust 35 participants Est. completion 2025-02-25 1 siteOther conditions: Kidney Transplant Failure, Allosensitization, ImmunosuppressionView official trial listing → -
Completed NCT NCT03696355
Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas
Not yet reported St. Jude Children's Research Hospital 27 participants Est. completion 2022-09-04 1 siteOther conditions: Brain and Central Nervous System TumorsView official trial listing → -
Active, not recruiting NCT NCT03697408
Itacitinib + Everolimus in Hodgkin Lymphoma
Not yet reported, Not yet reported University of Pennsylvania 23 participants Est. completion 2027-06 1 siteOther conditions: Classical Hodgkin LymphomaView official trial listing → -
Status unknown NCT NCT03698396
Islet Transplant in Patients With Type I Diabetes
Not yet reported, Not yet reported Kenneth Brayman, MD 10 participants Est. completion 2023-12-01 1 siteOther conditions: Diabetes Mellitus, Type 1View official trial listing → -
Completed NCT NCT03699631
PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant
Not yet reported Medical College of Wisconsin 29 participants Est. completion 2023-04-01 1 site Stand-aloneOther conditions: Hematologic MalignancyView official trial listing → -
Completed NCT NCT03703154
Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Immediate Release Tacrolimus to Slow Release Envarsus
University of Kansas Medical Center 30 participants Est. completion 2021-03-03 1 siteOther conditions: End Stage Renal DiseaseView official trial listing → -
Terminated NCT NCT03711929
LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye
Not yet reported Santen Inc. 145 participants Est. completion 2022-06-14 65 sitesOther conditions: Non Infectious UveitisView official trial listing → -
Completed NCT NCT03712878
2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 10 participants Est. completion 2025-03-19 1 site Stand-aloneOther conditions: Hematopoietic and Lymphoid Cell NeoplasmView official trial listing → -
Completed NCT NCT03713645
Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients
Not yet reported Temple University 36 participants Est. completion 2022-01-31 1 site Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Status unknown NCT NCT03715387
Tacrolimus for Malar Edema
Not yet reported, Not yet reported University of British Columbia 100 participants Est. completion 2019-07-01 1 site Stand-aloneOther conditions: Edema FaceView official trial listing → -
Status unknown NCT NCT03721614
Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions.
Not yet reported Meril Life Sciences Pvt. Ltd. 200 participants Est. completion 2022-06-22 Stand-aloneCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT03726307
Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study
Not yet reported Angus W. Thomson PhD DSc 28 participants Est. completion 2028-05 1 site Stand-aloneOther conditions: Kidney Transplant, Renal Transplant RecipientsView official trial listing → -
Completed NCT NCT03730142
A Study of WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma
Not yet reported Shanghai Jiatan Pharmatech Co., Ltd 82 participants Est. completion 2020-07-25 1 siteOther conditions: Advanced CancerView official trial listing → -
Completed NCT NCT03730428
Everolimus Related Pneumonitis in MBC
Fudan University 86 participants Est. completion 2020-06-15 1 siteOther conditions: Everolimus, PneumonitisView official trial listing → -
Completed NCT NCT03732248
Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders
Not yet reported Medical University of South Carolina 21 participants Est. completion 2020-01-20 1 siteAlcohol use disorderView official trial listing → -
Completed NCT NCT03734601
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation
Not yet reported Stanford University 22 participants Est. completion 2020-11-17 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorder, Chronic Lymphocytic Leukemia, B-cell Lymphoma, T-cell Lymphoma, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Chronic Myelomonocytic LeukemiaView official trial listing → -
Completed NCT NCT03737708
A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)
Not yet reported Astellas Pharma Korea, Inc. 21 participants Est. completion 2020-06-16 10 sites Stand-aloneOther conditions: Rheumatoid Arthritis (RA)View official trial listing → -
Terminated NCT NCT03740100
Single-arm Study With Bimiralisib in Patients With HNSCC Harboring NOTCH1 Loss of Function Mutations
Not yet reported M.D. Anderson Cancer Center 8 participants Est. completion 2020-12-09 1 siteOther conditions: HNSCCView official trial listing → -
Active, not recruiting NCT NCT03740334
Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL
Not yet reported Dana-Farber Cancer Institute 45 participants Est. completion 2027-04-30 12 sitesOther conditions: Acute Lymphoblastic Leukemia ALLView official trial listing → -
Status unknown NCT NCT03747614
Ocular Micro-vascular Research Base on Functional Slip Lamp Biomicroscopy
Not yet reported Zhongshan Ophthalmic Center, Sun Yat-sen University 20 participants Est. completion 2020-06-30 1 site Stand-aloneOther conditions: Dry Eye Syndromes, Inflammation, MicrovesselsView official trial listing → -
Completed NCT NCT03749356
Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients
Not yet reported Chong Kun Dang Pharmaceutical 141 participants Est. completion 2020-12-04 1 site Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT03751332
The Vienna Prograf and Endothelial Progenitor Cell Extension Study
Not yet reported Medical University of Vienna 87 participants Est. completion 2010-10Other conditions: Immunosuppression, Renal FailureView official trial listing → -
Completed NCT NCT03760263
Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus
Not yet reported Sentara Norfolk General Hospital 46 participants Est. completion 2023-11-01 1 siteOther conditions: Transplant;Failure,KidneyView official trial listing → -
Completed NCT NCT03762473
Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection
Not yet reported University of Alabama at Birmingham 89 participants Est. completion 2022-03-16 1 site Stand-aloneOther conditions: Renal Transplant InfectionView official trial listing → -
Completed NCT NCT03764670
Genetic Factors on Outcomes of Kidney Transplant Patients With Tacrolimus-based Therapy
National Taiwan University Hospital 98 participants Est. completion 2020-09-22 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT03767660
Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation
Not yet reported Peking Union Medical College Hospital 20 participants Est. completion 2022-07-01 1 siteOther conditions: Blue Rubber Bleb Nevus Syndrome, Venous MalformationView official trial listing → -
Status unknown NCT NCT03768518
GLP-1 Receptor Expression in CHI
Radboud University Medical Center 40 participants Est. completion 2019-02-01 1 siteOther conditions: Congenital HyperinsulinismView official trial listing → -
Status unknown NCT NCT03770663
Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung Disease
Not yet reported Assistance Publique - Hôpitaux de Paris 76 participants Est. completion 2024-01-02 1 site Stand-aloneOther conditions: Antisynthetase Syndrome (ASS), Interstitial Lung DiseaseView official trial listing → -
Completed NCT NCT03775824
Faecal Analyses in Rheumatoid Arthritis Therapy
Region Skane 50 participants Est. completion 2019-06-01Other conditions: Rheumatoid ArthritisView official trial listing → -
Active, not recruiting NCT NCT03778996
SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma
Not yet reported Sarcoma Oncology Research Center, LLC 31 participants Est. completion 2028-03-31 1 site Stand-aloneOther conditions: Sarcoma, Ewing, SarcomaView official trial listing → -
Active, not recruiting NCT NCT03779854
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Not yet reported Fred Hutchinson Cancer Center 45 participants Est. completion 2027-08-31 9 sites Stand-aloneOther conditions: Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blasts Under 25 Percent of Bone Marrow Nucleated Cells, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome/Acute Myeloid Leukemia, Burkitt Leukemia, Chronic Monocytic Leukemia, Lymphoblastic Lymphoma, Mast Cell Leukemia, Myeloproliferative NeoplasmView official trial listing → -
Completed NCT NCT03780959
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
Not yet reported, Not yet reported Amgen 69 participants Est. completion 1998-07-08 Stand-aloneOther conditions: Juvenile Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT03781050
Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome
Not yet reported Peking Union Medical College Hospital 10 participants Est. completion 2022-07-01 1 siteOther conditions: Peutz-Jeghers SyndromeView official trial listing → -
Terminated NCT NCT03781414
Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension
Not yet reported Novartis Pharmaceuticals 129 participants Est. completion 2023-04-20 29 sitesOther conditions: Liver Transplant RejectionView official trial listing → -
Status unknown NCT NCT03785431
Vascular Healing After Implantation of FANTOM Bioresorbable Scaffold in STEMI: A FANTOM STEMI Study
Not yet reported Medical University of Warsaw 20 participants Est. completion 2022-06-06 1 siteCardiovascular disease Other conditions: STEMI, Bioresorbable ScaffoldView official trial listing → -
Status unknown NCT NCT03789006
Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation
Not yet reported University of Khartoum 300 participants Est. completion 2024-03-21 1 siteOther conditions: Kidney Transplant RejectionView official trial listing → -
Status unknown NCT NCT03791827
Multicenter Registry of Pediatric Lupus Nephritis in China
Xiqiang Dang 1200 participants Est. completion 2024-11-30 1 siteOther conditions: Lupus Nephritis, Children, Steroid, Immunosuppressive TreatmentView official trial listing → -
Completed NCT NCT03794492
Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome
Not yet reported Chong Kun Dang Pharmaceutical 169 participants Est. completion 2023-04-27 1 site Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Active, not recruiting NCT NCT03797196
RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients
Not yet reported University Medical Center Groningen 374 participants Est. completion 2026-12 7 sites Stand-aloneOther conditions: Renal Transplant Recipients, Elderly Patients, ImmunosuppressionView official trial listing → -
Completed NCT NCT03799770
ONSD and Neurotoxicity in Liver Transplant
Mansoura University 100 participants Est. completion 2021-03-23 1 siteOther conditions: Liver Transplant; ComplicationsView official trial listing → -
Completed NCT NCT03800576
Clinical Outcome of Liver Transplant Patients With Tacrolimus-based Immunosuppression
National Taiwan University Hospital 113 participants Est. completion 2020-09-22 1 siteOther conditions: Liver TransplantationView official trial listing → -
Status unknown NCT NCT03804411
Prognostic Predictors of Response to Hypoglycemic Therapy
Not yet reported Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 800 participants Est. completion 2020-05 1 site Stand-aloneType 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT03816332
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
Not yet reported National Cancer Institute (NCI) 12 participants Est. completion 2027-09-17 7 sites Stand-aloneOther conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8, Metastatic Basal Cell Carcinoma, Metastatic Melanoma, Metastatic Merkel Cell Carcinoma, Metastatic Skin Squamous Cell Carcinoma, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage IIIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIB Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Pathologic Stage IV Cutaneous Melanoma AJCC v8, Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8, Unresectable Basal Cell Carcinoma, Unresectable Melanoma, Unresectable Merkel Cell CarcinomaView official trial listing → -
Completed NCT NCT03823768
Envarsus Neurotoxicity Burden in Liver Transplant Patients
Not yet reported Medical University of South Carolina 30 participants Est. completion 2024-01-30 1 siteOther conditions: Neurotoxicity, Liver Transplant; ComplicationsView official trial listing → -
Completed NCT NCT03828019
Adalimumab vs. Conventional Immunosuppression for Uveitis Trial
Not yet reported JHSPH Center for Clinical Trials 227 participants Est. completion 2024-09-09 26 sitesOther conditions: UveitisView official trial listing → -
Completed NCT NCT03828058
Envarsus XL Immunosuppression Following Liver Transplantation
Not yet reported Methodist Healthcare - Memphis 110 participants Est. completion 2020-12-31 1 siteOther conditions: Recipients of Liver TransplantView official trial listing → -
Status unknown NCT NCT03828682
Veloxis de Novo Kidney Transplant ECSWD
Not yet reported Simon Tremblay, PharmD, PhD 60 participants Est. completion 2022-06-30 2 sites Stand-aloneOther conditions: Kidney Transplantation, ImmunosuppressionView official trial listing → -
Completed NCT NCT03830255
Effect of Genetic Polymorphism on Calcineurin Inhibitors Levels in Egyptian Renal Transplant Patients
Helwan University 143 participants Est. completion 2020-03-29 1 siteOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT03834740
A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection
Not yet reported St. Joseph's Hospital and Medical Center, Phoenix 27 participants Est. completion 2022-02-18 3 sitesOther conditions: Glioblastoma Multiforme, Glioma of BrainView official trial listing → -
Terminated NCT NCT03839940
Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer
Not yet reported Alliance for Clinical Trials in Oncology 39 participants Est. completion 2022-08-03 319 sitesOther conditions: Malignant NeoplasmView official trial listing → -
Status unknown NCT NCT03840512
An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)
Not yet reported Kalytera Therapeutics Israel, Ltd. 36 participants Est. completion 2022-12-15 5 sites Stand-aloneOther conditions: Prevention aGVHDView official trial listing → -
Active, not recruiting NCT NCT03841097
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants
Not yet reported Roy D. Bloom, MD 60 participants Est. completion 2026-12 1 siteOther conditions: Kidney Transplant; ComplicationsView official trial listing → -
Active, not recruiting NCT NCT03842696
Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation
Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 43 participants Est. completion 2026-04-01 7 sites Stand-aloneOther conditions: Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase, Chronic Myelogenous Leukemia, Accelerated Phase, Chronic Myelogenous Leukemia, Blastic Phase, Myelodysplastic Syndromes, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Non Hodgkin Lymphoma, Graft Vs Host Disease, Graft-versus-host-diseaseView official trial listing → -
Terminated NCT NCT03856216
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2025-10-13 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Lymphocytic Neoplasm, LymphomaView official trial listing → -
Status unknown NCT NCT03864250
Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy
Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 124 participants Est. completion 2021-11 1 site Stand-aloneOther conditions: Tacrolimus, Idiopathic Membranous Nephropathy, Clinical TrialView official trial listing → -
Completed NCT NCT03864926
Envarsus in Delayed Graft Function (E-DGF)
Not yet reported University of Wisconsin, Madison 100 participants Est. completion 2022-07-22 1 site Stand-aloneOther conditions: Delayed Graft FunctionView official trial listing → -
Completed NCT NCT03865888
Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome
Not yet reported Pavly Moawd 60 participants Est. completion 2019-04-30 1 siteOther conditions: Dry Eye, Sjogren SyndromeView official trial listing → -
Status unknown NCT NCT03866681
Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNH
Not yet reported Peking Union Medical College Hospital 40 participants Est. completion 2022-04-01 1 site Stand-aloneOther conditions: Paroxysmal Nocturnal HemoglobinuriaView official trial listing → -
Completed NCT NCT03871361
Abatacept in Patients With Birdshot HLA A29 Uveitis
Not yet reported Universitaire Ziekenhuizen KU Leuven 15 participants Est. completion 2023-12-01 1 site Stand-aloneOther conditions: Eye Diseases, UveitisView official trial listing → -
Completed NCT NCT03880968
Treat-to-Target Strategy With Etanercept for Ankylosing Spondylitis
Second Affiliated Hospital, Zhejiang University, School of Medicine 311 participants Est. completion 2014-09-30Other conditions: Spondylitis, AnkylosingView official trial listing → -
Status unknown NCT NCT03882164
Blood-Bile Ratio Tacrolimus After Liver Transplantation
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 55 participants Est. completion 2020-05 1 siteOther conditions: Liver Transplant; Complications, Immunosuppression, Transplant Failure, Transplant; Complication, RejectionView official trial listing → -
Status unknown NCT NCT03886233
Treatment Outcome of Uveitis in Autoimmune Diseases
Assiut University 1 participants Est. completion 2021-02Other conditions: Autoimmune UveitisView official trial listing → -
Terminated NCT NCT03889496
Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin
Not yet reported Radboud University Medical Center 12 participants Est. completion 2021-06-14 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Completed NCT NCT03908450
Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter
Not yet reported InnoRa GmbH 70 participants Est. completion 2023-07-31 4 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT03910868
Impact of P-gp, MRP2, ENT-1 and CNT3 on the Blood Concentration / Intra-PBMC Concentration of Tacrolimus
Rennes University Hospital 60 participants Est. completion 2020-12-16 1 siteOther conditions: Liver Transplantation, Kidney TransplantationView official trial listing → -
Active, not recruiting NCT NCT03913026
UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia
Not yet reported Ciusss de L'Est de l'Île de Montréal 30 participants Est. completion 2027-06 1 site Stand-aloneOther conditions: High Risk Hematologic Malignancy, Cord Blood TransplantView official trial listing → -
Completed NCT NCT03916380
Drug Interaction With Envarsus XR and Grapefruit Juice
Shirley M. Tsunoda 11 participants Est. completion 2023-12-31 1 siteOther conditions: Kidney Transplant; Complications, Drug Interaction FoodView official trial listing → -
Status unknown NCT NCT03916432
HELIOS China Registry: Evaluation of the HELIOS Stent in a 'Real-World' Patient Population
Not yet reported Xijing Hospital 3000 participants Est. completion 2025-12-01 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT03918265
Tacrolimus Treatment for Refractory Autoimmune Cytopenia
Not yet reported Peking Union Medical College Hospital 80 participants Est. completion 2021-11-10 1 site Stand-aloneOther conditions: Autoimmune Hemolytic Anemia, Pure Red Cell Aplasia, Evans SyndromeView official trial listing → -
Active, not recruiting NCT NCT03922724
Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma
Not yet reported National Cancer Institute (NCI) 118 participants Est. completion 2030-10-31 2 sites Stand-aloneOther conditions: Peripheral T-cell Lymphomas, Lymphoproliferative Disorders, Immune System DiseasesView official trial listing → -
Completed NCT NCT03923114
Imaging Pituitary ActiVation by Exendin
Not yet reported Radboud University Medical Center 20 participants Est. completion 2024-04-03 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT03932539
Improving Immunosuppressive Therapy in Heart Transplantation
Fondazione IRCCS Policlinico San Matteo di Pavia 25 participants Est. completion 2021-12 4 sitesOther conditions: Rejection Heart Transplant, ImmunosuppressionView official trial listing → -
Active, not recruiting NCT NCT03933904
Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
Not yet reported University of Pennsylvania 7 participants Est. completion 2027-06-30 2 sites Stand-aloneOther conditions: Castleman Disease, Castleman's Disease, MulticentricView official trial listing → -
Completed NCT NCT03959241
TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)
Not yet reported Medical College of Wisconsin 431 participants Est. completion 2022-09-19 39 sites Stand-aloneOther conditions: Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia, LymphomaView official trial listing → -
Terminated NCT NCT03963024
Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT
Not yet reported IRCCS San Raffaele 9 participants Est. completion 2019-01-31 1 siteOther conditions: Irradiated Bone Marrow, Transplant-Related Hematologic Malignancy, Leukemia, Acute, Multiple Myeloma, Graft Vs Host DiseaseView official trial listing → -
Completed NCT NCT03968588
Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation
Not yet reported Ajou University School of Medicine 108 participants Est. completion 2017-06-14 4 sites Stand-aloneOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Completed NCT NCT03970044
Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.
Not yet reported Consano Clinical Research, LLC 67 participants Est. completion 2021-06-01 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT03972462
NPC-12G Gel 0.2% Sirolimus PK Bridging Study
Not yet reported Nobelpharma 12 participants Est. completion 2019-06-17 1 site Stand-aloneOther conditions: Bioavailability StudyView official trial listing → -
Withdrawn NCT NCT03978494
Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.
Not yet reported Sandoz Est. completion 2020-05-03 13 sites Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT03979365
Envarsus XR Compared to Immediate Release Tacrolimus
Not yet reported Mayo Clinic 261 participants Est. completion 2022-03-29 3 sitesOther conditions: Kidney Transplant RecipientsView official trial listing → -
Active, not recruiting NCT NCT03983850
Optimizing PTCy Dose and Timing
Not yet reported, Not yet reported National Cancer Institute (NCI) 105 participants Est. completion 2026-10-26 1 site Stand-aloneOther conditions: Graft Versus Host Disease, Hematologic NeoplasmsView official trial listing → -
Status unknown NCT NCT03987152
Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life
Not yet reported Radboud University Medical Center 75 participants Est. completion 2023-03-01 1 siteOther conditions: Vascular MalformationsView official trial listing → -
Terminated NCT NCT03995901
A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation
Not yet reported Talaris Therapeutics Inc. 15 participants Est. completion 2023-02-16 18 sitesOther conditions: Transplanted Organ RejectionView official trial listing → -
Active, not recruiting NCT NCT03997786
A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis
Not yet reported, Not yet reported Sun Pharmaceutical Industries Limited 135 participants Est. completion 2031-08-05 27 sites Stand-aloneOther conditions: Moderate-to-severe Chronic Plaque PsoriasisView official trial listing → -
Withdrawn NCT NCT04001231
Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus
Not yet reported AstraZeneca Est. completion 2021-07-02 Stand-aloneType 2 diabetesView official trial listing → -
Terminated NCT NCT04002115
Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML
Not yet reported Milton S. Hershey Medical Center 2 participants Est. completion 2022-11-07 1 site Stand-aloneOther conditions: Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT04009525
Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study
Not yet reported First Affiliated Hospital of Guangxi Medical University 823 participants Est. completion 2023-10-31 1 site Stand-aloneOther conditions: Thalassemia MajorView official trial listing → -
Status unknown NCT NCT04013620
CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction
Not yet reported Nantes University Hospital 48 participants Est. completion 2022-07-09 1 site Stand-aloneOther conditions: Chronic Kidney FailureView official trial listing → -
Status unknown NCT NCT04014595
PREPARE-CALC-COMBO: Severely Calcified Coronary Lesions Prepared With Rotational Atherectomy and Modified Balloons
Segeberger Kliniken GmbH 100 participants Est. completion 2025-07-31 1 siteCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT04018937
Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation
Not yet reported Emory University 43 participants Est. completion 2026-11 15 sites Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Completed NCT NCT04023760
Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients
Not yet reported University of Saskatchewan 14 participants Est. completion 2020-03-30 1 site Stand-aloneOther conditions: Pharmacokinetics, Kidney Transplant, Lung TransplantView official trial listing → -
Status unknown NCT NCT04027023
Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
Not yet reported Sciema UG 9 participants Est. completion 2021-05-31 2 sitesType 2 diabetesView official trial listing → -
Status unknown NCT NCT04029272
Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients
Not yet reported Peking Union Medical College Hospital 80 participants Est. completion 2020-12-31 1 site Stand-aloneOther conditions: Polycystic Ovary SyndromeView official trial listing → -
Completed NCT NCT04041219
Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients
Not yet reported Mayo Clinic 10 participants Est. completion 2019-10-08 1 site Stand-aloneOther conditions: Immunosuppression, Stem Cell Transplant, Bone Marrow TransplantView official trial listing → -
Status unknown NCT NCT04045171
Population Pharmacokinetics of Tacrolimus in Nephrotic Syndrome
The Third Xiangya Hospital of Central South University 200 participants Est. completion 2020-12-31Other conditions: Nephrotic Syndrome, Tacrolimus, PharmacokineticsView official trial listing → -
Completed NCT NCT04048161
Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome
Not yet reported The Children's Hospital of Zhejiang University School of Medicine 270 participants Est. completion 2023-07-12 12 sites Stand-aloneOther conditions: Nephrotic Syndrome in ChildrenView official trial listing → -
Completed NCT NCT04049552
RAPA-Keloid Study of Keloid Regression
Not yet reported The University of Texas Health Science Center at San Antonio 4 participants Est. completion 2021-05-02 1 siteOther conditions: KeloidView official trial listing → -
Status unknown NCT NCT04056962
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
Not yet reported West China Hospital 50 participants Est. completion 2024-10-28 1 site Stand-aloneOther conditions: Tacrolimus, Kaposiform Hemangioendothelioma, Tufted AngiomaView official trial listing → -
Terminated NCT NCT04063865
Everolimus Monotherapy as Immunosuppression After Liver Transplant
Not yet reported Indiana University 14 participants Est. completion 2020-07-02 1 siteOther conditions: Kidney FailureView official trial listing → -
Completed NCT NCT04066114
Treg Modulation With CD28 and IL-6 Receptor Antagonists
Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2023-09-14 7 sitesOther conditions: Living-Donor Kidney Transplant, Kidney Transplant RecipientsView official trial listing → -
Active, not recruiting NCT NCT04066348
TNF-α Treatment of Blast-Induced Tinnitus
Not yet reported Wayne State University 88 participants Est. completion 2027-02 4 sites Stand-aloneOther conditions: Tinnitus, Noise InducedView official trial listing → -
Status unknown NCT NCT04069065
Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)
Not yet reported Chong Kun Dang Pharmaceutical 146 participants Est. completion 2021-04-08 1 site Stand-aloneOther conditions: Liver TransplantView official trial listing → -
Status unknown NCT NCT04078750
PLATO - Medication Adherence in Transplant Recipients
Not yet reported University of British Columbia 99 participants Est. completion 2024-12-31 2 sites Stand-aloneOther conditions: Kidney Disease, Chronic, Medication Adherence, Renal Disease, Kidney Rejection TransplantView official trial listing → -
Status unknown NCT NCT04079374
Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel
Not yet reported Joint Stock Company "Farmak" 160 participants Est. completion 2023-12-03 10 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Withdrawn NCT NCT04080076
Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy
Not yet reported NephroNet, Inc. Est. completion 2024-09-06 1 siteOther conditions: Renal DiseaseView official trial listing → -
Completed NCT NCT04082416
Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)
Not yet reported RemeGen Co., Ltd. 335 participants Est. completion 2022-06-30 1 site Stand-aloneOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT04082910
Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells
Not yet reported, Not yet reported Chinese PLA General Hospital 30 participants Est. completion 2023-12-30 1 site Stand-aloneOther conditions: Solid Tumor, Hematological MalignancyView official trial listing → -
Completed NCT NCT04086745
A Study of Baricitinib in Participants With Rheumatoid Arthritis
Not yet reported Eli Lilly and Company 1050 participants Est. completion 2025-05-19 119 sitesOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT04094675
Sirolimus for Cowden Syndrome With Colon Polyposis
Not yet reported Ohio State University 5 participants Est. completion 2025-06-05 1 site Stand-aloneOther conditions: PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome, PTEN Hamartoma Syndrome, Cowden Syndrome, Bannayan Syndrome, Bannayan Zonana Syndrome, PolyposisView official trial listing → -
Terminated NCT NCT04095858
Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)
Not yet reported Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 11 participants Est. completion 2021-11-05 4 sites Stand-aloneOther conditions: Hematopoietic Stem Cell Transplantation, Acute Graft Versus Host Disease, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic SyndromesView official trial listing → -
Status unknown NCT NCT04101578
Clinical Prognosis and Progression of Myasthenia Gravis Patients
Da, Yuwei, M.D. 2000 participants Est. completion 2024-12-31 1 siteOther conditions: Myasthenia GravisView official trial listing → -
Completed NCT NCT04102943
Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.
Not yet reported Chong Kun Dang Pharmaceutical 128 participants Est. completion 2020-09-29 1 site Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT04103879
US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia
Not yet reported ExCellThera inc. 30 participants Est. completion 2026-02-28 3 sites Stand-aloneOther conditions: High Risk Hematological Malignancy, Cord Blood TransplantView official trial listing → -
Completed NCT NCT04104438
Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant
Not yet reported Fady M Kaldas, M.D., F.A.C.S. 71 participants Est. completion 2024-09-30 1 siteOther conditions: Asses Immunosuppression Modulation on Renal Recovery Post LTView official trial listing → -
Completed NCT NCT04107298
Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon
Not yet reported SurModics, Inc. 35 participants Est. completion 2024-01-30 8 sites Stand-aloneOther conditions: Peripheral Arterial Disease, Critical Lower Limb IschemiaView official trial listing → -
Completed NCT NCT04114097
The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover
Not yet reported Jacob Thyssen 36 participants Est. completion 2021-03-15 1 siteOther conditions: Atopic Dermatitis, Atopic EczemaView official trial listing → -
Completed NCT NCT04114188
Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)
Not yet reported Prof. Dr. Petra Reinke 68 participants Est. completion 2020-12-31 1 siteOther conditions: Renal Transplant RejectionView official trial listing → -
Status unknown NCT NCT04115423
A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Sungkyunkwan University 9508 participants Est. completion 2021-10-01 1 siteOther conditions: Infection, Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT04118075
PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT
Not yet reported Shanghai Jiao Tong University School of Medicine 23 participants Est. completion 2021-05-01 1 site Stand-aloneOther conditions: GVHD, AcuteView official trial listing → -
Withdrawn NCT NCT04127721
Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation
Not yet reported M.D. Anderson Cancer Center Est. completion 2020-09-22 1 site Stand-aloneOther conditions: Allogeneic Stem Cell Transplant Recipient, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell NeoplasmView official trial listing → -
Completed NCT NCT04128722
TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUN
Not yet reported University Hospital, Tours 12 participants Est. completion 2025-01-08 2 sites Stand-aloneOther conditions: Lingual Microcystic Lymphatic MalformationsView official trial listing → -
Status unknown NCT NCT04135989
Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES
Not yet reported Federico II University 2106 participants Est. completion 2024-10-24 13 sitesCardiovascular disease Other conditions: Acute Coronary Syndrome, Chronic Coronary SyndromeView official trial listing → -
Completed NCT NCT04138238
Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent
Sahajanand Medical Technologies Limited 1200 participants Est. completion 2022-05-31 26 sitesCardiovascular diseaseView official trial listing → -
Withdrawn NCT NCT04139915
Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly
Not yet reported Restorbio Inc. Est. completion 2019-11-15Other conditions: Clinically Symptomatic Respiratory IllnessView official trial listing → -
Active, not recruiting NCT NCT04141020
Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms
Not yet reported University of Miami 26 participants Est. completion 2027-11-01 1 site Stand-aloneOther conditions: Cerebral AneurysmView official trial listing → -
Status unknown NCT NCT04147390
Immunosuppression After Repeat Keratoplasty
Not yet reported, Not yet reported Shahid Beheshti University of Medical Sciences 58 participants Est. completion 2020-08 1 siteOther conditions: KeratopathyView official trial listing → -
Status unknown NCT NCT04150016
In-stent Repair and Vessel Reaction of STEMI Patients With OCT
Not yet reported Xijing Hospital 44 participants Est. completion 2021-12-01 1 site Stand-aloneCardiovascular disease Other conditions: Drug-eluting Stents, Percutaneous Coronary Intervention, Optical Coherence TomographyView official trial listing → -
Withdrawn NCT NCT04154735
Autologous Transplant Targeted Against Crohn's
Not yet reported Northwestern University Est. completion 2024-03 1 site Stand-aloneOther conditions: Crohn's DiseaseView official trial listing → -
Terminated NCT NCT04156204
Immunosuppressant Medication Dosed Daily After Kidney Transplant
Not yet reported University of Colorado, Denver 1 participants Est. completion 2020-11-27 1 site Stand-aloneOther conditions: Kidney Transplant Rejection, Medication AdherenceView official trial listing → -
Active, not recruiting NCT NCT04157153
First in Men Study: BIOMAG-I
Not yet reported Biotronik AG 116 participants Est. completion 2027-02 14 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT04168944
Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma
Not yet reported, Not yet reported RenJi Hospital 108 participants Est. completion 2022-09 Stand-aloneOther conditions: Hepatocellular CarcinomaView official trial listing → -
Terminated NCT NCT04172922
Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions
Not yet reported Nemours Children's Clinic 5 participants Est. completion 2024-02-15 2 sites Stand-aloneOther conditions: Vascular AnomalyView official trial listing → -
Completed NCT NCT04176380
RAPA-201 T Cell Therapy for Relapsed, Refractory Multiple Myeloma
Not yet reported Rapa Therapeutics LLC 15 participants Est. completion 2023-06-06 1 siteOther conditions: Relapsed, Refractory Multiple MyelomaView official trial listing → -
Active, not recruiting NCT NCT04177004
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
Not yet reported City of Hope Medical Center 52 participants Est. completion 2027-03-23 1 site Stand-aloneOther conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell NeoplasmView official trial listing → -
Completed NCT NCT04184947
Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists
University of Padova 10000 participants Est. completion 2020-02-29 1 siteType 2 diabetesView official trial listing → -
Status unknown NCT NCT04185350
Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma
Not yet reported Nanjing First Hospital, Nanjing Medical University 60 participants Est. completion 2020-05-05 1 siteOther conditions: InsulinomaView official trial listing → -
Active, not recruiting NCT NCT04188548
A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer
Not yet reported Eli Lilly and Company 379 participants Est. completion 2027-12 74 sitesOther conditions: Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Endometrial CancerView official trial listing → -
Active, not recruiting NCT NCT04195750
A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)
Not yet reported Merck Sharp & Dohme LLC 755 participants Est. completion 2026-10-14 172 sitesOther conditions: Carcinoma, Renal CellView official trial listing → -
Withdrawn NCT NCT04198350
Pancreatic Islet Transplantation to the Anterior Chamber of the Eye
Not yet reported Imperial College London Est. completion 2025-08-31 1 siteOther conditions: Type 1 Diabetes, Visual ImpairmentView official trial listing → -
Completed NCT NCT04198506
Viral Load Guided Immunosuppression After Lung Transplantation
Not yet reported Philipps University Marburg 146 participants Est. completion 2025-03-10 2 sites Stand-aloneOther conditions: Transplantation LungView official trial listing → -
Completed NCT NCT04200911
Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway
Not yet reported The University of Texas Health Science Center at San Antonio 10 participants Est. completion 2022-01-13 1 site Stand-aloneOther conditions: Cognitive Impairment, Mild, Alzheimer DiseaseView official trial listing → -
Terminated NCT NCT04203901
Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma
Not yet reported CoImmune 16 participants Est. completion 2023-09-28 9 sitesOther conditions: Advanced Renal Cell CarcinomaView official trial listing → -
Terminated NCT NCT04205240
Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma
Not yet reported Srinivas Devarakonda 1 participants Est. completion 2021-11-22 1 site Stand-aloneOther conditions: Recurrent Plasma Cell MyelomaView official trial listing → -
Status unknown NCT NCT04207177
Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects
Not yet reported Oslo University Hospital 100 participants Est. completion 2025-12-31 1 siteOther conditions: Kidney Transplant; Complications, Immune SuppressionView official trial listing → -
Status unknown NCT NCT04212702
ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments
National Taiwan University Hospital 123 participants Est. completion 2021-12-31 2 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Withdrawn NCT NCT04220008
Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma
Not yet reported M.D. Anderson Cancer Center Est. completion 2021-10-29 Stand-aloneOther conditions: Recurrent Aggressive Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Burkitt Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma, Recurrent Transformed B-Cell Non-Hodgkin LymphomaView official trial listing → -
Status unknown NCT NCT04224350
Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)
Not yet reported Chong Kun Dang Pharmaceutical 184 participants Est. completion 2020-11-30 1 site Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT04225988
Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients
Not yet reported Cedars-Sinai Medical Center 20 participants Est. completion 2023-07-11 1 site Stand-aloneOther conditions: Kidney Transplant RejectionView official trial listing → -
Completed NCT NCT04229004
A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer
Not yet reported Pancreatic Cancer Action Network 502 participants Est. completion 2025-02-05 25 sites Stand-aloneOther conditions: Metastatic Pancreatic Cancer, Metastatic Pancreatic AdenocarcinomaView official trial listing → -
Completed NCT NCT04230499
Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance
Not yet reported Rapamycin Holdings Inc. 30 participants Est. completion 2025-05-22 4 sitesOther conditions: Familial Adenomatous PolyposisView official trial listing → -
Completed NCT NCT04237246
Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver Transplants
Not yet reported University of Manitoba 20 participants Est. completion 2019-11-27 1 site Stand-aloneOther conditions: Liver FailureView official trial listing → -
Active, not recruiting NCT NCT04238546
Major Adverse Limb Events in Patients With Femoro-popliteal and Below-the-knee Peripheral Arterial Disease Treated With Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty
Not yet reported Nils Kucher 1200 participants Est. completion 2029-12-31 2 sites Stand-aloneOther conditions: Peripheral Arterial DiseaseView official trial listing → -
Completed NCT NCT04240444
Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis
Not yet reported B. Braun Medical International Trading Company Ltd. 260 participants Est. completion 2022-08-30 16 sites Stand-aloneCardiovascular disease Other conditions: In Stent RestenosisView official trial listing → -
Status unknown NCT NCT04247750
Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients (THALA-RAP)
Not yet reported Università degli Studi di Ferrara 45 participants Est. completion 2022-04-30 4 sites Stand-aloneOther conditions: Beta-ThalassemiaView official trial listing → -
Terminated NCT NCT04258423
Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function
Not yet reported Indiana University 4 participants Est. completion 2020-06-27 1 siteOther conditions: Kidney FailureView official trial listing → -
Active, not recruiting NCT NCT04262843
Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia
Not yet reported City of Hope Medical Center 33 participants Est. completion 2027-05-11 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, Myelodysplastic SyndromeView official trial listing → -
Withdrawn NCT NCT04263519
A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.
Not yet reported Massachusetts General Hospital Est. completion 2023-01-01Other conditions: Alzheimer Disease, Mild Cognitive ImpairmentView official trial listing → -
Completed NCT NCT04267991
Corneal Densitometry Changes With Adenoviral SEI
Benha University 63 participants Est. completion 2020-04-15 1 siteOther conditions: Corneal DiseaseView official trial listing → -
Active, not recruiting NCT NCT04280029
SELUTION SLR™ 014 In-stent Restenosis
Not yet reported M.A. Med Alliance S.A. 418 participants Est. completion 2029-08 48 sites Stand-aloneOther conditions: Coronary RestenosisView official trial listing → -
Terminated NCT NCT04280276
TruGraf Utilization in High IPV Levels
Not yet reported University of Maryland, Baltimore 13 participants Est. completion 2022-03-01 1 siteOther conditions: Kidney Transplant; ComplicationsView official trial listing → -
Status unknown NCT NCT04292418
Predictors of Rejection in Pediatric Kidney Transplantation
Assiut University 70 participants Est. completion 2021-10-01Other conditions: Rejection Acute RenalView official trial listing → -
Status unknown NCT NCT04299399
Corneal Biomechanical Changes of Allergic Conjunctivitis
Zhongshan Ophthalmic Center, Sun Yat-sen University 100 participants Est. completion 2021-06-30 1 siteOther conditions: Conjunctivitis, Allergic, KeratoconusView official trial listing → -
Terminated NCT NCT04305444
Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
Not yet reported Zhejiang DTRM Biopharma 55 participants Est. completion 2024-12-31 8 sitesOther conditions: Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Richter's TransformationView official trial listing → -
Completed NCT NCT04307797
Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes
Not yet reported Cambridge University Hospitals NHS Foundation Trust 10 participants Est. completion 2022-10-07 1 siteType 2 diabetes Other conditions: ObesityView official trial listing → -
Completed NCT NCT04311632
A Dose Escalation Study in de Novo Renal Transplantation
Not yet reported ITB-Med LLC 13 participants Est. completion 2023-10-03 4 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT04323033
Safety and Efficacy of Peripheral, Cobalt-chromium Sirolimus Eluting Stent (PERS) Versus Cobalt-chromium Stent (Neptune C)
Not yet reported Balton Sp.zo.o. 40 participants Est. completion 2021-11-09 3 sites Stand-aloneOther conditions: Peripheral Arterial DiseaseView official trial listing → -
Withdrawn NCT NCT04324411
Sirolimus Combined With ATRA for the Treatment of Auto-Immune Anemia
Not yet reported Peking Union Medical College Hospital Est. completion 2023-09-01 1 site Stand-aloneOther conditions: Autoimmune AnemiaView official trial listing → -
Completed NCT NCT04327609
SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications
Not yet reported M.A. Med Alliance S.A. 84 participants Est. completion 2025-07-23 3 sites Stand-aloneOther conditions: AV FistulaView official trial listing → -
Completed NCT NCT04339062
Cemiplimab in AlloSCT/SOT Recipients With CSCC
Not yet reported, Not yet reported Dana-Farber Cancer Institute 12 participants Est. completion 2025-03-01 1 site Stand-aloneOther conditions: Cutaneous Squamous Cell Carcinoma, Advanced CancerView official trial listing → -
Completed NCT NCT04339101
Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation
Not yet reported City of Hope Medical Center 59 participants Est. completion 2025-10-09 1 site Stand-aloneOther conditions: Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome, Primary Myelofibrosis, Secondary MyelofibrosisView official trial listing → -
Status unknown NCT NCT04341038
Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury
Not yet reported Hospital Universitari de Bellvitge 84 participants Est. completion 2020-07-01 1 site Stand-aloneOther conditions: COVID-19, Lung InjuryView official trial listing → -
Completed NCT NCT04341675
Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia
Not yet reported University of Cincinnati 32 participants Est. completion 2020-09-15 2 sitesOther conditions: COVID-19View official trial listing → -
Status unknown NCT NCT04345965
Sirolimus Eluting Balloon Utilization for Treatment of Vasculogenic Erectile Dysfunction
Clinica San Gaudenzio 100 participants Est. completion 2023-12-01 1 siteOther conditions: Erectile DysfunctionView official trial listing → -
Terminated NCT NCT04348292
Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer
Not yet reported Emory University 3 participants Est. completion 2022-11-04 1 site Stand-aloneOther conditions: Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8, Stage IA2 Lung Cancer AJCC v8, Stage IA3 Lung Cancer AJCC v8, Stage IB Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8View official trial listing → -
Status unknown NCT NCT04355858
Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer
Not yet reported Fudan University 319 participants Est. completion 2025-04-01 1 siteOther conditions: Breast Cancer, Metastatic CancerView official trial listing → -
Status unknown NCT NCT04360031
The Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation
Université Catholique de Louvain 100 participants Est. completion 2021-03 1 siteOther conditions: Kidney Transplant; Complications, Immunosuppression, Transplant FailureView official trial listing → -
Completed NCT NCT04368091
Clinical Use and Safety of the Xtreme Touch (Magic Touch PTA)- Neo Sirolimus Coated PTA Balloon Catheter in the Treatment of Infrainguinal Peripheral Arterial Disease
Concept Medical Inc. 50 participants Est. completion 2021-12-30 1 siteOther conditions: Peripheral Artery Disease, AtherosclerosisView official trial listing → -
Withdrawn NCT NCT04371640
Sirolimus in COVID-19 Phase 1
Not yet reported Walter K. Kraft Est. completion 2021-07-30 1 siteOther conditions: SARS-CoV-2, Covid-19View official trial listing → -
Withdrawn NCT NCT04374903
Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients
Not yet reported King Hussein Cancer Center Est. completion 2022-04-01 1 site Stand-aloneOther conditions: COVID-19 PatientsView official trial listing → -
Completed NCT NCT04377776
Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients
IRCCS San Raffaele 644 participants Est. completion 2020-05-18 1 siteOther conditions: Kidney Transplant, Pancreas Tranplant, Pancreatic Islet TransplantationView official trial listing → -
Completed NCT NCT04380311
Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant
Not yet reported University of Utah 17 participants Est. completion 2025-04-30 2 sites Stand-aloneOther conditions: Heart Transplant Failure and RejectionView official trial listing → -
Active, not recruiting NCT NCT04384692
Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis
Not yet reported Fred Hutchinson Cancer Center 53 participants Est. completion 2030-04-23 1 site Stand-aloneOther conditions: Primary Myelofibrosis, Secondary MyelofibrosisView official trial listing → -
Completed NCT NCT04388371
Glutamine PET Imaging in LAM
Not yet reported Vanderbilt University Medical Center 5 participants Est. completion 2021-08-10 1 site Stand-aloneOther conditions: Lymphangioleiomyomatosis (LAM)View official trial listing → -
Status unknown NCT NCT04390685
Prevention of Breast Cancer-related Lymphedma With Tacrolimus
Not yet reported, Not yet reported Odense University Hospital 60 participants Est. completion 2022-09 3 sites Stand-aloneOther conditions: LymphedemaView official trial listing → -
Terminated NCT NCT04393454
Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy
Not yet reported Albert Einstein College of Medicine 6 participants Est. completion 2023-05-16 1 site Stand-aloneOther conditions: Metastatic dMMR Solid Cancer, Solid Tumor, Cancer, Metastatic Solid TumorView official trial listing → -
Completed NCT NCT04398732
Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients
Pfizer 486 participants Est. completion 2020-10-01 1 siteOther conditions: Plaque PsoriasisView official trial listing → -
Status unknown NCT NCT04399382
A Clinical Study to Evaluate the Efficacy of Biologics in SpA
The University of Hong Kong-Shenzhen Hospital 40 participants Est. completion 2022-12 1 siteOther conditions: Spondyloarthritis (SpA)View official trial listing → -
Completed NCT NCT04403321
Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients
Not yet reported Peking Union Medical College Hospital 114 participants Est. completion 2022-07-31 1 site Stand-aloneOther conditions: Aplastic Anemia, Drug EffectView official trial listing → -
Status unknown NCT NCT04404127
Standard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant Recipients
Not yet reported King Faisal Specialist Hospital & Research Center 140 participants Est. completion 2025-05 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Status unknown NCT NCT04406870
Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH)
Not yet reported Shanghai Children's Medical Center 36 participants Est. completion 2025-06-30 1 site Stand-aloneOther conditions: Hemangioendothelioma of LiverView official trial listing → -
Terminated NCT NCT04409327
Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes
Not yet reported Restorbio Inc. 36 participants Est. completion 2021-01-24 1 siteOther conditions: COVID19View official trial listing → -
Status unknown NCT NCT04409691
SCMC Trial on KHE With KMP (V.2020)
Not yet reported Shanghai Children's Medical Center 20 participants Est. completion 2023-06-30 1 site Stand-aloneOther conditions: Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)View official trial listing → -
Status unknown NCT NCT04409912
Sirolimus Coated Angioplasty Versus Plain Balloon Angioplasty
Not yet reported Singapore General Hospital 170 participants Est. completion 2024-10 3 sites Stand-aloneOther conditions: End Stage Renal Failure on Dialysis, Arteriovenous Graft OcclusionView official trial listing → -
Status unknown NCT NCT04414735
Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients
Not yet reported Fundacion Clinic per a la Recerca Biomédica 30 participants Est. completion 2025-12 1 site Stand-aloneOther conditions: Kidney Transplant RejectionView official trial listing → -
Withdrawn NCT NCT04415476
Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS)
Not yet reported University of Maryland, Baltimore Est. completion 2028-06-30 Stand-aloneOther conditions: Disorder Related to Lung Transplantation, Chronic Rejection of Lung Transplant, Decreased Immunologic ActivityView official trial listing → -
Completed NCT NCT04420195
Envarsus XR in Lung Transplant
Not yet reported NYU Langone Health 41 participants Est. completion 2022-11-30 1 site Stand-aloneOther conditions: Lung TransplantView official trial listing → -
Withdrawn NCT NCT04420364
Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease
Not yet reported, Not yet reported Brigham and Women's Hospital Est. completion 2021-05-04Other conditions: COVID, Kidney Transplant; Complications, ImmunosuppressionView official trial listing → -
Completed NCT NCT04428411
Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).
Pfizer 486 participants Est. completion 2020-08-30 1 siteOther conditions: Plaque PsoriasisView official trial listing → -
Completed NCT NCT04428424
Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients
Pfizer 1493 participants Est. completion 2020-08-30 1 siteOther conditions: Arthritis, RheumatoidView official trial listing → -
Completed NCT NCT04431219
First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients
Not yet reported, Not yet reported Xenothera SAS 10 participants Est. completion 2022-03-28 1 site Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Completed NCT NCT04431713
Exenatide Once-weekly as a Treatment for Multiple System Atrophy
Not yet reported University College, London 50 participants Est. completion 2024-03-22 1 site Stand-aloneOther conditions: Multiple System AtrophyView official trial listing → -
Completed NCT NCT04440371
Phototherapy Combination With Topicals in Vitiligo
Not yet reported Jordan University of Science and Technology 41 participants Est. completion 2023-03-30 1 siteOther conditions: Vitiligo, GeneralizedView official trial listing → -
Status unknown NCT NCT04444817
Evaluation of the Impact of Tacrolimus-based Immunosuppression on Heidelberg Liver Transplant Cohort (HDTACRO): Study Protocol for an Investigator Initiated, Non-interventional Prospective Study
University Hospital Heidelberg 100 participants Est. completion 2021-12-30 1 siteOther conditions: Liver TransplantationView official trial listing → -
Status unknown NCT NCT04444843
Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2023-12-31 1 siteOther conditions: Kidney Transplant RecipientsView official trial listing → -
Completed NCT NCT04448873
Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma
Not yet reported Children's Hospital of Fudan University 30 participants Est. completion 2023-07-01 1 site Stand-aloneOther conditions: Kaposiform Hemangioendothelioma, Kasabach-Merritt SyndromeView official trial listing → -
Status unknown NCT NCT04449224
Comparative Effectiveness of Targeted Therapy in RA Patients
Hanyang University 506 participants Est. completion 2024-08-19 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT04461340
Efficacy and Safety of Sirolimus in COVID-19 Infection
Not yet reported Alexandria University 40 participants Est. completion 2020-11-30 1 site Stand-aloneOther conditions: COVID 19View official trial listing → -
Terminated NCT NCT04461886
A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I
Not yet reported Nobelpharma 100 participants Est. completion 2021-12-07 4 sites Stand-aloneOther conditions: NeurofibromatosisView official trial listing → -
Completed NCT NCT04470804
Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA
Not yet reported Bing Han 56 participants Est. completion 2022-07-31 1 site Stand-aloneOther conditions: Pure Red Cell Aplasia, AcquiredView official trial listing → -
Completed NCT NCT04473911
Haplo Peripheral Blood Sct In GVHD Prevention
Not yet reported Zachariah Michael DeFilipp 25 participants Est. completion 2024-08-19 1 site Stand-aloneOther conditions: GVHD, AML, ALL, MDS, MPN, CMML, Hodgkin Lymphoma, Non Hodgkin Lymphoma, Blood Stem Cell Transplant Failure, Graft Vs Host Disease, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorder, Chronic Myelomonocytic Leukemia, Chemosensitive Hodgkin LymphomaView official trial listing → -
Active, not recruiting NCT NCT04475783
Sirolimus- vs. Paclitaxel-Drug Coated Ballons in Patients With Peripheral Artery Disease
Not yet reported Jena University Hospital 478 participants Est. completion 2027-12-31 22 sites Stand-aloneOther conditions: Peripheral Artery DiseaseView official trial listing → -
Withdrawn NCT NCT04482712
Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS
Not yet reported, Not yet reported The University of Texas Health Science Center at San Antonio Est. completion 2023-01 2 sitesOther conditions: Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Respiratory Failure, Sars-CoV2View official trial listing → -
Completed NCT NCT04487197
SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)
Antonio Secchi 282 participants Est. completion 2021-01-15 1 siteOther conditions: Kidney Transplant, Pancreatic Transplat, Pancreatic Islets LangerhansView official trial listing → -
Completed NCT NCT04489134
P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release
Not yet reported Rennes University Hospital 27 participants Est. completion 2023-05-16 1 site Stand-aloneOther conditions: PharmacokineticsView official trial listing → -
Completed NCT NCT04496401
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus
Not yet reported Nantes University Hospital 25 participants Est. completion 2023-11-07 1 site Stand-aloneOther conditions: Kidney Transplantation, Pancreas Transplantation, DiabetesView official trial listing → -
Completed NCT NCT04498741
Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects
Not yet reported Enanta Pharmaceuticals, Inc 89 participants Est. completion 2021-06-01 1 site Stand-aloneOther conditions: RSV InfectionView official trial listing → -
Completed NCT NCT04503616
Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
Not yet reported, Not yet reported NYU Langone Health 46 participants Est. completion 2024-08-15 1 site Stand-aloneOther conditions: Graft-versus-host DiseaseView official trial listing → -
Completed NCT NCT04504370
Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects
Not yet reported PegBio Co., Ltd. 273 participants Est. completion 2022-11-28 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04504396
Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
Not yet reported PegBio Co., Ltd. 620 participants Est. completion 2023-05-26 1 site Stand-aloneType 2 diabetesView official trial listing → -
Completed NCT NCT04507776
Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel
Pfizer 763 participants Est. completion 2020-10-01 1 siteOther conditions: SpondyloarthrosisView official trial listing → -
Active, not recruiting NCT NCT04520490
Brain Activation and Satiety in Children 2
Not yet reported Seattle Children's Hospital 63 participants Est. completion 2026-02-12 1 siteOther conditions: Childhood ObesityView official trial listing → -
Withdrawn NCT NCT04521946
Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer
Not yet reported M.D. Anderson Cancer Center Est. completion 2022-12-20 Stand-aloneOther conditions: Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, Central Nervous System Germ Cell Tumor, Choroid Plexus Carcinoma, Intracranial Myeloid Sarcoma, Malignant Brain Neoplasm, Malignant Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, Recurrent Anaplastic Ependymoma, Recurrent Atypical Teratoid/Rhabdoid Tumor, Recurrent Malignant Brain Neoplasm, Recurrent Malignant Glioma, Recurrent Medulloblastoma, Recurrent Primitive Neuroectodermal TumorView official trial listing → -
Terminated NCT NCT04530487
Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults
Not yet reported M.D. Anderson Cancer Center 1 participants Est. completion 2024-08-26 1 site Stand-aloneObstructive sleep apnea Other conditions: Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small Round Cell Tumor, Recurrent Malignant Peripheral Nerve Sheath Tumor, Recurrent Malignant Solid Neoplasm, Recurrent Neuroblastoma, Refractory Desmoplastic Small Round Cell Tumor, Refractory Malignant Peripheral Nerve Sheath Tumor, Refractory Malignant Solid Neoplasm, Refractory NeuroblastomaView official trial listing → -
Completed NCT NCT04532710
Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis
Not yet reported Marinomed Biotech AG 64 participants Est. completion 2021-05-27 1 siteOther conditions: Allergic Conjunctivitis, Allergic RhinitisView official trial listing → -
Completed NCT NCT04539470
Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Not yet reported Genentech, Inc. 18 participants Est. completion 2023-02-24 8 sites Stand-aloneOther conditions: Acute Graft-versus-host DiseaseView official trial listing → -
Completed NCT NCT04541290
Tacrolimus as Treatment of Breast Cancer-Related Lymphedema
Not yet reported, Not yet reported Odense University Hospital 20 participants Est. completion 2022-01-06 1 siteOther conditions: Breast Cancer LymphedemaView official trial listing → -
Active, not recruiting NCT NCT04542733
The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient
Not yet reported King Chulalongkorn Memorial Hospital 50 participants Est. completion 2028-07 1 siteOther conditions: Kidney Transplant Infection, BK Virus InfectionView official trial listing → -
Status unknown NCT NCT04559048
Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation Patients
The Second Hospital of Tangshan 300 participants Est. completion 2024-06-30 1 siteOther conditions: Chronic Pain, Liver TransplantationView official trial listing → -
Active, not recruiting NCT NCT04561739
Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions
Not yet reported Xijing Hospital 2272 participants Est. completion 2027-05-05 1 siteCardiovascular disease Other conditions: De Novo StenosisView official trial listing → -
Active, not recruiting NCT NCT04561986
TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
Not yet reported Vastra Gotaland Region 50 participants Est. completion 2029-06 6 sitesOther conditions: Antibody-mediated RejectionView official trial listing → -
Status unknown NCT NCT04562740
ABLUMINUS DES BTK Registry - FIM
Not yet reported Concept Medical Inc. 30 participants Est. completion 2024-12-02 1 site Stand-aloneOther conditions: Peripheral Artery Disease, Arterial Disease of Legs, AtherosclerosisView official trial listing → -
Active, not recruiting NCT NCT04562805
Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)
Not yet reported Elixir Medical Corporation 2400 participants Est. completion 2028-07-31 19 sites Stand-aloneCardiovascular disease Other conditions: Ischemic Heart DiseaseView official trial listing → -
Status unknown NCT NCT04570345
3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI
Not yet reported Dong-A University 1002 participants Est. completion 2022-08 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT04571697
A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy
Janssen Research & Development, LLC 34647 participants Est. completion 2020-10-27 1 siteOther conditions: Dementia, Alzheimer DiseaseView official trial listing → -
Completed NCT NCT04582084
Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis
AryoGen Pharmed Co. 583 participants Est. completion 2018-03-19 10 sitesOther conditions: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic ArthritisView official trial listing → -
Active, not recruiting NCT NCT04582136
Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus
Not yet reported Chinese SLE Treatment And Research Group 146 participants Est. completion 2026-01 6 sites Stand-aloneOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Active, not recruiting NCT NCT04584710
A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults
Not yet reported Restorbio Inc. 60 participants Est. completion 2021-02 2 sitesOther conditions: Covid19View official trial listing → -
Withdrawn NCT NCT04585711
Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis
Not yet reported Duke University Est. completion 2027-02-28 1 siteOther conditions: Juvenile Idiopathic Arthritis, Rheumatoid Arthritis, ObesityView official trial listing → -
Status unknown NCT NCT04590183
The Effectiveness and Safety of FK-506 for the Treatment of Posner-Schlossman Syndrome
Not yet reported Peking University 30 participants Est. completion 2021-09 1 siteOther conditions: Posner Schlossman SyndromeView official trial listing → -
Status unknown NCT NCT04591938
FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study
Not yet reported Joost Daemen 50 participants Est. completion 2025-12-31 3 sitesOther conditions: Percutaneous Coronary Intervention, Myocardial Revascularization, Tomography, Optical CoherenceView official trial listing → -
Status unknown NCT NCT04594889
Comparison of Sirolimus vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia
Not yet reported Ospedale San Donato 170 participants Est. completion 2022-12-31 1 site Stand-aloneOther conditions: Critical Limb Ischemia, Drug EffectView official trial listing → -
Completed NCT NCT04595513
Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants
Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 5 participants Est. completion 2022-12-15 1 site Stand-aloneOther conditions: Tuberous Sclerosis Complex, EpilepsyView official trial listing → -
Status unknown NCT NCT04615910
A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass
Not yet reported Radboud University Medical Center 30 participants Est. completion 2025-07-01 2 sitesOther conditions: Diabetes MellitusView official trial listing → -
Status unknown NCT NCT04629118
Intervention With Selution SLR™ Agent Balloon for Endovascular Latent Limus Therapy for Failing AV Fistulas (ISABELLA) Trial
Singapore General Hospital 40 participants Est. completion 2023-10-30 1 siteOther conditions: Arteriovenous Fistula, Dialysis Access MalfunctionView official trial listing → -
Active, not recruiting NCT NCT04629248
A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy
Not yet reported Hoffmann-La Roche 142 participants Est. completion 2027-12-21 50 sitesOther conditions: Primary Membranous NephropathyView official trial listing → -
Active, not recruiting NCT NCT04629495
Rapamycin - Effects on Alzheimer's and Cognitive Health
Not yet reported The University of Texas Health Science Center at San Antonio 40 participants Est. completion 2027-03-05 1 siteOther conditions: Mild Cognitive Impairment, Alzheimer DiseaseView official trial listing → -
Status unknown NCT NCT04633733
The Study of Pharmacokinetic Interactions Between HL237 and Tacrolimus
Not yet reported Hanlim Pharm. Co., Ltd. 24 participants Est. completion 2021-01 1 site Stand-aloneOther conditions: Healthy Male VolunteersView official trial listing → -
Completed NCT NCT04645667
Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)
UNC Lineberger Comprehensive Cancer Center 38 participants Est. completion 2023-10-15 1 siteOther conditions: Acute GVHDView official trial listing → -
Completed NCT NCT04646356
Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)
Not yet reported Unity Health Toronto 10 participants Est. completion 2024-10-21 1 site Stand-aloneOther conditions: Hereditary Hemorrhagic Telangiectasia, Epistaxis NosebleedView official trial listing → -
Status unknown NCT NCT04657562
The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma
National Science Centre, Poland 380 participants Est. completion 2023-05 1 siteOther conditions: Immunosuppression, Kidney Transplant Rejection, Kidney Transplant; Complications, Liver Transplant Rejection, Liver Transplant; Complications, Metabolism Medication Toxicity, Genetic PredispositionView official trial listing → -
Active, not recruiting NCT NCT04665310
Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant
Not yet reported The Methodist Hospital Research Institute 46 participants Est. completion 2025-10-31Other conditions: Kidney Disease, End-Stage, Donor Specific Antibodies, Acute Rejection of Renal TransplantView official trial listing → -
Completed NCT NCT04669210
PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT
Not yet reported St. Petersburg State Pavlov Medical University 128 participants Est. completion 2025-03-28 2 sites Stand-aloneOther conditions: Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoid LeukemiaView official trial listing → -
Status unknown NCT NCT04670926
Immunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test
Not yet reported Transplant Genomics, Inc. 75 participants Est. completion 2023-09-30 1 site Stand-aloneOther conditions: Kidney Transplant Rejection, ImmunosuppressionView official trial listing → -
Completed NCT NCT04698512
MAgicTouch™ Intervention Leap for Dialysis Access (MATILDA) Trial
Singapore General Hospital 35 participants Est. completion 2021-01-30 1 siteOther conditions: Dialysis Access Malfunction, End Stage Renal Failure on Dialysis, End Stage Renal Disease, Fistulas Arteriovenous, StenosisView official trial listing → -
Status unknown NCT NCT04700709
Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients.
Not yet reported Chong Kun Dang Pharmaceutical 158 participants Est. completion 2025-01 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT04701528
Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients
Not yet reported Leiden University Medical Center 20 participants Est. completion 2022-10-25 1 site Stand-aloneOther conditions: Covid19, Kidney Transplant InfectionView official trial listing → -
Status unknown NCT NCT04705584
Topical Immuonosuppressant Drugs in Spring Catarrh
Not yet reported Assiut University 180 participants Est. completion 2022-02 1 site Stand-aloneOther conditions: Vernal KeratoconjunctivitisView official trial listing → -
Completed NCT NCT04706559
Efficacy of Oral Supplementation of Probiotics in Children With Atopic Dermatitis
Not yet reported B.P. Koirala Institute of Health Sciences 98 participants Est. completion 2021-12-15 1 site Stand-aloneOther conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT04707209
Sirolimus for Retinal Astrocytic Hamartoma
Not yet reported The Hospital for Sick Children 1 participants Est. completion 2024-03-22 1 site Stand-aloneOther conditions: Retinal Astrocytic HamartomaView official trial listing → -
Withdrawn NCT NCT04711291
Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes
Not yet reported Beth Israel Deaconess Medical Center Est. completion 2023-07-01 Stand-aloneOther conditions: Medication Adherence, Renal TransplantView official trial listing → -
Completed NCT NCT04718311
Study on Treatment for Patients With Symptomatic Oral Lichen Planus
Not yet reported University of Catania 60 participants Est. completion 2020-03-20 1 siteOther conditions: Lichen Planus, OralView official trial listing → -
Completed NCT NCT04720326
Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients
Not yet reported Edward Geissler 268 participants Est. completion 2026-10-29 15 sites Stand-aloneOther conditions: Prophylaxis Against Liver Transplant RejectionView official trial listing → -
Terminated NCT NCT04720664
Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer
Not yet reported Georgetown University 11 participants Est. completion 2023-02-10 5 sites Stand-aloneOther conditions: Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast CarcinomaView official trial listing → -
Completed NCT NCT04725682
Bioequivalence Study of Tacrolimus in Healthy Volunteers
Not yet reported Food and Drug Administration (FDA) 67 participants Est. completion 2021-06-17 1 siteOther conditions: Healthy VolunteersView official trial listing → -
Status unknown NCT NCT04733508
Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes
Not yet reported Radboud University Medical Center 28 participants Est. completion 2022-12-01 1 siteType 2 diabetes Other conditions: Diabetes MellitusView official trial listing → -
Not yet recruiting NCT NCT04736589
Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway
Not yet reported Peking Union Medical College 270 participants Est. completion 2027-02-02 1 siteOther conditions: Breast CancerView official trial listing → -
Not yet recruiting NCT NCT04736953
Sirolimus Treatment Of Patients With SLE
Not yet reported State University of New York - Upstate Medical University 220 participants Est. completion 2029-01-01Other conditions: Lupus Erythematosus, SystemicView official trial listing → -
Completed NCT NCT04738981
Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT
Not yet reported Peking University People's Hospital 130 participants Est. completion 2023-05-02 1 siteOther conditions: Graft Vs Host DiseaseView official trial listing → -
Status unknown NCT NCT04747080
The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
Not yet reported Peking University People's Hospital 120 participants Est. completion 2023-07-01 1 site Stand-aloneOther conditions: ITP, Immune ThrombocytopeniaView official trial listing → -
Completed NCT NCT04761731
To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients
Not yet reported Linical Korea 31 participants Est. completion 2017-12-14 Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT04763096
Evaluate the Efficacy and Safety of the ADVAGRAF®
Not yet reported Linical Korea 101 participants Est. completion 2020-04 1 site Stand-aloneOther conditions: Evidence of Liver TransplantationView official trial listing → -
Status unknown NCT NCT04765826
Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo
Not yet reported Alexandria University 60 participants Est. completion 2022-08 1 site Stand-aloneOther conditions: VitiligoView official trial listing → -
Status unknown NCT NCT04768465
Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis
Da, Yuwei, M.D. 160 participants Est. completion 2024-10-31 1 siteOther conditions: Myasthenia GravisView official trial listing → -
Terminated NCT NCT04773392
Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR
Not yet reported University of Southern California 20 participants Est. completion 2024-02-23 1 siteOther conditions: Kidney Transplantation, Kidney Transplant RejectionView official trial listing → -
Completed NCT NCT04775173
Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.
Not yet reported West China Hospital 79 participants Est. completion 2023-08-10 1 site Stand-aloneOther conditions: Kaposiform HemangioendotheliomaView official trial listing → -
Active, not recruiting NCT NCT04776434
SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study
Not yet reported M.A. Med Alliance S.A. 723 participants Est. completion 2028-12-31 27 sites Stand-aloneOther conditions: Peripheral Artery DiseaseView official trial listing → -
Withdrawn NCT NCT04776850
Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies
Not yet reported M.D. Anderson Cancer Center Est. completion 2022-12-05 Stand-aloneOther conditions: Beta Thalassemia Major, Sickle Beta 0 Thalassemia, Sickle Beta Plus Thalassemia, Sickle Beta Thalassemia, Sickle Cell Disease, Sickle Cell-SS DiseaseView official trial listing → -
Completed NCT NCT04788641
Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects
Not yet reported AstraZeneca 62 participants Est. completion 2021-09-16 1 site Stand-aloneOther conditions: HyperkalaemiaView official trial listing → -
Active, not recruiting NCT NCT04789070
Phase III Trial of Sirolimus in IBM
Not yet reported University of Kansas Medical Center 140 participants Est. completion 2027-12 10 sitesOther conditions: Inclusion Body MyositisView official trial listing → -
Completed NCT NCT04798287
Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)-Cancer Endpoints
Brigham and Women's Hospital 105711 participants Est. completion 2022-05-16 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Completed NCT NCT04805619
Evaluation of the Neointimal Healing by OCT of the Tapered DES Biomime Morph (TAPER-I Study)
Not yet reported University of Sao Paulo General Hospital 35 participants Est. completion 2021-12-08 1 site Stand-aloneOther conditions: AtherosclerosisView official trial listing → -
Completed NCT NCT04810143
Tacrolimus Microsampling
Not yet reported Children's Hospital Medical Center, Cincinnati 16 participants Est. completion 2022-07-28 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Completed NCT NCT04818632
AZD9833 China PK Study
Not yet reported AstraZeneca 28 participants Est. completion 2023-09-07 4 sitesOther conditions: ER+, HER2-, Metastatic Breast CancerView official trial listing → -
Completed NCT NCT04825262
Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore
Not yet reported Singapore General Hospital 74 participants Est. completion 2024-04-09 1 site Stand-aloneOther conditions: Kidney Transplant Rejection, Kidney Transplant; ComplicationsView official trial listing → -
Completed NCT NCT04838288
Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™
Not yet reported Vanderbilt University Medical Center 56 participants Est. completion 2025-10-22 1 site Stand-aloneOther conditions: Renal TransplantView official trial listing → -
Status unknown NCT NCT04849325
IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease
Not yet reported Biotyx Medical (Shenzhen) Co., Ltd. 120 participants Est. completion 2024-10 29 sites Stand-aloneOther conditions: Critical Limb Ischemia (CLI)View official trial listing → -
Completed NCT NCT04852523
18F-Fluciclovine PET/CT in the Assessment of Pancreatic Transplants
Not yet reported University of Utah 4 participants Est. completion 2022-10-06 1 siteOther conditions: Pancreatitis, Graft, Pancreatic Transplant Post-Transplant Dysfunction RejectionView official trial listing → -
Active, not recruiting NCT NCT04859946
Itacitinib for the Prevention of Graft Versus Host Disease
Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2027-04-01 1 site Stand-aloneOther conditions: Hematologic and Lymphocytic DisorderView official trial listing → -
Completed NCT NCT04862052
Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis
Not yet reported Semmelweis University Heart and Vascular Center 108 participants Est. completion 2025-01-30 2 sites Stand-aloneOther conditions: Coronary Stent RestenosisView official trial listing → -
Status unknown NCT NCT04867720
Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients
Not yet reported Chong Kun Dang Pharmaceutical 112 participants Est. completion 2023-02-22 1 site Stand-aloneOther conditions: Liver TransplantView official trial listing → -
Active, not recruiting NCT NCT04870203
Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis
Not yet reported University Hospital, Bordeaux 160 participants Est. completion 2027-03 36 sites Stand-aloneOther conditions: Rheumatoid ArthritisView official trial listing → -
Terminated NCT NCT04885816
Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty
Not yet reported Instituto Nacional de Cardiologia Ignacio Chavez 5 participants Est. completion 2021-09-29 1 siteCardiovascular disease Other conditions: High Bleeding Risk, Percutaneous Coronary Intervention (PCI)View official trial listing → -
Status unknown NCT NCT04892212
Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis
Not yet reported, Not yet reported Peking Union Medical College Hospital 20 participants Est. completion 2023-10-30 Stand-aloneOther conditions: Lupus Nephritis, Immunosuppression, Effect of DrugView official trial listing → -
Active, not recruiting NCT NCT04893291
Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II
Not yet reported Fondazione Ricerca e Innovazione Cardiovascolare ETS 1820 participants Est. completion 2030-08-30 53 sites Stand-aloneCardiovascular disease Other conditions: Coronary Artery StenosisView official trial listing → -
Terminated NCT NCT04895748
DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies
Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2026-02-13 11 sitesOther conditions: Carcinoma, Renal CellView official trial listing → -
Completed NCT NCT04897802
Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)
Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 42 participants Est. completion 2024-12-31 1 site Stand-aloneOther conditions: Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism, Psychological Disorder, Social Isolation, Hypothalamic Diseases, Pituitary Diseases, Oxytocin DeficiencyView official trial listing → -
Active, not recruiting NCT NCT04899141
Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice
Fundación EPIC 400 participants Est. completion 2028-05-01 20 sitesCardiovascular disease Other conditions: Ischemic Heart DiseaseView official trial listing → -
Status unknown NCT NCT04899583
ACOART SCB BIF: Treatment of Coronary Bifurcation Lesion by Sirolimus Coated Balloon vs Paclitaxel Coated Balloon
Not yet reported Acotec Scientific Co., Ltd 230 participants Est. completion 2025-11-01 1 site Stand-aloneOther conditions: Coronary Bifurcation LesionsView official trial listing → -
Withdrawn NCT NCT04903054
Selective CD28 Blockade in Renal Transplant Recipients
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2022-09-22 1 siteOther conditions: Kidney Transplantation, Renal Transplant RecipientsView official trial listing → -
Active, not recruiting NCT NCT04904588
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
Not yet reported Center for International Blood and Marrow Transplant Research 300 participants Est. completion 2026-12 39 sites Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, LymphomaView official trial listing → -
Completed NCT NCT04906304
Comparison of Safety and Efficacy of de Novo Everolimus
Not yet reported Shahid Beheshti University of Medical Sciences 35 participants Est. completion 2020-08-01 1 siteOther conditions: Cytomegalovirus InfectionsView official trial listing → -
Completed NCT NCT04909333
Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia
Not yet reported University Hospital, Basel, Switzerland 29 participants Est. completion 2024-04-30 1 site Stand-aloneOther conditions: Endogenous HyperinsulinismView official trial listing → -
Status unknown NCT NCT04912401
the Efficacy and Safety of Etanercept (Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis
Second Affiliated Hospital, Zhejiang University, School of Medicine 100 participants Est. completion 2025-12-04 40 sitesOther conditions: Psoriasis, EtanerceptView official trial listing → -
Status unknown NCT NCT04917718
Renal Tubular Injury and Transplant Outcomes in Cardiac Recipients Converting From IR Tacrolimus to XR Tacrolimus
Not yet reported Loyola University 42 participants Est. completion 2024-12-31 1 site Stand-aloneChronic kidney disease Other conditions: Heart TransplantView official trial listing → -
Status unknown NCT NCT04918615
Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions
Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 236 participants Est. completion 2024-12-31 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT04936282
Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING)
Not yet reported Fundación Canaria Instituto de Investigación Sanitaria de Canarias 80 participants Est. completion 2027-06-30 4 sites Stand-aloneOther conditions: Kidney Transplant Failure and RejectionView official trial listing → -
Withdrawn NCT NCT04936971
Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response
Not yet reported Edoardo Melilli Est. completion 2021-09 1 site Stand-aloneOther conditions: Kidney Transplantation, Cytomegalovirus InfectionsView official trial listing → -
Completed NCT NCT04942730
Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)
Not yet reported St. Petersburg State Pavlov Medical University 50 participants Est. completion 2024-04-30 1 site Stand-aloneOther conditions: Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndromes, Myeloproliferative NeoplasmView official trial listing → -
Completed NCT NCT04943757
Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies
Not yet reported St. Petersburg State Pavlov Medical University 50 participants Est. completion 2024-05-30 1 site Stand-aloneOther conditions: Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative NeoplasmView official trial listing → -
Active, not recruiting NCT NCT04945785
" SAVE Study (Switch AdVagraf® to Envarsus®) for Fast Metabolizers Kidney Transplant Recipients"
Nantes University Hospital 226 participants Est. completion 2026-05-28 1 siteOther conditions: Renal Transplant FailureView official trial listing → -
Active, not recruiting NCT NCT04948203
Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis
Not yet reported, Not yet reported University of Chicago 60 participants Est. completion 2026-12 1 siteOther conditions: Pulmonary Fibrosis, COVID-19 Pneumonia, Long COVIDView official trial listing → -
Active, not recruiting NCT NCT04953715
Microbiome and Immunosuppression: The Mission Study
The University of Texas Medical Branch, Galveston 140 participants Est. completion 2033-01-01 2 sitesOther conditions: Kidney Transplant Rejection, Kidney TransplantView official trial listing → -
Completed NCT NCT04956484
Belimumab In Early Systemic Lupus Erythematosus
Not yet reported Peking Union Medical College Hospital 16 participants Est. completion 2022-04-08 1 siteOther conditions: Lupus Erythematosus, SystemicView official trial listing → -
Withdrawn NCT NCT04961801
Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leukemia
Not yet reported, Not yet reported Shin Mineishi Est. completion 2030-01 Stand-aloneOther conditions: Lymphoma, LeukemiaView official trial listing → -
Completed NCT NCT04965597
Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)
Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2026-02-18 24 sites Stand-aloneOther conditions: Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia, Hereditary Sideroblastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Shwachman-Diamond Syndrome, Hematologic Neoplasm With Germline GATA2 Mutation, Hematologic Neoplasm With Germline SAMD9 Mutation, Hematologic Neoplasm With Germline SAMD9L MutationView official trial listing → -
Withdrawn NCT NCT04973982
ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT
Not yet reported Barts & The London NHS Trust Est. completion 2022-10-01 1 siteOther conditions: Renal Transplant FailureView official trial listing → -
Completed NCT NCT04976933
Post-HSCT Medication Adherence mHealth App
Micah Skeens 15 participants Est. completion 2023-01-31 1 siteOther conditions: Stem Cell TransplantationView official trial listing → -
Status unknown NCT NCT04979611
The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
Not yet reported First Affiliated Hospital of Fujian Medical University 60 participants Est. completion 2025-08-01 1 siteOther conditions: InsulinomaView official trial listing → -
Completed NCT NCT04989686
Microsampling Assays for Immunosuppressive Drugs in Children
Children's Hospital of Philadelphia 66 participants Est. completion 2025-05-01 1 siteOther conditions: ImmunosuppressionView official trial listing → -
Completed NCT NCT04990323
US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies
Not yet reported, Not yet reported ExCellThera inc. 13 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: High Risk Myeloid Malignancies, Cord Blood TransplantView official trial listing → -
Withdrawn NCT NCT04994561
VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements
Not yet reported Vitality in Aging Research Group, Inc. Est. completion 2023-12Other conditions: AgingView official trial listing → -
Status unknown NCT NCT05001074
Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients
Not yet reported Heleen Grootjans 145 participants Est. completion 2024-08-01 1 site Stand-aloneOther conditions: Lung Transplant; ComplicationsView official trial listing → -
Completed NCT NCT05005221
Home-based Therapeutic Drug Monitoring in Kidney Transplantation
Not yet reported University of Michigan 41 participants Est. completion 2024-05-08 1 site Stand-aloneOther conditions: Kidney TransplantView official trial listing → -
Status unknown NCT NCT05011916
The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization
Not yet reported, Not yet reported Zhongshan Ophthalmic Center, Sun Yat-sen University 60 participants Est. completion 2022-08-09 2 sitesOther conditions: Corneal NeovascularizationView official trial listing → -
Status unknown NCT NCT05013034
Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients
Not yet reported Fort Worth Clinical Sciences Working Group 300 participants Est. completion 2022-12-01 Stand-aloneOther conditions: SARS-CoV-2 Acute Respiratory Disease, SARS-CoV2 Infection, Cytokine StormView official trial listing → -
Status unknown NCT NCT05021276
Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD
Not yet reported The First Affiliated Hospital of Soochow University 50 participants Est. completion 2022-12-15 1 site Stand-aloneOther conditions: Safety and EfficacyView official trial listing → -
Completed NCT NCT05029310
Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients
Not yet reported Oslo University Hospital 13 participants Est. completion 2023-02-01 1 site Stand-aloneOther conditions: Hyperkalemia, Kidney TransplantView official trial listing → -
Completed NCT NCT05032248
Uses of Tacrolimus in Behcet Disease
Not yet reported Assiut University 40 participants Est. completion 2019-12-01 1 site Stand-aloneOther conditions: Oral Ulcer, Behcet SyndromeView official trial listing → -
Completed NCT NCT05051137
Real-World Emulation of the SWEFOT Trial
Karolinska Institutet 509 participants Est. completion 2020-11-16 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT05061303
Omeprazole and Famotidine in Chronic Dysfunction of the Transplanted Kidney
Poznan University of Medical Sciences 24 participants Est. completion 2024-06-30 1 siteOther conditions: Kidney Rejection TransplantView official trial listing → -
Terminated NCT NCT05065411
Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer
Not yet reported Veru Inc. 5 participants Est. completion 2024-01-09 30 sitesOther conditions: Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT05066789
CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4
Not yet reported Samsung Medical Center 100 participants Est. completion 2024-03-22 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT05073692
Comparison of Type 2 Diabetes Pharmacotherapy Regimens
Kaiser Permanente 241981 participants Est. completion 2025-03-12 6 sitesType 2 diabetesCardiovascular diseaseView official trial listing → -
Withdrawn NCT NCT05073822
NOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation
Not yet reported, Not yet reported University College, London Est. completion 2027-02-20Other conditions: Renal Transplant Rejection, Renal Transplant InfectionView official trial listing → -
Completed NCT NCT05076084
Evaluation of the Efficacy and Safety of Tacrolimus Drops in Children With Vernal Keratoconjunctivitis
Fondation Ophtalmologique Adolphe de Rothschild 15 participants Est. completion 2021-11-10 1 siteOther conditions: Vernal KeratoconjunctivitisView official trial listing → -
Completed NCT NCT05077254
COVID Protection After Transplant-Immunosuppression Reduction
Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2025-02-21 15 sitesOther conditions: Kidney Transplant Recipients, Liver Transplant RecipientsView official trial listing → -
Completed NCT NCT05080218
COVID-19 VaccinE Response in Rheumatology Patients
Not yet reported Jeffrey Curtis 841 participants Est. completion 2024-05-28 8 sitesOther conditions: Rheumatoid Arthritis, Psoriatic Arthritis, SpondylarthritisView official trial listing → -
Active, not recruiting NCT NCT05088356
Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
Not yet reported Stanford University 66 participants Est. completion 2028-05 1 site Stand-aloneOther conditions: Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndromes, Myeloproliferative DisordersView official trial listing → -
Completed NCT NCT05103358
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
Not yet reported Aadi Bioscience, Inc. 128 participants Est. completion 2024-12-23 166 sites Stand-aloneOther conditions: Tumor, Tumor, Solid, Metastasis, Metastatic Cancer, Cancer, Cancer Metastatic, Tumors, Neoplasms, Neoplasm Metastasis, Solid Tumor, Advanced Solid Tumor, Advanced Cancer, Malignant Solid Tumor, Malignant Solid Neoplasm, Malignant Neoplasm, Malignant Tumor, TSC, TSC1, TSC2, Metastatic Solid Tumor, Metastatic NeoplasmView official trial listing → -
No Longer Available NCT NCT05108740
MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer
Novartis PharmaceuticalsOther conditions: Advanced Hormone Receptor Positive (HR+) Breast CancerView official trial listing → -
Completed NCT NCT05109390
A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults
Not yet reported Alexion Pharmaceuticals, Inc. 72 participants Est. completion 2018-10-17 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT05115630
Off-the-shelf NK Cells + SCT for Myeloid Malignancies
Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2025-05-15 1 site Stand-aloneOther conditions: Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid LeukemiaView official trial listing → -
Status unknown NCT NCT05115903
Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis
Not yet reported University Health Network, Toronto 15 participants Est. completion 2024-08-01 1 site Stand-aloneOther conditions: Axial SpondyloarthritisView official trial listing → -
Status unknown NCT NCT05124431
Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma
Not yet reported Fudan University 30 participants Est. completion 2024-12 1 siteOther conditions: Renal Cell CarcinomaView official trial listing → -
Active, not recruiting NCT NCT05132361
SELUTION4SFA Trial
Not yet reported M.A. Med Alliance S.A. 300 participants Est. completion 2030-12-01 34 sites Stand-aloneOther conditions: Peripheral Arterial Disease, Superficial Femoral Artery StenosisView official trial listing → -
Available NCT NCT05134922
Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009
Celcuity Inc 5 sitesOther conditions: Breast Neoplasm Malignant FemaleView official trial listing → -
Status unknown NCT NCT05135312
Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
Not yet reported OptiSkin Medical 10 participants Est. completion 2022-08-08 1 siteOther conditions: Psoriasis, Psoriatic Arthritis, Psoriatic NailView official trial listing → -
Active, not recruiting NCT NCT05139004
90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome
Not yet reported City of Hope Medical Center 7 participants Est. completion 2027-06-13 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Secondary Acute Myeloid LeukemiaView official trial listing → -
Completed NCT NCT05139667
Evaluation of Mucoadhesive Tacrolimus Patch on Caspase-3 Inducing Apoptosis in Oral Lichen Planus
Not yet reported Ain Shams University 30 participants Est. completion 2021-10-20 1 site Stand-aloneOther conditions: Oral Lichen PlanusView official trial listing → -
Active, not recruiting NCT NCT05148715
Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)
Not yet reported Université de Sherbrooke 414 participants Est. completion 2026-01 9 sites Stand-aloneOther conditions: Organ Transplant Failure or Rejection, Brain Death, Ischemic Reperfusion InjuryView official trial listing → -
Completed NCT NCT05152628
A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients
Not yet reported Astellas Pharma China, Inc. 55 participants Est. completion 2024-03-06 4 sites Stand-aloneOther conditions: Liver Transplantation, Kidney TransplantationView official trial listing → -
Completed NCT NCT05153668
Everolimus Trial in Laryngotracheal Stenosis
Not yet reported Johns Hopkins University 8 participants Est. completion 2025-10-23 1 siteOther conditions: Idiopathic Subglottic Tracheal StenosisView official trial listing → -
Completed NCT NCT05153915
A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients
Not yet reported Astellas Pharma China, Inc. 56 participants Est. completion 2024-03-14 7 sites Stand-aloneOther conditions: Liver Transplantation, Kidney TransplantationView official trial listing → -
Active, not recruiting NCT NCT05156710
BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)
Not yet reported Sanofi 48 participants Est. completion 2026-10-20 27 sites Stand-aloneOther conditions: Transplant RejectionView official trial listing → -
Status unknown NCT NCT05161429
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
Brigham and Women's Hospital 550000 participants Est. completion 2024-06-30 5 sitesType 2 diabetesView official trial listing → -
Completed NCT NCT05180708
A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
Not yet reported Palvella Therapeutics, Inc. 87 participants Est. completion 2023-06-30 8 sitesOther conditions: Pachyonychia CongenitaView official trial listing → -
Status unknown NCT NCT05190627
Effect of Loratadine in Lymphangioleiomyomatosis
Not yet reported Institut d'Investigació Biomèdica de Bellvitge 62 participants Est. completion 2023-12-30 6 sitesOther conditions: LymphangioleiomyomatosisView official trial listing → -
Active, not recruiting NCT NCT05193565
Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients
Not yet reported Chong Kun Dang Pharmaceutical 206 participants Est. completion 2026-11 1 site Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT05202145
Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult Participants
Not yet reported Alexion Pharmaceuticals, Inc. 61 participants Est. completion 2022-03-21 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT05205499
A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease
Not yet reported Biotyx Medical (Shenzhen) Co., Ltd. 1059 participants Est. completion 2028-08 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Active, not recruiting NCT NCT05220917
Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study
Brigham and Women's Hospital 781430 participants Est. completion 2027-09-30 1 siteType 2 diabetes Other conditions: Cardiovascular Events, Renal DiseaseView official trial listing → -
Status unknown NCT NCT05221411
Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy
Not yet reported Leiden University Medical Center 86 participants Est. completion 2024-01 6 sites Stand-aloneOther conditions: Autoimmune HepatitisView official trial listing → -
Completed NCT NCT05247203
Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus
Not yet reported RemeGen Co., Ltd. 92 participants Est. completion 2023-11-13 19 sites Stand-aloneOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Completed NCT NCT05252585
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)
Not yet reported Novartis Pharmaceuticals 10 participants Est. completion 2026-10-13 4 sitesOther conditions: Renal AngiomyolipomaView official trial listing → -
Active, not recruiting NCT NCT05256537
Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil
Not yet reported Ronald Paquette 60 participants Est. completion 2027-01-07 1 siteOther conditions: Hematologic NeoplasmsView official trial listing → -
Status unknown NCT NCT05267548
Investigating the Safety and Clinical Performance of Seven iVascular Devices for Endovascular Intervention in the Popliteal and/or Infrapopliteal Arteries
iVascular S.L.U. 143 participants Est. completion 2025-05 8 sitesOther conditions: Peripheral Arterial Disease Below The KneeView official trial listing → -
Completed NCT NCT05274308
Stability of Tacrolimus, Cyclosporine A, Everolimus and Sirolimus in Whole Blood Patient Samples
Thermo Fisher Scientific Oy 46 participants Est. completion 2022-07-26 1 siteOther conditions: Transplantation Drugs StabilityView official trial listing → -
Status unknown NCT NCT05277792
Dosage of Tacrolimus Metabolites in Blood and Bile for Prediction of Its Side Effects in Liver Transplant Recipients
Rennes University Hospital 48 participants Est. completion 2024-06-08 1 siteOther conditions: Blood Concentration of Tacrolimus MetabolitesView official trial listing → -
Completed NCT NCT05281614
Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D
Not yet reported Benaroya Research Institute 20 participants Est. completion 2024-01-10 2 sites Stand-aloneOther conditions: Type 1 DiabetesView official trial listing → -
Withdrawn NCT NCT05293509
Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders
Not yet reported M.D. Anderson Cancer Center Est. completion 2023-09-18 1 site Stand-aloneOther conditions: Stem Cell TransplantationView official trial listing → -
Active, not recruiting NCT NCT05293964
Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer
Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 214 participants Est. completion 2025-09-08 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT05294666
Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment
Not yet reported Peking University Third Hospital 89 participants Est. completion 2021-07-01 1 site Stand-aloneOther conditions: Graft Versus Host Disease in EyeView official trial listing → -
Status unknown NCT NCT05294822
Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes
Not yet reported Shanghai Changzheng Hospital 20 participants Est. completion 2023-12 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Terminated NCT NCT05298358
RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis
Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 participants Est. completion 2024-11-21 1 site Stand-aloneOther conditions: Systemic SclerosisView official trial listing → -
Not yet recruiting NCT NCT05303727
Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma
Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 64 participants Est. completion 2027-08 1 site Stand-aloneOther conditions: NeuroblastomaView official trial listing → -
Status unknown NCT NCT05316038
Metabolic and Infectious Complications Post Belatacept Conversion
University Hospital, Grenoble 100 participants Est. completion 2024-06-01Cardiovascular disease Other conditions: Kidney Transplant Infection, Immunosuppression, Kidney Transplant; ComplicationsView official trial listing → -
Active, not recruiting NCT NCT05316701
Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Not yet reported Orca Biosystems, Inc. 187 participants Est. completion 2026-07 19 sites Stand-aloneOther conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia, Undifferentiated Leukemia, Myelodysplastic Syndrome, Acute Leukemia, Therapy-Related Myelodysplastic SyndromeView official trial listing → -
Completed NCT NCT05324618
Tacrolimus Versus Hydrocortisone in Atopic Dermatitis
Not yet reported Ain Shams University 200 participants Est. completion 2023-04-30 1 siteOther conditions: Atopic, DermatitisView official trial listing → -
Completed NCT NCT05325073
Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients
Not yet reported Northwestern University 9 participants Est. completion 2024-12-30 1 siteOther conditions: Liver Transplant RejectionView official trial listing → -
Status unknown NCT NCT05328843
Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function
Not yet reported PegBio Co., Ltd. 24 participants Est. completion 2022-10-01 1 siteOther conditions: Type2DiabetesView official trial listing → -
Status unknown NCT NCT05333640
A Real-world Registry Investigating Sirolimus-coated Balloon Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Dysfunctional Arteriovenous Fistula
Singapore General Hospital 200 participants Est. completion 2024-04-30 1 siteOther conditions: Dialysis Access Malfunction, StenosisView official trial listing → -
Completed NCT NCT05345119
Sirolimus in Graves' Orbitopathy
University of Pisa 30 participants Est. completion 2021-06-15 1 siteOther conditions: Graves OphthalmopathyView official trial listing → -
Terminated NCT NCT05347147
A Trial to Determine the Efficacy and Safety of Presendin in IIH
Not yet reported Invex Therapeutics Ltd. 14 participants Est. completion 2023-10-20 24 sitesOther conditions: Idiopathic Intracranial HypertensionView official trial listing → -
Completed NCT NCT05352880
Hypomagnesemia and Its Association With Calcineurin Inhibitors Use in Renal Transplant Recipients
Not yet reported Alexandria University 80 participants Est. completion 2022-09-10 1 site Stand-aloneOther conditions: Renal Transplantation; ComplicationView official trial listing → -
Status unknown NCT NCT05353010
A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy Volunteers
Not yet reported HK inno.N Corporation 12 participants Est. completion 2022-11-01 1 site Stand-aloneOther conditions: HealthyView official trial listing → -
Active, not recruiting NCT NCT05364762
Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants
Not yet reported City of Hope Medical Center 20 participants Est. completion 2027-03-25 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Primary Myelofibrosis, Secondary MyelofibrosisView official trial listing → -
Status unknown NCT NCT05379049
Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis.
University of Sulaimani 80 participants Est. completion 2022-10-01 1 siteOther conditions: Rheumatoid Arthritis, Inflammatory Arthritis, Ankylosing SpondylitisView official trial listing → -
Withdrawn NCT NCT05379322
The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients
Not yet reported Abu Dhabi Stem Cells Center Est. completion 2023-03-01 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Active, not recruiting NCT NCT05386914
This Study Consists of Two Study Parts Conducted Under a Single IRB. Part I: Short Term ApoE-dependent Cerebral Blood Flow Response to Sirolimus in Cognitively Normal Adults Part II: Short Term ApoE-dependent Cerebral Blood Flow and Lung Perfusion Response to Sirolimus in Cognitively Normal Adults
Not yet reported University of Missouri-Columbia 205 participants Est. completion 2027-12 1 site Stand-aloneOther conditions: Genetic Predisposition to Disease, Healthy VolunteersView official trial listing → -
Completed NCT NCT05396898
Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial)
Not yet reported University Hospital Tuebingen 44 participants Est. completion 2023-12-30 1 site Stand-aloneOther conditions: Posttransplant Diabetes MellitusView official trial listing → -
Withdrawn NCT NCT05423496
KidneyCare Immuno-optimization in Renal Allografts (KIRA)
Not yet reported CareDx Est. completion 2023-02-23Other conditions: Kidney Transplant, Immunosuppression, AllograftView official trial listing → -
Status unknown NCT NCT05424393
Real-World Study on Long-term Treatment With YISAIPU for Fujian RA Patients
The First Affiliated Hospital of Xiamen University 500 participants Est. completion 2025-12-31 1 siteOther conditions: Rheumatoid ArthritisView official trial listing → -
Status unknown NCT NCT05429684
Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer
Not yet reported First Affiliated Hospital Xi'an Jiaotong University 120 participants Est. completion 2024-02-28 2 sitesOther conditions: HER2+ Breast CancerView official trial listing → -
Enrolling by invitation NCT NCT05432518
Pilot Trial for Treatment of Recurrent Glioblastoma
Not yet reported AHS Cancer Control Alberta 10 participants Est. completion 2027-12-01 1 siteOther conditions: Glioblastoma, Recurrent Disease, Recurrent GlioblastomaView official trial listing → -
Not yet recruiting NCT NCT05432765
AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function
Not yet reported University of Florida 34 participants Est. completion 2031-01-01 1 site Stand-aloneOther conditions: Kidney Transplant RejectionView official trial listing → -
Status unknown NCT NCT05450042
Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation
Not yet reported University Hospital, Essen 70 participants Est. completion 2024-04-06 1 site Stand-aloneOther conditions: Peripheral Arterial Disease, Flow-mediated Dilation, Drug Eluting Balloon, Infrainguinal Peripheral Arterial DiseaseView official trial listing → -
Active, not recruiting NCT NCT05457556
Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome
Not yet reported Children's Oncology Group 66 participants Est. completion 2027-07-07 63 sites Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic SyndromeView official trial listing → -
Active, not recruiting NCT NCT05467397
Feasibility of [11C]Acetate-PET in LAM and TSC
Not yet reported, Not yet reported Brigham and Women's Hospital 7 participants Est. completion 2026-06-30 1 siteOther conditions: Lymphangioleiomyomatosis, Tuberous Sclerosis ComplexView official trial listing → -
Status unknown NCT NCT05471050
The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Not yet reported Peking University People's Hospital 120 participants Est. completion 2023-06-01 1 site Stand-aloneOther conditions: Immune ThrombocytopeniaView official trial listing → -
Active, not recruiting NCT NCT05477576
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Not yet reported RayzeBio, Inc. 343 participants Est. completion 2030-12 54 sitesOther conditions: GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors, Carcinoid, Carcinoid Tumor, Pancreatic NETView official trial listing → -
Completed NCT NCT05490342
Effect of SARS-CoV-2 Vaccination in Liver Transplant Recipients
University of Rome Tor Vergata 61 participants Est. completion 2022-06-30 1 siteOther conditions: SARS-CoV-2 Vaccination, Liver TransplantationView official trial listing → -
Completed NCT NCT05490511
Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus
Not yet reported Indiana University 57 participants Est. completion 2025-08-31 1 siteOther conditions: CBD, Transplant Complication, Kidney Disease, ChronicView official trial listing → -
Completed NCT NCT05495425
Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC
Not yet reported Nobelpharma 43 participants Est. completion 2024-10-30 5 sites Stand-aloneOther conditions: Tuberous Sclerosis ComplexView official trial listing → -
Terminated NCT NCT05501574
An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients
Not yet reported TFF Pharmaceuticals, Inc. 14 participants Est. completion 2024-12-23 2 sites Stand-aloneOther conditions: Lung Transplant RejectionView official trial listing → -
Status unknown NCT NCT05508620
A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors
Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 270 participants Est. completion 2024-12 Stand-aloneOther conditions: Malignant Solid TumorsView official trial listing → -
Active, not recruiting NCT NCT05508906
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
Not yet reported Olema Pharmaceuticals, Inc. 190 participants Est. completion 2028-01-31 16 sitesOther conditions: Metastatic Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, Breast Cancer, Locally Advanced Breast CancerView official trial listing → -
Status unknown NCT NCT05532111
Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial
Not yet reported RenJi Hospital 60 participants Est. completion 2024-09-30 Stand-aloneOther conditions: Efficacy and SafetyView official trial listing → -
Status unknown NCT NCT05546047
A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients
Not yet reported NephroNet, Inc. 34 participants Est. completion 2024-10-27 5 sitesOther conditions: Fibrillary GlomerulonephritisView official trial listing → -
Status unknown NCT NCT05548023
Time-trend Analysis of Clinical Characteristic and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Treated With PCI Over a 10-year Period
Not yet reported Chinese University of Hong Kong 500 participants Est. completion 2025-02-07 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT05553496
Assessment of Rituximab Therapeutic Response Versus Conventional Treatment
Not yet reported, Not yet reported Ain Shams University 40 participants Est. completion 2023-10-01Other conditions: Pharmacological ActionView official trial listing → -
Completed NCT NCT05556681
Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries
Not yet reported C. R. Bard 34 participants Est. completion 2025-11-24 10 sites Stand-aloneOther conditions: Peripheral Arterial Disease, Peripheral Artery Disease, Stenosis ArteryView official trial listing → -
Active, not recruiting NCT NCT05563220
Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer
Not yet reported, Not yet reported Stemline Therapeutics, Inc. 435 participants Est. completion 2028-12-28 83 sitesOther conditions: Breast Cancer, Metastatic Breast CancerView official trial listing → -
Terminated NCT NCT05571670
Bile Acids in Acute Insulin Resistance
Columbia University 3 participants Est. completion 2022-06-10 1 siteOther conditions: PI3K Gene Mutation, AKT Gene Mutation, MTOR Gene Mutation, Cancer, Insulin ResistanceView official trial listing → -
Completed NCT NCT05577637
Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo
Not yet reported Combined Military Hospital Abbottabad 60 participants Est. completion 2021-11-30 1 siteOther conditions: VitiligoView official trial listing → -
Active, not recruiting NCT NCT05589896
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Not yet reported, Not yet reported Ossium Health, Inc. 12 participants Est. completion 2029-05-31 9 sites Stand-aloneOther conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, Acute Undifferentiated Leukemia, CLL (Chronic Lymphocytic Leukemia), Chronic Myeloid Leukemia (CML), MDS (Myelodysplastic Syndrome), Non-Hodgkin Lymphomas, Hodgkins Lymphoma, Cutaneous T Cell Lymphomas (CTCL)View official trial listing → -
Completed NCT NCT05607901
A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone
Not yet reported Tanta University 100 participants Est. completion 2023-08-20 1 siteOther conditions: Dermatologic DiseaseView official trial listing → -
Active, not recruiting NCT NCT05613010
Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
Not yet reported Johns Hopkins University 65 participants Est. completion 2027-08-30 1 site Stand-aloneOther conditions: Transplant;Failure,Kidney, Transplant; Failure, Liver, Adherence, Medication, Adherence, Patient, Adherence, TreatmentView official trial listing → -
Status unknown NCT NCT05613166
Adjunctive Everolimus Treatment of Refractory Epilepsy
Not yet reported National Institute on Drug Dependence, China 108 participants Est. completion 2023-03 1 siteOther conditions: EpilepsyView official trial listing → -
Status unknown NCT NCT05618730
Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
Not yet reported Eximore Ltd. 20 participants Est. completion 2023-12-30 1 site Stand-aloneOther conditions: Dry Eye, Keratoconjunctivitis Sicca, Ocular InflammationView official trial listing → -
Active, not recruiting NCT NCT05621759
Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD
Not yet reported NYU Langone Health 27 participants Est. completion 2027-01-30 1 site Stand-aloneOther conditions: Graft Vs Host DiseaseView official trial listing → -
Status unknown NCT NCT05622123
BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation
Not yet reported Radboud University Medical Center 20 participants Est. completion 2024-03-30 1 siteOther conditions: Type 1 DiabetesView official trial listing → -
Active, not recruiting NCT NCT05622318
De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis
Not yet reported Medical College of Wisconsin 56 participants Est. completion 2028-08-06 1 site Stand-aloneOther conditions: Graft-versus-host DiseaseView official trial listing → -
Status unknown NCT NCT05625919
A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)
Not yet reported, Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 54 participants Est. completion 2024-11 1 site Stand-aloneOther conditions: Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)View official trial listing → -
Enrolling by invitation NCT NCT05655273
Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients
Not yet reported University Health Network, Toronto 40 participants Est. completion 2026-02-28 1 siteOther conditions: Liver Transplant Rejection, Immune System SuppressionView official trial listing → -
Status unknown NCT NCT05662618
To Verify the Efficacy and Safety of Rapamycin Coated Peripheral Balloon Catheter in the Treatment of Femoral Popliteal Artery Disease
Not yet reported Shanghai Bomaian Medical Technology Co., Ltd 276 participants Est. completion 2025-06-30 1 siteOther conditions: Peripheral Arterial DiseaseView official trial listing → -
Status unknown NCT NCT05666336
Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients
Not yet reported Fen Li 30 participants Est. completion 2024-06-30 1 site Stand-aloneOther conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT05667896
Prognostic Model of GC/TAC in the Treatment of MN
Qianfoshan Hospital 50 participants Est. completion 2023-12Other conditions: Idiopathic Membranous NephropathyView official trial listing → -
Status unknown NCT NCT05667922
Prognostic Model of TAC in the Treatment of MN
Qianfoshan Hospital 50 participants Est. completion 2023-12Other conditions: Idiopathic Membranous NephropathyView official trial listing → -
Completed NCT NCT05669001
A Study of TCD601 in de Novo Renal Transplant Recipients
Not yet reported ITB-Med LLC 76 participants Est. completion 2026-04-10 18 sitesOther conditions: Renal TransplantationView official trial listing → -
Completed NCT NCT05677711
Safety and Efficacy of the Ultimaster Stent
Yonsei University 204 participants Est. completion 2025-01-03 1 siteCardiovascular disease Other conditions: Drug-eluting StentsView official trial listing → -
Status unknown NCT NCT05678335
Tacrolimus for Thrombocytopenia in SS
Not yet reported, Not yet reported Peking Union Medical College Hospital 54 participants Est. completion 2024-03 Stand-aloneOther conditions: Sjogren Syndrome With Other Organ InvolvementView official trial listing → -
Status unknown NCT NCT05694130
Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS
Not yet reported, Not yet reported Peking Union Medical College Hospital 110 participants Est. completion 2024-12 Stand-aloneOther conditions: Sjogren Syndrome With Other Organ InvolvementView official trial listing → -
Status unknown NCT NCT05696106
Risk of Incident IMID in Patients Treated With Biologics and Immunosuppressive Drugs for a Single IMID
Assistance Publique - Hôpitaux de Paris 750000 participants Est. completion 2024-01-15 1 siteOther conditions: Inflammatory DiseaseView official trial listing → -
Status unknown NCT NCT05703646
Safety and Clinical Performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Stents in Routine Practice
Translumina GmbH 5000 participants Est. completion 2026-03-30 1 siteOther conditions: Ischemic Heart DiseaseView official trial listing → -
Active, not recruiting NCT NCT05705973
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
Terumo Europe N.V. 3000 participants Est. completion 2027-04-29 52 sitesCardiovascular disease Other conditions: Coronary Artery Occlusion, Ischemic Heart DiseaseView official trial listing → -
Completed NCT NCT05706636
T Central Memory Cells in Early Localized Non-Segmental Vitiligo
Not yet reported Cairo University 22 participants Est. completion 2025-04-15 1 siteOther conditions: VitiligoView official trial listing → -
Active, not recruiting NCT NCT05707377
A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy
Not yet reported, Not yet reported BeOne Medicines 178 participants Est. completion 2027-10 45 sitesOther conditions: Primary Membranous NephropathyView official trial listing → -
Status unknown NCT NCT05739630
M-PTCy vs BuCy in Haploidentical HSCT for Acute Leukemia
Not yet reported, Not yet reported The First Affiliated Hospital of Soochow University 60 participants Est. completion 2025-01-31 1 siteOther conditions: Acute LeukemiaView official trial listing → -
Status unknown NCT NCT05744635
Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients
Chiesi Hungary Ltd. 110 participants Est. completion 2026-06-01 2 sitesOther conditions: Liver FailureView official trial listing → -
Not yet recruiting NCT NCT05746689
Study of Sirolimus in IgG4-related Disease
Not yet reported Peking University International Hospital 20 participants Est. completion 2028-12-31 Stand-aloneOther conditions: IgG4-related DiseaseView official trial listing → -
Terminated NCT NCT05762744
Pharmacogenomics of GLP1 Receptor Agonists
Not yet reported University of Maryland, Baltimore 63 participants Est. completion 2022-10-31 1 siteType 2 diabetesView official trial listing → -
Terminated NCT NCT05773326
Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG
Not yet reported Nader Sanai 5 participants Est. completion 2025-10-16 1 siteOther conditions: High Grade Glioma, Glioma, Glioma, Malignant, GlioblastomaView official trial listing → -
Status unknown NCT NCT05797038
Study on the Application of Hyperspectral Imaging Technique in the Treatment of IMN by TAC
Qianfoshan Hospital 40 participants Est. completion 2023-12-30Other conditions: Idiopathic Membranous Nephropathy, Tacrolimus, Hyperspectral ImagingView official trial listing → -
Completed NCT NCT05799755
Myositis Interstitial Lung Disease Nintedanib Trial
Not yet reported Rohit Aggarwal, MD 62 participants Est. completion 2025-12-31 10 sitesOther conditions: Myositis Associated Interstitial Lund Disease (MA-ILD)View official trial listing → -
Active, not recruiting NCT NCT05806749
Immunological Tolerance in Patients With Mismatched Kidney Transplants
Not yet reported University of California, Los Angeles 16 participants Est. completion 2028-08 1 site Stand-aloneChronic kidney disease Other conditions: End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and RejectionView official trial listing → -
Status unknown NCT NCT05833815
Addition of Everolimus to Standard of Care in Carcinoma Gallbladder
Not yet reported, Not yet reported Banaras Hindu University 56 participants Est. completion 2024-12-30 1 siteOther conditions: Gallbladder CancerView official trial listing → -
Completed NCT NCT05835999
Everolimus Aging Study
Not yet reported University of Wisconsin, Madison 106 participants Est. completion 2026-07-22 1 siteOther conditions: Aging, Insulin ResistanceView official trial listing → -
Active, not recruiting NCT NCT05836025
Effect of Rapamycin in Ovarian Aging
Not yet reported Columbia University 50 participants Est. completion 2026-09 1 siteOther conditions: PerimenopausalView official trial listing → -
Status unknown NCT NCT05836441
Improved Phototherapy in Patients With Vitiligo
Not yet reported The First Affiliated Hospital with Nanjing Medical University 110 participants Est. completion 2023-12-30 1 siteOther conditions: VitiligoView official trial listing → -
Terminated NCT NCT05840510
Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)
Not yet reported Mirati Therapeutics Inc. 6 participants Est. completion 2024-12-27 3 sites Stand-aloneOther conditions: Solid Tumor, Adult, NSCLC, Advanced Cancer, Metastatic Cancer, Malignant Neoplastic DiseaseView official trial listing → -
Terminated NCT NCT05856994
Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns
Not yet reported Vanderbilt University Medical Center 1 participants Est. completion 2026-04-20 1 site Stand-aloneOther conditions: Burn InjuryView official trial listing → -
Active, not recruiting NCT NCT05860881
Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)
Not yet reported Melanoma and Skin Cancer Trials Limited 146 participants Est. completion 2027-09-30 6 sites Stand-aloneOther conditions: Solid Organ Transplant Recipients, Skin CancerView official trial listing → -
Status unknown NCT NCT05863936
Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis
Not yet reported Nanjing University School of Medicine 15 participants Est. completion 2024-12-31 1 siteOther conditions: Lupus Nephritis, Remission, Safety IssuesView official trial listing → -
Completed NCT NCT05885269
Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata
Not yet reported Combined Military Hospital Abbottabad 70 participants Est. completion 2023-04-30 1 siteOther conditions: Alopecia AreataView official trial listing → -
Status unknown NCT NCT05899907
Efficacy and Safety of Telitacicept in Early SLE
Not yet reported Peking Union Medical College Hospital 180 participants Est. completion 2025-09-01 20 sitesOther conditions: Lupus Erythematosus, SystemicView official trial listing → -
Active, not recruiting NCT NCT05907746
Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency
Not yet reported National Cancer Institute (NCI) 13 participants Est. completion 2028-07-31 1 site Stand-aloneOther conditions: GATA2, ImmunodeficiencyView official trial listing → -
Status unknown NCT NCT05913596
The Safety and Efficacy of CD38 Monoclonal Antibody Monotherapy for CaAMR in Renal Transplantation
Not yet reported First Affiliated Hospital of Zhejiang University 15 participants Est. completion 2024-08-30 1 site Stand-aloneOther conditions: Antibody-mediated Rejection, Kidney TranplantView official trial listing → -
Completed NCT NCT05915468
Large De-NOVo Coronary artEry Disease Treated With Sirolimus Drug Eluting Balloon (LOVE DEB)
Wrightington, Wigan and Leigh NHS Foundation Trust 306 participants Est. completion 2025-12-11 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT05916781
Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus
Not yet reported Chinese SLE Treatment And Research Group 220 participants Est. completion 2026-07-31 1 site Stand-aloneOther conditions: Systemic Lupus Erythematosus, Lupus NephritisView official trial listing → -
Status unknown NCT NCT05920512
Combination Regimen With Sodium Valproate for Severe Hemophilia: a Single-arm, Phase 1, Pilot Trial.
Not yet reported, Not yet reported Xue-chun Lu 10 participants Est. completion 2025-04-01 1 site Stand-aloneOther conditions: HemophiliaView official trial listing → -
Status unknown NCT NCT05929248
Exploring the Therapeutic Effect of Telitacicept on Lupus Erythematosus Complicated With Thrombocytopenia
Not yet reported Guanmin Gao 64 participants Est. completion 2024-12-30Other conditions: Systemic Lupus ErythematosusView official trial listing → -
Status unknown NCT NCT05938530
Sirolimus Drug-coated Balloon Versus Stent Graft
Not yet reported Singapore General Hospital 100 participants Est. completion 2026-08 1 site Stand-aloneOther conditions: Arteriovenous Shunt Thrombosis, Blood Vessel ProsthesisView official trial listing → -
Active, not recruiting NCT NCT05946629
SELUTION 4 De Novo Small Vessel IDE Trial
Not yet reported M.A. Med Alliance S.A. 960 participants Est. completion 2031-09 70 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Enrolling by invitation NCT NCT05950724
RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant
Not yet reported Northwestern University 20 participants Est. completion 2027-12 1 site Stand-aloneOther conditions: Lung Transplant; ComplicationsView official trial listing → -
Active, not recruiting NCT NCT05952206
Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
Not yet reported iVascular S.L.U. 2312 participants Est. completion 2030-01-13 38 sites Stand-aloneCardiovascular diseaseView official trial listing → -
Enrolling by invitation NCT NCT05973734
Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy
Not yet reported Stanford University 24 participants Est. completion 2030-12 1 site Stand-aloneOther conditions: Islet TransplantationView official trial listing → -
Completed NCT NCT05975450
Subcutaneous Abatacept in Renal Transplant Recipients
Not yet reported Idelberto Badell 16 participants Est. completion 2025-02-14 2 sites Stand-aloneOther conditions: Kidney Transplant RecipientView official trial listing → -
Completed NCT NCT05983770
Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
Not yet reported Eledon Pharmaceuticals 127 participants Est. completion 2025-09-25 43 sitesOther conditions: Kidney Transplant RejectionView official trial listing → -
Completed NCT NCT05997056
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
Not yet reported Aadi Bioscience, Inc. 12 participants Est. completion 2025-10-03 4 sites Stand-aloneOther conditions: Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor, Gastrointestinal Neuroendocrine Tumor, Pulmonary Neuroendocrine TumorView official trial listing → -
Status unknown NCT NCT06000982
Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis
Not yet reported Shanghai Jiao Tong University School of Medicine 138 participants Est. completion 2026-04-01 2 sites Stand-aloneOther conditions: GVHDView official trial listing → -
Active, not recruiting NCT NCT06001385
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
Not yet reported Center for International Blood and Marrow Transplant Research 313 participants Est. completion 2026-12-30 32 sites Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Myeloproliferative Neoplasm, Lymphoma, Chronic Myelomonocytic Leukemia, Pro-Lymphocytic Leukemia, MyelofibrosisView official trial listing → -
Active, not recruiting NCT NCT06019507
A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation
Not yet reported ITB-Med LLC 12 participants Est. completion 2029-06 1 siteOther conditions: Liver TransplantationView official trial listing → -
Completed NCT NCT06022068
Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography
Not yet reported, Not yet reported Karolinska Institutet 14 participants Est. completion 2025-01-17 1 site Stand-aloneOther conditions: Alzheimer DiseaseView official trial listing → -
Status unknown NCT NCT06029569
Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula
Not yet reported Shanghai Bomaian Medical Technology Co., Ltd 256 participants Est. completion 2025-12-15Other conditions: Peripheral Arterial DiseaseView official trial listing → -
Completed NCT NCT06035614
Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children
Not yet reported Clarteis 50 participants Est. completion 2023-07-01 1 siteOther conditions: Vitiligo, Pediatric ALL, Dermatologic Disease, Autoimmune DiseasesView official trial listing → -
Completed NCT NCT06044558
Effect of Azole/Echinocandin Use on Tacrolimus Pharmacokinetics
LI YAN 507 participants Est. completion 2023-06-01 1 siteOther conditions: Kidney Transplant PatientsView official trial listing → -
Status unknown NCT NCT06057545
Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation
Not yet reported University Hospital, Essen 30 participants Est. completion 2025-03 4 sites Stand-aloneOther conditions: Pediatric Kidney DiseaseView official trial listing → -
Completed NCT NCT06066476
Efficacy and Safety of GENOSS® DES in Patients with Coronary Artery Disease
Genoss Co., Ltd. 1022 participants Est. completion 2024-10-31 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT06066840
Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement
Not yet reported The First Affiliated Hospital of Soochow University 45 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Safety and EfficacyView official trial listing → -
Active, not recruiting NCT NCT06075368
Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)
Genoss Co., Ltd. 757 participants Est. completion 2027-12-31 1 siteOther conditions: Acute Coronary Syndrome, Percutaneous Coronary InterventionView official trial listing → -
Completed NCT NCT06080490
Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients
University of Pisa 125 participants Est. completion 2024-12-31 1 siteOther conditions: Graft Vs Host Disease, Transplant Failure, Stem Cell Transplant ComplicationsView official trial listing → -
Not yet recruiting NCT NCT06084780
Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)
Not yet reported Case Comprehensive Cancer Center 20 participants Est. completion 2027-12-31 1 site Stand-aloneOther conditions: Secondary Malignant Neoplasm of Retroperitoneum, Secondary Malignant Neoplasm of Peritoneum, Pseudomyxoma PeritoneiView official trial listing → -
Enrolling by invitation NCT NCT06086496
Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)
Genoss Co., Ltd. 1000 participants Est. completion 2027-12-31 1 siteCardiovascular disease Other conditions: Percutaneous Coronary InterventionView official trial listing → -
Completed NCT NCT06091995
Use of Belatacept to Delay Tacrolimus Initiation in Kidney Transplant Patients With Delayed Graft Function
Methodist Health System 67 participants Est. completion 2025-07-07 1 siteOther conditions: Use of Belatacept in Kidney Transplant PatientsView official trial listing → -
Completed NCT NCT06095895
Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment
Radboud University Medical Center 29 participants Est. completion 2025-11-20 1 siteOther conditions: Pharmacokinetics, Area Under Curve, Tacrolimus, Immunosuppressive Agents, Mycophenolic AcidView official trial listing → -
Status unknown NCT NCT06114953
Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients
Not yet reported Lee's Pharmaceutical Limited 152 participants Est. completion 2025-03-01 6 sites Stand-aloneOther conditions: Kidney Transplant ImmunosuppressionView official trial listing → -
Active, not recruiting NCT NCT06120140
Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib
Not yet reported Janssen Research & Development, LLC 305 participants Est. completion 2030-06-30 93 sites Stand-aloneOther conditions: Carcinoma, Non-Small-Cell LungView official trial listing → -
Not yet recruiting NCT NCT06122974
Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia
Not yet reported ReFlow Medical, Inc. 518 participants Est. completion 2037-12Other conditions: Critical Limb IschemiaView official trial listing → -
Enrolling by invitation NCT NCT06126380
Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients
Not yet reported Eledon Pharmaceuticals 132 participants Est. completion 2029-12 43 sitesOther conditions: Kidney Transplant RejectionView official trial listing → -
Active, not recruiting NCT NCT06126835
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants
Bristol-Myers Squibb 2828 participants Est. completion 2032-06-30 1 siteOther conditions: Ulcerative ColitisView official trial listing → -
Active, not recruiting NCT NCT06145282
Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function
Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 6 participants Est. completion 2027-11-26 1 site Stand-aloneOther conditions: Sickle Cell DiseaseView official trial listing → -
Not yet recruiting NCT NCT06147375
Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation
Not yet reported Wei Gao 47 participants Est. completion 2028-12 1 site Stand-aloneOther conditions: Immune Tolerance, Immunosuppression, Liver Transplant; ComplicationsView official trial listing → -
Status unknown NCT NCT06147648
Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation.
Not yet reported Beijing Tsinghua Chang Gung Hospital 352 participants Est. completion 2026-07-30 Stand-aloneOther conditions: Liver TransplantationView official trial listing → -
Status unknown NCT NCT06178146
Thymosin Alpha-1 for irAE Secondary to ICIs
Not yet reported Jun Wang 40 participants Est. completion 2025-04 1 siteOther conditions: IrAEView official trial listing → -
Suspended NCT NCT06195891
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
Not yet reported City of Hope Medical Center 33 participants Est. completion 2030-03-22 1 site Stand-aloneOther conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic SyndromeView official trial listing → -
Status unknown NCT NCT06196996
Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus
Not yet reported Shanghai Changzheng Hospital 18 participants Est. completion 2026-09 1 site Stand-aloneOther conditions: Brittle Type 1 Diabetes MellitusView official trial listing → -
Status unknown NCT NCT06197022
Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)
Not yet reported University National Heart Hospital 106 participants Est. completion 2024-12 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT06203470
Botox Versus Tacrolimus in Psoriasis Vulgaris
Not yet reported Assiut University 60 participants Est. completion 2026-10 Stand-aloneOther conditions: Psoriasis VulgarisView official trial listing → -
Completed NCT NCT06219616
Prediction of BK Virus Reactivation in Kidney Transplant Recipient
Not yet reported King Chulalongkorn Memorial Hospital 80 participants Est. completion 2025-05-31 1 siteOther conditions: Kidney Transplant Infection, BK Virus Infection, BK Virus NephropathyView official trial listing → -
Status unknown NCT NCT06225206
Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients
Methodist Health System 300 participants Est. completion 2024-12-31 1 siteOther conditions: Liver Transplant FailureView official trial listing → -
Status unknown NCT NCT06233591
Evaluating LP-10 in Subjects With OLP
Not yet reported Lipella Pharmaceuticals, Inc. 24 participants Est. completion 2025-06-01 7 sites Stand-aloneOther conditions: Oral Lichen PlanusView official trial listing → -
Completed NCT NCT06235905
Open-Label of SPN-820 in Adults With Major Depressive Disorder
Not yet reported Navitor Pharmaceuticals, Inc. 40 participants Est. completion 2024-08-18 1 siteOther conditions: Major Depressive DisorderView official trial listing → -
Active, not recruiting NCT NCT06239480
SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations
Not yet reported Palvella Therapeutics, Inc. 51 participants Est. completion 2026-07 15 sitesOther conditions: Microcystic Lymphatic MalformationView official trial listing → -
Active, not recruiting NCT NCT06241118
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
Not yet reported Sanofi 464 participants Est. completion 2028-09-29 154 sites Stand-aloneOther conditions: Dermatitis AtopicView official trial listing → -
Enrolling by invitation NCT NCT06257420
Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions
Simmaron Research Inc. 150 participants Est. completion 2027-07-01 5 sitesOther conditions: Myalgic Encephalomyelitis, Long-COVIDView official trial listing → -
Active, not recruiting NCT NCT06257966
A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin
Not yet reported Beijing Dongfang Biotech Co., Ltd. 600 participants Est. completion 2026-11-30 1 siteType 2 diabetesView official trial listing → -
Active, not recruiting NCT NCT06268769
Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs
Not yet reported Edward Geissler 322 participants Est. completion 2028-11 13 sites Stand-aloneOther conditions: ImmunosuppressionView official trial listing → -
Status unknown NCT NCT06279494
Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors
Not yet reported, Not yet reported Peking University People's Hospital 6 participants Est. completion 2025-03 Stand-aloneOther conditions: Acute Leukemia, Myelodysplastic Syndromes, Severe Aplastic AnemiaView official trial listing → -
Not yet recruiting NCT NCT06291103
Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)
Not yet reported, Not yet reported University Hospital, Rouen 290 participants Est. completion 2032-08-01 1 siteOther conditions: Kidney Transplant RejectionView official trial listing → -
Not yet recruiting NCT NCT06300268
Advapro Coronary Stent System in Coronary Artery Diseased Patients.
Not yet reported Advanced MedTech Solutions Pvt. Ltd. 120 participants Est. completion 2026-12Cardiovascular disease Other conditions: De Novo Stenosis Lesion, Coronary Stent ImplantationView official trial listing → -
Not yet recruiting NCT NCT06301386
Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients
Not yet reported Fudan University 25 participants Est. completion 2026-12-01 2 sitesOther conditions: Colon CancerView official trial listing → -
Active, not recruiting NCT NCT06305286
Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)
Not yet reported, Not yet reported University of Chicago 70 participants Est. completion 2029-03 1 siteOther conditions: Type 1 Diabetes MellitusView official trial listing → -
Enrolling by invitation NCT NCT06306274
Topical Tacrolimus for Breast Cancer-related Lymphedema
Not yet reported, Not yet reported Odense University Hospital 80 participants Est. completion 2026-03-31 3 sites Stand-aloneOther conditions: LymphedemaView official trial listing → -
Status unknown NCT NCT06306989
Observational Clinical Study of Letermovir for Preventing CMV Infection After Allo-HSCT
Cao Weijie 150 participants Est. completion 2025-12-01 1 siteOther conditions: Letemovir for the Prevention of CMV Infection After Allo-HSCTView official trial listing → -
Status unknown NCT NCT06307808
Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination
University Hospital, Grenoble 66 participants Est. completion 2025-10-01 1 siteOther conditions: HBV, Kidney Transplantation, Liver TransplantationView official trial listing → -
Status unknown NCT NCT06317298
Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy
Not yet reported Peking University First Hospital 36 participants Est. completion 2025-12-01 1 siteOther conditions: Renal Cell Carcinoma, Clear Cell, SomaticView official trial listing → -
Status unknown NCT NCT06319391
Analysis of the Effect of Donor CYP3A5 Gene Polymorphism on Early Tacrolimus Concentration and Postoperative Acute Renal Injury After Liver Transplantation
Ziqiang Li 60 participants Est. completion 2025-10-01 1 siteOther conditions: Complete and Accurate Statistical Data of 60 Patients, CYP3A5*3 Genotypes of 60 Donors and Recipients Were Analyzed Accurately, Postoperative Tacrolimus Concentrations Were Accurately Recorded in 60 Patients, According to the Diagnosis and Grading Criteria of Acute Kidney Injury, the Cases and Grading of Postoperative Acute Kidney Injury in 60 Patients Were Counted, Scientific and Rigorous Statistical Analysis of DataView official trial listing → -
Status unknown NCT NCT06338306
Tacrolimus and Personalized Therapy to Prevent Acute Rejection Episodes
Fondazione IRCCS Policlinico San Matteo di Pavia 25 participants Est. completion 2025-06-30 1 siteOther conditions: Heart Transplant FailureView official trial listing → -
Completed NCT NCT06342505
Tacrolimus in CD3+ T Lymphocytes
Erasmus Medical Center 28 participants Est. completion 2022-11-10 1 siteOther conditions: ImmunosuppressionView official trial listing → -
Status unknown NCT NCT06348446
Tacrolimus Exposure in Kidney Transplantation
Seoul National University Hospital 12000 participants Est. completion 2024-08-30 4 sitesOther conditions: Kidney Transplant RejectionView official trial listing → -
Status unknown NCT NCT06348602
Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT
Not yet reported, Not yet reported Hospital Universitario Dr. Jose E. Gonzalez 60 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: Ocular Graft-versus-host DiseaseView official trial listing → -
Status unknown NCT NCT06361732
Prevalence of CYP3A5 Polymorphisms in the Donors and ABCB1 Polymorphisms in the Recipients Undergoing Pediatric Liver Transplant and Their Influence on Tacrolimus Levels and Graft Function.
Institute of Liver and Biliary Sciences, India 80 participants Est. completion 2024-10-30 1 siteOther conditions: Pediatric Liver TransplantView official trial listing → -
Completed NCT NCT06362005
The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus
Not yet reported Al-Azhar University 50 participants Est. completion 2025-10-01 1 site Stand-aloneOther conditions: Lichen Planus, OralView official trial listing → -
Terminated NCT NCT06365437
A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation
Not yet reported ITB-Med LLC 33 participants Est. completion 2024-12-11 7 sites Stand-aloneOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT06392074
A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorders
Not yet reported mAbxience Research S.L. 141 participants Est. completion 2025-05-12 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Not yet recruiting NCT NCT06405100
Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD
Not yet reported Air Force Military Medical University, China 81 participants Est. completion 2027-04Other conditions: Minimal Change DiseaseView official trial listing → -
Enrolling by invitation NCT NCT06438679
3T Therapy in the Treatment of MDA5-positive Dermatomyositis
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 133 participants Est. completion 2026-12 1 site Stand-aloneOther conditions: DermatomyositisView official trial listing → -
Suspended NCT NCT06445205
Utilising Volumetric Absorptive Microsampling (VAMS) Technology to Monitor Tacrolimus and Creatinine
Lancashire Teaching Hospitals NHS Foundation Trust 50 participants Est. completion 2026-11-30 1 siteOther conditions: Kidney Transplant Rejection, Kidney ReplacementView official trial listing → -
Status unknown NCT NCT06449235
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh
Not yet reported Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders 938 participants Est. completion 2025-06 1 siteOther conditions: Type2diabetesView official trial listing → -
Completed NCT NCT06488651
Trajectory of Immunosuppression-Caused Tremor In Kidney and Lung Transplant Recipients
University Medical Center Groningen 72 participants Est. completion 2025-09-12 1 siteOther conditions: Kidney Transplantation, TremorView official trial listing → -
Not yet recruiting NCT NCT06490562
Low-dose Cyclophosphamide or CNI in the Prevention of Acute Graft-versus-host Disease After gDLI
Not yet reported Institute of Hematology & Blood Diseases Hospital, China 66 participants Est. completion 2028-12Other conditions: Acute Graft-versus-host DiseaseView official trial listing → -
Active, not recruiting NCT NCT06494150
Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
Not yet reported University of Oklahoma 37 participants Est. completion 2029-09 1 site Stand-aloneOther conditions: Low Grade Ovarian Serous AdenocarcinomaView official trial listing → -
Active, not recruiting NCT NCT06503731
A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)
Not yet reported argenx 33 participants Est. completion 2027-11 23 sites Stand-aloneOther conditions: Antibody-mediated RejectionView official trial listing → -
Status unknown NCT NCT06504225
EVEROLD LONG TERM FOLLOW-UP
University Hospital, Brest 260 participants Est. completion 2025-08-01 14 sitesOther conditions: Transplant; Complication, FailureView official trial listing → -
Status unknown NCT NCT06561022
Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping
Not yet reported Fudan University 260 participants Est. completion 2026-06-30 1 siteOther conditions: Breast CancerView official trial listing → -
Completed NCT NCT06563635
Frequency of Tuberculosis in Psoriasis Patients
Bezmialem Vakif University 719 participants Est. completion 2023-07-31 1 siteOther conditions: Psoriasis Vulgaris, TuberculosisView official trial listing → -
Status unknown NCT NCT06584773
Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients
Not yet reported University of Sao Paulo General Hospital 80 participants Est. completion 2025-07 1 site Stand-aloneOther conditions: Disorder Related to Renal TransplantationView official trial listing → -
Completed NCT NCT06585293
Comparability of Fingerprick vs Venous Blood for Tacrolimus Monitoring
Nottingham University Hospitals NHS Trust 56 participants Est. completion 2025-03-14 1 siteOther conditions: ImmunosuppressionView official trial listing → -
Active, not recruiting NCT NCT06596798
Deep Learning Model and Risk Factors for Tacrolimus-related Acute Kidney Injury
Qianfoshan Hospital 1200 participants Est. completion 2026-12-30 1 siteOther conditions: AKIView official trial listing → -
Status unknown NCT NCT06607198
Clinical-pathological Evaluation of Pit-NETs
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 940 participants Est. completion 2026-10-01 1 siteOther conditions: Pituitary, Cancer, Neuroendocrine TumorsView official trial listing → -
Active, not recruiting NCT NCT06621524
EucaLimus Post-Market Registry
OrbusNeich 251 participants Est. completion 2029-01 10 sitesOther conditions: Coronary ArteriosclerosesView official trial listing → -
Completed NCT NCT06638879
Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host Disease (cGVHD)
Not yet reported Children's Hospital Medical Center, Cincinnati 7 participants Est. completion 2026-02-18 1 site Stand-aloneOther conditions: Chronic Graft Versus Host Disease OralView official trial listing → -
Active, not recruiting NCT NCT06653842
A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations
Not yet reported Palvella Therapeutics, Inc. 15 participants Est. completion 2026-03 10 sitesOther conditions: Cutaneous Venous MalformationsView official trial listing → -
Active, not recruiting NCT NCT06665256
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
Not yet reported Novartis Pharmaceuticals 21 participants Est. completion 2032-11-29 68 sitesOther conditions: Idiopathic Inflammatory MyopathiesView official trial listing → -
Suspended NCT NCT06680661
ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
Not yet reported Leland Metheny 20 participants Est. completion 2028-10-31 1 site Stand-aloneOther conditions: Acute Myelogenous Leukemia, Acute Lymphatic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndromes, Myelodysplastic Syndrome Other, Chronic Myelomonocytic Leukemia, Lymphoma, Hodgkin LymphomaView official trial listing → -
Active, not recruiting NCT NCT06680921
A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)
Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 482 participants Est. completion 2028-08-31 57 sitesOther conditions: Locally Advanced or Metastatic Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06682767
A Nutritional and Pharmacological Intervention for Body, Brain, and Longevity Effects (NIBBLE)
Not yet reported, Not yet reported Cedars-Sinai Medical Center 60 participants Est. completion 2028-06 1 siteOther conditions: Cerebral Blood Flow, APOE 4View official trial listing → -
Status unknown NCT NCT06683118
Registration Trial of the Drug-coated Balloon for the Symptomatic Cerebral Atherosclerotic Stenosis
Not yet reported MicroPort NeuroTech Co., Ltd. 212 participants Est. completion 2026-07-27 2 sitesOther conditions: Cerebral Atherosclerotic StenosisView official trial listing → -
Not yet recruiting NCT NCT06708455
Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma
Not yet reported Rapa Therapeutics LLC 65 participants Est. completion 2029-09-30 1 siteOther conditions: Malignant Melanoma With Metastasis, Malignant Melanoma, Malignant Melanoma Stage IIIc, Malignant Melanoma Stage IVView official trial listing → -
Active, not recruiting NCT NCT06821542
A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy
Not yet reported Incyte Corporation 9 participants Est. completion 2032-11-30 130 sitesOther conditions: Chronic Graft-versus-host-diseaseView official trial listing → -
Active, not recruiting NCT NCT06841510
Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease
Genoss Co., Ltd. 1118 participants Est. completion 2025-11-30 1 siteOther conditions: Coronary Arterial Disease (CAD)View official trial listing → -
Enrolling by invitation NCT NCT06843811
Sirolimus for Leigh Syndrome
Not yet reported Matthew Demczko 15 participants Est. completion 2027-12 1 site Stand-aloneOther conditions: Leigh SyndromeView official trial listing → -
Not yet recruiting NCT NCT06867042
Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment
Not yet reported Jina Pharmaceuticals Inc. 150 participants Est. completion 2026-04 Stand-aloneOther conditions: Ulcerative Colitis (UC), Ulcerative Colitis, Active ModerateView official trial listing → -
Enrolling by invitation NCT NCT06880042
COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO
Not yet reported Dr ayesha wahid 60 participants Est. completion 2025-08-30 1 siteOther conditions: Vitiligo - Macular Depigmentation, TacrolimusView official trial listing → -
Not yet recruiting NCT NCT06928883
Ticin Pilot Study: Sirolimus-Eluting Balloon for Stabilization and Regression of Non-Obstructive Coronary Plaques.
Not yet reported Cardiocentro Ticino 24 participants Est. completion 2028-12-31 1 site Stand-aloneCardiovascular disease Other conditions: Coronary Arterial Disease (CAD), Vulnerable Coronary Plaques, Coronary Vessel, Acute Coronary Syndromes (ACS)View official trial listing → -
Not yet recruiting NCT NCT06941142
A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer
Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 382 participants Est. completion 2028-06 Stand-aloneOther conditions: Advanced Breast CancerView official trial listing → -
Not yet recruiting NCT NCT06942156
Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea
Not yet reported Chong Kun Dang Pharmaceutical 140 participants Est. completion 2030-12 1 siteOther conditions: Heart TransplantView official trial listing → -
Not yet recruiting NCT NCT06949267
A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Not yet reported Ruijin Hospital 56 participants Est. completion 2028-03-31 Stand-aloneOther conditions: Acute Graft-versus-Host DiseaseView official trial listing → -
Not yet recruiting NCT NCT06960824
Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence
Chiesi SAS 165 participants Est. completion 2027-12-31 1 siteOther conditions: Chronic Renal DiseaseView official trial listing → -
Active, not recruiting NCT NCT06991829
Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes
Not yet reported Shanghai Zhongshan Hospital 29 participants Est. completion 2027-10-31 1 siteOther conditions: Diabetes MellitusView official trial listing → -
Not yet recruiting NCT NCT07003438
Study on the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Steroid - Dependent /Steroid-resistant Nephrotic Syndrome in Children
Not yet reported Zhang Ting 120 participants Est. completion 2028-04-01Other conditions: Steroid-Resistant Nephrotic Syndrome, Steroid-Dependent Nephrotic SyndromeView official trial listing → -
Completed NCT NCT07030660
Model-based Medication Dosing Assist for Tacrolimus in Kidney Transplantation
Not yet reported KU Leuven 357 participants Est. completion 2025-03-28 1 siteOther conditions: Kidney TransplantationView official trial listing → -
Completed NCT NCT07041112
Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors
Juan Ruano Ruiz 1000 participants Est. completion 2024-06-01 1 siteMetabolic syndrome Other conditions: Psoriasis, Psoriatic Arthritis (PsA), Cardiovascular Risk Factors, Drug Survival, PharmacogeneticsView official trial listing → -
Completed NCT NCT07049172
Rituximab and Targeted Nursing for Pediatric Nephrotic Syndrome
Not yet reported Wuhan Children's Hospital 91 participants Est. completion 2023-12-31 1 siteOther conditions: Nephrotic Syndrome in ChildrenView official trial listing → -
Active, not recruiting NCT NCT07058974
A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
Not yet reported Icahn School of Medicine at Mount Sinai 20 participants Est. completion 2027-06-15 1 site Stand-aloneOther conditions: Smokers, Former SmokersView official trial listing → -
Not yet recruiting NCT NCT07083830
ECP-DL Cell Infusion for Induction in Living Donor Kidney (LDK) Transplants
Not yet reported Northwestern University 24 participants Est. completion 2029-08-25 Stand-aloneOther conditions: Kidney Transplant Failure and Rejection, Kidney Transplant; ComplicationsView official trial listing → -
Enrolling by invitation NCT NCT07118475
Autologous Islet Transplantation for Diabetes
Not yet reported Shanghai Zhongshan Hospital 24 participants Est. completion 2027-05-30 1 siteType 2 diabetesView official trial listing → -
Not yet recruiting NCT NCT07138742
Tacrolimus Eye Drops in Treatment of Vernal Keratoconjunctivitis
Not yet reported Sohag University 90 participants Est. completion 2027-09 Stand-aloneOther conditions: Vernal KeratoconjunctivitisView official trial listing → -
Not yet recruiting NCT NCT07157514
Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML
Not yet reported, Not yet reported Actinium Pharmaceuticals 306 participants Est. completion 2034-02 Stand-aloneOther conditions: Acute Leukemia, Myeloid Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, Myelogenous Leukemia, Myelogenous Leukemia, Acute, Myelogenous Leukemia in Relapse, Transplant-Related Disorder, Allogeneic Disease, Refractory AMLView official trial listing → -
Enrolling by invitation NCT NCT07159087
The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss® SCB' Versus 'SeQuent® Please NEO' in Patients With Coronary ISR
Not yet reported Genoss Co., Ltd. 94 participants Est. completion 2027-01-31 1 site Stand-aloneOther conditions: Coronary Arterial Disease (CAD)View official trial listing → -
Not yet recruiting NCT NCT07162896
Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis
Not yet reported Shalamar Institute of Health Sciences 66 participants Est. completion 2027-06 1 siteOther conditions: Atopic Dermatitis, Atopic Dermatitis (AD)View official trial listing → -
Not yet recruiting NCT NCT07166354
Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)
Not yet reported, Not yet reported Applied Biology, Inc. 100 participants Est. completion 2027-12-15Other conditions: Canities, Grey HairView official trial listing → -
Not yet recruiting NCT NCT07173556
A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer
Not yet reported, Not yet reported Qilu Pharmaceutical Co., Ltd. 96 participants Est. completion 2028-10Other conditions: Advanced Breast CancerView official trial listing → -
Not yet recruiting NCT NCT07203664
Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.
Not yet reported Hospital Universitario La Paz 30 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant RecipientsView official trial listing → -
Completed NCT NCT07239128
Photobiomodulation in Combination With Topical Cyclosporine A or Tacrolimus
Not yet reported University of Seville 160 participants Est. completion 2025-06-01 2 sites Stand-aloneOther conditions: Dry Eye Disease (DED)View official trial listing → -
Completed NCT NCT07302932
Metformin and Molecular Aging in Prediabetes
Not yet reported Diabetes Foundation, India 112 participants Est. completion 2025-01-30 1 sitePrediabetesView official trial listing → -
Not yet recruiting NCT NCT07307534
Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study
Not yet reported Xijing Hospital 60 participants Est. completion 2027-10-01 1 site Stand-aloneOther conditions: Vitiligo, Halo NevusView official trial listing → -
Withdrawn NCT NCT07349771
Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial
Not yet reported Mayo Clinic Est. completion 2033-06-01 3 sites Stand-aloneOther conditions: Hematopoietic and Lymphatic System NeoplasmView official trial listing → -
Not yet recruiting NCT NCT07352566
Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
Not yet reported University of California, San Francisco 10 participants Est. completion 2030-06-01 1 site Stand-aloneOther conditions: Psoriasis, Atopic DermatitisView official trial listing → -
Active, not recruiting NCT NCT07354620
A Pilot Study on Reverse Aging (The REVERSE Study)
Not yet reported The Christ Hospital 52 participants Est. completion 2026-05 1 siteOther conditions: AgingView official trial listing → -
Not yet recruiting NCT NCT07364123
Kidney Transplant Immunosuppressive Therapy Adherence Trial (KITE)
Not yet reported University of Gaziantep 60 participants Est. completion 2026-08-15 1 siteOther conditions: Kidney Transplantation, Medication Non-Adherence, Immunosuppressive Therapy, Renal Transplant RecipientsView official trial listing → -
Not yet recruiting NCT NCT07367932
Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis
Not yet reported Cairo University 30 participants Est. completion 2026-07Other conditions: Dermatitis, Atopic, EczemaView official trial listing → -
Completed NCT NCT07368673
Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled Trial
Not yet reported Dow University of Health Sciences 120 participants Est. completion 2026-01-05 1 siteOther conditions: VitiligoView official trial listing → -
Enrolling by invitation NCT NCT07386587
Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis
Not yet reported University of Child Health Sciences and Children's Hospital, Lahore 60 participants Est. completion 2026-07-27 1 site Stand-aloneOther conditions: Juvenile Idiopathic ArthritisView official trial listing → -
Not yet recruiting NCT NCT07408674
COMPETE-LM Trial: Drug-Coated Balloon-Enhanced Provisional Stenting in Complex Left Main Disease.
Not yet reported Rede Optimus Hospitalar SA 186 participants Est. completion 2029-05Other conditions: Complex Left Main Bifurcation Stenosis, Left Main Coronary Artery Stenosis, Coronary Bifurcation StenosisView official trial listing → -
Not yet recruiting NCT NCT07422012
Tacrolimus in Pregnancy
Baylor Research Institute 55 participants Est. completion 2028-03 1 siteOther conditions: Unbound Tacrolimus in Pregnant Uterus Transplant Recipients, Whole Blood Tacrolimus in Pregnant Uterus Transplant RecipientsView official trial listing → -
Active, not recruiting NCT NCT07430683
Valganciclovir Prophylaxis Versus Preemptive Therapy for Cytomegalovirus in Living Donor Kidney Transplant Recipients
Not yet reported University of Guadalajara 68 participants Est. completion 2026-07-31 1 site Stand-aloneOther conditions: Cytomegalovirus InfectionsView official trial listing → -
Not yet recruiting NCT NCT07435584
Everolimus in CDK12-Deficient Metastatic Colorectal Cancer (EVER-RECODE)
Not yet reported, Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 38 participants Est. completion 2028-12-31Other conditions: Colorectal CancerView official trial listing → -
Not yet recruiting NCT NCT07436611
Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains
Not yet reported AFT Pharmaceuticals, Ltd. 30 participants Est. completion 2027-10 2 sitesOther conditions: Port Wine StainsView official trial listing → -
Not yet recruiting NCT NCT07437534
Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis
Not yet reported Hayat Abad Medical Complex, Peshawar 148 participants Est. completion 2026-08-30 1 site Stand-aloneOther conditions: Atopic DermatitisView official trial listing → -
Completed NCT NCT07475546
Combination Gerotherapeutic Interventions for Healthspan Improvement
Not yet reported AgelessRx 26 participants Est. completion 2026-04-09 1 siteOther conditions: Healthspan Improvement, Aging, LongevityView official trial listing → -
Not yet recruiting NCT NCT07514988
Sirolimus-Coated vs Paclitaxel-Coated DCBs in ACS Treatment
Not yet reported China National Center for Cardiovascular Diseases 60 participants Est. completion 2028-07-01 1 site Stand-aloneOther conditions: Acute Coronary Syndromes (ACS)View official trial listing → -
Active, not recruiting NCT NCT07519005
Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure
Not yet reported Xijing Hospital 1 participants Est. completion 2026-12-31 1 site Stand-aloneOther conditions: Hepatic FailureView official trial listing → -
Not yet recruiting NCT NCT07519031
Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo
Not yet reported, Not yet reported Xijing Hospital 96 participants Est. completion 2028-03 1 site Stand-aloneOther conditions: Vitiligo, Mesenchymal Stem Cells, ExosomesView official trial listing → -
Not yet recruiting NCT NCT07519174
A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks
Not yet reported Foundation University Islamabad 72 participants Est. completion 2027-01-01 1 site Stand-aloneOther conditions: Atopic DermatitisView official trial listing → -
Not yet recruiting NCT NCT07524530
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
Not yet reported National Cancer Institute (NCI) 102 participants Est. completion 2036-06-01 1 site Stand-aloneOther conditions: Core Binding Factor Alpha Subunits, Hematologic Neoplasms, Leukemia, LymphomaView official trial listing → -
Completed NCT NCT07532330
Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo
Not yet reported Minia University 67 participants Est. completion 2026-04-15 1 site Stand-aloneOther conditions: VitiligoView official trial listing → -
Not yet recruiting NCT NCT07549230
Model-Informed Precision Dosing of Tacrolimus in Pediatric Kidney Transplantation
Helwan University 130 participants Est. completion 2027-06-01Other conditions: Pediatric Kidney TransplantationView official trial listing → -
Not yet recruiting NCT NCT07570433
HORUS-Cytomegalovirus Open Proof-of-concept Exploratory Trial
Not yet reported Oriol Manuel 100 participants Est. completion 2028-03 4 sites Stand-aloneOther conditions: CMV InfectionView official trial listing → -
Not yet recruiting NCT NCT07572695
Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40 participants Est. completion 2028-12Other conditions: Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia, AML, Relapsed/RefractoryView official trial listing → -
Not yet recruiting NCT NCT07612657
A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations
Not yet reported VIVUS LLC 300 participants Est. completion 2029-11-30 Stand-aloneOther conditions: Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), Pulmonary Arterial Hypertension PAH, Pulmonary Arterial Hypertension WHO Group IView official trial listing → -
Not yet recruiting NCT NCT07634536
Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant
Not yet reported Stanford University 30 participants Est. completion 2028-08 1 site Stand-aloneOther conditions: Acute Myeloid Leukemia, Myeloproliferative Neoplasm, Myelodysplastic SyndromesView official trial listing → -
Not yet recruiting NCT NCT07634601
Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer
Not yet reported Jonsson Comprehensive Cancer Center 50 participants Est. completion 2029-12-18 1 siteOther conditions: Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Cancer, Stage IV Endometrial CancerView official trial listing → -
Not yet recruiting NCT NCT07656493
Liposomal Amphotericin B for Invasive Fungal Disease in Solid Organ Transplant Recipients
Sichuan Provincial People's Hospital 120 participants Est. completion 2028-06-30 1 siteOther conditions: Invasive Fungal Infection, Solid Organ Transplantation, Opportunistic InfectionsView official trial listing → -
Not yet recruiting NCT NCT07660783
Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases
Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2035-09 2 sitesOther conditions: Bone Marrow Failure, Hemoglobinopathies, Primary Immune Deficiency (PID), Autoimmune Cytopenia, Immune Dysregulation, Hemophagocytic Lymphohistiocytosis (HLH), Non Malignant DisordersView official trial listing → -
Not yet recruiting NCT NCT07680673
ENCRT-103-hPI: Evaluation of an Immune-protected ENCRT-103-hPI Containing Primary Human Islets in Adults With Type 1 Diabetes, With and Without Standard-of-care Portal Vein Islet Infusion.
Not yet reported Encellin 10 participants Est. completion 2029-01 2 sitesOther conditions: Type 1 DiabetesView official trial listing → -
Not yet recruiting NCT NCT07684287
A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma
Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 40 participants Est. completion 2027-11-30 1 site Stand-aloneOther conditions: Epithelioid HemangioendotheliomaView official trial listing → -
Not yet recruiting NCT NCT07709845
CC-101 (f/k/a NR1) Neural Stem Cell Transplantation for Adults With Chronic Ischemic Stroke
Not yet reported Clarion Cells, Inc. 36 participants Est. completion 2029-01 Stand-aloneCardiovascular diseaseView official trial listing → -
Not yet recruiting NCT NCT07713186
Azithromycin in Atopic Dermatitis
Not yet reported Cairo University 40 participants Est. completion 2027-01 1 site Stand-aloneOther conditions: Atopic DermatitisView official trial listing → -
Not yet recruiting NCT NCT07715734
Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
Not yet reported Washington University School of Medicine 22 participants Est. completion 2031-04-30 1 site Stand-aloneOther conditions: Kidney Transplant Recipient, Cutaneous Squamous Cell Carcinoma (CSCC), Advanced Cutaneous Squamous Cell Carcinoma, Kidney TransplantView official trial listing → -
Not yet recruiting NCT NCT07718308
CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients
Not yet reported wujianyong 20 participants Est. completion 2028-03-15 Stand-aloneOther conditions: Kidney Transplantation, Antibody-mediated RejectionView official trial listing → -
Not yet recruiting NCT NCT07725874
Safety and Efficacy of Liposomal Amphotericin B for Patients With Invasive Mold Diseases in Liver Transplant Recipients
Not yet reported Beijing Friendship Hospital 60 participants Est. completion 2028-08-15 Stand-aloneOther conditions: Invasive Mold DiseasesView official trial listing → -
Not yet recruiting NCT NCT07737249
Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease
Not yet reported Peking Union Medical College Hospital 60 participants Est. completion 2027-08-31 1 siteOther conditions: Interstitial Lung DiseasesView official trial listing → -
Not yet recruiting NCT NCT07769567
Optimization of Therapeutic Drug Monitoring in Pediatric Kidney Transplant
Children's Hospital Medical Center, Cincinnati 25 participants Est. completion 2028-12-31Other conditions: Kidney TransplantView official trial listing → -
Not yet recruiting NCT NCT07796620
Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNI
Not yet reported, Not yet reported Peking University People's Hospital 40 participants Est. completion 2028-09-30 Stand-aloneOther conditions: Acute Leukemia, Myelodysplastic Syndromes, Severe Aplastic Anemia (SAA)View official trial listing → -
Not yet recruiting NCT NCT07806136
Biomarker-Guided Mycophenolate Mofetil Elimination in Low-Risk Older Adult Kidney Transplant Recipients
Not yet reported Virginia Commonwealth University 20 participants Est. completion 2029-08-01 Stand-aloneOther conditions: Kidney Transplant RecipientView official trial listing → -
Completed NCT NCT07806240
Safety and Efficacy Study of RTP-008 (an Absorbable Tacrolimus Lacrimal Canalicular Plug) for Dry Eye
Not yet reported Zhejiang Raytone Bioscience Co.,Ltd 40 participants Est. completion 2026-02-28 1 site Stand-aloneOther conditions: Dry Eye Disease (DED)View official trial listing → -
Not yet recruiting NCT NCT07808112
CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation
Not yet reported Medical College of Wisconsin 72 participants Est. completion 2031-11 1 site Stand-aloneOther conditions: Graft -Versus-host-diseaseView official trial listing → -
Not yet recruiting NCT NCT07812974
Extracellular Vesicle-based Strategy to Stratify Islets and Improve Their FItness Before Transplantation
University Hospital, Strasbourg, France 25 participants Est. completion 2032-01 1 siteOther conditions: Type 1 Diabetes (T1D)View official trial listing → -
Not yet recruiting NCT NCT07815938
Immune Monitoring-Guided Individualized Tacrolimus Therapy in Renal Transplant Recipients: An Observational Study and PK/PD Modeling
Zhongnan Hospital 50 participants Est. completion 2028-12-31Other conditions: Transplant Recipient (Kidney)View official trial listing → -
Completed NCT NCT07819071
EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITIS
Not yet reported Pierre Fabre Dermo Cosmetique 33 participants Est. completion 2026-01-10 1 site Stand-aloneOther conditions: Atopic Dermatitis (AD)View official trial listing → -
Not yet recruiting NCT NCT07828223
Cardiac Improvement by Eplerenone Among Patients Under Cyclosporine or Tacrolimus for Kidney Transplantation.
Not yet reported Central Hospital, Nancy, France 132 participants Est. completion 2030-12 3 sitesOther conditions: Kidney TransplantationView official trial listing → -
Not yet recruiting NCT NCT07835581
Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation
Not yet reported Eledon Pharmaceuticals 620 participants Est. completion 2033-03Other conditions: Kidney Transplant RejectionView official trial listing → -
Not yet recruiting NCT NCT07853105
Phase I/II Trial of Dinutuximab Beta in Combination With Irinotecan and Rapamycin in Pediatric, Adolescents and Adult Patients With Relapsed/Refractory Bone Tumors.
Not yet reported, Not yet reported University Hospital, Strasbourg, France 89 participants Est. completion 2033-02 12 sites Stand-aloneObstructive sleep apnea Other conditions: Bone Cancer, Ewing SarcomasView official trial listing → -
Not yet recruiting NCT NCT07865130
Study of CDK8 Inhibitor RVU120 in Combination With Everolimus in Children With Recurrent or Progressive Group 3 or 4 Medulloblastoma
Not yet reported Bożenna Dembowska Bagińska 48 participants Est. completion 2033-06 1 siteOther conditions: Medulloblastoma Recurrent, MedulloblastomaView official trial listing → -
Completed NCT NCT07869953
Oftac Eye Drops (0.05% Tacrolimus Ophthalmic Emulsion) for the Treatment of Active Non-infectious Anterior Uveitis
Not yet reported, Not yet reported BioNanoSim Ltd. 18 participants Est. completion 2025-03-25 7 sites Stand-aloneOther conditions: Non-Infectious Anterior UveitisView official trial listing → -
Not yet recruiting NCT NCT07877103
Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients
Not yet reported The First Affiliated Hospital of Guangzhou Medical University 100 participants Est. completion 2028-12-30 1 site Stand-aloneOther conditions: End-Stage Renal DiseaseView official trial listing → -
Completed NCT NCT07884084
Effect of Probiotics on Immunosuppressant Therapy in Kidney Transplant Recipients
Not yet reported Federico II University 40 participants Est. completion 2025-10-03 1 siteOther conditions: Kidney Transplantation, Kidney Transplantation RecipientsView official trial listing → -
Not yet recruiting NCT NCT07892339
Efficacy of Crisaborole 2% Ointment Versus Tacrolimus 0.1% Ointment in the Treatment of Intertriginous and/or Anogenital Psoriasis.
Not yet reported Cairo University 40 participants Est. completion 2027-01-10 1 siteOther conditions: Psoriasis, Psoriasis GenitalView official trial listing → -
Not yet recruiting NCT NCT07893691
Microbiota Changes Related to Outcomes in Kidney Transplantation
Hospices Civils de Lyon 30 participants Est. completion 2029-01-15 1 siteOther conditions: End-stage Renal Disease (ESRD), Kidney TransplantationView official trial listing → -
Not yet recruiting NCT NCT07896928
Study of Allogeneic Stem Cell Transplant in Myelodysplastic Syndrome Following Conditioning With Fludarabine and Total Body Irradiation 800 cGy
Not yet reported Ronald Paquette 20 participants Est. completion 2030-12 1 site Stand-aloneOther conditions: MDS, Myelodysplastic Syndrome MDS, Myelodysplastic Syndrome (MDS), Myelodysplastic SyndromeView official trial listing → -
Not yet recruiting NCT NCT07904780
Withdrawal Versus Continued TNF Inhibitor Monotherapy Treatment in Children With Inactive Juvenile Idiopathic Arthritis
Not yet reported Oslo University Hospital 90 participants Est. completion 2030-11-11 3 sites Stand-aloneOther conditions: Juvenile Idiopathic Arthritis (JIA)View official trial listing → -
Not yet recruiting NCT NCT07919873
Efficacy of Fractional Co2 Laser With Topical Tacrolimus 0.1 in the Treatment of Nail Psoriasis
Not yet reported Cairo University 29 participants Est. completion 2027-02Other conditions: Nail PsoriasisView official trial listing → -
Not yet recruiting NCT NCT07920055
Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)
Not yet reported Sir Run Run Shaw Hospital 106 participants Est. completion 2028-11-30 1 site Stand-aloneCardiovascular disease Other conditions: Coronary In-stent RestenosisView official trial listing → -
Completed NCT NCT07931352
Evaluation of the Effects of Anti-TNF Therapy on the Retina in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis
Ankara City Hospital Bilkent 53 participants Est. completion 2026-06-23 1 siteOther conditions: Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS)View official trial listing → -
Completed NCT NCT07932119
GLP-1 Receptor Agonists in the Surgical Patient: Prevalence, Epidemiology, and Pulmonary Complications
University of Virginia 25505 participants Est. completion 2026-02-28 1 siteOther conditions: GLP-1 Receptor Agonist TreatmentView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Tacrolimus, Prograf, Prograf (SOC), Islets of Langerhans transplantation, Islets of Langerhan, Basiliximab, Sirolimus, Etanercept, Exenatide
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
